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Abstract 
 
Psychological intervention has been recommended to address some of the common 
problems reported in acute psychiatric inpatient services, such as having nontherapeutic 
environments, minimal provision of therapeutic interactions and activities and high 
readmission rates. There is a small evidence base investigating the effectiveness of acute 
inpatient psychological therapy, however, this has never been reviewed or synthesised. 
Robust investigation of cross-diagnostic inpatient psychological intervention is also 
absent, and whether this is feasible is unknown.  
  
Informed by the Medical Research Council (MRC) framework, this thesis examined and 
synthesised the current evidence base of controlled trials of psychological therapy for 
acute psychiatric inpatients for the first time. It also tested the feasibility of implementing 
and evaluating cross-diagnostic psychologically informed acute mental health care in 
comparison to treatment as usual. The latter was largely based on the Woodhaven 
Approach, which is theory-driven psychological model of care. The model offers 
psychological intervention for acute inpatients and targets mechanisms of psychological 
dysfunction identified by the Interacting Cognitive Subsystems model (ICS). This thesis, 
therefore, comprises two main studies: 1) a meta-analysis, and 2) a feasibility study. 
 
The meta-analysis focused on the effectiveness of brief inpatient psychological therapy 
on psychotic symptoms, risk of readmissions, and emotional distress (depression and 
anxiety). Results showed that in randomised and single-blind studies psychological 
intervention had little effect on psychotic symptoms. Other outcomes, however, showed 
more promising results. For example, although not significant, robust evidence suggests 
that brief psychological therapy may reduce emotional distress and risk of readmission 
for some acute inpatients.  
 
The feasibility study aimed to test the feasibility of implementing and evaluating a cross-
diagnostic psychological model of acute inpatient care, and gather preliminary clinical 
outcome data. Using a framework of methodological issues, the feasibility study showed 
that some aspects of the trial processes were run successfully, i.e. some clinical outcomes 
 iii
had good completion rates, some intervention components were successfully 
implemented and some outcomes produced effects which favoured the intervention group 
over the control group. However, other aspects of the trial processes were problematic 
and required amendment before progressing to a full trial. Key issues identified by the 
feasibility study include problematic eligibility criteria, poor implementation of some 
intervention components, poor engagement, poor completion of follow-up questionnaires 
and therefore poor trial retention. The feasibility study also highlighted methodological 
issues which have not yet been addressed, but are important in planning a future definitive 
trial, i.e. randomisation and assessor blinding.  
 
This thesis has provided the first study to test the feasibility of evaluating the effectiveness 
of this psychological model, in comparison to treatment as usual, and it was the first time 
the impact of this psychological model has been investigated in relation to readmissions. 
Overall, this thesis indicates that a cross-diagnostic approach to acute psychiatric 
inpatient psychological therapy is feasible, however further work is needed to fully 
implement the model into routine practice.  
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1 Introduction to the thesis 
This thesis presents the work completed within a three-year PhD. Overall this thesis has 
drawn on a scientific framework for developing and evaluating complex interventions 
and provided a novel contribution to the literature that examines psychological 
intervention delivered in acute mental health inpatient settings in two ways. First, it 
reviews and synthesises the existing literature, and second it investigates the feasibility 
of delivering cross-diagnostic psychological therapy in a National Health Service (NHS) 
acute mental health inpatient service. This chapter introduces the scientific framework 
for the development and evaluation of complex interventions used to guide this thesis. 
This chapter then briefly summarises the aims and original contributions of the thesis, 
provides an overview of the thesis structure and locates each chapter within the scientific 
framework. 
 
1.1 A scientific framework for developing and evaluating complex interventions 
Complex interventions, such as acute psychiatric inpatient care, have been defined by the 
Medical Research Council (MRC) as interventions which comprise of a number of 
separate, but interacting, elements or components (Craig et al., 2008). Evaluating such 
interventions is challenging. The MRC have published an updated framework to provide 
guidance on developing and evaluating complex interventions (Campbell et al., 2000; 
Craig et al., 2013). The aim of the MRC framework is to encourage systematic 
development and evaluation of complex interventions in a phased approach, although it 
should be noted that phases may not always be conducted in a linear manner (Craig et al., 
2013), i.e. phase two or three may reinform phase one (phases described below). This 
methodical approach is now considered best practice and includes four phases: 
development, feasibility/piloting, evaluation and implementation (Craig et al., 2013), 
which are described in the remainder of this chapter.  
 
1.1.1 Phase 1: development  
The first step identified by the MRC framework involves developing appropriate 
interventions which are expected to have the desired effect. First, this includes identifying 
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the existing evidence base through existing systematic reviews and meta-analyses, or 
conducting a systematic review or meta-analysis where one does not exist. Based on such 
evidence, phase one also includes identifying and developing theories which highlight 
rationale for the intervention and related changes. Modelling these processes and 
outcomes is also considered important in developing the intervention, and in designing 
an appropriate intervention evaluation. This may involve multiple studies which 
gradually refine the design of both the intervention and the evaluation. Qualitative work, 
specifically, is recommended to inform how and why interventions (and associated 
evaluations) work or not. Such work may also be included in the feasibility/pilot phase.  
 
1.1.2 Phase 2: feasibility/piloting 
This phase involves testing the feasibility of the intervention and the proposed methods 
to evaluate it. Often, this can involve assessing recruitment, retention, acceptability, 
delivery, safety, adverse events and estimating parameters to inform a main definitive 
trial. Without testing and assessing such processes, larger intervention evaluations can be 
weakened by unforeseen problems with trial processes such as recruitment and retention 
(Lancaster, Dodd, & Williamson, 2004). Outcomes proposed for a main trial may also be 
assessed during the feasibility/piloting phase, however it is recommended that formal 
hypothesis testing is not the purpose of doing so. Rather, testing the acceptability of the 
measures (i.e. proportion of completed outcomes) and estimating effects (size and 
direction) and precision should be the aim of including outcome measures in the 
feasibility/piloting phase (Eldridge et al., 2016). 
 
1.1.3 Phase 3: evaluation 
Phase three of the MRC framework involves intervention evaluation using the best and 
most appropriate designs. The aim of the evaluation phase is to determine the 
effectiveness or efficacy of the intervention. Researchers must decide which primary and 
secondary outcomes are most suitable to measure effectiveness. Such decisions should be 
informed by prior development and pilot/feasibility work. Researchers are also advised 
to conduct a process evaluation which explores how the intervention is delivered within 
the study, e.g. assessing treatment fidelity, and identifying influential contextual factors 
or causal mechanisms (Craig et al., 2013; Moore et al., 2015). This is important in 
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understanding intervention adaptations that may be required to implement the 
intervention in different contexts (Moore et al., 2015). 
 
1.1.4 Phase 4: Implementation 
Phase four involves intervention implementation. Wide-spread implementation should be 
informed by the work carried out in all previous phases. Findings from prior process 
evaluations are of particular importance in this phase as they should inform required 
adaptations necessary to implement the intervention in different context (Moore et al., 
2015). Implementation also requires surveillance, monitoring of the intervention and long 
term follow-up (Craig et al., 2013).  
 
1.2 Aims and original contributions of the thesis 
The overall objective of the thesis was to contribute to the development and evaluation 
of a cross-diagnostic psychological intervention for an acute mental health inpatient 
setting. To do so, the thesis had two main aims and novel contributions to research which 
aimed to inform a future definitive trial.  
 
The first stage of this thesis aimed to review and synthesise the existing acute inpatient 
psychotherapy evidence base, for the first time, using meta-analysis. This maps onto 
phase one of the MRC framework (Craig et al., 2008, 2013). Specifically, the meta-
analysis aimed to assess the benefit of acute inpatient psychotherapy in relation to 
psychotic symptoms, readmissions and emotional distress in controlled trials.  
 
The second stage of this thesis draws on phase two of the MRC framework (Craig et al., 
2008, 2013) as the aim was to pragmatically test the feasibility of implementing and 
evaluating a cross-diagnostic, psychological intervention for acute inpatients (largely 
based on the Woodhaven Approach (Clarke & Wilson, 2009)), in preparation for 
progression to a full definitive trial. The main objectives were to assess the feasibility of 
implementing the intervention, to test the feasibility of the trial processes, and to test 
whether the psychological intervention, compared to treatment as usual (TAU), could 
produce effects which favour the intervention on relevant outcomes (i.e. readmissions, 
psychological distress and mental health related self-efficacy).  
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1.3 Structure of the thesis 
Chapter two of the thesis provides a brief historical background of the development of 
inpatient care and describes modern acute mental health inpatient services in the UK. 
Chapter two also reviews different psychological approaches to severe mental illness and 
presents the psychological model, and associated theoretical underpinning, of the 
intervention relevant to feasibility trial reported Chapters four, five and six. Chapter three 
presents the first study of the thesis which reviews and synthesises the current acute 
inpatient psychotherapy evidence base. It therefore addresses phase one of the MRC 
framework (described above). The second study of this thesis is addressed in the 
remainder of the thesis. In line with the MRC framework (Craig et al., 2008, 2013), 
chapter four provides an in-depth and transparent description of the chosen methods used 
for the feasibility study and provides an extensive justification for the methods that were 
used (including protocol amendments). Chapter five reports data from the feasibility 
study using Shanyinde, Pickering and Weatherall's (2011) methodological issues as an 
analytical framework. Guided by the ADePT process (A process for Decision-making 
after Pilot and feasibility Trials) (Bugge et al., 2013), Chapter 6 provides a detailed 
discussion of the feasibility study findings with a particular focus on progressing to a 
future definitive trial. Chapter 6 therefore contributes to the preparation of phase 3 of the 
MRC framework (Craig et al., 2008, 2013), i.e. intervention evaluation.  
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2 General introduction 
 
This chapter aims to introduce and summarise the development of psychiatric inpatient 
services, define the role of modern acute inpatient psychiatric services and highlight the 
problems currently associated with acute inpatient care. This chapter also intends to 
provide a brief overview of different therapeutic approaches to serious mental illness 
(SMI) relevant to this thesis, and the associated evidence, and highlight the challenges of 
providing psychological intervention in acute inpatient settings. Finally, this chapter 
describes and reviews different models of acute inpatient psychosocial care, with a 
particular focus on the Woodhaven Approach (Clarke & Wilson, 2009). 
 
2.1 Background 
2.1.1 A brief history of inpatient psychiatric care 
Bethlem Hospital, London, was the first of many mental health inpatient facilities to open 
in the UK (Chambers, 2009). These were typically large asylums, originally designed to 
provide care and shelter for vulnerable people, such as people with mental health 
problems, physical disabilities or homeless people. Such hospitals were initially small 
services, however the number patients grew, despite limited access to adequate space and 
resources. To cope with the influx of patients many of the original values, centred on 
‘moral treatment’, were lost (Fakhoury & Priebe, 2007). Instead, structured and efficient 
care became a priority. Consequently, hospitals such as Bethlem were criticised for 
providing inhumane care, poor hygiene, poor living conditions and overcrowding 
(Fakhoury & Priebe, 2007). Such criticism provoked a reform of both values and logistics, 
leading to deinstitutionalization: a process that continues today. The Mental Treatment 
Act of 1930 helped to improve conditions of the remaining inpatient units, however, it 
also brought the amalgamation of mental and physical illness and therefore approval of 
the medical model in management and treatment of mental health problems (Moncrieff, 
2003). This saw the introduction of treatments such as electro-compulsive therapy and 
frontal lobotomy, which aimed to physically correct mental health problems, followed by 
medications for sedation, antidepressants or antipsychotics (Moncrieff, 2003). In the 
1950s mental health hospitals were integrated into the National Health Service (NHS) in 
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the UK with the medical model being the primary approach to treatment of mental health 
problems. 
 
2.1.2 The medical approach and the anti-psychiatry movement 
The medical model is the traditional approach to treating both physical and mental illness 
and remains dominant in modern acute psychiatric inpatient services. In treating mental 
illness it applies the process of identifying, diagnosing and treating problems with 
emotion, thought, behaviour and interpersonal relationships with the assumption that the 
problem derives from a physical or biological cause (Engel, 1977). Therefore, treatment 
is primarily physical or biological and recovery from mental illness is defined by a 
reduction or resolution of symptoms, which are used to identify a specific disorder. 
However, this approach is often criticised for adopting a reductionistic and paternalistic 
manner which promotes the notion of ‘normal’ (British Psychological Society, 2014). In 
response to such criticisms, an anti-psychiatry movement emerged in the 1960s, which 
emphasised the role of non-biological factors in understanding and treating mental illness. 
This saw the opening of inpatient treatment centres such as Kingsley Hall, followed by 
Soteria House, which prioritised non-pharmacological treatment. Kingsley Hall was a 
London based residential treatment centre, developed by Dr Robert D. Laing, where, 
unlike inpatient units in the NHS, doors were unlocked, antipsychotics were not used and 
labels such as ‘patient’ and ‘professional’ were discouraged (Torn, 2012). This approach 
to treat severe mental illnesses such as psychosis was considered radical, however Laing 
was also praised for his compassionate understanding of mental illness which was that 
symptoms are a rational response to horrible experiences (Torn, 2012). Inspired by 
Kingsley Hall, Loren Mosher developed The Soteria House Project in America (Mosher, 
Vallone, & Menn, 1995). Again, a psychosocial approach to intervention was adopted 
which aimed to resolve patients’ emotional crisis by focussing largely on personal or 
interpersonal problems. The intention was to create a therapeutic milieu in which anti-
psychotic medication was used minimally (Mosher et al., 1995). The ultimate aim of 
Soteria House was to reduce the number of early-episode patients becoming long-term 
mental health service users. A systematic review of controlled trials of the Soteria 
Paradigm (k=3) was carried out (Calton, Ferriter, Huband, & Spandler, 2008). Results 
show that patients who received treatment under the Soteria Paradigm, i.e. received only 
non-pharmacological treatment, had significantly greater reductions in global 
psychopathology and the number of readmissions when compared to patients who were 
hospitalisation as usual (Calton, et al., 2008). These results are promising, however, as 
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the reviewers point out, most studies included only participants who provided end-point 
or data or completed treatment in the analysis and the randomisation methods used by the 
included studies, where they were implemented (k=2), were questionable or unclear 
(Calton, et al., 2008). Such promising results may  therefore be biased (Sedgwick, 2015).  
 
More recently, the effect of cognitive therapy for people diagnosed with schizophrenia 
not taking medication has again been evaluated in a randomised, single-blind controlled 
trial (RCT) (Morrison et al., 2014). The results showed little group differences on some 
outcomes, for example, negative psychotic symptoms, depression and symptom related 
distress. However, the findings also showed that patients receiving cognitive therapy had 
significantly larger reductions in psychiatric symptoms (specifically positive and general 
psychotic symptoms, as measured by the positive and negative symptoms scale (Kay, 
Fiszbein, & Opler, 1987)) and significantly larger improvements in social and personal 
functioning compared to those receiving just usual treatment (Morrison et al., 2014). Such 
results provide initial evidence to suggest that some patients can benefit from cognitive 
therapy, whether receiving parallel pharmacotherapeutic treatment or not. 
 
Psychological treatment in the absence of medication was, and still is, considered radical 
and has been criticised. It has been argued that withholding or discouraging evidence-
based treatment, such as anti-psychotic drugs, on the basis of a psychosocial ideology, is 
inappropriate and unethical practice (Carpenter & Buchanan, 2002; Shah & Mountain, 
2007). However, treatment centres such as Soteria House and Kingsley Road have had a 
positive impact on mental health treatment as they have marked the first exploration into 
alternative treatment options, and encouraged investigation of psychosocial cause and 
treatment of severe mental illness.  
 
2.2 Modern acute psychiatric inpatient services 
Acute psychiatric inpatient services now make up one component of the network of care 
available to patients in crisis. NICE (National Institute for Health and Care Excellence, 
2014) recommends a specialised system of both inpatient and outpatient services for 
individuals experiencing an acute episode of mental illness. This includes community 
crisis teams (Intensive Home Treatment Teams (IHTT) or Crisis Resolution Teams 
(CRT) and acute hospital admissions. Community crisis teams offer regular nursing visits 
at home and access to crisis houses which are designed to provide rest bite and a safe 
place away from home. Acute inpatient care typically provides medication as the primary 
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treatment option. It aims to ‘provide treatment when a person’s illness cannot be managed 
in the community, and where the situation is so severe that specialist care is required in a 
safe and therapeutic space. Admissions should be purposeful, integrated with other 
services, as open and transparent as possible and as local and as short as possible’ (The 
Commission on Acute Adult Psychiatric Care, 2015).  
 
Like other forms of crisis care, described above, acute psychiatric inpatient services in 
the NHS provide care for people with a variety of diagnoses at different stages of 
recovery. Diagnoses commonly found in acute psychiatric inpatient services include 
psychosis, schizophrenia, bipolar disorder, major depression, borderline personality 
disorder and people who have experienced trauma (British Psychological Society, 2012). 
Although deliberate self-harm or suicidality is not a diagnosis, it is also a common 
problem resulting in brief hospital admission. A brief description of the prevalence and 
typical symptomology of such diagnoses is provided in the following paragraph.  
 
Psychotic disorders are serious mental illnesses that are characterised by symptoms such 
as delusions, hallucinations and thought disorder. They include a range of diagnoses such 
as schizophrenia, major depressive disorder with psychotic symptoms, bipolar disorder 
with psychotic symptoms, and substance induced psychosis (Kirkbride et al., 2012). In a 
systematic review carried out by the department of health policy research, it was reported 
that 1 in every 1000 people in England have an active psychotic disorder (Kirkbride et 
al., 2012). Major depressive disorder is also considered a serious mental illness. It 
includes a range of symptoms but is broadly characterised by low mood and loss of 
pleasure (McCrone, Dhanasiri, Patel, Knapp, & Lawton-Smith, 2008). As previously 
mentioned, in more severe cases, patients may also experience psychotic symptoms. The 
prevalence of depression in England ranges between 29 to 42 in every 1000 people 
(McCrone et al., 2008). Borderline personality disorder is another diagnosis which is 
common in acute inpatient services. It is thought to affect around 0.7% of people in the 
United Kingdom (UK) (National Collaborating Centre for Mental Health, 2009) and is 
characterised by a range of emotional challenges which often result in difficulties creating 
and maintaining good relationships, impulsive behaviour and self-harm. 
 
Due to the variety of patients using acute inpatient services, they are distinctly different 
from other psychiatric inpatient services. For example, unlike specialist inpatient services 
that select patients based on their diagnosis and appropriateness for the service (e.g. 
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borderline personality disorder inpatient services), acute inpatient services must respond 
to the diverse patient group they receive, sometimes with little notice and on an as-needed 
basis. Acute inpatient services also differ from personality disorder services, and 
rehabilitation inpatient services, in that admissions are short in length, and the usual 
length of stay is often unpredictable. Acute services must therefore be responsive and 
flexible to treat acute inpatients accordingly. 
 
2.2.1 The need for change 
While admission to hospital was once considered the only choice of care (discussed 
earlier in this chapter), it is now considered the last resort, in part due to the high cost of 
inpatient beds (Sainsbury Centre for Mental Health, 2005). In a population size of one 
million, it is calculated that the cost of providing acute psychiatric inpatient care ranges 
between £4,321,170 and £24,654,930, depending on the number of beds provided for the 
population (Bowers & Flood, 2008). Financial resources allocated to mental health 
services are, however, increasingly limited, with around 40% of mental health trusts in 
England reporting reduced funding between 2013/14 and 2014/15 (King’s Fund, 2015). 
The government have continuously focused on improving community crisis services to 
reduce inpatient costs (Department of Health, 1999). Consequently, in the last few 
decades the number of inpatient beds has reduced. Between 1955 and 2012 the number 
of inpatient beds has reduced from 150,000 to 22, 300 (The Commission on Acute Adult 
Psychiatric Care, 2015). In Scotland alone, the number of acute beds has decreased by 
34% from 2004 to 2013 (ISD, 2013).  
 
Despite continuous reductions, the demand for psychiatric beds remains (King’s Fund, 
2015), and the number of people being detained under the Mental Health Act continues 
to increase (NHS Digital, 2016). Consequently, the threshold for admission has increased 
(Brooker, Ricketts, Bennett, & Lemme, 2007), suggesting the acute inpatient population 
now consists of patients who are more severely ill (British Psychological Society, 2012). 
Furthermore, the vast majority of wards currently run at overcapacity with few adequately 
trained staff (The Commission on Acute Adult Psychiatric Care, 2015). Little has been 
done to address such changes, which has consequently negatively impacted those using 
and working in psychiatric inpatient services (Mind, 2004). The quality of psychiatric 
inpatient care, for example, is continuously criticised (Care Quality Commission [CQC], 
2016; MIND, 2013; Royal College of Psychiatrists, 2009; Royal College of Psychiatrists 
Centre for Quality Improvement, 2010; Sainsbury Centre for Mental Health., 1998; 
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Schizophrenia Commission, 2012; The Commission on Acute Adult Psychiatric Care, 
2015), despite the development of guidelines which aim to improve the standard of care 
(Royal College of Psychiatrists, 2010; Royal College of Psychiatrists Centre for Quality 
Improvement, 2014). Specifically, inpatient services are reported to be particularly unsafe 
and nontherapeutic environments (Mind, 2004; Schizophrenia Commission, 2012), 
which are lacking in therapeutic activities and interactions (British Psychological Society, 
2015; Mind, 2004). According to a recent qualitative comparison of nurse and service 
users’ views of acute services, patients found interactions with staff were ‘non-
therapeutic’ and focused mainly on medication and administration duties (Rose, Evans, 
Laker, & Wykes, 2015). Staff also expressed a need to spend more time with patients but 
felt powerless in their ability to do so due to administration duties and lack of qualified 
staff on shift (Rose et al., 2015).  
 
The number of readmissions are also a problem in psychiatric inpatient services at a 
national and regional level. In the UK, 13% of people detained under section 136 of the 
Mental Health Act in 2012/13 had also been detained in the previous 90 days (Care 
Quality Commission, 2015). In Scotland, the ISD (Information Services Division 
Scotland, 2012) found 55% of those admitted to psychiatric hospitals were readmissions. 
And in NHS Lanarkshire, approximately 20% of all acute inpatient admissions, and 
approximately 24% of all psychiatric beds occupied, were ‘revolving door’ patients 
(Cogan, Shajahan, & Pethe-kulkarni, 2012). This data demonstrates the strain on 
psychiatric inpatient services at a national and regional level and suggests patients are 
either prematurely discharged or are not receiving sufficient support during their 
admission. Improving the quality of care, and thus outcomes for patients and acute 
inpatient services, is clearly important. 
 
2.2.2 A solution 
Treatment offered in routine clinical practice in acute psychiatric inpatient services 
primarily consists of medication (Sainsbury Centre for Mental Health, 2005). Such 
services have been described as ‘the last bastion of the medical model in its pure form’ 
(Clarke & Wilson, 2009, pp. 2). However, it has been suggested that providing 
psychological therapy in this context may address some of the key problems (Bright, 
2008) described earlier in this chapter, i.e. nontherapeutic environment, poor patient 
outcomes and the high risk of readmission. Some clinicians, for example, argue that it 
may create an opportunity to engage patients at a critical point, who may otherwise be 
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difficult to engage, and that opportunity may be used to identify problematic thoughts, 
feelings and behaviours leading to the current crisis (Clarke, 2015; Jacobsen, Peters, & 
Chadwick, 2016). Access to psychological therapies, that are appropriate for severe 
mental illness, is now recommended during acute psychiatric admissions by a number of 
inpatient initiatives and regulatory bodies (Bright, 2014; British Psychological Society, 
2012, 2015; Joint Commissioning Panel for Mental Health, 2013; Royal College of 
Psychiatrists Centre for Quality Improvement, 2014). Such recommendations are largely 
based on clinical expertise (Clarke & Wilson, 2009) and the development of 
psychological therapies for severe mental illness.  
 
2.2.3 The development of psychological intervention for severe mental illness 
The National Institute for Health and Care Excellence (NICE) recommend that a variety 
of psychological interventions, such as cognitive behavioural therapy (CBT) and family 
intervention, are available for patients with diagnoses of severe mental illnesses which 
are common in acute psychiatric settings (British Psychological Society, 2012, 2015): 
psychosis and schizophrenia (National Institute for Health and Care Excellence, 2014), 
personality disorder (National Institute for Health and Care Excellence, 2009), bipolar 
disorder and depression (National Excellence Institute for Health and Care, 2016). Such 
recommendations are based on the continued development and evaluation of 
psychological therapies, over the last 20 years, for people who were once thought to be 
too ill to engage in therapy. Although multiple therapies have been developed, such as 
family therapy and CBT, the following sections will focus only on therapies relevant to 
this thesis, i.e. CBT and relevant third wave therapies.  
 
2.2.3.1 CBT 
The development of CBT has occurred in stages, or ‘waves’. The first wave of evidence 
based therapies, known as behavioural therapies, were originally developed from 
Pavlovian conditioning as a desensitising treatment for anxiety disorders and phobias 
(Öst, 2008). Later, in the 1970s, cognitive therapies were developed by Beck (1976), 
which were soon integrated with behavioural therapies, consequently developing one of 
the most commonly used and researched therapies today: CBT. CBT is a talking therapy 
in which therapists and clients work together to identify, understand and alter unhelpful 
thoughts, feelings and behaviours. While initially developed for depression, many 
cognitive behavioural psychological models of psychosis have also been developed in the 
last 20 years (Bentall, Corcoran, Howard, Blackwood, & Kinderman, 2001; Chadwick & 
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Birchwood, 1994; Garety, Kuipers, Fowler, Freeman, & Bebbington, 2001; Kingdon & 
Turkington, 1994; Morrison, Haddock, & Tarrier, 1995). Similar to cognitive behavioural 
models for depression, unhelpful automatic appraisals, beliefs and safety seeking 
behaviours are thought to sustain symptoms of psychosis and related distress, and are 
therefore a target of CBT for psychosis (CBTp). The ultimate aim of therapy is to monitor 
and question problematic thoughts and feelings in order to adapt these into new strategies 
of coping with symptoms, which in theory will reduce distress and improve functioning 
and wellbeing (Hutton, 2016).  
 
The CBT evidence base covers a range of diagnoses, with a particular focus on CBTp in 
recent years. Many meta-analyses have been conducted which show that in high quality 
evidence CBTp is effective in reducing symptoms of psychosis with a small effect (Jauhar 
et al., 2014; Turner, Van Der Gaag, Karyotaki, & Cuijpers, 2014; Van der Gaag, 
Valmaggia, & Smit, 2014; Wykes, Steel, Everitt, & Tarrier, 2008) and it is now a growing 
opinion that patients with psychotic symptoms should have a choice of treatments which 
includes CBT, or other psychological therapies (Morrison et al., 2014; Morrison, Hutton, 
Shiers, & Turkington, 2012).  
 
Meta-analysis has also investigated the effectiveness of CBT for other severe mental 
illness diagnoses that are commonly found in acute inpatient services, i.e. bipolar disorder 
and major depression. Lynch et al (2010), for example, investigated the effectiveness of 
CBT for major psychiatric disorders in general using meta-analysis, in which nine studies 
included participants with major depressive disorder. Results suggested CBT was 
effective in reducing symptoms of depression and in reducing relapse for people 
diagnosed with major depressive disorder. Four studies looking at CBT for the prevention 
of relapse in patients with bipolar disorder were also included (Lynch et al., 2010). The 
overall treatment effect, however, was not statistically significant, from which the authors 
concluded that CBT is ineffective in preventing relapse of bipolar disorder (Lynch et al., 
2010). However since publication, this meta-analysis has been heavily criticised for 
reasons such as using inconsistent and questionable inclusion/exclusion criteria (Hutton, 
Wood, Taylor, Irving, & Morrison, 2014). More recently, a systematic review 
investigating the effect of psychotherapy on symptoms of anxiety in bipolar disorder has 
been conducted (Stratford, Cooper, Di Simplicio, Blackwell, & Holmes, 2015). Fourteen 
of the 22 included studies investigated CBT. The results suggest that CBT, including a 
component that specifically targets anxiety, reduces symptoms of anxiety, cyclothymic, 
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refractory and rapid cycling when compared to usual treatment, and therefore concluded 
that CBT for anxiety may result in improved outcomes for people diagnosed with bipolar 
disorder (Stratford, et al., 2015).  
 
2.2.3.2 ‘Third wave’ cognitive behavioural therapies 
Over the last 10 to 15 years third wave therapies have emerged as an extension of CBT. 
They are thought to differ, or expand (Hofmann, Sawyer, & Fang, 2010), from CBT in 
that the focus of therapy is the inner experience rather than the content. Therapy 
emphasises validation, acceptance and attentional control rather than simply thought and 
behaviour change (Hofmann, et al., 2010). Third wave therapies are therefore thought to 
bridge the gap that traditional CBT cannot, i.e. achieving rational cognition and emotional 
conviction of that rationale (Clarke, 2009a, 2015). Such therapies include, but are not 
limited to, Mindfulness, Compassion-Focused Therapy (Gilbert, 2005, 2009), 
Acceptance and Commitment Therapy (Hayes, 2004), Dialectical Behavior Therapy 
(Linehan, 1993), and Mentalization Based Therapy (Bateman & Fonagy, 2010). Different 
third wave therapies relevant to this thesis are briefly described below.  
 
Mindfulness 
Mindfulness has become a popular therapeutic technique which is integrated into various 
therapies for depression and anxiety, personality disorder and psychosis (Chadwick et al., 
2016; Linehan, Cochran, Kehrer, & Barlow, 2001; Segal, Williams, & Teasdale, 2002). 
The primary aim is to direct attention away from rumination or intolerable emotion, which 
may lead to unhelpful coping mechanisms (e.g. taking drugs, self-harm, dissociation from 
reality), and redirect attention to the present moment (e.g. breath and bodily sensations or 
an object such as a pebble). The initial evidence base for mindfulness for severe mental 
illness is promising. One meta-analysis of 6 RCTs, for example, has shown that 
mindfulness-based cognitive therapy reduces relapse of major depression by around 34% 
compared to controls (Piet & Hougaard, 2011). Additionally, another meta-analysis of 
the effectiveness of mindfulness-based therapy for psychosis has provided evidence 
which suggests that patients may benefit from learning mindfulness techniques in terms 
of reducing negative symptoms and rehospitalisation with small to moderate effects 
(Khoury, Lecomte, Gaudiano, & Paquin, 2013). However, of the thirteen studies included 
in this meta-analysis, only 7 were controlled trials, with the remaining 6 making a pre-
post comparison. Due to the varied quality of the included studies, the meta-analysis 
results should be interpreted with caution.  
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Compassion focused therapy (CFT) 
Compassion focused therapy (CFT) refers to therapy in which a compassion model is 
applied, while compassionate mind training (CMT) is concerned with exercises that 
improve compassion related skills (Gilbert, 2009). Both therapy and training are 
underpinned by a biopsychosocial philosophy (see Gilbert (2009) for further detail), in 
which self-soothing techniques are taught to individuals with feelings of shame, low self-
esteem and are highly self-critical (Gilbert, 2005). High self-criticism and low self-esteem 
are associated with a variety of mental health problems, particularly psychosis, in relation 
to relapse or readmission to hospital (Gumley & Schwannauer, 2006), and early life 
trauma (Gilbert, 2005, 2009). The aim of CFT or CMT is to acknowledge negative 
automatic reactions, accept that these are difficult to control and realise they occur 
because of learned defences (Gilbert, 2006). Metacognitive awareness (i.e. awareness of 
one’s cognitions), acceptance of acknowledged thoughts and compassionate skills are 
therefore key learning outcomes of CFT. One randomised control trial, including a sample 
with mental health problems (i.e. psychotic symptoms), has been conducted (Braehler et 
al., 2013). Results showed that those who received group compassion focused therapy 
had larger improvement in terms of clinical global improvement and compassion, when 
compared to treatment as usual, and improvements in compassion were associated with 
reduced depression (Braehler et al., 2013). A systematic review of compassion focused 
therapy demonstrates that the current evidence base for compassion based therapies is 
still small and mostly of limited quality (Leaviss & Uttley, 2015). However, the authors 
conclude that initial evidence shows encouraging results, specifically in terms of reducing 
symptoms of depression for people receiving treatment for trauma (Leaviss & Uttley, 
2015). Clearly more rigorous evaluation is necessary, however the evidence base, in its 
current form, does suggest that compassion focused therapy maybe beneficial for people 
experiencing different mental health problems, e.g. schizophrenia, depression, bipolar 
affective disorder, personality disorder and deliberate self-harm (Leaviss & Uttley, 2015).  
 
Dialetical behaviour therapy (DBT) 
DBT is an evidence-based, emotion focussed treatment originally developed by Marsha 
Linehan (Linehan, 1993) for borderline personality disorder. Acceptance and validation 
of emotions and emotion regulation are the key aspects of therapy which set it apart from 
more traditional CBT. The aim of DBT is to improve patients’ emotion regulation, 
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mindfulness skills, interpersonal skills and distress tolerance. Typical DBT comprises of 
individual therapy, group skills training and multidisciplinary work.  
 
The benefit of DBT for borderline personality disorder has been widely researched with 
promising results. Meta-analysis of 16 studies of the effectiveness of DBT for borderline 
personality disorder showed moderate overall improvements in all studies (Kliem, 
Kröger, & Kosfelder, 2010). In just RCTs (k=8), results showed small or small to 
moderate improvements in suicidal and self-injury behaviour and general outcomes, 
respectively (Kliem, et al., 2010). In another meta-analysis including just two studies, 
DBT has also been shown to reduce symptoms of anger, parasuicidality and overall 
mental health when compared to usual treatment with moderate to large effects (Stoffers 
et al., 2012). However, as pointed out by Chapman (2006), the evidence primarily 
supports application of the entire DBT package, while different settings (i.e. acute 
inpatient settings) are likely to require treatment adaptations. For example, an acute 
inpatient setting may require a more flexible approach to address the chaotic nature of the 
ward, unpredictable discharges and the mostly short length of stays. Consequently, the 
evidence base does not currently apply to an acute inpatient environment (discussed 
further in this chapter), despite regular care for people diagnosed with personality 
disorder in acute inpatient services. 
 
Mentalization based therapy (MBT) 
Like DBT, MBT was originally developed for patients with personality disorder 
(Bateman & Fonagy, 2010). Mentalization is defined as the ability to make sense of 
ourselves and others, both implicitly and explicitly. Therefore, the aim of MBT is to 
improve such skills which in turn should have a positive impact on ones’ relationship 
with themselves and others. Poor mentalization skills have primarily been associated with 
personality disorder, however some recent evidence suggests patients with first episode 
psychosis who present with negative symptoms also have difficulty mentalizing 
(MacBeth et al., 2016) and research to investigate the effectiveness of mentalization-
based therapy for psychosis is currently being planned (Weijers et al., 2016). 
 
2.3 The challenges of providing psychological intervention in acute inpatient 
settings 
While developments in psychotherapeutic approaches have undoubtedly had a positive 
impact on treatments offered to people with severe mental illness, there are a number of 
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challenges associated with providing psychological intervention in the acute psychiatric 
inpatient context. Firstly, as pointed out by Clarke and Wilson (2009), there may be a 
fundamental clash of cultures’ between psychological interventions and the acute 
inpatient environment. Key principles of many psychological therapies, for example, are 
collaboration between patient and therapist and normalising patients’ unusual or 
distressing experiences, which are not inherent to the medical model that dominates most 
acute inpatient services.  
 
Other challenges of providing psychological intervention in such settings include the high 
levels of distress and arousal associated with an acute crisis, the diagnostic diversity and 
uncertainty that are characteristic of the acute inpatient population (Clarke & Wilson, 
2009), and the typically short admission lengths (Mental Health Network, 2012) coupled 
with unpredictable discharges that are common in acute inpatient services. To address 
these challenges, therapy may need to be flexible in length, and the content should be 
accessible to patients who are highly distressed (discussed in the ‘Woodhaven Approach’ 
section). Given that this population includes a range of diagnoses, co-morbidities and 
diagnostic uncertainty, it is also reasonable to argue that a cross-diagnostic approach to 
therapy may be efficient in an acute inpatient service.  
 
2.3.1 The cross-diagnostic approach 
While many psychological interventions have been developed to address specific 
diagnoses, the concept that common processes exist across diagnoses has grown 
momentum (Mansell, Harvey, Watkins, & Shafran, 2009). The key principle of the cross-
diagnostic approach (also referred to as the trans-diagnostic approach) is that while 
symptoms of different diagnostic categories manifest in different ways, they are driven 
by shared dysfunctional processes. Theoretically, treatment of common pathologies 
should benefit people with different disorders, such as depression or schizophrenia 
(Larsen-Barr, 2009). While not considered to be unique treatments, cross-diagnostic 
therapies utilise treatments whose effectiveness are already evidenced in diagnostically 
diverse groups (Larsen-Barr, 2009; Mansell et al., 2009), for example CBT and third 
wave therapies (discussed earlier in this chapter).  
 
Three main advantages of the cross-diagnostic approach to CBT have been identified by 
Mansell et al. (2009). First, theories of shared processes are likely to be more theoretically 
parsimonious than multiple theories underpinning different diagnoses. The second 
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advantage is that cross-diagnostic research may prove more fruitful in understanding the 
working mechanisms of therapies. And the third reason is that cross-diagnostic 
psychological intervention may prove to be more pragmatic for services (Mansell et al., 
2009), particularly in time and resource restricted services, such as the acute inpatient 
wards. For example, services which focus on common processes, as opposed to diagnostic 
specificity, within staff training, patient assessment and delivery of psychological 
interventions, could potentially increase the provision of staff training and therapeutic 
intervention with a lower cost (Mansell et al., 2009).  
 
Overall, while interventions targeting single diagnoses may be beneficial for some acute 
inpatients, a cross diagnostic approach may address some key problems highlighted in 
acute inpatient services: limited provision of therapeutic intervention and lack of 
sufficiently trained staff (Royal College of Psychiatrists, 2009; Royal College of 
Psychiatrists Centre for Quality Improvement, 2010, 2014). 
 
2.4 Psychotherapeutic initiatives for acute psychiatric inpatient services 
As previously mentioned, although psychological intervention has been recommended 
for acute psychiatric inpatient services (British Psychological Society, 2012, 2015) 
(discussed earlier in this chapter), medication remains the primary treatment during 
admission, and access to therapeutic activity is limited (British Psychological Society, 
2012; Joint Commissioning Panel for Mental Health, 2013). It has been reported that less 
than 20% of inpatients are offered CBT while in hospital (Sainsbury Centre for Mental 
Health, 2005). This may be due to the challenges of delivering psychological intervention 
in this environment (discussed earlier in this chapter, section 2.3). Although not routinely 
offered in clinical practice, in the last decade four notable psychosocial therapeutic 
initiatives have been developed for acute inpatient settings: the Tidal Model, the 
Refocusing Model, Star Wards and the Woodhaven Approach. These approaches will 
now be discussed.  
 
2.4.1 The Tidal Model 
The Tidal Model, developed by Barker (2001), is a nurse led initiative which aims to 
improve the quality of staff-patient interactions and ward milieu. The model is based on 
a philosophical approach to nursing (interpersonal relations in nursing) which is a 
conceptual reference for psychodynamic nursing. It is recovery focused in that person-
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centred care is advocated and less importance is placed on medical diagnoses. It aims to 
help patients understand their difficulties, reduce distress and develop therapeutic 
relationships with staff through patients telling their unique stories, through writing, in a 
one-to-one session or in a group setting (Barker, 2001). Evaluations of the model, 
including pre- and post-implementation comparisons, have shown that incidents on the 
ward (from 32% to 14%) and mean length of stay has either reduced or remained the same 
post-implementation (depending on the study) (Gordon, 2005). Furthermore, nurses rated 
the Tidal Model as ‘better’ or ‘much better’ than previous ways of working (Gordon, 
2005) and patient outcomes improved after implementation of the intervention 
(Stevenson, Barker, & Fletcher, 2002). Such evaluations, however are not rigorous, and 
there has been no RCT conducted to evaluate the benefit of this initiative (Barker, 2001). 
Furthermore, unlike other psychologically informed inpatient initiatives (Clarke & 
Wilson, 2009) (discussed later in this chapter), the Tidal Model (Barker, 2001) is lacking 
guidance from an empirical evidence base, and is lacking psychological support for staff 
(e.g. clinical supervision). 
 
2.4.2 Refocusing Model  
Also developed in the UK, the Refocusing Model aims to increase and improve staff-
patient interactions (Dodds & Bowles, 2001). Key aspects of the model include increased 
one-to-one sessions and group activities for patients. Nurses also have increased 
responsibility in terms of practical decision-making regarding patients. To evaluate the 
impact of implementing this initiative, an interrupted times series study was carried out, 
in which audit data collected at pre- and post- implementation was compared (Dodds & 
Bowles, 2001). The data shows that after implementation there were fewer incidents of 
self-harm on the ward, absence without leave, violent incidents and hours lost to staff 
sickness were recorded when compared to pre-implementation. This suggests that the 
intervention is associated with a positive impact on both staff and patients, however no 
other research has investigated this model and more scientifically robust evidence is 
necessary to confirm such conclusions.  
 
2.4.3 Star Wards 
Another recovery focussed project, called Star Wards, has been developed to improve 
acute inpatient care (Bright, 2008; Janner, 2007). Designed by Marion Janner, a 
psychiatric inpatient service user, Star Wards aims to create a ward culture that is actively 
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therapeutic and thus improve patient outcomes. This is done through providing ideas for 
various psychosocial activities, ranging from recreational activities to talking therapies. 
Star Wards has proved popular in uptake, with a reported 300 wards becoming members 
of the project (Bright, 2008). However, the development of psychotherapeutic activity, in 
particular, is reported to be slow (Bright, 2008). Janner, (2007) argues that talking 
therapies should have equal presence to medication in inpatient wards, and it is 
acknowledged that offering medication alone to psychiatric inpatients is ‘completely 
unacceptable’ (Bright, 2008). However, it is noted that there is an absence of workable 
service models that promote continuous psychological training, supervision and patient 
care, and it is suggested that structured guidance regarding therapy type, format and 
delivery is required (Bright, 2008). Poor uptake is also thought to be due to a lack of 
resource, trained personnel and time (Bright, 2008). 
 
Although this project is likely to have improved many inpatient services in the UK, no 
RCT has been conducted to definitively and rigorously evaluate it. There is therefore still 
work to be done in terms of impact evaluation and identification or development of a 
working psychological model of care with a theoretical basis.  
 
2.4.4 The Woodhaven Approach 
One notable model of psychologically informed acute inpatient care is the Woodhaven 
approach, developed by Isabel Clarke and colleague (Clarke & Wilson, 2009). It is a 
cross-diagnostic model of acute inpatient psychological intervention guided by evidence 
based therapy (i.e. CBT), and underpinned by a theoretical framework of cognition 
(Barnard & Teasdale, 1991). Like early models of psychological intervention for 
psychiatric inpatients (e.g. ‘Soteria House’ and Kingsley Hall (described earlier in this 
chapter)) and modern inpatient initiatives described above, the Woodhaven Approach 
aims to create a more therapeutic environment for both staff and patients and ultimately 
improve outcomes for patients. The Woodhaven Approach, the Tidal Model and Star 
Wards, however, differ from older psychological models of inpatient care because they 
are cross-diagnostic, and are applied in addition to treatment as usual, i.e. they do not 
discourage pharmacotherapy.  
 
The Woodhaven Approach extends the inpatient initiatives described above, in two ways. 
First, unlike Star Wards, the psychological intervention is manualised and is adapted from 
evidence based psychological therapy, such as CBT. Second, unlike Star Wards and the 
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Tidal Model, the Woodhaven Approach is underpinned by a theoretical framework of 
cognitive processing – the Interacting Cognitive Subsystems model (ICS) (Barnard & 
Teasdale, 1991) (described in the following section). This framework conceptualises the 
mechanisms responsible for dysfunctional processing, which lead to symptom 
development and maintenance of symptoms, or an acute crisis, which are relevant to a 
variety of mental health problem (Clarke, 1999; Gumley, White, & Power, 1999). 
However, similar to the acute inpatient approaches discussed above, the evidence base 
for the Woodhaven Approach is small and does not currently include a definitive RCT to 
evaluate effectiveness or efficacy (a review of the evidence base is provided later in this 
chapter, p27).  
 
The main aims of the Woodhaven Approach are: 1) to improve patient outcomes by 
providing access to psychological interventions and facilitating therapeutic engagement 
with staff, 2) to improve staff morale and facilitate a psychologically minded and 
compassionate inpatient staff team, and 3) to create a therapeutic milieu via aims one and 
two. The intervention includes different components for both staff (psychological 
training, clinical supervision and reflective practice) and patients (individual formulation 
and brief CBT-based and third-wave-based group therapies). In line with guidance from 
the British Psychological Society (2012), the Woodhaven Approach is a recovery 
focused, skills-based approach to therapy, in that hospital admission is considered a 
critical turning point in which self-management skills are taught to improve outcomes for 
patients.  
 
2.4.4.1 The interactive cognitive subsystems model 
As previously mentioned the Woodhaven Approach is underpinned by a theoretical 
framework of cognition – the ICS (Barnard & Teasdale, 1991). The ICS is a model of 
information processing (Barnard & Teasdale, 1991) which is used as a theoretical 
framework to explain shared cognitive processes of different mental illnesses and lends 
itself well to understanding the beneficial processes of third wave therapies for a variety 
of diagnoses. The model proposes that different types of information are processed in 
different subsystems. Two subsystems of relevance are the propositional and the 
implicational. These are conceptually similar to Linehan’s rational and emotional mind 
(Linehan et al., 2001). The propositional subsystem processes verbal information and, 
like the rational mind (Linehan et al., 2001), is associated with conceptual meaning that 
can be validated using logic and evidence (Walz & Rapee, 2003). In contrast, the 
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implicational subsystem processes sensory and body state information and, like the 
emotional mind (Linehan et al., 2001), is associated with meaning that is described as 
schematic (Walz & Rapee, 2003). Information with implicational meaning is abstract in 
nature and is related to emotion (Gumley et al., 1999), for example a personal feeling or 
sense such as the feeling of being Scottish (Gillanders & Fleming, 2006). Such meaning 
is created through reoccurring experiences of interactions with others, cultural norms, 
values and traditions (Gillanders & Fleming, 2006). Implicational processing is automatic 
and immediate, and only the implicational subsystem can directly generate emotional 
meaning. However, the body state subsystem is closely connected and in a high state of 
arousal can trigger the implication subsystem to generate emotion. For example, tense 
muscles and a fast heartbeat can pass from the body state subsystem to the implicational 
subsystem to induce negative emotions such as stress or worry.  
 
The hypothesis that information is processed in different subsystems, depending on the 
meaning, has been empirically tested. Walz and Rapee (2003) did this by using a Stroop-
type decision task which included emotionally and neutrally expressed (i.e. spoken) 
words, which had either an emotional or neutral content (i.e. ‘fury’ or ‘jury’). Such stimuli 
were used to separately manipulate expression and content, therefore eliciting 
implicational and propositional processing, respectively. Participants were asked to 
quickly determine whether the word expression was emotional or neutral (expression 
task). The authors hypothesised that, according to the ICS, emotionally expressed words 
would decrease reaction times in the expression task, because emotional expression 
would prime direct processing of implicational meaning (Walz & Rapee, 2003). 
Furthermore, they hypothesised that the content of the word would have no impact on 
decision times in the expression task because, according to the ICS, content has 
propositional meaning and the propositional subsystem is not used to identify expression. 
The results supported these hypotheses, thus providing initial evidence that information 
with implicational and propositional meaning is processing in separate subsystems (Walz 
& Rapee, 2003).  
 
Information processing is thought to occur dynamically in both the propositional and 
implication subsystems, and like the wise mind (Linehan et al., 2001), optimal processing 
(and functioning) occurs when they interact fluidly (Clarke, 2009b). However, this 
balance can be disrupted where by one subsystem becomes dominant. For example, when 
arousal is high or overwhelming emotions occur, implicational processing becomes 
  
22
dominant, leading to reduced or complete loss of rational processing of information in 
the propositional subsystem. Acute episodes of mental illness, often characterised by 
overwhelming emotional distress and high states of arousal, are hypothesised to result 
from such disruption (Clarke, 1999; Teasdale, 1993). Symptoms of various, or all, mental 
health problems are also hypothesised to result from such dysfunctional processing. 
When implicational processing prevails and emotions are too overwhelming, or are 
overwhelming for an extended period of time, symptoms such as dissociation (psychosis), 
hopelessness (depression), misplaced worry (anxiety) and drug and alcohol use become 
ways of coping with this negative emotion (Clarke, 2009a, 2015). The ICS may, therefore, 
provide a framework for understanding shared dysfunctional processing across 
diagnoses, and has implications for psychological therapy designed for acute crisis. For 
example, theoretically, acute inpatient psychological work needs to address disconnected 
processing, and it needs to be accessible at the implicational level of processing. 
 
The ICS and early life adverse events 
Trauma and other adverse childhood experiences are now widely acknowledged as risk 
factors of mental illness (Read & Bentall, 2012) and the ICS provides a framework which 
underpins this. As previously mentioned, the implicational subsystem is related to 
processing sensory and body state information to form abstract meaning about the self. 
Such meaning develops throughout life and is largely influenced by key relationships and 
events in early life (Clarke, 1999). This concept is not new and has been previously 
recognised by developmental theories, e.g. attachment theory (see Bowlby, (1969) for 
detail). There is a now general consensus that, as a result of adverse life experiences or 
trauma, negative self-constructs are likely to be formed (Read & Bentall, 2012).  
 
The ICS extends this concept, in that the implicational subsystem (storing and processing 
abstract information about the self) has a close and automatic communication with the 
body state subsystem (storing and processing arousal related information).Therefore, the 
construction of the self in early life is thought to develop in parallel with the development 
of arousal patterns (Clarke, 2009b). This automatic connection is designed to protect the 
self against threat, i.e. to prepare the body to respond to threat (fight, flight or freeze). 
Where constant exposure to threat is experienced in early life, negative constructs about 
the self (e.g. shame and worthlessness) are developed and automatic responses (i.e. 
increased arousal leading to fight, flight or freeze) are reinforced and stored, therefore 
creating hyper-vigilance to perceived threat (either external or internal). This pattern of 
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processing is not considered to be diagnostic specific, therefore such experiences which 
create dysfunctional processing can increase the risk of developing a variety of mental 
illnesses in adult life. The following examples describe how this may lead to depression 
or psychosis.  
 
Continuous exposure to a negative implicational understanding of the self (due to adverse 
experiences) leads to embedded negative propositional understanding of the self and an 
automatic response to threat, i.e. giving up (Gillanders & Fleming, 2006). This creates a 
feedback loop which reinforces and maintains negative beliefs about the self, thus 
preserving a negative mood and the associated automatic response. This pattern of 
information processing is considered involuntary and has been termed the ‘depressive 
interlock’ (Teasdale, 1993). There is initial empirical support for this concept. Gillanders 
and Fleming (2006) tested the hypothesis that information processing becomes ‘stuck’, 
or repetitive, for people diagnosed with depression, and that such processing is negatively 
inclined (characteristics of the ‘depressive interlock’). This was done by comparing 
clinically depressed and non-depressed participants on a task which tests the effect of 
emotional stimuli on information processing. The authors hypothesised that depressed 
participants would respond more repetitively than non-depressed participants, and this 
would be more evident for emotionally related stimuli (Gillanders & Fleming, 2006). 
Results supported both hypotheses, and therefore the depressive interlock. The depressive 
interlock therefore provides a theoretical understanding of sustained depressive moods 
supported by initial empirical evidence and it offers a theoretical understanding of the 
potential influence of adverse childhood experiences in adult mental health problems.  
 
Another hypothesis derived from the ICS is that negative information stored about the 
self may lie dormant due to effective interaction between implicational and propositional 
processing (Clarke, 1999; Gumley, White, & Power, 1999). Then, implicational stores, 
and associated arousal stores, are triggered by later life events (e.g. a traumatic 
experience) or circumstance (i.e. extreme or constant stress) which mimic negative or 
threatening early life events, or circumstance. This interrupts processing that is usually 
balanced (i.e. the implicational subsystem becomes dominant or disconnected from the 
propositional subsystem), resulting in an acute episode of mental illness or relapse. 
Gumley et al. (1999) argue that this process can lead to the onset and relapse of psychosis 
– and that access to implicational and arousal information stored in early life may evolve 
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and become faster with each episode or relapse. Such hypotheses, however, are yet to be 
empirically tested.  
 
It is important to note that when someone has not experienced trauma in early life, the 
perceived self may still be disrupted. Losing self-defining roles and relationships or 
experiencing transitions in life (e.g. divorce, losing a job, or moving to a new city), for 
example, can also lead to extreme distressing emotions, such as fear, anger or pain 
(Clarke, 2009a). However, in each of these scenarios, the ICS continues to support the 
notion that mental illness (whether severe and enduring or short-term and acute) is a result 
of dominant implicational processing, therefore creating automatic, and overwhelming, 
emotional and physical arousal for an extended period of time.  
 
Symptomatic coping 
In line with the recovery approach and Laing’s early conception of severe mental illness 
(discussed earlier in this chapter), The Woodhaven Approach considers symptoms of 
severe mental illness to be a reasonable reaction to overwhelming negative emotion, 
which is explained by dominant implicational processing (described in previous sections). 
For example, symptoms of depression, such a hopelessness and giving up, have been 
attributed to a reasonable reaction of continued overwhelming emotion and high arousal 
(i.e. dominant implicational processing) (Gilbert, 1992). Individuals may also attempt to 
escape overwhelming negative emotion using various learned and unhelpful behaviours, 
such as drug or alcohol use (addiction), withdrawal or submission (depression), worry 
and hyper-vigilance (anxiety), compulsions or displaced anxiety (i.e. obsessive 
compulsive behaviours or eating disorders) or dissociation (e.g. psychotic experiences) 
(Clarke, 2009b). Although these responses differ in presentation, Clarke (2009b) argues 
that the common feature is that they act as coping strategies which people have learned 
as a form of short term relief from adverse feelings which have resulted in dysfunctional 
processing (described in previous sections). Unfortunately, such coping strategies are 
unhelpful in the long-term, thus resulting in poor mental health and sometimes hospital 
admission. The ICS therefore provides a conceptual understanding of shared 
dysfunctional processing, leading to overwhelming emotion and extreme distress, which 
may underlie acute crisis presenting in a variety of way. This has several implications for 
psychological therapy for the acute inpatient population  
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2.4.4.2 Therapeutic components of the Woodhaven Approach 
The ICS provides a theoretical framework of cross-diagnostic dysfunctional processing 
that underlies symptoms of severe mental illness and acute crisis. The Woodhaven 
Approach has drawn on this to link mechanisms of change to third-wave and CBT based 
techniques. The importance of acknowledging and managing emotion and closely related 
physicality within therapeutic work is emphasised, and a recovery orientated response by 
means of CBT- and ‘Third-wave’-based therapies is promoted. The overall aim of therapy 
is to help patients’ make sense of their current situation and improve their ability to help 
themselves. In keeping with the person-centred approach, individual formulation is at the 
heart of this process.  
 
Emotion focused crisis formulation 
As pointed out by Clarke (2009a), individual therapy provided during an acute hospital 
admission differs in a number of ways from a community setting. For example, the time 
from referral to appointment is considerably shorter in hospital due to generally short 
admissions, the exact length of admissions is often unpredictable (previously discussed 
in this chapter) and prior knowledge of the client may be limited in comparison to 
community settings (Clarke & Wilson, 2009). However, according to the Woodhaven 
Approach, exploring a patients’ complex history is not advised in this context due to the 
highly emotive state the individual is likely to be in (Clarke & Wilson, 2009). Instead, 
and in keeping with the person-centred approach, it is advised that therapy aims to 
validate and make sense of each individuals’ unique experience by determining past 
(briefly) and current factors which trigger and maintain imbalanced processing (i.e. 
dominant processing of implicational (emotional) information with associated high 
arousal) that have led to the current admission (Clarke, 2009a). Also in accordance with 
the recovery approach, patients are encouraged to take control of their crisis through 
identifying resolutions for unbalanced or disconnected processing. Such resolutions are 
likely to include appropriate third-wave and CBT based therapeutic approaches, which 
provide alternative skills-based coping strategies that help break self-defeating patterns 
of behaviour (Clarke, 2009a).  
 
The process of emotion focused crisis formulation centres around ‘spiky diagram’ (see 
Figure 1) (Clarke, 2009b, 2015). Similar to CBT formulation, the spiky diagram aims to 
provide validation of negative feelings and behaviours via acknowledgement of past 
adverse experience, although, unlike outpatient CBT, exploration of such experiences is 
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not recommended at this stage. Then, recent stress or adverse events are identified, along 
with patterns of current (unhelpful) coping strategies that maintain problems and 
overwhelming distress. Such patterns are named ‘vicious cycles’. With the aim of giving 
each individual full responsibility of their own situation, new ways of coping are 
identified. Central to this process is mindfulness (described earlier in this chapter). 
Mindfulness based techniques are taught to allow patients to become more tolerable of 
overwhelming negative emotion and control physiological responses (associated with 
implicational processing), thus allowing time to choose a helpful coping strategy before 
automatically resorting to learned unhelpful patterns of behaviour (e.g. self-harm or 
taking drugs) (Clarke, 2015). Figure 1 demonstrates a typical formulation for someone 
experiencing symptoms associated with psychosis. Individual formulation, in this form, 
is considered central to acute inpatient psychological intervention. 
Figure 1 Emotion focused formulation example for psychosis (Clarke, 2009b). 
 
Group therapy components 
All group components of the Woodhaven approach (Clarke & Wilson, 2009) are drawn 
from CBT-based and third-wave-based approaches (e.g. mindfulness, compassion and 
DBT), and have the common aim to interrupt unhelpful coping strategies which maintain 
distress, as identified by individual formulation. This is done through managing the 
The past 
Recent stress 
Overwhelming emo on:  
Fear, 
sense of threat 
Intrusive thoughts 
Tense, 
sweaty, 
heart 
races 
This 
means I’m 
bad and 
others 
want to 
hurt me 
Hearing voices 
Escapes from 
thoughts by 
slipping into 
unshared world  
This means I’m bad 
and others want to 
hurt me 
Withdrawal, 
hides OR fight, 
becomes 
aggressive 
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threshold between the two detached/disconnected subsystems related to current acute 
distress. One group draws on mindfulness techniques and aims to manage high states of 
arousal (‘Stress and Anxiety Management’), one draws on compassion focused therapy 
(Gilbert, 2009) and aims to increase self-esteem (‘Making Friends with Yourself’), one 
group aims to normalise unshared experiences (‘What is Real and What is Not’) and one 
group draws on DBT and is designed to improve distress tolerance and emotion regulation 
(‘Coping With Emotions’). Group therapy is considered to be a cost-effective approach 
to address limited resource in acute inpatient services and is advocated by inpatient 
initiatives such as Star Wards (Bright, 2008). Unlike Star Wards, Woodhaven 
psychological group interventions are manualised to allow ward staff to co-facilitate and 
facilitate sessions (further detail of group components is provided in chapter four).  
  
2.4.4.3 A brief review of the evidence  
A small evidence base has emerged which aims to evaluate some components of the 
Woodhaven Approach. The studies are small in size and are not controlled, however 
encouraging results have come from a total of five studies. First, an informal evaluation 
(n=11) of the compassion focused group intervention was conducted, in which inpatients 
were subjectively judged by an independent researcher to find the group acceptable (Hill, 
Clarke, & Wilson, 2009). The evaluation also showed that measures of self-reported 
mental health related self-efficacy indicated patterns of improvement in most patients 
following the intervention (n=7), however there were too few participants to allow for 
statistical analysis. Another small study (n=31) was carried out which aimed to evaluate 
the effectiveness of the ‘What is Real and What is Not?’ group ([WRWN] psychosis 
group) (Wilson, Clarke, & Phillips, 2009). The results showed increased self-reported 
locus of control (in relation to mental health) at post-treatment compared to pre-treatment. 
Additionally, a trend of reduced psychological distress was reported by the authors, 
however statistical significance was not reached on this outcome (Wilson et al., 2009). 
Again, these initial results are promising, however it is difficult to attribute improvements 
directly to the intervention without a control group. More recently, a larger, non-
randomised, non-blind controlled trial (n=113) of the WRWN group (n=71) found 
improved self-efficacy at post-intervention and follow-up, when compared to treatment 
as usual (Owen, Sellwood, Kan, Murray, & Sarsam, 2015). Again, patterns of decreasing 
distress emerged in the intervention group at follow-up, however authors report that the 
data collected was inadequate to allow for statistical comparisons to be made between 
groups. Together, these studies provide initial results which are promising, however they 
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are lacking in quality and they focus on evaluating the impact of specific intervention 
components rather than the entire intervention. Only two studies have aimed to evaluated 
the whole intervention (Araci & Clarke, 2016; Durrant, Clarke, Tolland, & Wilson, 2007) 
to date, and have produced results which are in keeping with the findings described above 
(Hill et al., 2009; Owen, Sellwood, et al., 2015; Wilson et al., 2009). Results indicate that 
the intervention, as a whole, was associated with benefits for inpatients in terms of 
increasing self-reported self-efficacy and confidence in expressing emotions and 
perceived locus of control (n=14) at post-treatment when compared to pre-treatment 
(Durrant, et al., 2007). This study, however, also lacked a control condition, therefore 
limiting the conclusions that can be drawn from the results. A more recent, and larger, 
study (n=131) including patients from four acute services (both inpatient and outpatient) 
also aimed to evaluated the benefit of the whole service with similar results (Araci & 
Clarke, 2016). Again, findings indicated reduced distress and increased self-efficacy, in 
relation to mental health, at post-treatment in comparison to pre-treatment assessment. 
However, similar limitations apply due to the absence of a comparison group, and 
therefore randomisation and assessor blinding. Despite such limitations, the study also 
reported the feasibility of embedding the model within four acute services (inpatient and 
outpatient). The authors reported extensive implementation of the model: providing over 
200 multidisciplinary staff with introductory training and 340 referrals to the model. 
However, it is unclear what time span this has been recorded and the latter may be 
inaccurate as the authors report potential incomplete recording of data. A two-week snap 
shot of clinical activity is also reported in this study (Araci & Clarke, 2016). From four 
acute services, 25 referrals were made, 36 one to one emotion focused formulation 
sessions were delivered, 52 patients attended group intervention components and 21 staff 
were involved in intervention delivery (including psychologists, nurses and occupational 
therapists). This data suggests implementation is feasible and acceptable across 
disciplines, however further good quality research is necessary (Araci & Clarke, 2016) 
 
Summary and conclusion 
Overall, the current literature provides initial promising evidence to suggest that 
components of the Woodhaven Approach, and the model as a whole may be beneficial 
for patients in terms of improving mental health related self-efficacy and perceived locus 
of control. However, the evidence consists mostly of studies of limited size and quality, 
and as pointed out by Araci and Clarke (2016), more rigorous evaluation is needed. To 
date no controlled trial has evaluated this cross-diagnostic psychological intervention as 
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whole, specifically assessing the impact on readmissions. To determine whether this 
psychological model can address some of the problems associated with acute inpatient 
services (i.e. high levels of readmissions) and improve outcomes for patients, a 
scientifically robust definitive trial is needed. The Medical Research Council (MRC) 
considers a phased approach as best practice to systematically develop and evaluate 
complex interventions (see Chapter 1) (Craig et al., 2008, 2013). This includes both 
development and feasibility/piloting of an intervention before definitive evaluation. This 
thesis, therefore, aims to address both these phases in preparation for a future definitive 
trial.  
 
2.5 Implications for the thesis 
The arguments made in this chapter have two main implications for the thesis. First, this 
chapter has highlighted that there is evidence to support the effectiveness of CBT and 
third-wave therapies for a variety of SMIs. This evidence suggests that the cross-
diagnostic application of such therapies may be feasible. However, previous meta-
analyses have included both inpatient and outpatient populations with severe mental 
illnesses, therefore such evidence is not easily generalised to an acute inpatient setting. 
Additionally, studies examining the effectiveness of psychological intervention 
specifically for acute inpatients are often small and therefore lack power (see chapter 
three). A comprehensive synthesis of controlled trials of psychological intervention 
delivered in acute inpatient settings would address these issues and is currently lacking. 
The current thesis aims to address this gap.  
 
The second implication for the thesis is that, given the diagnostic variability of inpatients 
in acute services, it might be useful to take a cross-diagnostic approach to psychological 
intervention, in this context. Some acute inpatient psychological initiatives advocate such 
an approach but lack formal guidance on a working psychological approach with a 
theoretical basis (Bright, 2008), with one notable exception: the Woodhaven Approach 
(Clarke & Wilson, 2009). Initial evaluation of the Woodhaven Approach is promising but 
contains small studies which lack power. And whether such an intervention benefits acute 
inpatients with regards to emotional distress or benefits acute inpatient services with 
regards to the number of readmissions has not yet been tested. A definitive randomised 
controlled trial is needed to address these issues. Initial development and pilot/feasibility 
work is recommended to inform the design of a full trial (Craig et al., 2008, 2013). This 
thesis therefore aims to address these gaps. Chapter 3 contributes to the development of 
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inpatient psychological intervention in reviewing and synthesising the initial evidence 
base. Chapters 4, 5 and 6 contribute to determining the feasibility of conducting a 
definitive trial of a cross-diagnostic psychological intervention for acute inpatients.  
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3 Meta-analysis of trials of the effectiveness of brief 
psychotherapy for acute mental health inpatients 
This chapter presents a meta-analysis of brief psychotherapy for acute psychiatric 
inpatients. It aims to identify, review and synthesise the current evidence base of 
controlled trials reporting the effectiveness of brief inpatient psychological intervention 
for acute mental health inpatients for the first time. This maps onto the primary stages of 
developing and evaluating complex interventions (i.e. reviewing and meta-analysing the 
existing evidence base), as recommended by the Medical Research Council (MRC) 
framework (Craig et al., 2013).  
 
3.1 Justification for meta-analysis 
Psychiatric inpatient services have continuously been criticised for having particularly 
nontherapeutic environments (Mind, 2004; Schizophrenia Commission, 2012), minimal 
provision of therapeutic activities (British Psychological Society, 2015; Mind, 2004) and 
a high rate of readmissions (Care Quality Commission, 2015; Information Services 
Division Scotland, 2012) (see Chapter 2). To address some of these problems, it has been 
recommended that acute psychiatric inpatients should have access to psychological 
intervention during their admission (British Psychological Society, 2012, 2015; Royal 
College of Psychiatrists Centre for Quality Improvement, 2014). In the past 20 years, 
psychological therapies have been developed for severe mental illnesses which are 
common in acute inpatient services (e.g. psychosis, schizophrenia, bipolar disorder, 
personality disorder and major depressive disorder), and there is a growing evidence base 
which has provided some encouraging results (see Chapter 2). However, much of this 
evidence base either focuses on patients who are not in the acute phase of illness or 
includes both inpatients and outpatients (see Jauhar et al., 2014; Khoury, Lecomte, 
Gaudiano, & Paquin, 2013; Leaviss & Uttley, 2015; Stoffers et al., 2012; Turner, Van 
Der Gaag, Karyotaki, & Cuijpers, 2014; Van der Gaag, Valmaggia, & Smit, 2014). Many 
participants are therefore likely to be less severely ill than the acute inpatient population. 
The evidence base also evaluates interventions which are longer than a typical acute 
admission (Mental Health Network, 2012; NHS Confederation, 2014), therefore such 
therapies are not appropriate for application in acute inpatient services. Consequently, it 
is difficult to generalise this evidence base to an acute inpatient setting. 
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Recently, some evidence has emerged which suggests brief psychological intervention is 
effective for outpatients with some severe mental health problems (i.e. presenting with 
suicidality and psychotic symptoms) (Husain et al., 2014; Johns et al., 2016; Naeem et 
al., 2015). However, the acute ward environment is not always considered to be 
therapeutic, safe or conducive to emotional disclosure (Bowers et al., 2002; Jones et al., 
2010; Schizophrenia Commission, 2012), therefore it is possible that treatment outcomes 
of psychotherapy are moderated by the milieu of an acute ward. Some guidelines even 
recommend that therapy begin after discharge (National Institute for Health and Care 
Excellence, 2014). However, there is increasing demand for inpatient therapeutic 
interaction and activities (Csipke et al., 2014; Rose et al., 2015), and professional bodies 
continue to recommend that acute inpatient services provide some form of 
psychotherapeutic activity (British Psychological Society, 2015; Department of Health, 
2002; Royal College of Psychiatrists Centre for Quality Improvement, 2014). 
Determining the effectiveness of brief psychological intervention for acute psychiatric 
inpatients is therefore important.  
 
Recently, a review of the entire evidence base for group cognitive behavioural therapy 
for psychosis (CBTp) in acute care was published (Owen, Speight, Sarsam, & Sellwood, 
2015). Results suggest that CBTp, in addition to usual care, has the potential to reduce 
patients’ distress and affective symptoms, and to increase patients’ knowledge of 
symptoms. Additionally, the intervention was associated with reduced readmissions. 
However, this review only synthesised results from studies which target patients with 
psychosis, and only two of the ten studies included in the review were randomised 
controlled trials (RCTs), while the rest adopted either a pre- post- experimental design or 
were cohort studies. Therefore, conclusions drawn from the review are not definitive, and 
can only be generalised to acute inpatients with psychosis. 
 
At present, an up-to-date cross-diagnostic systematic review and meta-analysis of 
controlled trials is lacking. The current systematic review and meta-analysis endeavoured 
to identify and synthesis the current evidence base. The aim was to establish the effect of 
therapy delivered in an acute inpatient setting on psychotic symptoms, risk of readmission 
and emotional/psychological distress.  
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3.2 Methods 
3.2.1 Protocol registration 
A review protocol was developed and registered online (PROSPERO 
CRD42015026732). Subsequent changes include specification of additional subgroup 
analyses, i.e. contact with a therapist in the control group, therapy type and diagnosis.  
 
3.2.2 Inclusion/Exclusion Criteria 
All randomised and non-randomised trials of talking psychological therapies for adult 
receiving acute inpatient care, where the comparator was usual care, usual care plus 
waiting list, or usual care plus ‘inactive’ psychological intervention (e.g. non-directive’ 
interventions such as befriending or supportive counselling) (see Table 1, page 37, for 
included therapies and control) and that were conducted after 1980 were included, if a 
published or unpublished report was available in English. Given the broad focus of the 
review, i.e. to identify the benefit of any talking psychological therapy, studies in which 
two talking therapies were compared were excluded. Given that this was the first cross-
diagnostic review of acute inpatient psychotherapy and the limited number of studies, 
inclusion of non-randomised trials was planned largely to obtain a broad overview of 
current evidence base. The extent to which this led to a reduction in internal validity was 
determined by subgroup analysis of trials which are, and are not, randomised and single-
blinded (i.e. assessors were blind). Uncontrolled studies, including case studies and case 
series were excluded due to associated risks of bias (Higgins & Green, 2011). 
 
For the purpose of this meta-analysis, psychotherapy was defined as: “meeting with a 
therapist (..) to talk about feelings and thoughts and how these affect behaviour and 
wellbeing” (National Institute for Health and Care Excellence, 2014, para. 1); “Any group 
of therapies, used to treat psychological disorders, that focus on changing faulty 
behaviours, thoughts, perceptions, and emotions that may be associated with specific 
disorders” (Gerrig, Zimbardo, Campbell, & Cumming, 2011, p. 575) where therapy is 
delivered verbally. Examples of interventions fitting this description include, but was not 
limited to, cognitive behavioural therapy (CBT), psychodynamic therapy (PT), 
acceptance and commitment therapy (ACT) and meta-cognitive therapy (MCT). 
Interventions were included regardless of delivery format (e.g. group or individual). 
Interventions not satisfying the definition are those primarily aiming to reduce substance 
misuse, to aid reintegration into the community (reintegration therapy), increase 
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compliance with medication (compliance therapy), increase knowledge of mental illness 
(psychoeducation), decrease muscle tension (muscle relaxation training, Progressive 
Muscle Relaxation Therapy), improve employability (vocational rehabilitation), improve 
neurocognitive functioning (Cognitive Remediation or Cognitive Rehabilitation). Trials 
where interventions were delivered via art, music or computers also did not meet the 
working definition of psychological therapies and were therefore excluded. Additionally, 
therapies considered ‘non-directive’ or ‘less sophisticated’, e.g. psychoeducation, 
supportive counselling or befriending, were not categorised as ‘directive’ or 
‘sophisticated’ psychological therapy for the purpose of this review.  
 
This review was primarily concerned with the effect of therapy for patients in a specific 
setting (i.e. acute psychiatric inpatient settings) therefore no restriction was placed on the 
diagnosis of participants. However, trials where less than 50% of participants were 
inpatients (and where data for inpatients could not be separated from data for outpatients) 
were excluded. Only studies where usable data relating to either severity of psychotic 
symptoms, depression, anxiety or number of readmissions were included. Criteria 
developed by The Mental Health Network (Mental Health Network, 2012) were used to 
define acute inpatient mental health care leading to the exclusion of wards for adolescents, 
older adult wards, specialist wards (e.g. for eating disorder, learning disability, national 
obsessive compulsive disorder (OCD), anxiety disorders, mother and baby unit beds for 
perinatal psychiatry, residential psychotherapy for personality disorder, autistic 
spectrum), forensic wards, rehabilitation wards, crisis houses or respite beds and inpatient 
substance misuse units. While length of stay in an acute inpatient ward can vary, in order 
to specifically evaluate acute inpatient therapy a limit was placed on length of stay in this 
meta-analysis. According to the NHS Confederation (2012), the average length of stay in 
acute inpatient mental health care is 90 days, therefore studies where the average length 
of stay of participants was longer than this were not considered to be studies of acute 
treatment and were therefore excluded. 
 
3.2.3 Outcomes 
Psychotic symptoms are often encountered in acute inpatient settings, occur over a range 
of diagnoses and are commonly measured in intervention trials, therefore overall 
psychotic symptoms were chosen as the primary outcome. This was defined by group 
differences in mean post-treatment Positive and Negative Symptom Scale (PANSS) (Kay 
et al., 1987) total scores but where this was not available, group difference in mean change 
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was used. If neither were available, the nearest post intervention mean was used, as per 
previous meta-analyses (Jauhar et al., 2014). If no PANSS total scores were reported but 
subscale scores were reported, then these were combined using the method specified by 
Jauhar et al., (2014). If PANSS was not used, the Brief Psychiatric Rating Scale ([BPRS], 
Overall & Gorham, 1962) or the Global Assessment of Functioning ([GAF], (Hall, 1995) 
mean scores were converted to PANSS scores using conversion tables provided by Leucht 
and colleagues (Leucht, Rothe, Davis, & Engel, 2013) and Samara and colleagues 
(Samara et al., 2014). Further details on the process of data conversion can be found in 
Appendix 1. 
 
Secondary outcomes included follow-up PANSS total score, number of readmissions, 
symptoms of depression and symptoms of anxiety. Depression and anxiety were thought 
to be useful indicators of emotional distress (Derogatis, 2001), which is often the target 
of psychological interventions and is considered by some researchers to contribute to the 
onset and maintenance of a variety of SMIs (Birchwood, Shiers, & Smith, 2014; Clarke, 
1999). If available, Beck Depression Inventory ([BDI], Beck, Steer, & Carbin, 1988) or 
BDI-2 (Beck, Steer, & Brown, 1996) data was extracted for the depression outcome. If 
unavailable, Hamilton rating Scale of Depression ([HMRD], Hamilton, 1960) data was 
used. If neither were available other measures reported by the authors were used if 
adequate reliability and validity were reported (see Appendix 2). For example, the anxiety 
outcome included a combination of data from the anxiety subscale of the Hospital 
Anxiety and Depression Scale ([HADS], Zigmond & Snaith, 1983), Hamilton Anxiety 
Rating Scale ([HAMA], Hamilton, 1959) and the Symptom Checklist – 90 – Revised 
([SCL-90-R], van der Laan, Van Spaendonck, Horstink, & Goris, 1999).  
 
3.2.4 Search Strategy 
As suggested by Lipsey and Wilson (2001) three methods were used to search the 
literature thoroughly: (i) the use of two or more computerised databases, (ii) manually 
searching the reference lists of related meta-analyses and reviews, (iii) making contact 
with researchers for relevant material. The electronic databases ASSIA, Embase, Cinahl, 
Cochrane, Medline and PsycINFO were searched in October 2014 and again in February 
2016, with the following search strategy: ((SU.EXACT.EXPLODE(“Cognitive 
behavioural psychotherapy”) OR SU.EXACT(“Cognitive psychotherapy”) OR 
SU.EXACT(“Individual psychotherapy”) OR SU.EXACT(“Group psychotherapy”) OR 
SU.EXACT(“Behavioural psychotherapy”)) OR (cognitive therap* OR behavio?r* 
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therap* OR cognitive behavio?r* therap* OR CBT OR psychological therap* OR group 
therap* OR individual therap* OR dialectical behavio?r* therap* OR DBT OR 
compassion focus?ed therap* OR compassionate mind training OR CMT OR 
psychological treatment OR psychological intervention OR mindfulness OR emotion 
regulation OR acceptance commitment therap* OR ACT OR mindfulness based OR third 
wave therap* OR third wave cognitive therap*)) AND (((psychiatric inpatient care) OR 
(acute inpatient mental health care)) OR (mental health AND inpatient care)) AND (acute 
psychosis OR psychosis OR psychotic OR schizo* OR personality disorder OR PD OR 
borderline personality disorder OR BPD OR severe mental illness) AND (inpatient OR 
acute). Clinical trial registries were also searched for potential unpublished trials 
(clinicaltrials.gov; ISRCTN). Titles and abstracts were screened first and studies 
obviously not meeting inclusion exclusion criteria were removed. Full texts of the 
remaining papers were then accessed and reviewed.  
 
3.2.5 Data Extraction 
One reviewer (CP) extracted data from each study specifically for this review. Any 
uncertainties were discussed with other reviewers. Attempts to obtain missing or unclear 
data were made by contacting trial authors. In keeping with recommendations from 
Lipsey and Wilson (2001), a variety of study features were extracted and grouped. For 
each study, information on a number of design, treatment, and outcome related variables 
were extracted. This included method of randomisation, use of assessor blinding, length 
of follow-up, diagnosis of participants, equivalence of groups, overall sample size, type 
of intervention and control, likely contact with therapist in control group, sample for 
analysis (see Appendix 3 for further detail) and duration of therapy (including number of 
sessions and total therapy time in minutes) (reported later in this chapter). Finally, 
reported outcome measures were extracted and grouped under general concepts (see 
Appendix 4 for more detail). 
 
3.2.6 Data conversion and analysis 
Procedures outlined in the Cochrane Handbook (Higgins & Green, 2011) were used to 
combine groups where studies had more than two relevant treatment or control arms. 
Where multiple follow-up data was reported, the longest was included. Meta-analysis was 
carried out using Comprehensive Meta-Analysis (CMA, version 2.0) (Borenstein & 
Rothstein, 2004). For continuous outcomes, pooled standardised mean differences (SMD) 
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and 95% confidence intervals were calculated, with Hedge’s g adjustment for small 
samples. Using the SMD allows multiple continuous measures of the same construct to 
be combined. All SMDs were interpreted using Cohen's (1988) guidelines: 0.2 signifies 
a small effect, 0.5 a medium effect and 0.8 a large effect. Odds ratios and 95% confidence 
intervals were used to quantify group differences in dichotomous outcomes. A random-
effects model was applied in all analyses due to the variation between studies (Borenstein, 
2009) (i.e. therapy type, length, diagnosis, control group).  
 
3.2.7 Assessment of study and outcome quality 
One author (CP) assessed study-level risk of bias with the Cochrane Collaboration risk 
of bias tool (Higgins et al., 2011). This tool measures the potential risk of bias associated 
specifically with randomisation, allocation, blinding, incomplete data and selective 
reporting. Outcome quality was also measured using the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) approach (Guyatt et al., 2008). For 
each outcome, this approach assesses the type of evidence included, the quality of the 
included studies, the consistency among study results, the generalisability of the result, 
the precision of the estimated treatment effect and the risk of publication bias. Any 
uncertainties were discussed at review meetings with other authors. Further details of 
ratings and rationale are provided in the appendices (see Appendices 7 and 8).  
 
Table 1 
Grouping of therapies and comparators 
Therapy/comparator groups Therapies/Comparators Included 
Psychological therapies CBT; ACT; CT; MCT; DBT; SST; EMDR; 
IPP; ‘Psychological approach’ 
Control group with extra therapist 
contact  
Relaxation therapies; PMR; Psycho-
education; Supportive counselling; 
Befriending; TAUP 
Usual Treatment TAU; Waiting list; Newspaper reading 
group; TAUP; ETAU 
All controls TAU; TAUP; Waiting list; Newspaper 
reading group; Medication; Relaxation 
therapies; PMR; Psycho-education; 
Supportive counselling; Befriending 
Acceptance and Commitment Therapy, ACT; Cognitive Behavioural Therapy, CBT; Cognitive 
Therapy, CT; Dialectical Behaviour Therapy, DBT; Eye-Movement Desensitisation 
Reprocessing, EMDR; Interpersonal psychotherapy, IPP; Meta-Cognitive Therapy, MCT; 
Progressive Muscle Relaxation, PMR; Social Skills Training, SST; Treatment as Usual with 
Psychotherapy, TAUP; Treatment as Usual, TAU.  
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3.2.8 Subgroup analysis 
Subgroup analyses were carried out on all outcomes where there were at least 4 studies 
to investigate the effect of randomisation and assessor blinding. Studies were categorised 
as either randomised and single-blind (i.e. assessors were blind) (Aghotor, Pfueller, 
Moritz, Weisbrod, & Roesch-Ely, 2010; Bechdolf et al., 2004; Bowers, 1990; Habib, 
Dawood, Kingdon, & Naeem, 2015; Haddock et al., 1999; Kim, Choi, & Kim, 2010; 
Lewis et al., 2002; Moritz, Veckenstedt, Randjbar, Vitzthum, & Woodward, 2011; 
Schramm et al., 2007) or not randomised and single-blind (Bach & Hayes, 2002; 
Gaudiano, 2006; Gibson, Booth, Davenport, Keogh, & Owens, 2014; Hall & Tarrier, 
2003; Hayashi, Yamashina, Igarashi, & Kazamatsuri, 2001; Kumar et al., 2010; Miller, 
Norman, Keitner, Bishop, & Dow, 1989; Mortan, Sutcu, & Kose, 2011; Shelley, 
Battaglia, Lucey, & Opler, 2001; Startup, Jackson, & Bendix, 2004; Veltro et al., 2006). 
Additional subgroup analyses were carried out on the primary outcome to examine the 
effect of therapy type and the nature of control groups (i.e. extra contact with a therapist 
in the control group). Studies were categorised into three groups to look at differences in 
therapy types: CBT and cognitive therapies (Bechdolf et al., 2004; Habib et al., 2015; 
Haddock et al., 1999; Hall & Tarrier, 2003; Hayashi et al., 2001; Lewis et al., 2002; 
Shelley et al., 2001; Startup et al., 2004), third-wave therapies (Aghotor et al., 2010; Bach 
& Hayes, 2002; Gaudiano & Herbert, 2006; Kumar et al., 2010; Moritz et al., 2011) and 
other therapies (Kim et al., 2010; Schramm et al., 2007). Additionally, some studies 
included control groups that had more contact with a therapist than usual treatment. This 
is thought to mediate the summary effect (Button & Munafò, 2015; Wykes et al., 2008), 
therefore all studies were categorised into two groups: probable extra contact with a 
therapist in the control group (Bach & Hayes, 2002; Bechdolf et al., 2004; Gaudiano & 
Herbert, 2006; Haddock et al., 1999; Kim et al., 2010; Lewis et al., 2002; Moritz et al., 
2011; Schramm et al., 2007) and no probable extra contact with a therapist in the control 
group (Aghotor et al., 2010; Habib et al., 2015; Hall & Tarrier, 2003; Hayashi et al., 2001; 
Kumar et al., 2010; Shelley et al., 2001; Startup et al., 2004). Details of therapies and 
control group categories can be found in Table 1, Table 3 and Table 4 (page 37, 45 and 
47). Additional subgroup analysis was conducted to explore the moderating role of 
diagnosis in the depression symptom outcome. Three diagnostic groups were identified: 
depression (Bowers, 1990; Miller et al., 1989; Schramm et al., 2007), psychosis (Habib 
et al., 2015; Hall & Tarrier, 2003; Mortan et al., 2011) and ‘other’ which included one 
study which evaluated the effectiveness of therapy for behaviours of self-harm (Gibson 
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et al., 2014). As only one study was included in the ‘other’ group it was excluded from 
this subgroup analysis.  
 
3.2.9 Sensitivity Analyses  
Startup et al. (2004) only reported 6- and 12-month follow-up data, therefore 6-month 
data was used in the post treatment analysis and 12-month data was used as follow-up 
data. Sensitivity analysis was carried out to investigate the effect of excluding Startup et 
al. (2004) from post PANSS total score and follow-up PANSS total score.  
 
3.2.10 Analysis of homogeneity and publication bias  
The I-squared statistic was calculated to determine the proportion of homogeneity in 
outcome estimates (Lipsey & Wilson, 2001). Heterogeneity was investigated further if 
the proportion was judged to be at least moderate, defined as an I-squared value of 40% 
or more (Higgins & Green, 2011). Duval and Tweedie’s Trim and Fill method (Duval & 
Tweedie, 2000) was used to look for missing studies due to publication bias where ten or 
more studies were included in the analysis (see Appendix 5 for Trim and Fill results).  
 
3.3 Results 
A total of 512 studies were retrieved from searching online databases, 13 were retrieved 
from searching reference lists of included studies and meta-analyses, reviews and other 
relevant studies (Jauhar et al., 2014; Lynch et al., 2010; Mehl, Werner, & Lincoln, 2015; 
Turner, et al., 2014) and one unpublished study was found from emailing relevant authors. 
Of the 526 reports that were examined, 20 individual studies (described in 27 separate 
reports) were identified for inclusion in one or more of the meta-analyses (Aghotor, et al., 
2010; Bach & Hayes, 2002; Bechdolf et al., 2004; Bowers, 1990; Gaudiano & Herbert, 
2006; Gibson,et al., 2014; Habib, et al., 2015; Haddock et al., 1999; Hall & Tarrier, 2003; 
Hayashi, et al., 2001; Kim, et al., 2010; Kumar et al., 2010; Lewis et al., 2002; Miller, et 
al., 1989; Moritz, et al., 2011; Mortan, et al., 2011; Schramm et al., 2007; Shelley, et al., 
2001; Startup, et al., 2004; Veltro et al., 2006). The process of study selection is 
summarised in the PRISMA flow diagram (Figure 2, page 40) and a list of studies 
excluded after inspection of the full-text is provided in the appendices (Appendix 6).
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Figure 2 PRISMA flow diagram 
27 studies included in meta-
analysis (20 individual trials) 
186 full text articles assessed 
for eligibility  
Articles excluded (159): 
Participants were not acute inpatients, 
treatment being explored was not 
psychotherapy, psychotherapy was not 
delivered in an acute mental health 
inpatient service or comparator was not 
adequate/was not a controlled trial (128). 
Not in English (12). 
Incomplete, or unclear data (after 
contacting authors), symptoms outcome 
measures not reported. (15). 
Other (3). 
 
1 full text untraced (thesis). 
449 records screened (titles 
and abstracts) after duplicates 
removed (77).  Records excluded 263 
512 records identified 
through database 
14 records found from other sources: 13 
Records found within reference lists of  
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3.3.1 Treatment characteristics 
Eleven trials examined CBT (Bechdolf et al., 2004; Bowers, 1990; Habib, et al., 2015; 
Haddock et al., 1999; Hall & Tarrier, 2003; Lewis et al., 2002; Miller, et al., 1989; 
Mortan, Set al., 2011; Shelley, et al., 2001; Startup, et al., 2004; Veltro et al., 2006), and 
the remaining examined MCT (k=3) (Aghotor et al., 2010; Kumar et al., 2010; Moritz et 
al., 2011), ACT (k=2) (Bach & Hayes, 2002; Gaudiano & Herbert, 2006), dialectical 
behaviour therapy (DBT; k=1) (Gibson et al., 2014), eye-movement desensitisation and 
reprocessing (EMDR; k=1) (Kim et al., 2010), interpersonal psychotherapy (IPT; k=1) 
(Schramm et al., 2007) or social skills training (SST; k=1) (Miller et al., 1989) (see Table 
4, page 47, for therapy descriptions). One trial investigated the effectiveness of a 
‘psychological approach’, which in content appeared to be similar to CBT and was 
therefore included in the CBT category for subgroup analysis (Hayashi et al., 2001). 
Seven studies used a group format to deliver treatment, eleven used an individual format 
and two used a mixture of both. The period between baseline and post treatment 
assessment ranged between 2 and 12 weeks. The total number of sessions available 
ranged between 3 and 54, and the number of sessions available per week was between 1 
and 7. The actual number of hours of therapy available ranged widely, between 3 and 133 
(see Table 2, p43). 
 
3.3.2 Comparator Characteristics 
Sixteen trials compared psychological therapy to TAU alone (k=13) or to TAU plus a 
comparator intervention (i.e. relaxation therapy (k=2), and supportive counselling (k=1)). 
The remaining trials compared psychological therapy to psychoeducation (k=2), 
cognitive remediation (k=1) and supportive counselling (k=1). See Table 3 (page 45) for 
a description of comparators. 
 
3.3.3 Risk of Bias  
As shown in Table 5 (page 51) the studies tended to perform well with regards to random 
sequence generation, with a minority (k=4) judged to have a high risk of bias in this area, 
due to non-randomisation. However, the studies performed very poorly in relation to 
selective reporting bias, with all but two being judged to have a high risk of bias due to a 
lack of preregistration (k=18). Attrition bias was also judged to be high, with over half of 
the studies being judged to have a high risk of this bias (k=11-14). Almost all studies 
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were judged to have a high risk of performance bias due to an unavoidable lack of 
blinding of personnel and participants, due to the nature of the interventions. Over half of 
the studies had a high risk of detection bias because assessors were aware of groups that 
participants were allocated to. Risk of bias ratings for individual studies can be found in 
the Table 5 (page 51) and further detail and justification for these ratings can be found in 
Appendix 7.  
 
A summary of outcome quality ratings can be found in the Table 6 (page 57). Of the 20 
outcomes (including subgroup outcomes), 12 were rated as very low quality, 8 were rated 
low and none were rated as moderate or high. Further detail of these ratings can be found 
in table 5 and justification for ratings can be found in Appendix 8.  
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Table 2 
Summary of study interventions  
Name 
Intervention 
type 
Extra therapy 
info Format 
Duration 
(weeks) 
Number of 
sessions 
(total) 
No. 
sessions 
(per 
week) 
Length 
of 
session 
(mins) 
Total 
offered 
(mins) 
Aghotor (Aghotor et al., 2010) 
MCT Focus on 
schizophrenia Group 4 8 2 60 480 
Bach (Bach & Hayes, 2002) ACT Focus on psychosis Individual 2 4 1-4 50 200 
Bechdolf (Bechdolf et al., 2004) CBT Focus on 
schizophrenia Group 8 16 2 90 1440 
Bowers (Bowers, 1990) CT Focus on depression Individual Unclear 12 7 50 600 
Gaudiano (Gaudiano & Herbert, 2006) ACT Focus on psychosis Individual Unclear 3 Unclear 60 180 
Gibson (Gibson et al., 2014) DBT Focus on DSH Group 6 24 4 60 1440 
Habib (Habib et al., 2015) CBT Focus on psychosis Individual 8 16 2 60 960 
Haddock (Haddock et al., 1999) 
CBT Focus on early psychosis Individual 5 
17.5 (+4 
booster 
outpatient) 
4 50 875 
Hall (Hall & Tarrier, 2003) 
CBT 
Focus on low self-
esteem in 
psychosis 
Individual 7 7 1 Unclear Unclear 
Hayashi (Hayashi et al., 2001)  Psychological 
approach 
Focus on 
schizophrenia Individual 8 8 1 50 400 
Kim (Kim et al., 2010) EMDR Focus on 
schizophrenia Individual 3 3 1 90 270 
  
44
Table 2 
Summary of study interventions  
Name 
Intervention 
type 
Extra therapy 
info Format 
Duration 
(weeks) 
Number of 
sessions 
(total) 
No. 
sessions 
(per 
week) 
Length 
of 
session 
(mins) 
Total 
offered 
(mins) 
Kumar (Kumar et al., 2010) MCT Focus on 
schizophrenia Group 4 8 2 60 480 
Lewis (Lewis et al., 2002) 
CBT Focus on early 
schizophrenia Individual 5 
17.5 (+4 
booster 
outpatient) 
4 50 875 
Miller (Miller et al., 1989) CT + SST Focus on depression Individual Unclear Unclear 7 50 Unclear 
Moritz (Moritz et al., 2011) 
MCT 
Focus on 
delusional 
symptoms in 
schizophrenia 
Group + 
individual Unclear 8 Unclear 60 480 
Mortan (Mortan et al., 2011) 
CBT 
Focus on coping 
with auditory 
hallucinations 
Group 5 10 2 80 8000 
Schramm (Schramm et al., 2007) IPP Focus on depression 
Group + 
individual 5 15 3 50 750 
Shelley (Shelley et al., 2001) CBT Symptom specific Group 12 54 5 Unclear Unclear 
Startup (Startup et al., 2004) CBT Focus on acute 
schizophrenia Individual Unclear 25 Unclear 90 2250 
Veltro (Veltro et al., 2006) CBT Focus on group for inpatients Group Unclear Unclear Unclear 90 Unclear 
ACT, Acceptance and Commitment Therapy; CBT, Cognitive Behavioural Therapy; CT, Cognitive Therapy; DBT, Dialectical Behaviour Therapy; DSH, Deliberate 
Self Harm; EMDR, Eye Movement Desensitisation Reprocessing; IPP, Interpersonal Psychotherapy; MCT, Metacognitive Therapy/Training; SST, Social Skills 
Training. 
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Table 3 
Characteristics of control conditions 
Control Definition N of studies 
N of 
participants 
receiving 
intervention Studies 
Usual Treatment 
Newspaper discussion 
group (grouped as TAU) 
Described in the study as a group discussion of issues 
in a current newspaper. Participants were also asked 
to discuss and summarise these topics and received 
usual treatment such as medication.  
1 14 Aghotor (Aghotor et al., 2010) 
TAU a TAU refers to usual treatment received by inpatients. 
This varies between studies, however all participants 
in these studies received just usual treatment.  
12 410 Bowers (Bowers, 1990); Gibson 
(Gibson et al., 2014); Habib (Habib 
et al., 2015); Hall (Hall & Tarrier, 
2003); Hayashi (Hayashi et al., 
2001); Kumar (Kumar et al., 2010); 
Lewis (Lewis et al., 2002); Miller 
(Miller et al., 1989); Mortan (Mortan 
et al., 2011); Shelley (Shelley et al., 
2001); Startup (Startup et al., 2004); 
Veltro (Veltro et al., 2006) 
TAU including 
psychotherapy (TAUP)b 
This varied between studies but includes some form 
of individual therapy (described as individual 
psychotherapy sessions with a psychologist or 
psychoeducation) with a focus on psychoeducation, 
stress management, mood management, anxiety 
management, exercise groups, craft groups, and 
symptom identification. All participants in these 
studies (control and intervention) received TAUP.  
3 60 Bach (Bach & Hayes, 2002); 
Gaudiano (Gaudiano & Herbert, 
2006); Kim (Kim et al., 2010) 
Total   16 514 
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Table 3 
Characteristics of control conditions 
Control Definition N of studies 
N of 
participants 
receiving 
intervention Studies 
Less sophisticated control interventions 
Supportive Counselling  A talking therapy described as delivering basic 
assessment, psycho-education and counselling in a 
supportive and empathetic unstructured style. Often 
used as an active comparator to psychological 
therapy to control for therapy time.  
2 117 Haddock (Haddock et al., 1999); 
Lewis (Lewis et al., 2002) 
Psycho-educationc Provision of information relating to patients’ mental 
health diagnosis to aid understanding and coping. 
This intervention is commonly delivered in a group 
setting. Substantial variations exist within this 
intervention as it can act as a means to provide 
information or teaching coping skills.  
2 109 Bechdolf (Bechdolf et al., 2004); 
Schramm (Schramm et al., 2007) 
PMR/Relaxation 
Therapy 
PMR is led by a therapist. It is used to monitor and 
control the tension of muscles with the aim to relax.  
2 19 Bowers (Bowers, 1990); Kim (Kim 
et al., 2010) 
Cognitive Remediation d Neuropsychological therapy consisting of exercises 
that aim to improve cognitive processing and 
functioning such as memory, attention and problem 
solving.  
1 24 Moritz (Moritz et al., 2011) 
Total  7 239  
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Table 3 
Characteristics of control conditions 
Control Definition N of studies 
N of 
participants 
receiving 
intervention Studies 
TAU, Treatment as Usual; TAUP, Treatment as Usual with Psychotherapy; PMR, Progressive Muscle Relaxation.  
a. medication alone (MA) (Miller et al., 1989) and waiting list (Gibson et al., 2014) also used to describe TAU. 
b. Enhanced treatment as usual (ETAU) also used to describe TAUP 
c. Clinical management also used to describe psycho-education. 
d. Cognitive Remediation is a psychologically active therapy, however differs from psychotherapies included in this analysis as it targets cognitive 
processes rather than cognition and behaviour and can therefore be used as a control.  
 
 
Table 4 
Characteristics of included therapies 
Treatment Definition N of studies 
N of participants 
receiving intervention Studies 
Metacognitive 
Training/Therapy 
Encourages thinking about thinking. Aims to 
identify typically negative cognitive bias 
such as dysfunctional attribution styles, 
jumping to conclusions, over confidence in 
errors, negative schemata. Therapy aims to 
address these and challenge them. 
3 46 Aghotor (Aghotor et al., 
2010); Kumar (Kumar et 
al., 2010); Moritz (Moritz 
et al., 2011) 
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Table 4 
Characteristics of included therapies 
Treatment Definition N of studies 
N of participants 
receiving intervention Studies 
Cognitive Behavioural Therapy Uses techniques such as formulation, 
problem solving, guided discovery, reality 
testing, distraction techniques, exposure, 
rational responding and more. It aims to 
increase awareness of connections between 
thoughts, behaviours and mood in order 
begin change. 
10 868 Bechdolf (Bechdolf et al., 
2004); 
Bowers (Bowers, 1990); 
Habib (Habib et al., 2015); 
Haddock (Haddock et al., 
1999); Hall (Hall & Tarrier, 
2003);  
Lewis (Lewis et al., 2002); 
Miller (Miller et al., 1989); 
Mortan (Moritz et al., 
2011); Startup (Startup et 
al., 2004); Veltro (Veltro et 
al., 2006) 
Acceptance and Commitment 
Therapy  
Mindfulness and acceptance exercises are 
used to address and decrease avoidance and 
difficult internal experiences (e.g. disturbing 
thoughts and emotions). 
2 52 Bach (Bach & Hayes, 
2002); Gaudiano 
(Gaudiano & Herbert, 
2006) 
Dialectical Behaviour Therapy  Derives from CBT. It aims to change harmful 
behaviours with a particular focus on 
regulating and reducing intense emotional 
distress. Often targets behaviours such as 
deliberate self-harm, eating problems and 
substance abuse. Acceptance is a key focus of 
therapy. 
1 58 Gibson (Gibson et al., 
2014) 
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Table 4 
Characteristics of included therapies 
Treatment Definition N of studies 
N of participants 
receiving intervention Studies 
Psychological Approach Described as creating a collaborative 
approach with a focus on self-esteem. 
Patients’ attitudes and understanding of their 
illness are discussed and new perspectives 
are encouraged. Psycho-educational 
techniques are also used. Content described 
similarly to CBT therefore grouped as CBT 
for analysis. 
1 25 Hayashi (Hayashi et al., 
2001) 
Eye Movement Desensitization 
& Reprocessing  
A psychological therapy used to release 
blocked traumatic memories with continuous 
sounds, taps or eye movements. Stressful life 
event, trauma experienced during childhood 
or adulthood, distressing psychotic 
symptoms or adversities related to treatment 
were key focuses. 
1 11 Kim (Kim et al., 2010) 
Interpersonal Psychotherapy  IPP primarily focuses on the way our 
relationships affect us and also how other 
mental health difficulties can affect our 
relationships. 
1 63 Schramm (Schramm et al., 
2007) 
Rational Emotive Behaviour 
Therapy  
Described as a specific type of CBT. It 
focuses on resolving emotional and 
behavioural disturbances. Grouped as CBT. 
1 25 Shelley (Shelley et al., 
2001) 
Social Skills Training  A psychotherapy used to improve social 
skills. Primarily behavioural, however can 
involve some cognitive elements.  
1 10 Miller (Miller et al., 1989) 
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Table 4 
Characteristics of included therapies 
Treatment Definition N of studies 
N of participants 
receiving intervention Studies 
CBT, Cognitive Behavioural Therapy; IPP, Interpersonal Psychotherapy. 
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Table 5 
Summary of risk of bias ratings 
Study 
Random 
sequence 
Allocation 
concealment 
Blinding of 
participants and 
personnel 
Blinding of 
assessor 
(symptom 
outcomes) 
Blinding of assessor 
(readmissions outcome) 
(N/A: study does not report 
readmission data) 
Incomplete 
data 
(attrition 
bias) 
Selective 
outcome 
reporting 
Aghotor et al. 
(2010) Low High High Low N/A High High 
Bach & Hayes 
(2002) Low Unclear Low High Low High High 
Bach et al. (2013)a Low High High High Low Low High 
Bechdolf et al. 
(2004) Low Low High Low Low High High 
Bowers (Bowers, 
1990) Low Unclear High Low N/A High High 
Gaudiano 
(Gaudiano & 
Herbert, 2006) 
Low High High High Low Low High 
Gibson (Gibson et 
al., 2014) High Unclear High Unclear N/A High High 
Habib (Habib et 
al., 2015) Low Unclear High Low N/A High High 
Haddock 
(Haddock et al., 
1999) 
Low Unclear Low Low Low Low High 
Hall (P. L. Hall & 
Tarrier, 2003) Low Low High High N/A High High 
Hayashi (Hayashi 
et al., 2001) Low Unclear High High N/A High High 
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Table 5 
Summary of risk of bias ratings 
Study 
Random 
sequence 
Allocation 
concealment 
Blinding of 
participants and 
personnel 
Blinding of 
assessor 
(symptom 
outcomes) 
Blinding of assessor 
(readmissions outcome) 
(N/A: study does not report 
readmission data) 
Incomplete 
data 
(attrition 
bias) 
Selective 
outcome 
reporting 
Kim (Kim et al., 
2010) Low Unclear High Low Unclear Low
b
 Highb Low 
Kumar (Kumar et 
al., 2010) Low Low High Unclear N/A High High 
Lewis (S. Lewis et 
al., 2002) Low Low High Low N/A Low
a
 Higha High 
Miller (I. W. 
Miller et al., 1989) Low Unclear High High N/A High High 
Moritz (Moritz et 
al., 2011) Low Low Low Low N/A Low Low 
Mortan (Mortan et 
al., 2011) High Unclear High Unclear N/A High High 
Schramm 
(Schramm et al., 
2007) 
Low Unclear High Low Unclear Highb Lowb High 
Shelley (Shelley et 
al., 2001) High Unclear High High Unclear High High 
Startup (M Startup 
et al., 2004) Low Low High High N/A High High 
Veltro (Veltro et 
al., 2006) High High High N/A Unclear N/A High 
H, high risk of bias; L, low risk of bias; N/A, not applicable; Unclear, unclear risk of bias. 
a. Bach (Bach et al., 2013) carries out an intention to treat analysis using data from Bach (Bach & Hayes, 2002) and Gaudiano (Gaudiano & Herbert, 
2006), therefore data from Bach (Bach et al., 2013) was used in outcomes where Bach (Bach & Hayes, 2002) and Gaudiano (Gaudiano & Herbert, 
2006) were both included. 
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Table 5 
Summary of risk of bias ratings 
Study 
Random 
sequence 
Allocation 
concealment 
Blinding of 
participants and 
personnel 
Blinding of 
assessor 
(symptom 
outcomes) 
Blinding of assessor 
(readmissions outcome) 
(N/A: study does not report 
readmission data) 
Incomplete 
data 
(attrition 
bias) 
Selective 
outcome 
reporting 
b. Complete data at post intervention but incomplete data at follow-up.  
 
  
54
3.3.4 Outcomes 
The results of all meta-analyses and subgroup analyses are reported below and in Table 
6 (page 57). Forest plots for subgroup analyses are available in the supplement.  
 
3.3.4.1 Psychotic symptoms (primary outcome) 
Fifteen studies reported post-intervention symptom data, and the pooled estimate 
suggested psychological therapy was associated with a small to medium benefit over 
comparators (SMD -0.39; CI -0.64, -0.14; p=0.00) (see Figure 4, page 55). Heterogeneity 
was high (I²=68%) but there was no clear evidence of publication bias. The quality of the 
evidence was downgraded due to the majority of included studies having been judged as 
having a high risk of bias on more than one domain, including selective reporting, 
incomplete data and non-blinding of assessors. Six studies were included in the analysis 
for follow-up PANSS total scores. The overall effect was small (SMD -0.21) and not 
significant (CI -0.52 to 0.09) (see Figure 5, page 55). Moderate heterogeneity (I²=59%), 
wide confidence intervals (including both a moderate effect favouring intervention and a 
small effect favouring control) and high risk of bias meant the evidence was judged to be 
very low in quality. There were too few studies to assess publication bias. Startup, et al. 
(2004) did not report end of treatment data (Startup et al., 2004), but inclusion of their 6-
month follow-up data in the end of treatment meta-analysis and their 12-month follow-
up data in the follow-up meta-analysis had no effect on these estimates.  
 
3.3.4.2 Depression and anxiety (secondary outcomes) 
Data from six studies suggested psychological therapy had a moderate effect on 
depression when compared to comparators (k=7, SMD -0.49, CI -0.83 to -0.15, p = 0.01) 
(see Figure 6, page 56). Inclusion of follow-up data from Startup et al. (2004) had no 
effect on estimates. Four studies provided data on anxiety. The pooled estimate suggested 
psychological therapy had a moderate to large benefit at end of treatment (k=4, SMD -
0.68, CI -1.29 to -0.07, p = 0.03) (see Figure 7, page 56). Imprecision and risk of detection 
bias, selective reporting bias and attrition bias meant the evidence was judged to be very 
low in quality. Some heterogeneity was observed (depression I²=50%; anxiety I²=60%), 
however there was a clear direction of effect for both estimates. There were too few 
studies to assess publication bias.  
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Study name Statistics for each study Hedges's g 
and 95% CIHedges's Lower Upper 
g limit limit
Bechdolf 2004 0.166 -0.250 0.583
Hall 2003 -1.009 -1.954 -0.064
Kim 2010 -0.092 -0.822 0.637
Lewis 2002 -0.109 -0.426 0.208
Schramm 2007 0.000 -0.384 0.384
Startup 2004 -0.780 -1.287 -0.273
-0.214 -0.523 0.094
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Psychotic symptoms at follow-up 
Meta Analysis
Figure 5 Forest plot showing SMD of psychotic symptoms at follow-up 
Figure 4 Forest plot showing SMD of psychotic symptoms at post-intervention 
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper 
g limit limit
Aghotor 2010 -0.224 -0.973 0.525
Bach 2002 -0.444 -1.060 0.172
Bechdolf 2004 0.289 -0.129 0.707
Gaudiano 2006 -0.444 -1.060 0.172
Habib 2015 -1.048 -1.682 -0.413
Haddock 0.532 -0.328 1.392
Hall 2003 -1.152 -2.008 -0.296
Hayashi 2001 -0.248 -0.796 0.300
Kim 2010 -0.105 -0.754 0.544
Kumar 2010 -0.619 -1.570 0.332
Lewis 2002 -0.025 -0.348 0.297
Moritz 2011 -0.449 -1.013 0.115
Schramm 2007 -0.242 -0.594 0.109
Shelley 2001 -1.540 -2.177 -0.904
Startup 2004 -0.564 -1.051 -0.077
-0.391 -0.640 -0.143
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Psychotic symptoms
Meta AnalysisFigure 3 Forest plot showing SMD of psychotic symptoms at post-intervention 
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Study name Statistics for each study Hedges's g 
and 95% CIHedges's Lower Upper 
g limit limit
Gibson -1.13 -1.69 -0.56
Hall -1.21 -2.07 -0.34
Kim -0.11 -0.76 0.54
Morton -0.15 -1.23 0.94
-0.68 -1.29 -0.07
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Anxiety
Meta Analysis
Figure 6 Forest plot showing SMD of symptoms of depression 
Figure 7 Forest plot showing SMD of symptoms of anxiety 
Study name Statistics for each study Hedges's g 
and 95% CIHedges's Lower Upper 
g limit limit
Bowers -0.436 -1.183 0.311
Gibson -1.125 -1.690 -0.561
Hall -1.205 -2.067 -0.343
Kim -0.108 -0.757 0.541
Miller -0.012 -0.604 0.580
Mortan -0.148 -1.234 0.939
Schramm -0.402 -0.755 -0.048
-0.486 -0.826 -0.146
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Depression
Meta Analysis
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Table 6 
Summary of results of meta-analyses and subgroup analyses 
Outcomes (k studies) N 
SMD or 
OR 95% CI P Z-Score I² (%) Tau T² 
Quality 
rating 
Post PANSS total (15) 993 -0.39 -0.64, -0.14 0.00 -3.44 67.86 0.41 0.17 VL 
Post PANSS total (randomised and 
single-blind studies) (8) 686 -0.16 -0.45, 0.13 0.28 -1.08 56.10 0.30 0.09 VL 
Post PANSS total (non-randomised 
and non-blind studies) (7) 307 -0.68 -1.02, -0.35 0.00 -3.44 49.79 0.33 0.11 VL 
Post PANSS total (probable contact 
with therapist in control group) (8) 520 -0.12 -0.38, 0.13 0.35 -0.94 30.68 0.17 0.03 L 
Post PANSS total (no probable 
contact with therapist in control 
group) (7) 
295 -0.75 -1.06, -0.44 0.00 -4.67 55.04 0.38 0.14 VL 
Post PANSS total CBT (8) 670 -0.44 -0.80, -0.07 0.02 -2.33 82.06 0.59 0.34 VL 
Post PANSS total third-wave (5) 170 -0.43 -0.92, 0.06 0.09 -1.72 0.00 0.00 0.00 VL 
Post PANSS total other (2) 
153 -0.18 -0.89, 0.52 0.61 -0.51 0.00 0.00 0.00 L 
Follow-up PANSS total (6) 501 -0.21 -0.52, 0.09 0.18 -1.35 58.50 0.29 0.08 VL 
Follow-up PANSS total (randomised 
and single-blind studies) (4) 420 -0.01 -0.22, 0.19 0.91 -0.12 0.00 0.00 0.00 VL 
Follow-up PANSS total (non-
randomised and non-blind studies) 
(2) 
81 -0.83 -1.28, -0.38 0.00 -3.64 0.00 0.00 0.00 VL 
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Readmissions (7) 1376 0.62 (OR) 0.46, 0.84 0.00 -3.05 11.34 0.14 0.02 L 
Readmissions (randomised and 
single-blind studies) (4) 523 0.83 (OR) 0.54, 1.28 0.40 -0.85 0.00 0.00 0.00 L 
Readmissions (non-randomised and 
non-blind studies) (3) 853 0.52 (OR) 0.37, 0.73 0.00 -3.77 0.00 0.00 0.00 L 
Depression (7) 
338 -0.49 -0.83, -0.15 0.01 -2.80 49.65 0.32 0.10 VL 
Depression (randomised and single-
blind studies) (3) 183 -0.32 -0.83, 0.18 0.21 -1.26 0.00 0.00 0.00 L 
Depression (non-randomised and 
non-blind studies) (4) 155 -0.65 -1.14, -0.15 0.01 -2.56 68.33 0.56 0.32 VL 
Depression (psychosis) (3) 74 -0.46 -0.99, 0.08 0.09 -1.84 53.63 0.49 0.00 L 
Depression (depression) (3) 
199 -0.30 -0.69, 0.09 0.14 -2.23 0.00 0.00 0.00 L 
Anxiety (4) 149 -0.68 -1.29, -0.07 0.03 -2.22 59.98 0.48 0.23 VL 
H (high); L, low; M, moderate; OR, odd ratio; PANSS, Positive and Negative Symptom Scale;SMD, Standardised mean difference; VL, very low.  
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3.3.4.3 Readmissions (secondary outcome) 
Six studies provided readmission data, and together these suggested that active 
psychological therapy reduced the odds of readmission by just over a third (OR 0.62, CI 
0.46, 0.84, z=-3.05, p=0.00) (see Figure ). No heterogeneity was observed (I²=0%), 
however the relative weight was not evenly distributed between studies with one study 
(Veltro et al., 2006) contributing approximately 50%. Excluding this study did not change 
the magnitude or the significance of the effect (OR=0.68, CI 0.47 to 0.99). The quality of 
evidence was judged to be low because of a high risk of detection bias, attrition bias and 
selective reporting bias. There were too few studies to assess publication bias.  
 
Figure 7  Forest plot showing OR of readmissions (Bach, 2012 includes data from Bach 
& Hayes, 2002 and Guadiano, et al., 2006). 
 
3.3.5 Moderator analyses  
3.3.5.1 Randomisation and single blinding 
Eight studies were randomised and single-blind in the primary outcome (Aghotor et al., 
2010; Bechdolf et al., 2004; Habib et al., 2015; Haddock et al., 1999; Kim et al., 2010; 
Lewis et al., 2002; Moritz et al., 2011; Schramm et al., 2007), while seven studies were 
not (Bach & Hayes, 2002; Gaudiano & Herbert, 2006; Hall & Tarrier, 2003; Hayashi et 
al., 2001; Kumar et al., 2010; Shelley et al., 2001; Startup et al., 2004). The overall effect 
Study name Odds ratio 
and 95% CIOdds Lower Upper 
ratio limit limit
Bach 2012 0.419 0.191 0.919
Bechdolf 2005 0.413 0.116 1.469
Kim 2010 0.357 0.058 2.217
Lewis 2002 0.999 0.602 1.659
Schramm 2007 0.764 0.192 3.039
Veltro 2006 0.545 0.373 0.796
0.619 0.455 0.842
0.10.2 0.5 1 2 5 10
Psychotherapy Control
Readmissions
Meta Analysis
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of treatment on psychotic symptoms at post treatment increased when randomised single-
blind studies were excluded (SMD -0.68, CI=-1.02, -0.35; p=0.00), and decreased when 
studies without randomisation and single-blinding were excluded (SMD -0.16, CI=-0.45, 
0.13; p=0.28). This difference was significant (Q=5.47, df=1, p=0.02), suggesting that 
study quality was significantly and inversely associated with estimates of effectiveness 
in this domain. However, both overall estimates were judged to be very low quality, partly 
because dividing the data like this introduced imprecision to both estimates. At follow-
up, randomised studies with single-blinding (k=4) suggested there was no effect of 
therapy on symptoms (SMD -0.01, CI-0.22, 0.19; p=0.91; very low quality evidence), 
whereas non-randomised studies with no single-blinding (k=2) suggested there was a 
large effect (SMD -0.83, CI -1.28, -0.38; p=0.00; very low-quality evidence). Again, this 
difference was significant (Q=10.71, df=1, p=0.00).  
 
Randomisation and single-blinding did not emerge as a significant moderator of 
readmission (Q=2.78, df=1, p=0.10). However, the overall effect size in four randomised 
and single-blind studies was small and non-significant compared to control (0.83; CI 0.54, 
1.28; p=0.40; low quality evidence). The evidence was rated as low quality because 
included studies were judged to have a high risk of bias and because the confidence 
intervals for the estimate were very wide. The overall effect size for three studies without 
randomisation and single-blinding compared to all controls was larger and significant -
0.52 (CI 0.37, 0.73; p=0.00; low quality evidence). Psychological therapy had a small 
non-significant effect on depression in randomised and single-blind studies (SMD -0.32 
CI-0.83, 0.18; p=0.21) and a moderate to large effect in non-randomised studies that were 
not single-blind (SMD -0.65 (CI -1.14, -0.15; p=0.01), however this difference was not 
significant (Q=0.84, df=1, p=0.36). These outcomes were judged to be low and very low 
in quality, respectively, in part because of the risk of bias in the individual studies and in 
part because the estimate was imprecise. There were too few studies to examine the 
relationship between study quality and the effect of therapy on anxiety. 
 
3.3.5.2 Therapy type  
The overall effect of treatment on psychotic symptoms at end of treatment was not 
significantly moderate by therapy type (Q=0.43, df=2, p=0.81). CBT (k=8) had an overall 
moderate effect (SMD -0.44, CI -0.80, -0.07; p=0.02; very low quality evidence). ‘Third-
Wave’ approaches (k=5) had an effect of similar size (SMD, -0.43, CI -0.92, 0.06; p=0.09; 
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very low quality evidence) and ‘other’ approaches (k=2) combined had a small, non-
significant effect (SMD -0.18 (CI -0.89, 0.52; p=0.61; low quality evidence). 
 
3.3.5.3 Contact with a therapist in the control group  
Probable contact with a therapist in the control group emerged as a significant moderator 
of treatment effect on psychotic symptoms at end of treatment. The effect of active 
therapy in trials where there was no probable therapist contact in the control group (k=7) 
was large (SMD -0.75, CI=-1.06, -0.44; p=0.00; very low quality evidence), and 
significantly higher (Q=9.46, DF=1, p=0.00) than the effect size for studies with probable 
therapist contact in the control group (k=8; SMD = -0.12, CI=-0.38, 0.13; p=0.35; low 
quality evidence). 
 
3.3.5.4 Diagnosis (post hoc analysis) 
A post hoc analysis found no evidence that participant diagnosis moderated the effect of 
therapy on depression (Q=4.05, df=2, p=0.13). The effect of psychological therapy on 
depression was moderate but non-significant in trials where participants also had 
psychosis (k=3; SMD -0.46, CI -0.99, 0.08; p=0.09; low quality evidence), and small but 
non-significant where participants had depression only (k=3; SMD -0.30, CI -0.69, 0.09; 
p=0.14; low quality evidence), however these estimates were not significantly different.  
 
3.4 Discussion 
This review provided the first meta-analytical assessment of findings from controlled 
trials of brief psychological intervention for acute psychiatric inpatients. The review 
focused on clinician and patient important outcomes: psychotic symptoms, risk of 
readmission, and emotional distress (depression and anxiety). Overall, psychological 
therapy was significantly more effective than control groups in reducing psychotic 
symptoms at post treatment, risk of readmissions and emotional distress. However, like 
other meta-analyses of psychological intervention for severe mental illness (Turner et al., 
2014; Wykes et al., 2008), randomisation and assessor blinding, together, emerged as a 
significant mediator of effect for some outcomes. Findings from randomised and single-
blind studies suggest that brief psychological intervention is not effective in reducing 
psychotic symptoms for acute inpatients. Although not significant, there is also some 
promising evidence that suggests brief psychological intervention may reduce emotional 
distress (depression and anxiety) and the risk of readmission for some acute inpatients in 
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studies which are randomised and single-blind. Each outcome will now be examined, 
followed by a discussion of strengths and limitations of this study. 
 
3.4.1 Main findings 
Psychotic symptoms 
A total of 14 studies reported psychotic symptoms and included mostly participants with 
a diagnosis of psychosis. Meta-analysis of these produced a small to medium effect (-
0.39), which is consistent with previous trials and meta-analyses of psychotherapy for 
psychosis (Turner et al., 2014; Wykes et al., 2008) and of antipsychotics such as 
quetiapine (Hutton, Taylor, Mulligan, Tully, & Moncrieff, 2015) and clozapine 
(Moncrieff, 2003). A high degree of heterogeneity was identified across studies which 
was explored using subgroup analyses of therapy type, contact with a therapist in the 
control group, and the use of randomisation and assessor blinding. Therapy type was not 
a significant moderator of treatment effect of overall psychotic symptoms, however CBT 
(-0.44) and third-wave therapies (-0.43) had larger effects than other therapies (-0.18). 
Previous meta-analyses, of mostly outpatients with psychotic symptoms, have shown 
different therapies have varying effects, depending on the type of psychotic symptoms 
targeted (Turner et al., 2014; Zimmermann, Favrod, Trieu, & Pomini, 2005). Perhaps 
taking this approach to investigate psychological interventions for acute inpatient with 
psychosis in future studies would be informative.  
 
Extra contact with a therapist in the control group (i.e. psycho-education, supportive 
counselling or unstructured therapy time) significantly moderated the overall treatment 
effect. Similar patterns of effect have previously been acknowledged (Button & Munafò, 
2015). However, it is important to note that some of the included trials (Haddock et al., 
1999; Bechdolf, et al., 2004; Lewis, et al., 2002), one of which had a large sample size 
(Lewis et al., 2002), used less sophisticated control interventions (labelled by the authors 
as psycho-education or supportive counselling) which contained components that 
resemble CBTp: formulation, relapse prevention and guided discovery (Morrison & 
Barratt, 2010). It is possible that treatment in the control group was too similar to the 
intervention of interest to produce a difference in effect. Alternatively, it may simply be 
that time with a therapist during an acute hospital admission is particularly beneficial for 
inpatients, despite therapy type. However further work is necessary to investigate whether 
this is true, and if it is, exactly why therapist time is important for inpatients and whether 
therapy type is important. Given that few acute psychiatric inpatient services routinely 
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offer time with a therapist (British Psychological Society, 2012; Joint Commissioning 
Panel for Mental Health, 2013; Sainsbury Centre for Mental Health, 2005), the 
implications for service design are clear.  
 
As expected, randomisation and single-blinding also significantly moderated treatment 
effects. Excluding randomised and single-blind studies inflated the effect size (-0.68), 
while excluding studies that were not randomised or single-blinded decreased the effect 
(-0.16). The direction of this effect is to be expected, as trials lacking randomisation and 
assessor blinding are well known to inflate the overall effect (Higgins & Green, 2011). 
These findings suggest that brief psychological intervention is not beneficial for acute 
inpatient in terms of reducing psychotic symptoms, despite much of the psychotherapy 
evidence base having focussed on this treatment outcome. It is possible that outcomes 
other than psychotic symptoms should be the focus of treatment and associated treatment 
evaluations in future (Birchwood & Trower, 2006). 
 
Readmissions 
Findings showed that psychological intervention was more effective than control in 
reducing risk of readmission. The results suggest that the odds of readmission are reduced 
by approximately 38% after receiving brief inpatient psychotherapy, compared to control. 
This is a substantial reduction. Although the effect of randomisation and single-blinding 
did not emerge as a significant moderator, it is important to note that the overall treatment 
effect reduced when studies that were not randomised or single-blind were excluded, and 
significance was lost. Despite this, the effect suggests that for some people, the odds of 
readmission are reduced by approximately 17% if they receive brief inpatient 
psychological intervention, compared to control. It is possible that significance was lost 
in this outcome due to the small number of studies that were randomised and single-blind 
(k=4) resulting in limited power. Confidence intervals around the treatment effect, 
remained wide, suggesting that only some patients benefit from inpatient psychotherapy. 
However, given that the number of readmissions is a major problem for acute psychiatric 
inpatient services (Care Quality Commission, 2015; Cogan et al., 2012; Information 
Services Division Scotland, 2012), this result may be considered a meaningful difference 
in readmissions that warrants further investigation. Future work should aim to confirm 
such promising results and identify exactly who benefits from psychological therapy, as 
clearly not everyone does.  
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Emotional distress 
Promising results were also found in relation to emotional distress (depression and 
anxiety). Psychological intervention was significantly more effective than controls in 
reducing depression (-0.49) and anxiety (-0.68). However, similar to outcomes of 
psychotic symptoms and readmissions, significance was lost when non-randomised 
studies with no assessor blinding were excluded from the depression outcome. Despite 
this lack of statistical significance, the magnitude of effect survived (-0.33), suggesting 
that brief psychological intervention may be beneficial for some acute inpatients in terms 
of reducing depression. Only three studies that were randomised and single-blinded 
reported depression, therefore it is possible that the small sample size resulted in 
inadequate power to detect significant group differences. Furthermore, the effect of 
randomisation and single-blinding on estimated treatment outcome was not significant, 
however again, this may be due to limited power. Future research is needed to investigate 
these uncertainties further. There were too few randomised, single-blind studies that 
reported anxiety to explore the effect of randomisation and assessor blinding, therefore 
whether this positive result would survive in more rigorous studies is unknown. Further 
research is necessary to confirm the promising results found in this outcome, however 
this initial evidence suggests that therapies which target emotional distress, such as those 
advocated in the Woodhaven approach (described in chapter two), may be appropriate for 
an acute inpatient environment.  
 
Overall, the results of this meta-analysis suggest that while brief psychological therapy 
has little benefit for acute inpatients in terms of reducing psychotic symptoms, it may 
reduce the risk of readmission and emotional distress for some acute inpatients.  
 
3.4.2 Strengths and limitations 
A strength of this study is that, using the MRC framework (Craig et al., 2008, 2013), it 
has informed the primary stages of developing and evaluating complex interventions. 
Another strength of the study is that, for the first time, the evidence base of controlled 
trials of brief acute psychiatric inpatient psychotherapy has been identified, reviewed and 
synthesised using meta-analysis. While this study makes an original contribution to the 
field, a number of limitations should be acknowledged and are discussed below.  
 
The definition of psychological therapy adopted in this review focused on ‘directive’ 
psychotherapies, therefore excluding ‘non-directive’ or ‘less sophisticated’ psychosocial 
  
65
therapies such as befriending and supportive counselling. Whether ‘non-directive’ 
therapies improve outcomes for acute inpatients compared to usual treatment, and 
whether ‘directive’ therapies improve outcomes more than ‘non-directive’ therapies is 
unknown. Given that extra contact with a therapist in the control condition significantly 
decreased the treatment effect in the primary outcome, such uncertainties warrant further 
investigation.  
 
Consistent with the pragmatic aim of the review, there was no restriction on diagnosis or 
therapy type. The diversity of the included studies can be considered both a strength and 
a weakness. While this approach is likely to produce findings of greater relevance to the 
entire (diagnostically diverse) acute inpatient population, it is also likely to produce more 
heterogeneous estimates of effect, therefore conclusions that can be drawn are less 
definitive. A variety of therapies were also included in the meta-analysis, although a large 
proportion were CBT based. This is to be expected given the attention CBT has received 
in recent years, particularly for psychosis. Although effect of therapy type on psychotic 
symptoms was explored, unfortunately there were too few studies to explore this within 
other outcomes. This review is therefore unable to inform which types of therapies are 
most effective in acute psychiatric inpatient services. This study was also unable to shed 
light on an acceptable and effective duration and intensity of therapy due to the small 
sample size. Future work is needed to explore what characteristics of therapy, i.e. type, 
duration, format and intensity, are acceptable and effective for inpatients and is feasible 
to deliver in acute inpatient services. 
 
A potential concern with this meta-analysis is that non-randomised controlled trials were 
included. This increases the possible risk of bias; for example, there is an increased risk 
of selection bias and unbalanced confounding factors between groups in non-randomised 
trials (Higgins & Green, 2011). However, without including these trials, initial evidence 
regarding the effect of brief inpatient psychological intervention on anxiety would not 
have been synthesised, and initial investigation of therapy and control type would not 
have been conducted. Furthermore, study quality was considered throughout this review 
and the moderating effect of randomisation (and assessor blinding) was investigated 
empirically, thus avoiding overstated conclusions drawn from the results.  
 
Another limitation is that effect sizes for continuous data (i.e. all outcomes but 
readmissions) were interpreted using Cohen’s guidance of effect magnitude (Cohen, 
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1988). This interpretation is widely used, therefore allowing for easy comparison between 
studies, however the importance of such effects, in relation to patients and services, are 
context dependent. Therefore although 0.2 is considered a small effect when interpreted 
using Cohen’s terms, it may be a significant effect to someone who is experiencing 
extreme emotional distress or acute psychotic symptoms. However, factors such as time 
and effort involved in receiving therapy, and the potential risk of adverse effects must 
also be taken into consideration.  
 
Although the primary outcome (psychotic symptoms) was observer rated, depression and 
anxiety measures were self-report. It can be argued that self-report measures increase risk 
of bias (Higgins & Green, 2011). However, measures that ask patients directly for their 
perspective can also be considered important and are, in turn, more consistent with the 
person-centred approach (Crawford et al., 2011). With increasing importance placed on 
person centred care, outcomes that are important to patients (e.g. self-rated quality of life, 
self-efficacy and self-esteem) are recommended in mental (and physical) healthcare 
evaluation (Crawford et al., 2011; Guyatt, Oxman, Kunz, Atkins, et al., 2011). 
Unfortunately, due to a lack of reporting, the current review was unable to include such 
outcomes. This was also the case for adverse events. Recording adverse events is 
considered important to assess the potential harm associated with intervention (Duggan, 
Parry, McMurran, Davidson, & Dennis, 2014). Whether brief inpatient psychological 
intervention has positive effects on ‘patient important’ outcomes, or causes adverse 
effects is therefore currently unknown. Future research should aim to include such 
outcomes. 
 
3.4.3 General recommendations for research 
This review and meta-analysis has identified gaps in the current evidence base that may 
be fruitful for future research. For example, further examination of ‘what works for 
whom’ would be useful. Specifically, identification of patient characteristics that predict 
therapy response and non-response would be particularly informative. Additionally, 
investigation of what duration, format and intensity of therapy is acceptable and effective 
for inpatients, and is feasible for inpatient services, is necessary to inform future practice. 
As more evidence emerges, a network meta-analysis comparing all psychosocial 
interventions, ‘directive’ and ‘non-directive’, for acute inpatients would be very 
informative. Network meta-analysis allows for the effectiveness of interventions to be 
compared against each other in the absence of direct comparison in the literature (Mills, 
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Thorlund, & Ioannidis, 2013). However, until then, rigorous, adequately powered, 
definitive trials are recommended to investigate these issues. Specifically, randomisation 
(individual or cluster) and assessor blinding should be implemented in definitive trials, 
and all studies should pre-register the trial protocol in a public domain. This will allow 
more definitive conclusions to be drawn, therefore allowing more specific 
recommendations for practice to be made.  
 
It is recommended that a definitive trial adopts a pragmatic approach that has no 
restriction on diagnosis. A cross-diagnostic sample, as opposed to a diagnostic specific 
sample, will represent the diagnostic variability, diagnostic uncertainty and comorbidities 
often found in acute inpatient services. The results will therefore be more generalisable 
to the acute inpatient population. It is also recommended that an intervention which 
targets emotional distress is first evaluated using outcomes that focus on emotional 
distress, as opposed to psychotic symptoms. Not only has the important role of emotions 
been recognised in serious mental illnesses, particularly during an acute episode of illness 
(Clarke, 2015) (see Chapter 2), but this may be conducive to a cross-diagnostic approach, 
i.e. therapy that targets shared dysfunctional processes leading to emotional distress may 
be beneficial to more acute inpatients with a variety of diagnoses. Finally, it is 
recommended that a definitive trial include outcomes which are important to patients, and 
that adverse events are recorded. As highlighted in this meta-analysis, there was minimal 
reporting of such outcomes and adverse events in the current evidence base. However, 
there is increasing pressure to adopt a person-centred approach in mental health inpatient 
services (The Commission on Acute Adult Psychiatric Care, 2015), and the importance 
of identifying potential risk associated with receiving treatment has been recognised 
(Duggan, et al., 2014). Future research should therefore include outcomes that are 
important to patients (such as quality of life, self-efficacy and self-esteem) and record 
adverse events to establish whether brief inpatient therapy has benefits on such outcomes, 
and whether it is harmful to patients.  
 
It is important to note that preliminary work is recommended before undertaking a large 
RCT, therefore pilot/feasibility work is more appropriate at this stage (Craig et al., 2013). 
During the feasibility stage, it may be beneficial to compare characteristics of those who 
do and do not want to engage in psychological therapy in this environment and to 
qualitatively investigate which components of therapy patients find most beneficial and 
why. This would allow identification of therapies, or components of therapies, that are 
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the most acceptable. Additionally, understanding why patients feel benefit from specific 
components can inform the adaptation of therapies for acute inpatient application with 
the hope to provide more value. However, first it is recommended that a feasibility trial 
be undertaken to assess the feasibility of implementing and evaluating a cross-diagnostic 
psychological therapy.  
 
3.4.4 Recommendations for practice 
Results from this review have been suggestive but not conclusive, therefore 
recommendation for practice cannot be definitive based on the current evidence. As 
previously mentioned acceptable and effective therapy type, duration, and intensity 
cannot yet be advised as meta-analysis does not allow for investigation of these 
characteristics. However, the current analysis provides initial evidence to suggest that 
some inpatients may benefit from some form of brief inpatient psychotherapy in terms of 
reducing emotional distress and acute inpatient services may benefit in terms of reducing 
the risk of readmission for some patients. It is therefore recommended that brief therapy, 
perhaps targeting distressing emotions (e.g. emotion focussed formulation and distress 
management (see Chapter two)), be offered to acute inpatients that wish to receive it. This 
is a pragmatic approach that allows psychological intervention to be utilised by a variety 
of inpatients, despite diagnosis. 
 
3.4.5 Conclusion 
In attempting to answer the question of whether brief inpatient psychotherapy is 
beneficial for acute inpatients, the current meta-analysis has drawn on the small evidence 
base and provided initial insight. Overall, it has produced initial evidence which indicates 
that psychotherapy may be beneficial for some acute inpatients in terms of reducing self-
reported depression and anxiety and the risk of readmission. However, many of the 
included studies are of low quality and many of the therapies are diagnostic specific, 
therefore cannot be generalised to an entire acute inpatient population. The recommended 
type, duration and intensity of therapy has yet to be determined, and for whom exactly 
inpatient psychotherapy is most beneficial is still unknown. Future high quality work is 
needed to strengthen the evidence base and enable more specific recommendations to be 
made. Prior feasibility work is necessary in preparation for a large definitive RCT.  
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3.5 Implications for the thesis 
Findings from this meta-analysis have suggested that while brief inpatient psychological 
therapy may not be effective in reducing psychotic symptoms it may be effective in 
reducing risk of readmissions and emotional distress (i.e. depression and anxiety) for 
some acute inpatients with a variety of diagnoses. However, clearly further work is 
needed to identify exactly who benefits from inpatient psychotherapy, and what type and 
dose of therapy is most effective. As discussed in Chapter 2, a cross-diagnostic approach 
to inpatient therapy and related evaluation is pragmatic approach to investigate these 
issues further. For example, cross-diagnostic psychological intervention, in theory, 
should benefit patients with a number of diagnoses which characterise the acute inpatient 
population. One notable model of cross-diagnostic psychologically informed acute 
psychiatric inpatient care is the Woodhaven Approach (described in Chapter 2). 
Understanding and addressing patients’ extreme emotional distress is central in the 
Woodhaven Approach, and is supported by the results of this meta-analysis. The evidence 
base evaluating this model of care, as it stands, remains scarce (see Chapter 2 for a brief 
review). To date, no trial using a control group, has evaluated the impact of this cross-
diagnostic psychological intervention, as a whole, on outcomes of both readmissions and 
emotional distress. Whether this is feasible is currently unknown.  The remainder of this 
thesis aims to address this. 
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4 Feasibility study: methods 
4.1 Introduction 
This chapter describes the design of a pragmatic, parallel, non-randomised, cluster 
feasibility trial of cross-diagnostic psychological intervention applied in an acute mental 
health inpatient context. The intervention investigated in this study was largely based on 
the Woodhaven approach (discussed in Chapter 2): a cross-diagnostic psychological 
intervention which has been successfully implemented in acute services (inpatient and 
outpatient) in the New Forest (Araci & Clarke, 2016; Clarke & Wilson, 2009). Initial 
evaluation of the Woodhaven Approach has produced promising results (see chapter two 
for a brief review of evidence), however more robust evidence is needed.  
 
According to the MRC, psychologically informed acute mental health care is a complex 
intervention, i.e. it is ‘made up of various interconnecting parts’ (Campbell et al., 2000; 
Craig, 2012). For example, acute inpatient care involves contact with multiple healthcare 
professionals and the psychological intervention of interest consists of multiple 
components which target both staff and patients. Evaluation should therefore be phased, 
including development, feasibility/piloting, implementation and evaluation (Craig, 2012; 
Craig et al., 2008, 2013) (see Chapter 1 for more detail). Development of the 
psychological intervention in the current study, i.e. identifying underlying theory for 
acute inpatient psychotherapy and reviewing the current acute inpatient psychological 
evidence base, has been addressed in preceding chapters. However, whether it is feasible 
to implement and evaluate this cross-diagnostic psychological intervention in an RCT is 
currently unknown. This chapter describes a feasibility study aiming to inform a future 
definitive trial which rigorously evaluates this intervention (Lancaster, 2015; Moore et 
al., 2015). 
 
4.2 Aims 
After receiving ethical approval (REC No: 15/SS/0093) and trial registration 
(researchregistry509) the main aims of this study changed. Detail of amendments can be 
found in the ‘Protocol amendments’ section of this chapter (page 110). The remainder of 
this section (and chapter) describes the amended aims (and the amended trial protocol).  
 
  
71
This study has two primary aims as they were considered to be of equal importance to 
inform a future definitive trial (Lancaster, 2015; Moore et al., 2015). The primary study 
aims were to test the feasibility of implementing and evaluating a cross-diagnostic, 
psychological intervention in an acute mental health inpatient setting in order to inform a 
future definitive trial of effectiveness. The secondary study aim was to gather exploratory 
clinical outcome data, likely to be used in a larger trial, and estimate treatment effects.  
 
4.2.1 Specific aims 
1. Pilot and test the feasibility of implementing a cross-diagnostic psychological 
intervention in an acute inpatient context (primary study outcome):  
a. To investigate the number of sessions of each component successfully 
delivered overall. 
b. To examine the number of inpatients engaged in the intervention.  
2. To pilot and test the feasibility of chosen trial process in an acute inpatient context 
(primary study outcome):  
a. To investigate the number of inpatients approached, screened, consented, 
recruited and retained.  
b. To investigate reasons for refusal where possible. 
c. To examine the completion rate at post-intervention and follow-up to provide 
information on the appropriateness of chosen outcomes and the acceptability 
of self-report clinical outcome measures and a predictor outcome measure. 
d.  To investigate reasons for attrition where possible. 
3. To gather preliminary clinical outcome data likely to be used to test the psychological 
model compared to treatment as usual (TAU) (secondary study outcomes):  
a. To describe the potential effect on the expected future definitive trial primary 
outcome (i.e. readmissions) data using descriptive statistics. 
b. To describe chosen clinical outcome data using descriptive statistics. 
c. To investigate whether clinical outcomes can produce adequate effects in the 
right direction. 
d. To record adverse events. 
4. To summarise and assess the findings of this feasibility study using the data collected 
for the above aims: 
a. To investigate the extent to which key methodological issues, defined by 
Shanyinde, Pickering and Weatherall (2011), were addressed by this study.  
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Further detail of the study aims and rationale are described throughout the remainder of 
this chapter. 
 
4.3 Trial design 
The current trial is considered exploratory as it encompasses characteristics of 
feasibility/pilot trials, as defined by Eldridge, Chan, et al. (2016) and Lancaster (2015), 
which are considered by the MRC to be in phase 2 (piloting/feasibility) of the framework 
for developing and evaluating complex interventions (Craig et al., 2013). It also adopted 
a primarily pragmatic approach according to criteria identified by (Loudon et al., 2015) 
(see ‘Pragmatic and explanatory trials’ section). The current study was also a cluster, non-
randomised, feasibility trial of a psychological intervention for acute mental health 
inpatiens. The psychological intervention (as piloted in one acute inpatient ward) plus 
TAU was compared with TAU delivered in another acute inpatient ward. A longitudinal 
design was adopted to allow for multiple data collection points: baseline, post treatment 
and 6-month post discharge follow-up (referred to from now on as follow-up).  
 
Where applicable, this trial was reported in accordance with a combination of the 
Consolidated Standards for Reporting of Trials (CONSORT) statement for randomised 
controlled trials (RCTs) (Schulz, Altman, Moher, & Group, 2010), the extension to 
randomised pilot and feasibility trials (Eldridge, Chan, et al., 2016), the extension to non-
pharmacological treatments (Boutron, Moher, Altman, Schulz, & Ravaud, 2008) and the 
extension to pragmatic trials (Zwarentein et al., 2009). 
 
4.3.1 Justification of trial design 
The current study was a pragmatic, non-randomised, non-blind feasibility cluster trial. 
Rationale for and implications of the trial design characteristics are discussed at length 
below.  
 
Pilot and feasibility studies 
The current study characterised a feasibility design according to recently published 
guidelines and recommendations for pilot and feasibility trials (Eldridge, Chan, et al., 
2016). As previously mentioned, the aims were to determine the feasibility of 
implementing and evaluating a psychological intervention for acute mental health 
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inpatients. Additionally, preliminary clinical outcome data was gathered to establish 
whether adequate effects in the right direction can be produced, even in the absence of 
any attempt of formal testing for statistical significance. The current trial is not adequately 
powered to detect significant differences on any chosen outcomes measures. It is 
important to note that conclusions drawn from such effects will be made with 
consideration of design (i.e. no assessor blinding or randomisation) and sample size 
limitations (Thabane et al., 2010), and that such effects will be interpreted as a guidance 
of treatment effect rather than definitive (Lancaster et al., 2004).  
 
Although the distinction between pilot and feasibility trials is ambiguous (Lancaster, 
2015), the UK National Institute for Health Research (NIHR) provide definitions which 
clearly differentiate between pilot and feasibility studies. Feasibility studies are defined 
as trials which aim to test whether a larger study can be done via estimation of parameters 
needed for a main study of effectiveness or efficacy (e.g. estimation of standard deviation 
of outcome measures, follow-up rates, time needed to collect data, willingness of 
participants to be recruited, etc.). Alternatively, pilot trials are considered smaller 
versions of the main trial which aim to pilot key processes of the main trial when 
implemented together (e.g. randomisation, treatment, assessment, follow-up) (National 
Institute for Health Research, 2015). Therefore, it is recommended that feasibility studies 
are completed first.  
 
The terminology regarding pilot and feasibility trials, however, are not concrete. A new 
framework for defining pilot and feasibility trials and reporting guidelines considers them 
to overlap (Eldridge, Chan, et al., 2016; Eldridge, Lancaster, et al., 2016) because they 
both aim to inform large definitive trials. In keeping with the NIHR’s definition, the new 
framework considers pilot studies to be conducted as a small version of the future 
definitive RCT, however rather than a conceptually different design, they are also 
considered a subgroup of feasibility studies (Eldridge, Chan, et al., 2016). According to 
Eldridge, Lancaster, et al. (2016), the current study is in line with the umbrella term of 
‘feasibility studies’. Additionally, as some evaluation processes of a larger trial were also 
implemented, e.g. gathering preliminary clinical outcome data and implementing the 
intervention, this study may also fall into Eldridge, Lancaster, et al.'s (2016) subcategory 
of non-randomised pilot trials. However, given that the primary aims of the trial are to 
determine the feasibility of implementing the intervention and the feasibility of evaluating 
it in a future larger trial, this study is referred to as a feasibility study, therefore mapping 
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onto phase two of the MRC framework for developing and evaluating complex 
interventions (Craig et al., 2008). 
 
The MRC recommends initial pilot or feasibility trials be carried out to inform larger 
definitive RCTs (Craig et al., 2008, 2013). While a definitive trial aims to establish the 
efficacy or effectiveness of an intervention, reasons for conducting a pilot/feasibility 
study have been categorised as 1) process: to assess the feasibility of the main stages of 
a future study, e.g. recruitment rate, retention rate, etc., 2) resource: to determine the time 
and resource needed to complete aspects of the study, e.g. the time taken to complete 
outcome measures, 3) management: to identify potential problems related to personnel 
and data management, 4) scientific: to determine dose levels and response and to estimate 
treatment effect and direction, and variance (Thabane et al., 2010). This study addressed 
reasons one and four. The feasibility of implementing and evaluating the psychological 
intervention was considered important to determine in order to guide future definitive 
evaluation of the intervention ( Eldridge, Lancaster, et al., 2016; Lancaster, 2015; 
Thabane et al., 2010).  
 
Pragmatic and explanatory studies 
Whether definitive or feasibility, trials can be classed as pragmatic or explanatory, which 
are considered to be at either end of a spectrum and are associated with different aims, 
advantages and limitations (Loudon et al., 2015). The current trial adopts a largely 
pragmatic approach. Justifications and implications are discussed in this section. 
 
According to Schwartz & Lellouch (2009), explanatory trials are concerned with the 
efficacy of a treatment and are carried out in controlled conditions with specific 
inclusion/exclusion criteria that define a homogeneous sample. The aim is usually to test 
a causal research hypothesis therefore internal validity is important. On the other hand, 
pragmatic trials aim to evaluate the effectiveness of treatment in usual conditions 
(Schwartz & Lellouch, 2009; Thorpe et al., 2009). Heterogeneity of participants, of 
adherence to intervention and of intervention delivery is expected (Dunn, 2013), and is 
likely necessary to successfully achieve the aims of a pragmatic trial. It is more important 
for pragmatic trials to have external validity as they try to answer the question of whether 
an intervention can work in the ‘real world’. This would be the case for a future definitive 
trial of the psychological intervention of interest. 
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There are both advantages and disadvantages associated with these approaches which 
result in each design suiting different trial aims and settings (Loudon et al., 2015). 
Controlled conditions, i.e. a homogeneous sample, standardised treatment, etc., increase 
internal validity in a trial and is characteristic of an explanatory trial. Internal validity 
refers to the extent to which a trial measures what it set out to (Dunn, 2013). However, 
such controlled conditions also decrease external validity, i.e. the extent to which findings 
can be generalised to other settings and people (Dunn, 2013). A pragmatic approach, on 
the other hand, allows for more heterogeneity in terms of population, treatment adherence 
and delivery, and therefore asks the question of whether an intervention works in the ‘real 
world’ (Dunn, 2013). Consequently, a pragmatic approach was considered appropriate 
for evaluating interventions in an acute inpatient setting because the population and 
treatment is likely to be heterogeneous. Patients are typically diagnostically diverse, often 
including multiple diagnoses and comorbidities. Additionally, an acute inpatient ward is 
often chaotic in nature and discharges can be quick and unpredictable, therefore 
delivering structured therapies (i.e. a specified number of sessions is delivered over a 
specific amount of time) is unfeasible in this environment (Clarke & Wilson, 2009). If an 
explanatory approach was used to determine the efficacy of psychological treatment in 
this environment then this could result in approval and delivery of ineffective or 
unfeasible therapies which may have previously produced promising results in well-
designed RCTs evaluating inflexible therapy for a homogenous group. Furthermore, the 
intervention of interest (the Woodhaven Approach, Clarke & Wilson, 2009) is designed 
for cross-diagnostic application, therefore a pragmatic approach is more fitting. For these 
reasons a pragmatic approach was taken for the current study and should be taken for 
future definitive trials. 
 
As previously mentioned, characteristics of the current study differ from an explanatory 
trial in that the intervention was not standardised between participants (i.e. patients attend 
different therapeutic components of the model, in a different order, a different number of 
times) and participants consisted of a heterogeneous group. As recognised by the new 
MRC guidance, complex interventions can work best when tailored for specific local 
services and are flexible for patients (Craig et al., 2013). This is true of the psychological 
intervention investigated in the current study, which is considered a strength and a 
limitation. The pragmatic approach of this study is advantageous because the evaluation 
considers feasibility of intervention delivery, trial design and outcomes when the complex 
intervention is applied in an NHS Lothian acute inpatient service. Additionally, this 
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approach is in keeping with the flexible nature of the intervention (see ‘Intervention’ 
section for details of the intervention). However, evaluating non-standardised 
interventions can also be considered problematic as it reduces generalisability of the 
intervention across all acute services. Nevertheless, it has been suggested that careful 
consideration of how to tailor the intervention to other similar services (i.e. other acute 
inpatient services) would allow implementation on a wider basis (Craig et al., 2013; 
Moore et al., 2015). Furthermore, documentation of contextual factors in both the 
intervention and control condition are important to allow generalisability of the trial 
results (Zwarentein et al., 2009). 
 
It has been argued that trials of complex psychological interventions may (or should) 
adopt both pragmatic and explanatory aims (Dunn, 2013), and there are now criteria 
published to help researchers position a study design on the continuum1 (Loudon et al., 
2015). The current trial adopted a primarily pragmatic approach according the following 
criteria (Loudon et al., 2015): 
1. Participant eligibility: limited inclusion criteria were implemented beyond that of 
being admitted to the acute inpatient ward at time of recruitment (see 
inclusion/exclusion criteria section) (very pragmatic). 
2. Recruitment: participants are only recruited if they are admitted to the included 
acute inpatient wards (very pragmatic).  
3. Settings: trial conducted in identical setting to which the results will be applied 
(very pragmatic).  
4. Organisation: intervention took place in the same organisation as usual care. 
Practitioners were required to have appropriate therapeutic training to provide 
therapy, however they differed in experience. All individuals with sufficient 
therapeutic training could deliver the intervention. Additional therapeutic training 
was provided for organisation staff in order to implement the intervention (very 
explanatory) 
5. Flexibility of the experimental intervention (delivery): delivery of the intervention 
was flexible, i.e. although each group included a specific number of sessions 
according to the manual, patients could attend as many or as few as they like. The 
trial was not concerned with how practitioners varied the intervention as 
                                                 
1
 Each domain is scored on a 5-point Likert scale: 1) very explanatory, 2) rather 
explanatory, 3) equally pragmatic and explanatory, 4) rather pragmatic, and 5) very 
pragmatic (Loudon et al., 2015). 
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flexibility was a key characteristic of the intervention. Additionally, individual 
sessions were delivered flexibly depending on each patient, and other 
interventions were permitted, e.g. occupational therapy (very pragmatic). 
6. Flexibility (adherence): psychological intervention was not mandatory in the 
intervention group, therefore adherence was measured indirectly (number of 
sessions attended) for the purposes of the trial with no strategy to improve or 
enforce engagement (very pragmatic). 
7. Follow-up intensity: follow-up assessments were longer term than patients’ 
hospital admissions (follow-up at 6-months post discharge) and required patient 
contact (via phone or in person) (rather pragmatic). 
8. The proportion of readmissions at 6-months post discharge is the planned primary 
outcome of a future definitive trial (see outcomes section). Therefore, events were 
monitored following discharge to establish whether the proportion of 
readmissions reduced following the experimental intervention. This outcome is 
more relevant to some patients (i.e. ‘revolving door patients) than others (rather 
pragmatic).  
9. Analysis of the expected primary outcome in a future definitive trial: non-
adherence to intervention was not considered in the initial analysis, characterising 
an intention to treat analysis. However, a sensitivity analysis excluding 
participants in the intervention group who did not directly engage with 
psychological intervention (see analysis section) was also carried out (per 
treatment protocol analysis). This trial, therefore, characterises both pragmatic 
and explanatory trials (equally pragmatic and explanatory). 
 
Superiority, non-inferiority and equivalence 
One aim of the current study was to determine whether the psychological intervention 
can provide evidence of a group difference in the expected direction, in comparison to 
usual treatment. Detecting this difference as part of feasibility work is an essential 
characteristic ahead of undertaking a definitive superiority trial. A psychological 
intervention, as part of a definitive future trial, would be hypothesised to be more 
effective, rather than inferior or equivalent to usual treatment. Implications of this design 
are discussed in this section. 
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Trials can be categorised as testing superiority, non-inferiority or equivalence depending 
on the objectives. A superiority trial, for example, aims to show a new treatment is more 
effective than current treatment. However, if the null hypothesis (i.e. there will be no 
difference between treatments) is not rejected equivalence should not be assumed 
(Sedgwick, 2013a). Equivalence trials aim to show a new treatment has a similar effect 
to another treatment (usual current standard treatment). This is useful to develop new 
treatments which are therapeutically similar but may have fewer adverse effects or be 
cheaper. Non-inferiority trials are similar to equivalence trials in that they aim to 
determine whether a new treatment is not less effective than another treatment (Piaggio, 
Elbourne, Pocock, & Evans, 2012), therefore the hypothesis would be that the control 
treatment is similar or less effective than the new treatment. Where superiority trials use 
statistical significance to determine whether the null hypothesis can be rejected, 
equivalence and non-inferiority trials base analysis and conclusions on confidence 
intervals, i.e. in relation to a pre-specified non-inferiority boundary (Sedgwick, 2013a). 
As the current study is a feasibility trial the focus is on effect estimations along with 
precision of estimated intervals which will be used to inform a future larger trial 
(Lancaster et al., 2004). However, the estimated effects are expected in favour of the 
intervention, which would also be true of a future definitive trial. Therefore, the current 
study is considered a feasibility study in preparation of a future, larger superiority trial. 
 
Cluster trials 
The current feasibility study was based on a cluster trial design. Rationale for adopting 
this design will be discussed in this section.  
 
As in the current study, allocation of individuals to trial groups is not always possible or 
preferable due to context, resulting in randomisation or allocation of clusters (i.e. a group 
of individuals nested in a social unit, e.g. a household, a town or an institution) (Campbell, 
Piaggio, Elbourne, & Altman, 2012). As the psychological intervention in this trial was 
piloted in one acute inpatient ward in NHS Lothian, allocation of individual participants 
was not possible without incurring considerable contamination bias (discussed below). 
Instead, whole wards were allocated to trial groups. Therefore, the wards were the unit of 
group allocation and the unit of intervention, the unit of observation was the participants 
and the unit of analysis was the wards. 
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Cluster trials differ from regular trials and therefore require some methodological 
considerations. For example, there can be substantial contamination effects within 
clusters, where participants and/or staff will discuss with each other the aspects of the 
intervention or trial. As a result, participants from the same cluster are likely to be 
correlated, therefore producing homogeneity of outcomes within a cluster compared to a 
random sample (Eldridge & Kerry, 2012). To account for this, sample size is often 
required to be larger than other individually randomised definitive trial designs, the extent 
of which is decided by the strength of correlations within clusters: the intra-cluster 
correlation coefficient (ICC) (Campbell et al., 2012). Analysis should also account for 
the correlation within clusters to avoid inflated precision of estimated effects, and 
interpretation of the results must consider influences of clusters and individual 
participants (Campbell et al., 2012). As no formal sample size calculation informed this 
feasibility study, no ICC was calculated for the current trial.  
 
Consent also needs to be considered in cluster RCTs. As clusters are randomised to trial 
groups, individuals are not always able to consent to randomisation to a group. Such a 
circumstance instead requires consent to be sought from individuals to receive the 
intervention associated with their group, and to be follow-up, therefore ethical concerns 
should be addressed (Campbell et al., 2012; Eldridge & Kerry, 2012). In the current trial, 
verbal consent was provided by each cluster (i.e. from the charge nurse of each ward), 
and written consent was obtained from individual participants.  
 
Randomisation and blinding  
Two trial design characteristics considered key to ensuring methodological rigour in 
intervention evaluation are randomisation (of either clusters or individuals) and blinding. 
Neither were employed in the current study. Reasons and implications are discussed in 
this section.  
 
Randomisation 
Randomisation of individuals was not possible in the current study. Reasons for failing 
to randomise and associated limitations are discussed in the remainder of this section. 
Randomisation aims to reduce selection bias and, where randomisation occurs at 
participant level, ensures confounders are controlled for, i.e. unknown influencing 
variables are evenly distributed between groups. As a result the internal validity of 
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statistical tests is preserved (Dunn, 2013). However, as was the case for the current trial, 
randomisation is not always possible in health care research, due to organisational 
restrictions or intervention and service complexities (Craig et al., 2013; Habicht, Victora, 
& Vaughan, 1999). As previously mentioned, the intervention investigated in this study 
was implemented within a whole acute inpatient ward to which patients were admitted 
based on their residential location. Individuals were, therefore, not randomised as 
everyone in the ward was expected to be exposed to the intervention. Randomisation of 
clusters (wards) was not possible due to organisational constraints, i.e. implementation 
was already underway in the intervention ward. Non-randomisation is associated with 
limitations such as selection bias (Higgins & Green, 2011); these are acknowledged in 
the interpretation of the findings from the current study. Additionally, as non-
randomisation of individual participants can lead to baseline differences between groups, 
even in the presence of randomised clusters (Eldridge & Kerry, 2012), participant 
characteristics, e.g. diagnosis, ages, length of stay, previous admissions, were 
investigated descriptively to identify potential differences. 
 
Blinding 
Blinding of assessors, personnel and participants to treatment group was not possible in 
this study. Justification for the lack of blinding and associated limitations are discussed 
in this section.  
 
Blinding of assessors and personnel to treatment groups reduces detection bias (i.e. 
assessors/researchers wanting a desired effect) and blinding of participants to trial groups 
reduces performance bias (i.e. participants self-reporting outcomes that are considered 
desirable to clinicians or researchers) (Button & Munafò, 2015). Due to the nature of 
treatment in psychotherapy trials it is difficult to blind participants, staff and therapists to 
group allocation, therefore more importance is placed on assessor blinding. It is argued 
by some that non-blinding of participants and clinicians is pragmatic in design because 
in routine clinical practice both staff and patients are aware of treatment received (Hotopf, 
2002). However, non-blinding of assessors is known to increase the risk of bias in trials 
(Button & Munafo, 2015), therefore assessor blinding is expected to be implemented 
where possible. In the current study blinding of personnel and participants could not occur 
due to the nature of the intervention, and assessors were not blind due to limited resource. 
In order to blind assessors in the current study, an independent researcher or volunteer, 
responsible for data collection only, could have been needed. Due to limited resources 
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the PI was involved in management of the trial and data collection therefore assessor 
blinding was not feasible. Alternatively, the researcher could have met participants 
outside of the ward to maintain allocation concealment. However, this method is 
sometimes unreliable as participants may tell the researcher what treatment they have 
received. Furthermore, given that all inpatient wards were locked, some participants 
would likely need escorted by ward staff to multiple data collection meetings off the ward. 
Given the high bed occupancy levels, the staff shortages (The Commission on Acute 
Adult Psychiatric Care, 2015) and the busy nature of acute inpatient services (Clarke & 
Wilson, 2009), this option was also not feasible. Limitations associated with failure to 
blind assessors are considered in the interpretation of results (see Chapter 6). 
 
4.4 Recruitment, participants and sample size 
Cluster recruitment and inclusion/exclusion  
Clusters were inpatient wards recruited from the Royal Edinburgh Hospital, NHS 
Lothian. Potential clusters were identified and approached by a member of the 
psychological team (SH). Potential clusters were considered appropriate if they were not 
in receipt of psychological input at the time of recruitment. 
 
Participant recruitment  
Participants were recruited from two acute inpatient wards at the Royal Edinburgh 
Hospital (REH), NHS Lothian, between October 2015 and October 2016. As part of usual 
clinical service, patients were allocated to acute wards by their residential location. 
According to the Scottish Index of Multiple Deprivation (SMID), 5% (Scottish 
Government, 2016a) and 14% (Scottish Government, 2016b) of the areas which the 
control and intervention ward (respectively) provide care for are in the 20% most 
deprived areas in Scotland. Such characteristics of residential location are considered 
later in the thesis (see Chapter 6). 
 
All patients who consented provided written informed consent. All patients were 
recruited via poster advertisement on the ward or by the researcher. Recruitment rate 
estimation was challenging, as on request, there was no data available with regards to 
patient turnover in relevant acute services. Recruitment was expected to be challenging 
due to the nature of acute inpatient services and the severity of patients using such 
services (i.e. a high percentage of participants were expected to decline participation or 
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were expected to be lost to follow-up after initial consent). Originally, six months were 
allocated to recruitment and agreed with Senior Charge Nurses. However, recruitment 
was extended to 12 months to enable recruitment of the planned sample size (see 
‘Protocol amendments’ section, page 110). Recruitment of clusters is described in the 
Control section (page 81 and 83).  
 
Participant inclusion/exclusion 
In order to take a pragmatic approach to recruitment, as few eligibility criteria as possible 
were used (Godwin et al., 2003; Loudon et al., 2015). Inpatients were considered eligible 
to participate if they were a current inpatient in either the intervention ward or the control 
ward, with no restriction on diagnosis. People were included if they were aged between 
16 and 65, deemed able to give informed consent (decided by nursing or medical staff), 
admitted to one of the acute wards at time of first data collection point, were classed as 
‘stabilised’ by medical staff or nursing staff (i.e. unlikely to find questionnaires too 
distressing, thoughts were not too chaotic) and were likely to be admitted for more than 
3 days (as judged by ward staff). Participants were excluded if they had received a 
diagnosis of moderate or severe and profound learning disability, dementia or organic 
mental disorder, were unable to understand self-report questionnaires due to impaired 
cognitive processes, concentration, had severe cognitive difficulties which may hinder 
engagement in talking therapy interventions, did not speak English, presented unsafe 
behaviour, i.e. severe hostility/aggression or sexually uninhibited behaviour towards staff 
or were discharged or moved to a different ward within 2 days of completing the first 
assessment. Inclusion/exclusion criteria for clusters is described in the ‘Control’ section 
(page 81 and 83).  
 
Sample size  
Sample size was based primarily on published recommendations using simulated data for 
feasibility trials with binary outcomes. A sample size of 60 per group has been 
recommended for pilot trials with binary outcomes (Teare et al., 2014). Therefore, as the 
proposed primary clinical outcome for future trials is a binary outcome (i.e. proportion 
readmitted) (see ‘Clinical outcomes’ section, page 95) the target sample size was 120. 
Teare et al. (2014) simulated a feasibility study at least 10, 000 times each for a range of 
sample sizes, in steps of five subjects, for proportions in the range up to 0.5 in increments 
of 0.05. Results showed that for binary outcomes anything greater than n=60 in the 
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intervention arm did not provide any relative gain in precision, i.e. estimates predicted to 
be within the 95% confidence interval. Although this is larger than traditional feasibility 
studies, it is now deemed more efficient to use large external pilot studies to reduce 
variation around statistical power for future definitive trials (Eldridge, Costelloe, Kahan, 
Lancaster, & Kerry, 2015). A sample of 120 between groups is deemed more than 
sufficient to identify potential problems on a range of other outcomes which have a 5% 
probability of occurring (Viechtbauer et al., 2015). These are namely the feasibility of 
conducting a trial in an acute inpatient context, e.g. eligibility rate, consent rate; secondly, 
to inform the feasibility of collecting data on an acute inpatient ward, and to inform the 
feasibility of implementing the intervention, e.g. number of sessions delivered and 
average number of sessions per person. In addition, 120 participants was deemed 
sufficient as it is larger than the sample recruited in previous acute inpatient pilot trials 
(range=12-40) (Gaudiano & Herbert, 2006; Haddock et al., 1999; Hall & Tarrier, 2003; 
Kim et al., 2010; Mortan et al., 2011). However, as is frequently the case with PhD 
studies, the ideal aspirations of this sort of work are restricted by the time restrictions of 
the PhD, and therefore a maximum of one year had to be allocated to data collection, in 
part as a direct consequence of the extended recruitment period.  
 
Although 120 was the desired recruited number, attrition and drop-outs during the 
feasibility study was also accounted for. Allowing for 20% attrition (base on similar 
studies (Bechdolf et al., 2004; Lewis et al., 2002)), means an overall number of 150 
participants were required for the study. It should be noted that this sample size was 
calculated after the study began, due to protocol amendments (see ‘Protocol amendments’ 
section for detail, page 110). 
 
4.5 Control 
Treatment as usual (TAU) was chosen as the control condition. This choice is 
advantageous as results from the current study will inform a larger future trial which will 
aim to show that psychological therapy plus TAU is more effective than TAU alone. 
However, comparing interventions to TAU has been associated with inflated treatment 
effects due to a failure to control for non-specific effects of treatment (Button & Munafò, 
2015). Less sophisticated control interventions (e.g. befriending) can be used to counter 
this limitation, although this was not possible in the current study due to limited resource. 
A second option is to use an active treatment as a comparator. However again, this study 
did not have enough resource to deliver another active treatment. Furthermore, use of an 
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active treatment asks the question of which treatment is most effective, rather than 
whether the novel treatment of interest is more effective than current usual treatment. 
Given that psychological therapy is not currently routinely offered in acute inpatient 
settings comparing a new approach with another active treatment was not deemed 
appropriate at this point in time (Thompson & Schoenfeld, 2007). Another option might 
be to compare the new intervention to an intervention which mimics the format of the 
new intervention but is missing the active ingredient, i.e. offering individual sessions and 
groups which are not psychologically orientated. Due to restricted resource, this option 
was also not feasible in the current study.  
 
The choice of the control ward was determined by one main factor: no inpatient access to 
psychological therapies. Two eligible wards were identified within the same national 
health board, one of which met eligibility criteria2. The chosen control ward was a low 
security, 25 bed, mixed sex ward for acute inpatients residing in Midlothian and East 
Lothian. TAU in this ward included, at the time of recruitment, initial consultation with 
a psychiatrist on admission, followed by weekly or ‘as-required’ reviews, formation of a 
care plan, patient involvement in care planning, occupational therapy input, 
pharmacotherapy input and assignment of a key worker (staff nurse). No psychological 
intervention was routinely available or provided.  
 
The control ward differed from the intervention ward in that Consultant Psychiatrists are 
not resident to the ward. Instead, they work between community and inpatient services, 
therefore patients maintain contact with the same psychiatrist while admitted to hospital. 
Similar to the intervention ward, there is a constant flow of medical students and one 
senior charge nurse, a charge nurse and a team of resident nurses and nursing assistants. 
In addition to a medical team there is also an Occupational Therapist and an in-house 
Recreation Officer. Differences between the intervention and control ward are discussed 
later in this thesis (see Chapter 6). 
 
4.6 Intervention  
Setting 
The intervention ward was a low security 40 bed acute mental health inpatient ward for 
people residing in North West Edinburgh and is divided into two separately secure 
                                                 
2
 One ward had input from an art therapist therefore was excluded.  
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sections: male and female. At the time of recruitment, the ward had three resident 
consultant psychiatrists, four junior doctors and a continuous flow of medical students. 
Additionally, two senior charge nurses (one for each section), two charge nurses (one for 
each section) and a team of nurses and nursing assistants (each section had dedicated staff 
teams) were employed during data collection. Outside the medical team, the ward also 
had an Occupational Therapist, a Recreation Officer and psychological input. 
Psychological input was provided specifically for this study and was additional to usual 
treatment. This included a Consultant Clinical Psychologist who provided three hours of 
individual sessions per week and a Clinical Psychologist/Advance Nurse Practitioner 
(17.5 hours per week) who was responsible for running groups, providing individual 
sessions for patients, providing clinical supervision to ward staff delivering components 
of the psychological intervention and facilitating group reflective practice. All 
participants in the intervention ward received TAU, like the control group described 
above. They also had access to the psychological intervention (described in the following 
section). 
 
4.6.1 Cross-diagnostic, psychological intervention 
The meta-analysis in chapter three highlighted the need for evaluation of cross-diagnostic 
inpatient psychological therapy. Additionally, it provided evidence which suggests 
inpatient therapy may be beneficial in terms of reducing emotional distress (see Chapter 
3). This study investigated a cross-diagnostic, psychological intervention which aims to 
reduce overwhelming emotion (i.e. depression and anxiety) for acute inpatients. The 
intervention is largely based on the Woodhaven Approach (Clarke & Wilson, 2009). The 
Woodhaven Approach addresses some notable problems experienced in acute inpatient 
services (e.g. limited access to psychological therapy, poor therapeutic milieu, poor 
quality of care and frequent staff burnout and poor patient outcomes leading to 
readmission) (see chapter 2 for further discussion). The main aims of the Woodhaven 
Approach are as follows, however it should be noted that the current study primarily 
investigated the feasibility of implementing patient components of the intervention and 
evaluating outcomes related to patient benefit (see specific aims section): 
1. Provide acute inpatients with an opportunity to make sense of their admission 
using psychological formulation and encourage patients to take responsibility for 
maintaining good mental wellbeing by teaching them skills to cope with 
overwhelming emotion. This should lead reduced emotional distress and 
increased self-efficacy in relation to coping with their mental health (see patient 
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components, below). In turn, the risk of future admissions, and other contact with 
other crisis services (see ‘Clinical outcomes’ section, page 95) should be reduced.  
2. To facilitate staff members psychological and empathic understanding of patients 
so as to improve therapeutic engagement.  
3. As a product of 1 and 2, the Woodhaven Approach also aims to enhance 
therapeutic milieu, staff morale, quality of care and patient experience (Clarke & 
Wilson, 2009). 
 
People in the intervention group had access to individual and group psychological 
intervention on the ward. Individual sessions were offered to patients identified by staff 
or to patients who self-identified. Groups were advertised on the wards through posters 
and staff in both the male and female ward, however all groups were delivered on the 
female ward for practical reasons.  
 
According to the Woodhaven Approach (Clarke & Wilson, 2009), patients should receive 
individual therapy to identify current problems and ‘exit strategies’ via emotion focussed 
formulation (described in the following section) of the current acute crisis (see Chapter 
two for formulation example). Patients should then be directed to appropriate CBT-based 
and ‘third-wave’-based group therapies. However, to suit the unpredictable nature of an 
acute inpatient environment the intervention remains flexible, therefore patients can 
attend groups without first attending individual sessions and patients can attend as few or 
as many groups as they wished, and they could leave therapeutic sessions early if 
necessary. Group therapies for patients, adopted from the Woodhaven Approach, 
included ‘Anxiety and Stress Management’, ‘Making Friends with Yourself’, ‘What is 
Real and What is Not?’ (described in the following sections). An additional emotion 
regulation group, called ‘Living Well with Emotions’, was offered to patients. These 
therapeutic components were brought together to target dual and uncertain diagnoses and 
high levels of distress which are characteristic of acute inpatients (Durrant & Tolland, 
2009).  
 
The model of intervention also included training for staff. Mentalisation Based Therapy 
(MBT) skills training and basic CBT skills training was available for staff, in addition to 
weekly group reflective practice and Clinical supervision for staff facilitating groups. 
Staff components of the intervention aimed to support staff in their work in what can 
often be a chaotic and stressful environment. As a result, staff should be better equipped 
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for the demands of this environment and feel more supported. Additionally, the overall 
environment of the ward should become more therapeutic thus improving the service 
users experience (Clarke & Wilson, 2009). Components of the psychological intervention 
piloted in the current study are described below and summarised in Table 7 (page 92). 
 
Patient components 
 
Emotion focused formulation (individual therapy) 
As suggested by Clarke and Wilson (2009) weekly one hour individual therapy sessions 
were offered to patients once admitted and stabilised. Two clinical psychologist and one 
specialist nurse therapist delivered individual sessions. These typically involved 
assessment of inpatients’ acute crisis to allow the development of emotion focussed 
formulation. Formulation aims to provide a new perspective on the individuals’ distress 
for both the patient and the multidisciplinary team working with them (Kinderman, 2009), 
leading to increased confidence in coping with such distress for patients. Formulation in 
this context specifically aims to identify current problems leading to the index admission 
and introduces potential ‘exit strategies’ for inpatients (see Chapter two for an example 
of formulation). Previous qualitative analysis of staff and patient perspectives of the 
effects of team formulation delivered in psychiatric inpatient settings highlighted that 
staff felt formulation increased their understanding of patients, improved team 
collaboration and improved interpersonal awareness (Berry et al., 2016).  
 
Group therapies 
Group therapies were initially delivered by a clinical psychologist or an advanced nurse 
practitioner. However, ward staff were expected to co-facilitate group sessions until they 
felt confident in facilitating them alone. All group therapies are manualised (see Table 7, 
page 92), allowing staff to easily co-facilitate and facilitate groups. Although staff did not 
receive training specifically for facilitating group therapies, those who did facilitate or 
co-facilitated groups received clinical supervision from either a clinical psychologist or a 
specialist nurse practitioner. This was thought to be key to sustaining the delivery, and 
quality of delivery, of the intervention long term. Patients could attend all or any group 
sessions and could drop in and out as they wished. Due to this flexibility, participation 
was monitored. 
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Only three (‘Anxiety and Stress Management’, ‘Living Well with Emotions’ and ‘Being 
Friends with Yourself’) of the intended four group therapies were delivered during the 
study period, due to implementation challenges (see ‘Protocol amendments’ section, page 
110). All intended group therapy components are described below. 
 
Anxiety and Stress Management 
The anxiety and stress management group was adopted from the Woodhaven approach 
(Clarke & Wilson, 2009). It is a two-session group delivered once weekly and lasts 
approximately an hour. The aim is to introduce the concept of the physiological safety 
system, i.e. the flight or fight reaction to threat situations, and teach mindfulness and 
arousal management skills to reduce distress (i.e. anxiety) and distress related arousal (i.e. 
somatization), and increase patients’ confidence in coping with anxiety and stress.  
 
Mindfulness and arousal management are core coping mechanism of the Woodhaven 
Approach (Clarke, 2015). Overwhelming emotion is closely linked with high states of 
arousal, largely due to the fight flight response (i.e. the body physically prepares to 
combat threat). It is argued that acute inpatients often find themselves admitted to acute 
inpatient services due to behaviours or reactions which are a response to overwhelming 
emotion (Clarke & Wilson, 2009). When emotion becomes overwhelming, different 
levels of processing - implicational (emotional) and propositional (rational) - become 
disconnected or unbalanced (see ‘ICS’ section in Chapter two for further discussion). 
Mindfulness and arousal management techniques provide the opportunity to reconnect 
rational and emotional processing. Management of high arousal is essential to begin 
rational processing and appraisal again (Clarke, 2015).  
 
This group psychological intervention primarily comprised of psycho-education and 
mindfulness techniques. Patients are taught to identify factors which maintain or trigger 
threat reactions, and to identify associated physical feelings that lead to panic, avoidance 
or other unhelpful coping strategies (i.e. self-harm or taking drugs). Once these factors 
and feelings can be recognised coping techniques (i.e. controlled breathing and 
mindfulness techniques) can be implemented to manage arousal, therefore allowing time 
to employ rational processing and more useful coping strategies. As a result, distress 
should decrease while self-efficacy related to coping with mental health should increase. 
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Making friends with yourself (compassion based group) 
The making friends with yourself group is three-session group also adopted from the 
Woodhaven approach (Clarke & Wilson, 2009; Hill, Clarke, & Wilson, 2009). It draws 
on elements of compassionate mind training and compassion focused therapy (see Gilbert 
& Procter, 2006) and is designed for inpatients with low self-esteem that results in self-
criticism and feelings of shame. The group teaches skills to cope with and improve 
negative internal relationships with the aim to decrease negative emotions (i.e. 
depression) and improve patients’ confidence in managing such feelings. The following 
topics are covered: i) identifying what influences actions and feelings/mood; ii) 
recognition that thoughts about the self can affect feelings about the self; iii) 
understanding the role of core beliefs; iv) teaching alternative ways to think about 
themselves; v) practice of alternative techniques with support from other group members; 
vi) practice in real life situations. 
 
What is real and what is not? (WRWN) 
This group was also adopted from the Woodhaven approach (Clarke & Wilson, 2009; 
Hill et al., 2009) and is designed for inpatients who have encountered unusual perceptual 
experiences such as hearing voices or sensory/visual hallucinations. It aims to normalise 
the phenomena of hearing voices and other unusual perceptual experiences (Romme & 
Escher, 1989) in order to help patients make sense of and gain control of such 
experiences, consequently improving self-esteem. As a result, confidence in coping with 
unusual experiences should improve and distress should decrease. This weekly group 
lasts approximately one hour and includes four sessions with the following topics: i) 
introduction to openness and normalising unusual experiences, ii) different states of mind 
(and factors that influence it, e.g. stress and life events) and different sorts of reality, iii) 
coping strategies including distraction, relaxation, arousal management, mindfulness and 
education.; iv) identifying what is real and what is not.  
 
Living Well with Emotions 
Living Well with Emotions is a manualised (see Appendix 10) emotion regulation group 
developed for an acute inpatient setting (Lennon, 2015). It comprises of six sessions 
delivered twice weekly. It is an open, rolling group, therefore participants can join and 
leave as needed. This level of flexibility is suitable for the unpredictable nature of an 
acute inpatient environment. Similar to the emotion regulation group developed by Clarke 
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and colleagues (Rendle & Wilson, 2009), this group primarily draws on Dialectical 
Behaviour Therapy (DBT) (Linehan, 1993) but also incorporates mindfulness based 
exercises (see Chapter two for detail of DBT and mindfulness). In contrast to Linehan’s 
work, the group is designed for brief admissions and is applied cross-diagnostically. 
Emotion dysregulation is seen as central to all pathology under the ICS framework, 
therefore all inpatients who want to attend the group are encouraged to (Clarke, 1999; 
Teasdale, 1993).  
 
Key elements covered in the six sessions are labelling emotions, identifying the function 
of emotions, learning effective and ineffective expression of emotions, reducing 
vulnerability to emotions, learning self-soothing techniques and increasing positive 
emotions and learning how to act opposite to difficult emotions (Lennon, 2015). Clarke 
(2015) proposes that once mindfulness skills are achieved (i.e. reduced arousal and 
disconnection from overwhelming emotion) patients can reflect on and make sense of 
emotions associated with their current crisis. The overall goal of this group is for patients 
to become aware of, recognise, understand and cope with emotions that have been 
previously avoided. In turn, mental health related self-efficacy and emotional distress 
should improve.  
 
Staff components 
All staff were encouraged to attend all training where possible, however due to staff 
shortages, which are common in acute inpatient wards (The Commission on Acute Adult 
Psychiatric Care, 2015), attendance was not guaranteed and was ultimately decided by 
charge nurses.  
 
Introduction to the model and CBT based skills training 
This one day training session was delivered by a consultant clinical psychologist and a 
clinical psychologist or advanced nurse practitioner for all available ward staff. The aim 
was to teach the underpinning values and rationale of the intervention being implemented 
(see Chapter two for detail of the underpinning values and theoretical rationale) and 
improve integration of the psychological approach within the service. This covered the 
following topics: i) philosophy of the model (validation, control and change), ii) 
introducing the aims of the model, iii) detail of training and support available to staff and 
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detail of therapeutic interventions available to patients, iv) detail of implementation 
logistics and feedback from staff.  
 
MBT Skills Training 
Drawn from mentalisation based therapy (MBT) (Bateman & Fonagy, 2010), two days 
of MBT-based skills training were provided by a psychiatrist/psychotherapist and a 
clinical psychologist. This was available to all ward staff able to attend. The aim was to 
teach mentalisation-based skills in order to facilitate more effective communication with 
acutely distressed, and often challenging, patients. Techniques include learning to think 
about thinking, becoming aware of one’s own thoughts and beliefs and evaluating 
whether these are useful, truthful and based on reality.  
 
Group Reflective Practice 
Group reflective practice was offered once fortnightly to provide time for ward staff to 
discuss challenging situations with colleagues and reflect on the use of MBT and CBT 
skills on the ward. The aim of the group is to provide time for nurses to share and 
formulate their experiences and promote personal and professional development.
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Table 7 
Summary of intervention components 
Name 
Component 
type Recipient 
Therapeutic 
alliance Origin Aim 
Number of 
sessions Delivery  
Emotion 
focused 
formulation 
Individual 
therapy 
Patient N/A Woodhaven 
approach1 
Identify emotional distress 
and unhelpful coping 
mechanisms 
Flexible 1 hour, 
weekly, 
flexible 
delivery 
 
Anxiety and 
stress 
management  
Group 
therapy 
Patients Psycho-
education, 
mindfulness, 
arousal 
management 
Woodhaven 
approach1 
Teach concept of 
physiological safety system 
in relation to stress and 
anxiety and teaches 
mindfulness and arousal 
management skills to cope 
2 1 hour, 
weekly, 
manualised 2 
Making 
friends with 
yourself  
Group 
therapy 
Patients Compassion 
focused therapy, 
DBT, CBT, 
mindfulness 
Woodhaven 
approach1 
Increase self-esteem and 
decrease self-criticism 
3 1 hour, 
weekly, 
manualised 2 
What is real 
and what is 
not? 
Group 
therapy 
Patients CBTp, 
mindfulness, 
arousal 
management 
Woodhaven 
approach1 
Normalise non-shared 
experiences, identify 
triggers, recognise and 
reduce arousal 
4 1 hour, 
weekly, 
manualised 2 
Living well 
with emotions 
Group 
therapy 
Patients ACT, DBT, 
mindfulness 
Developed for 
current model 
Emotion regulation 6 1 hour, twice 
weekly, 
manualised 3 
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Induction Staff 
training 
Staff CBT Developed for 
current model 
To introduce staff to 
philosophy of the model and 
introduce CBT based skills 
such as formulation 
1 1 full day 
MBT skills 
training 
 
Staff 
training 
Staff MBT Developed for 
current model 
To improve quality of staff-
patient interaction  
2 2 full days 
Clinical 
supervision 
Staff 
component 
Staff N/A Routine 
component of 
psychological 
practice  
Provides a forum to 
problem solve with a 
clinical supervisor 
Flexible – only 
offered to staff 
who co-
facilitate or 
facilitate 
groups 
1 hour, 
frequency is 
flexible 
Reflective 
Practice 
Staff 
component 
Staff N/A Routine 
component of 
psychological 
practice  
Provides a group forum to 
problem solve 
Rolling 1 hour, 
weekly 
Acceptance and commitment therapy (ACT); Cognitive behavioural therapy (CBT); Cognitive behavioural therapy for psychosis (CBTp); Dialectal 
behaviour therapy (DBT); Mentalization based therapy (MBT); Not applicable, (N/A). 
1. (Clarke & Wilson, 2009). 
2. (Clarke, n.d.) 
3. See appendices. 
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4.7 Assessment 
A variety of data were collected to achieve the aims of the study (see ‘Specific aims’ 
section, page 71). Data relating to feasibility of implementing and evaluating the 
intervention were collected for the primary outcomes of the study, in order to inform 
development of the intervention and future definitive evaluation. Detail of the feasibility 
data recorded can be found in the ‘Analysis plan’ section, presented later in this chapter 
(page 111). The secondary outcome of the study was to gather clinical outcome data 
relating to effect and data on adverse events. Clinical outcomes were collected in the 
current study to acquire preliminary evidence of the direction of any treatment effect and 
to estimate completion rates of the chosen clinical outcomes (Lancaster et al., 2004; 
Thabane et al., 2010). The remainder of this section describes and justifies the chosen 
clinical outcomes proposed for future trials. 
 
Clinical outcome data collected for this feasibility study included questionnaires, 
readmission data and data on adverse events. All questionnaires were collected at 
baseline, post-treatment and 6-month follow-up (see Table 8). They were primarily 
collected in person where possible. Alternatively, participants were contacted by 
telephone, by post or via their clinical psychiatric nurse (CPN). All other data 
(readmission and adverse events data) were extracted from NHS Lothian electronic 
medical records.  
 
Table 8 
Timeline of clinical outcome data collection 
Baseline measures Post-treatment Measures 6-month follow-up 
Measures 
MHCS 
CORE 10 
BSI-18 
 
MHCS 
CORE 10 
BSI-18 
CTQ-SF 
LOS 
 
MHCS 
CORE 10 
BSI-18 
Readmission data 
Adverse events data 
Brief Symptom Inventory Scale-18 (BSI-18), Clinical Outcome of Routine Evaluatio-10 
(CORE-10), Childhood Trauma Questionnaire-Short Form (CTQ-SF), length of stay 
(LOS), Mental Health Confidence Scale (MHCS). 
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4.7.1 Clinical outcomes 
Proposed primary outcomes for main trial 
The proportion of readmissions at 6-months following discharge of the index admission 
is the proposed primary outcome measure for a future trial. The number of readmissions, 
or ‘revolving door patients’ is a significant problem for acute inpatient services in the UK 
(Cogan et al., 2012) and worldwide (Loch, 2014). Readmissions are expensive for 
services (Personal Social Services Research Unit [PSSRU], 2010) and may have a 
negative effect on patient outcome, i.e. a predictor of readmissions is the number of 
previous admissions (Information Services Division Scotland, 2009). One aim of the 
psychological intervention is to use acute admissions as a turning point for patients, which 
involves identify problems resulting in the current admission and teaching patients’ new 
ways of coping in future (Clarke & Wilson, 2009). Consequently, patients are supported 
to take responsibility for maintaining their mental health which may have implications 
for future service use, specifically readmission. Understanding whether this cross-
diagnostic psychological intervention can reduce the risk of readmissions is valuable to 
both patients and services, however is currently unknown.  
 
Although informative, there are also limitations associated with recording only the 
proportion of readmissions (Fischer et al., 2014). For example, individuals who have not 
been discharged at follow-up may not be considered readmitted. Additionally, the 
proportion of individuals discharged from the index admission may influence the 
proportion of people readmitted during the follow-up period. Additional information 
would need to be gathered to address this in a full trial. To address these limitations in 
the current study, the number of days admitted to an acute inpatient ward within 6-months 
of the index discharge was also recorded for each participant to further inform service use 
following discharge.  
 
Although the proportion of readmissions at 12-months was pre-specified, the proportion 
of readmissions was recorded at 6-months instead (see ‘Protocol amendments’ section, 
page 110). The length of follow-up was reduced due to slow recruitment and time 
restrictions, therefore 6 months was the longest follow-up possible. Previous research of 
psychological intervention in acute inpatient settings has used between three- and 24-
month follow-up (Bach & Hayes, 2002; Bechdolf, Köhn, Knost, Pukrop, & Klosterkötter, 
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2005; Gaudiano & Herbert, 2006; Schramm et al., 2007; Tarrier et al., 2004), therefore 
six months was considered acceptable for the current feasibility trial.  
 
Proposed secondary outcomes for main trial 
Three other clinical outcomes measures were pre-specified and collected. These included 
two self-report measures of emotional/psychological distress and one self-report measure 
of self-efficacy in relation to coping with metal health (see Appendix 11). Self-report 
measures have previously been rated as more acceptable measures, than clinician rated 
measures, to those with lived experiences of psychosis and affective disorder (Crawford 
et al., 2011), therefore only self-report questionnaires were used in this feasibility trial.  
 
Questionnaires 
Psychological/emotional distress  
In line with the aims of the intervention, psychological (or emotional) distress was 
considered an important outcome to include in evaluating the psychological intervention. 
The influential and maintaining role of emotional/psychological distress in severe mental 
illnesses (SMI) and acute exacerbation of symptoms has been recognised (Birchwood & 
Trower, 2006; Clarke, 2015; Linehan, 1993). Additionally, results from the meta-analysis 
reported in Chapter three suggest that brief psychological therapy delivered during an 
acute psychiatric admission may reduce inpatients emotional distress (i.e. depression and 
anxiety) at post-intervention. Two measures of psychological distress were collected, one 
of which has been used in previous evaluation of the Woodhaven approach, therefore 
allowing for easy comparison. The second measure of psychological distress was 
included because it specifically measures physical symptoms of psychological distress 
(somatization). Details of these measures are described below.  
 
The Clinical Outcomes in Routine Evaluation (CORE) 10 (Connell & Barkham, 2007) 
was one questionnaire used to measure psychological distress. It is a 10-item 
questionnaire measuring total psychological distress and three domains of distress: 
‘problems’ largely relating to anxiety and depression (6 items), general and social 
‘functioning’ (3 items) and ‘risk’ to self (1 item). Each item is measured on a 5-point 
scale ranging from 0 (not at all) to 4 (most or all of the time) with a higher score indicating 
higher severity. The 10 items have been taken from the 34-item CORE-OM. Although 
the CORE-OM is recommended where possible, the CORE 10 lends itself better to an 
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acute inpatient environment as it requires less time to complete. The CORE 10 has shown 
to have good internal reliability (.90) (Barkham et al., 2013), good internal consistency 
(0.82) in a primary care clinical sample (Connell & Barkham, 2007). Furthermore, it has 
previously been used by Clarke and colleagues to evaluate the Woodhaven Approach 
(Durrant & Tolland, 2009) (see Chapter 2). 
 
According to the theory underpinning the psychological intervention (see intervention 
section), high states of arousal are associated with emotional distress experienced by 
acute inpatients (Clarke, 1999; Teasdale, 1993). The intervention, therefore, 
predominantly focuses on teaching or improving skills to cope with and tolerate such 
arousal (see intervention section and introduction). Consequently, reduced arousal was 
considered an important outcome of treatment. The Brief Symptom Inventory Scale (BSI-
18) (Derogatis, 2001) was chosen to capture this. The BSI-18 is a shortened version (18 
items) of the BSI (Derogatis & Melisaratos, 1983) which is a 57-item self-report measure 
of psychological distress with nine dimensions. (Derogatis, 2001). Each item is scored on 
a 5 point Likert scale (0='not at all' to 4='extremely') with a higher score indicating higher 
severity. The BSI-18 was developed to include the most prevalent psychiatric symptoms 
of psychological distress: somatisation (6 items), depression (6 items) and anxiety (6 
items), therefore the questionnaire was considered suitable to measure psychological 
distress in a cross-diagnostic population. Specifically, questions within the somatization 
subscale, such as ‘how much were you distressed by pains in your heart or chest, trouble 
getting your breath, spells of terror or panic, etc.’, were thought appropriate to capture 
changes in physical arousal targeted by the intervention. Furthermore, the BSI-18 is quick 
to administer, therefore suiting an acute inpatient population. The BSI-18 has shown good 
reliability for the global symptom index (GSI), somatization, depression and anxiety (.90, 
.68, .84, and .79 respectively) and good internal consistency (.89, .74, .84, and .79, 
respectively) (Derogatis, 2001).  
 
Self-efficacy  
There is strong support for the notion that self‐efficacy mediates the relationship between 
coping, and positive and negative outcomes (Salanova, Grau, & Martinez, 2006). In line 
with the person-centred approach, an aim of treatment was to increase patients’ feeling 
of control in terms of their symptoms, as opposed to just reducing presentation of 
symptoms. According to Clarke and colleagues (Durrant & Tolland, 2009), 
improvements in self-efficacy should be expected following recovery based interventions 
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that incorporate a coping strategy (e.g. attention control, self-compassion, distress 
tolerance and emotion regulation). Self-efficacy should therefore indicate intervention 
effectiveness. The Mental Health Confidence Scale (MHCS) was used to measure self-
efficacy (Carpinello, Knight, Markowitz, & Pease, 2000). This measure was developed 
by a group involving mental health researchers, recipients of mental health services and 
individuals who have recovered from mental illness (Carpinello et al., 2000). It can 
therefore be considered a patient important outcome. The MHCS has also been identified 
as a recovery-related measure, therefore is in keeping with the recovery approach (Ralph, 
Kidder, Edmund, & Phillips, 2000). This measure was thought to be acceptable to 
participants as it contains ‘positive’ items which is an important feature of outcome 
measures identified by service user (Crawford et al., 2011). The MHCS measures self-
efficacy in relation to mental health using 16 items that are rated on a six point Likert 
scale that ranges from 1 (very non-confident) to 6 (very confident) with a higher score 
indicating higher levels of self-efficacy. The 16 items include three domains: optimism, 
coping and advocacy. A total score is made up of the total of all items. Construct validity 
of this scale is high and error variance is low, therefore the measure is considered by the 
authors to be reliable (Carpinello et al., 2000).  
 
Adverse events 
Trials of psychological intervention have been criticized for failing to measure adverse 
events (Duggan et al., 2014). Therefore, as recommended, adverse events are reported in 
the current study (Duggan et al., 2014). The number of people who made contact with 
intensive home treatment teams (IHTT), the number of people who made contact with 
A&E services (in relation to mental health), the number of deaths related to mental health 
(e.g. suicide) and the number of participants not discharged at follow-up were recorded. 
 
Proposed predictor of treatment outcome for main trial 
Theoretically, the role of childhood adversity has been highlighted as a contributing factor 
of adulthood mental health problems (Clarke, 2002; Teasdale & Barnard, 1995); and in 
the last decade, supporting evidence has emerged. For example, a meta-analysis of 18 
case controls, 10 prospective and quasi-experimental studies and 8 population based 
cross-sectional studies suggests childhood trauma is strongly associated with increased 
risk of developing psychosis in later life (Varese et al., 2012). Furthermore, a recent study, 
including 251 participants, has shown a positive correlation between the number of 
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experienced adverse childhood events and number of psychotic symptoms (Longden, 
Sampson, & Read, 2016). A recent meta-analysis has also suggested that childhood 
adversity is strongly associated with bipolar disorder compared to non-clinical controls 
(Palmier-Claus, Berry, Bucci, Mansell, & Varese, 2016). Given that acute psychiatric 
inpatient services commonly provide care for people with the diagnoses previously 
mentioned, it is possible that trauma may be a predicting factor of treatment outcome of 
psychological interventions delivered in acute inpatient settings. However, whether this 
is the case is currently unknown. To investigate this issue in a future definitive trial, an 
outcome of childhood trauma may be collected. However, some patients may find 
completing outcomes which measures childhood trauma unacceptable, given the sensitive 
nature of the questions. In order to determine the feasibility of exploring childhood trauma 
as a predictor of outcome of acute inpatient psychological intervention, a measure of 
childhood trauma was collected during the current study. The aim was to determine the 
feasibility of collecting a measure of childhood trauma as a predictor of treatment 
outcome in future definitive trials, based on the completion rate.  
 
The Childhood Trauma Questionnaire Short Form (CTQ-SF) (Bernstein et al., 2003) is a 
retrospective self-report measure of childhood abuse and neglect. It consists of 28 items 
that focus on constructs of adverse childhood experiences such as emotional abuse, 
physical abuse, neglect and sexual abuse. Each item is rated on a 5-point scale from 
‘Never true’ to ‘Very often true’, where a higher score indicates higher constructs of 
trauma. This measure includes five types of maltreatment: emotion abuse, physical abuse, 
sexual abuse, emotional neglect and physical neglect. It also includes a denial scale to 
detect false negative trauma. The scale is a valid measure in both clinical and non-clinical 
samples and has good criterion-related validity (Bernstein et al., 2003).  
 
4.8 Trial procedures 
Once ethical approval was obtained (see Appendix 14) both potential participating wards 
(clusters) were identified and verbal consent was sought from ward psychiatrists and 
charge nurses to participate in the study. Once cluster consent was obtained, electronic 
medical databases were checked daily by the primary researcher to identify newly 
admitted patients and check available eligibility criteria. For the intervention ward this 
occurred between October 2015 and October 2016 and for the control ward this occurred 
between October 2015 and June 2016 (due to other therapeutic work beginning, i.e. art 
therapy). Once potential participants were identified, the researcher then met with ward 
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staff (nursing or medical) to check remaining eligibility criteria. Once approved by 
medical or nursing staff, patients were approached in the ward by the primary researcher, 
were given the information sheet (see Appendices 12 and 13) and invited to take part in 
the study. In addition, posters advertising group therapies (in the intervention ward) and 
study details (see Appendix 15) were presented on ward notice boards with contact details 
for the primary researcher, although no participants were recruited using this method. 
 
If patients agreed to take part in the study written consent was obtained and the first 
assessment (baseline) was completed. Patients then either received TAU (control ward) 
or TAU plus psychological input (intervention ward). Patients in the intervention ward 
were advised which therapy they may benefit most from, however all patients allocated 
to intervention had access to all group therapies. The number and type of therapy 
components attended while in hospital and length of stay (LOS) were recorded. The 
researcher aimed to approach participants again before discharge to complete the second 
clinical outcome measures. Unfortunately, this was not always possible, due to the busy 
nature of the ward, or due to unexpected discharges. If unable to meet participants on the 
ward for the post-intervention assessment the researcher made contact with participants 
where possible via telephone, or through their clinical psychiatric nurse (CPN) in order 
to complete assessments over the phone, by post or to arrange an assessment appointment 
within a week of being discharged. If participants preferred to make an assessment 
appointment this was organised either at the hospital (REH), during a CPN meeting or in 
a community mental health centre of convenience to the participant. Participants were 
contacted again, via telephone or through contact with their clinical psychiatric nurse 
(CPN) after 6-month following discharge and asked to complete the final assessment. 
Readmission and adverse event data were also obtained from hospital records at 6-month 
follow-up. 
 
4.9 Analysis plan 
Statistical analyses were performed using IBM SPSS 23 (IBM, 2016). Analysis plans for 
each aim of the study are reported below in the following order: feasibility of evaluating 
the intervention, feasibility of implementing the intervention, treatment effects on chosen 
clinical outcomes and assessing the findings from this feasibility study.  
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4.9.1 Aim 1: feasibility of evaluating the intervention (primary outcome) 
Descriptive summaries are reported to investigate the feasibility of the trial. These 
outcomes were not pre-registered (see ‘Protocol amendments’ section for detail, page 
110). The following data is reported to address recruitment, retention and the acceptability 
of the clinical outcome measures chosen for a definitive trial:  
1. Eligibility rate: proportion of those who were eligible to participate as a percentage 
of those screened (i.e. fulfilled eligibility criteria of the study). 
2. Consent rate: proportion of those who consented to participate as a percentage of 
those who were approached to participate. 
3. Trial entry rate: proportion of those who consented that officially entered the trial as 
a percentage of those that consented and completed baseline measures, and had not 
been discharged or moved wards within two days of doing so.  
4. Completion rate:  
a) Proportion of clinical outcome questionnaires (CORE-10, BSI-18 and MHCS) 
completed at each time point (baseline, post-intervention and follow-up) as a 
percentage of those who entered the trial, with reasons for attrition where possible 
and assumed missing data mechanisms. This also provided an inverted measure 
of trial attrition.  
b) Proportion of readmission data successfully collected as a proportion of those who 
entered the trial, with reasons for missingness were possible and assumed missing 
data mechanism. 
c) Proportion of predictor outcome questionnaires completed in total (CTQ-SF) as a 
proportion of those who entered the trial.  
 
4.9.2 Aim 2: feasibility of implementing the intervention (primary outcome) 
Additional descriptive summaries (together with any relevant estimates of variability) are 
reported to investigate the feasibility of implementing the patient components of the 
psychological model. The following data addresses feasibility of implementing patient 
components of the intervention: 
1. Number of components delivered. 
2. Number of components not delivered, with reasons where possible. 
3. Number of sessions (of each component) delivered.  
4. Average number of overall sessions received by participants 
5. Average number of group sessions received by participants. 
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6. Average number of individual sessions received by participants. 
7. Proportion of participants who self-referred and were referred by ward staff to 
individual sessions. 
8. Number and proportion of participants who engaged. 
9. Number and proportion of participants who did not engage (with reasons where 
possible). 
 
4.9.3 Aim 3: preliminary clinical outcome data 
As this study was a feasibility trial and not adequately powered for effective hypothesis 
testing, no inferential statistical analyses were conducted using the clinical outcome data 
collected (Arain, Campbell, Cooper, & Lancaster, 2010; Eldridge, Chan, et al., 2016). 
Underpowered studies can result in biased conclusions because the distribution of the 
sample estimates is too wide (i.e. estimates are not precise) and replication is unlikely to 
yield the same estimates (Eldridge, Chan, et al., 2016). Therefore, all analyses were 
descriptive and exploratory, as opposed to definitive. Descriptive statistics, assessment 
of whether estimated treatment effects were in the expected direction, and confidence 
intervals were therefore the main focus of this study, while no formal statistical 
significance testing was conducted (Eldridge, Chan, et al., 2016; Lancaster, 2015; 
Lancaster et al., 2004). Specifically, means, standard deviations (SD), change in mean 
scores (SD) and standardised mean difference (SMD) are presented for continuous 
outcomes of effect, or medians and interquartile ranges where appropriate. All SMDs 
were interpreted using Cohen's (1988) guidelines: 0.2 signifies a small effect, 0.5 a 
medium effect and 0.8 a large effect. Count data, percentages and absolute risk 
differences are presented for dichotomous outcomes of effect. There is no standardised 
interpretation of risk difference magnitude. The Scottish Government (2010), however, 
has previously identified a 10% reduction in readmissions in one year as a meaningful 
difference, therefore this guided interpretation of risk difference. Additionally, 
descriptive summaries are reported for adverse event data. 
 
4.9.3.1 Approaches to intervention non-engagement and trial noncompliance 
Clinical trials are often burdened with intervention noncompliance and missing outcomes 
(Dunn, 2013), both of which can result in biased results, and interpretation. In the current 
study, both exist in the form of non-engaging participants in the intervention group and 
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loss to follow-up in both groups. Methods used to deal with both are described in the 
remainder of this section.  
 
Non-adherence 
There are two main approaches to the analysis of clinical outcome data: intention to treat 
(ITT) and per protocol (PP). An intention to treat analysis includes all recruited 
participants who are compared on the basis of their originally allocated group. It is 
therefore considered the least biased approach, in that confounding factors remain 
balanced between groups (Sedgwick, 2015). It is also considered the most pragmatic 
approach, in that treatment effects reflect real world clinical practice, e.g. treatment non-
compliance (Sedgwick, 2015), therefore such analyses are often used in pragmatic trials. 
In contrast, per protocol analyses include participants who have completed the treatment 
protocol (i.e. received minimum dose) and the trial protocol (i.e. provided outcome data). 
This analysis is often used in explanatory trials because the treatment effect is measured 
more directly, in that the results reflect the effect of the intervention, unaffected by non-
adherence and protocol deviations (Dunn, 2013). Nevertheless, per protocol analyses may 
be biased, as the balance of confounding factors, achieved through randomisation, may 
no longer be balanced and group differences may be a result of this imbalance, rather than 
the treatment of interest (Sedgwick, 2015). Furthermore, treatment effects derived from 
per protocol analyses may not remain when applied in real life.  
 
As this is a pragmatic trial, an intention to treat analysis is suitable. However, after the 
trial began, an additional exclusion criterion was added (see ‘Protocol amendments’, page 
110): patients were excluded if they were discharged or moved wards within two day of 
consenting and completing baseline measures. This was included to increase the chances 
of patients actually receiving the intervention. This is characteristic of an intention to treat 
analysis as all participants are included according to original groups, regardless of 
treatment received (Higgins & Green, 2011). However, to maintain transparency of 
reporting, this analysis is referred to as a modified intention to treat analysis for the 
purpose of this study because some participants were excluded after giving consent (see 
‘Protocol amendments’ and ‘Inclusion/exclusion criteria’). Although modified intention 
to treat analyses can overestimate the treatment effect (Abraha et al., 2015), this is 
dependent on the type of modifications made and can be accounted for in the design of a 
future trial. The modified intention to treat analysis, in this trial, aims to descriptively 
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summarise data and estimate treatment effects, with confidence intervals, for all 
participants who officially entered the trial. 
 
Although this was a pragmatic trial, a large proportion of participants in the intervention 
group did not receive the psychological intervention, partly due to unavailability, and 
little change in ward culture was observed (see consort diagram in Chapter 5 and the 
‘Protocol amendments’ section later in this chapter, page 110, for more detail). This had 
clear implications for the clinical outcomes collected in the present study, i.e. those who 
did not directly receive the intervention are unlikely to have benefited. To address non-
engaging participants in the intervention group in the current trial, a per treatment 
protocol analysis was conducted to supplement the modified intention to treat analysis 
on all clinical outcome data (i.e. readmission data, questionnaires and adverse event data) 
in an attempt to directly estimate intervention effects of those who received the 
intervention as well as the effect of treatment decisions (Dunn, 2013). The per treatment 
protocol analysis aims to descriptively summarise and estimate treatment effects, with 
confidence intervals, for all participants who officially entered the trial and received the 
intervention. Therefore, participants in the intervention group who did not receive at least 
one session of the intervention (non-engaging intervention group) were excluded from 
the per treatment protocol analysis. The excluded group of non-engaging participants was 
also not included in the control group for analysis because it is also possible that, being 
in the intervention ward, they received some benefit from a therapeutically enhanced 
environment, therefore potentially diluting any effect of treatment.  
 
Analysis of only participants who adhered to treatment (or in this case received at least 
one session of intervention) is sometimes criticised as the results are likely to reflect the 
maximum treatment benefit and confounding factors addressed with randomisation may 
influence treatment outcomes (Sedgwick, 2013c; Dunn, 2013). However, given that this 
trial was not randomised and did not aim to estimate definitive treatment effects, such 
limitations were less concerning. Therefore, the addition of per treatment protocol 
analysis was thought to supplement the modified intention to treat analysis, in that both 
analyses are more informative for intervention development and designing a future trial. 
Furthermore, the results of the current study will be interpreted with consideration of 
these limitations.  
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To conduct both a modified intention to treat analysis and a per treatment protocol 
analysis, descriptive summaries of clinical outcome data (i.e. questionnaire data and 
readmission data) and adverse event data are reported for two intervention groups (one 
as a subset of the other), and the control group as follows:  
1. Intervention modified intention to treat group (i.e. all participants who entered the 
trial and were in the intervention group). 
2. Control group (i.e. all participants who entered the trial and were in the control 
group)3.  
3. Intervention per treatment protocol group (i.e. participants in the intervention 
group who received at least one session of psychological intervention, as a subset 
of 1).  
Additionally, the following analyses estimate treatment effects, with 95% confidence 
intervals for all clinical outcome data (i.e. questionnaire data and readmission data): 
1. Primary analysis: control group versus intervention modified intention to treat 
group.  
2. Supplementary analysis: control group versus intervention per treatment protocol 
group.  
 
Dealing with missing data 
Missing data are common in clinical trials, and includes either missing outcomes, e.g. due 
to non-compliance, drop-out, loss to follow-up, etc., or missing responses within 
outcomes, e.g. due to patients finding some questions unacceptable or difficulty 
understanding some questions. Missing data can be problematic because, if ignored, 
sample size reduces, therefore decreasing the study power, and the benefit of 
randomisation in RCTs, i.e. balanced confounders, is reduced. Inferences made from the 
available data cannot be generalised to the entire target population, and the robustness of 
an intention to treat analysis may be compromised (Dunn, 2013). Investigating patterns 
of missing data can help identify what group of participants is likely to have missing data 
or whether particular responses are likely to be missing (Dziura, Post, Zhao, Fu, & 
Peduzzi, 2013). Three categories are used to identify how data has come to be missing 
(Little & Rubin, 2002) which have implications for the chosen analysis (Graham, 2009): 
                                                 
3
 As all participants in the control group received treatment, the control modified intention to treat 
group includes the same participants as the control per treatment protocol group. For ease, this 
group will only be labelled ‘control group’. 
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Missing Completely at Random (MCAR), Missing at Random (MAR) and Missing Not 
at Random (MNAR). MCAR is the mechanism where by missing data is assumed to be 
completely unrelated to any observed or unobserved variables, therefore the chance of 
missingness is equal between individuals and groups and the complete cases represent all 
cases originally included (Dziura et al., 2013). Furthermore, where a trial is randomised, 
the benefit of randomisation, i.e. equally balanced confounders between groups, is not 
compromised by missingness that is completely random, therefore missingness does not 
introduce bias in the analysis (Dziura et al., 2013). Such missing data is considered 
ignorable (Graham, 2009), but is rare. When data are considered to be MAR, recorded 
variables are accountable for differences in the distribution of missing variables for 
observed and missing cases, i.e. missingness is related to observed variables but not 
unobserved or missing variables (Dziura et al., 2013), therefore missingness is 
conditional (Graham, 2009). Depending on the amount of missing data, this mechanism 
is considered ignorable as unbiased estimates can be obtained (Graham, 2009). Methods 
to handle data that are MAR, however, are recommended to minimise bias in estimated 
parameters and maintain study power (Graham, 2009). MNAR refers to missing data 
where missingness is related to unobserved variables (Dziura et al., 2013). Such 
missingness is non-ignorable because it is likely to produce biased estimates if not dealt 
with appropriately in the analysis (Graham, 2009). To produce unbiased results, statistical 
modelling is required to relate outcomes of interest and the probability of non-response 
(Dziura et al., 2013). These techniques may be considered beyond the scope of a 
feasibility trial, because the aim of this type of trial is not to provide a definitive 
assessment of treatment effects, and is unlikely to have sufficient power to allow these 
analyses.  
 
Imputing missing values in questionnaires 
Associated guidelines were used to impute missing questionnaire values where possible. 
Such guidelines, and methods used where guidelines were not available, are now 
described. Missing values of the BSI-18 were imputed as recommended by the scoring 
manual (Derogatis, 2001). Each participant’s subscale score can be computed if four or 
more items have been answered (i.e. 2 missing values per subscale). Therefore, the BSI 
18 can be computed with up to 6 missing values across 3 subscales. Where a participant’s 
questionnaire has missing values within these specified limits all subscales and overall 
score can be calculated. To do so the values for all items responded to were summed and 
divided by the number of answers completed. This value was then rounded to the nearest 
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whole number and substituted for each of the missing items (<0.5 round down; > or equal 
to 0.5 round up). Missing values of the CORE-10 were also imputed as recommended by 
the user manual (Connell & Barkham, 2007). Where one value is missing the clinical 
score (i.e. total score) can be calculated using the total mean score (i.e. the total score is 
divided by the number of completed items). These methods of imputation were 
considered appropriate for the current study because 1) they are parsimonious, 2) they 
allow for complete case analysis to be carried out, whilst maintaining sample size and 
power, 3) they minimise disadvantages associated with mean-imputation and last 
observation carried forward such as underestimated variability (Dziura et al., 2013), 
because imputed values are participant specific (and subscale specific for the BSI-18). 
Furthermore, this follows the scale recommendations and enables standardization of use 
of the scale across all experiments.   
 
No guidelines for handling missing values were provided by the MHCS, therefore mean 
individual imputation was also used to impute missing values. Mean individual 
imputation has been shown to be a reliable method of imputation in self-report measures 
of depression but a simpler method than others, e.g. multiple imputation (Shrive, Stuart, 
Quan, & Ghali, 2006) and was therefore considered an appropriate method. 
 
Missing outcomes 
Preliminary outcome data for this study was collected via questionnaires or from 
electronic medical files, both of which had missing data. To maintain sample size, missing 
data were imputed using multiple imputation in SPSS 23 (IBM, 2016) and the imputed 
dataset was descriptively analysed under the assumption that data are missing at random 
(MAR) (Little & Rubin, 2002). Reasons for assuming MAR are described in the Chapter 
5. Multiple imputation uses all available data to obtain multiple possible values for each 
missing observation, and then combines all possible values (Graham, 2009). This method 
has been shown to produce unbiased estimates of treatment effects under the assumption 
that data are MAR (Dziura et al., 2013), and was therefore considered suitable for the 
current study. The multiple imputation model included the following variables: total 
inpatient days (during follow-up), number of intensive home treatment team episodes, 
number of A&E episodes, length of index admission stay, gender, diagnosis, 
readmissions during follow-up, all questionnaire questions and group allocation. Some of 
these were auxiliary variables (i.e. they inform estimations of incomplete data but are not 
part of the main analysis) and some were outcome variables. As per recent 
  
108
recommendations, 50 imputations were used to match the percentage of missing data 
(Lee, Roberts, Doyle, Anderson, & Carlin, 2016) and non-normal variables were entered 
unmodified (von Hippel, 2013).  
 
Where a large percentage (approximately 50%) of data was missing, a sensitivity analysis 
was conducted to assess the robustness of the missing data assumption. The sensitivity 
analysis excluded imputed data under the assumption that data were missing completely 
at random (MCAR) (i.e. complete case analysis) (Dziura et al., 2013).  
 
Although no data were thought likely to be missing as a result of the intervention, 
sensitivity analysis to investigate the robustness of the results when data were analysed 
under the assumption that data were missing not at random (MNAR) was judged to be 
beneficial. However, to obtain unbiased results under the assumption that data are 
MNAR, advanced statistical methods are recommended (Dziura et al., 2013; Little et al., 
2012). The current study was not adequately powered for such statistical methods. Detail 
of analyses planned for all preliminary clinical outcome data are described below. 
 
4.9.3.2 Effect 
Readmission data 
Descriptive summaries (n (%)) and estimated treatment effect and 95% CI for number of 
readmissions, were reported. Additionally, descriptive summaries (median (IQR)) and 
estimated treatment effect and 95% CI were reported for total number of inpatient days 
during the follow-up period will. These results were used to investigate whether these 
outcomes indicated change in the predicted direction, i.e. favouring the intervention. 
 
Questionnaire data: psychological distress and mental health related self-efficacy  
Descriptive summaries (means (SD)) were reported at pre-intervention, post-intervention 
and 6-month follow-up. Additionally, to estimate treatment effect and 95% Cis, mean 
change was calculated from baseline to post-intervention and from baseline to 6-month 
follow-up between groups. Mean change was used, rather than post-intervention, to 
account for pre-intervention differences. This was used to investigate whether the chosen 
outcome measures produce change in the expected direction and will be used to inform 
clinical outcomes for a future definitive trial.  
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4.9.3.3 Adverse events 
Descriptive summaries (n (%)) are reported for each measure of safety (i.e. contact with 
the Intensive Home Treatment Team (IHTT), contact with A&E, not discharged from 
index admission at follow-up and deaths (related to mental health). It should be noted that 
IHTT contact relating to initial discharge was not included as this is often routine practice. 
If a participant was readmitted and received input from IHTT again following discharge, 
the readmission itself was recorded but not the contact with IHTT as this would count the 
adverse event twice. 
 
4.9.4 Aim 4: summarise and assess the findings of this feasibility study 
As recommended by Bugge et al. (2013), data collected for aims one to three were 
presented using Shanyinde, Pickering and Weatherall (2011) as an analytical framework 
to highlight the extent to which this study addressed each issue, and to examine the type 
of problems encountered during the trial, i.e. relating to the trial, the real world or both. 
This maps onto stage one (of three) of the ADePT (a process for decision-making after 
pilot and feasibility trials) process (Bugge et al., 2013). Stages two and three of the 
ADePT process are addressed in Chapter 6.  
 
4.10 Intracluster correlation coefficient (ICC) 
Similarities between patients within each ward are expected, therefore variability of 
treatment effects within each cluster (ward) is reduced (Eldridge & Kerry, 2012; Medical 
Research Council, 2000). An ICC is sometimes estimated from a feasibility trial when 
there is sufficient data. This calculation compares within-group variance to between-
group variance and is used to account for the effect of clusters in sample size calculations 
and analysis of trial data (Eldridge & Kerry, 2012). However, ICC estimations can often 
be imprecise, especially when calculated using pilot/feasibility data (due to the small size 
of pilot/feasibility studies and non-randomised sample of clusters). Data from the current 
feasibility trial were not used because few clusters were included (k=2), and clusters were 
not randomised. The included clusters are unlikely to represent a random sample of the 
population of clusters, and ICCs calculated using data from such clusters are unlikely to 
represent the true variation of the cluster population (Eldridge & Kerry, 2012). No ICC 
has previously been published for an acute mental health inpatient environment with a 
binary outcome (i.e. number of readmissions), therefore a relevant ICC was calculated in 
this study using other sources (Eldridge & Kerry, 2012). There is evidence to suggest that 
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ICC calculations vary depending on outcome, setting, prevalence (of event in a binary 
outcome), size of a cluster (based on the context) and type of measurement (Campbell, 
Fayers, & Grimshaw, 2005). Relevant, existing ICC estimates were used to calculate an 
appropriate ICC for a future definitive trial and are reported in section 5.1 in Chapter 5.  
 
4.11 Sample size calculation for a definition trial 
Clinical outcome data collected during pilot/feasibility studies are often used to calculate 
the sample size for a larger main trial, however this is not recommended if the study is 
underpowered to accurately estimate such parameters (Eldridge et al., 2016). As this 
study was not adequately powered to accurately estimate treatment effects, the required 
sample size for a future definitive trial could not be confidently calculated based on these 
parameters. Instead, this calculation was based on a meaningful change in readmissions 
identified by the Scottish Government: 10% reduction in one year (Scottish Government, 
2010), using G-Power (version 3.1.9.2) (Faul, Erdfelder, Lang, & Buchner, 2007). The 
effect of cluster randomisation was also accounted for in the calculation (see ICC section 
above) (Eldridge & Kerry, 2012, section 7.2). The only data from the current feasibility 
trial used to calculate sample size was related to attrition. The calculation is reported in 
section 5.1 in Chapter 5.  
 
4.12 Ethical approval  
Ethical approval was provided by Edinburgh Napier University and NHS Lothian (REC 
No: 15/SS/0093) (see appendices).  
 
4.13 Registration 
The trial protocol was registered, before recruitment began, on a publically accessible 
database (researchregistry509). Amendments made after original ethical approval and 
registration of the trial protocol are detailed in the ‘Protocol amendments’ section 
(below).  
 
4.14 Protocol amendments  
After original ethical approval and registration of the trial protocol (researchregistry509), 
amendments were made to the study. Important changes are discussed at length in this 
section, followed by a list of other amendments. 
  
111
 
The first important amendment was made to the aims of the study. The original aims of 
the thesis were to assess whether the addition of psychological intervention to TAU was 
more effective than TAU alone with regards to reducing readmissions, reducing 
psychological distress and increasing mental health related self-efficacy. An additional 
aim was to investigate the role of childhood trauma as a predictor of treatment outcome. 
However, in light of newly developed conceptual frameworks that define and guide 
reporting of pilot and feasibility trials (Eldridge, Chan, et al., 2016; Eldridge, Lancaster, 
et al., 2016; Lancaster, 2015) it became clear, during the course of this PhD research, that 
the original aims and proposed methodology were ambitious and beyond the scope of this 
study. According to Eldridge, Lancaster, et al., (2016), the current study fitted under the 
umbrella term of ‘feasibility studies’. As some aspects of a larger trial were also 
implemented in this study, e.g. gathering preliminary clinical outcome data (and predictor 
outcome data) and implementing the intervention, it may also fall into Eldridge, 
Lancaster, et al.'s (2016) subcategory of non-randomised pilot trials. However, as the 
primary aims are to determine the feasibility of implementing the intervention and the 
feasibility of evaluating it in a future larger trial, the current study is referred to as a 
feasibility study, therefore mapping onto phase two of the MRC framework for 
developing and evaluating complex interventions (Craig, 2012; Craig et al., 2008). Roll-
out of the psychological intervention as planned was challenging, suggesting that the 
model is in early stages of development and evaluation. Consequently, the aims and 
outcomes of the trial were re-specified (see ‘Specific aims’ section, page 71) according 
to the CONSORT guidelines for pilot and feasibility trials (Eldridge, Chan, et al., 2016) 
prior to analysis. Redefining the aims was deemed important and informative to guide a 
future, adequately powered, definitive trial of this intervention (Lancaster, 2015). 
Changing the aims, and therefore the outcomes, of a study is often considered a concern 
as it increases the risk of bias, for example due to selective reporting (Higgins & Green, 
2011). However, in reporting all amendments in the current study, the decision to make 
changes remains transparent and is therefore in keeping with the open science framework.  
 
A limitation related to changing the current design from a proposed effectiveness trial to 
a feasibility trial during the study period is that important feasibility data may not have 
been recorded. For example, it is recommended that data such as recruitment rates, 
retention rates, refusal rates, etc. (see Thabane et al., (2010) for more examples) should 
be recorded during the feasibility phase. Accordingly, a variety of feasibility data were 
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recorded throughout the study, however it became apparent during the study that other 
useful data was not, i.e. reasons for not participating in the study or engaging with the 
intervention and acceptability of the intervention and trial processes. These issue will be 
discussed further later in the thesis (Chapter 6).  
 
The second important post registration amendment was the addition of per treatment 
protocol analyses (i.e. excluding participants in the intervention group who did not 
receive the intervention), with the following rationale. A large proportion of participants 
in the intervention group did not receive the psychological intervention (see consort 
diagram in results and amendments to trial section for more detail). Additionally, through 
direct observation, it was evident that ward staff involvement in co-facilitating and 
facilitating the groups was slow and in some cases absent. The ward psychologist 
facilitated group sessions where possible, however due to other commitments (i.e. 
individual sessions) delivery relied heavily on ward staff. Unfortunately, there was no 
protected time for ward staff to deliver groups, therefore given the busy nature of an acute 
inpatient ward staff few group therapies were delivered: only three group rolled out 
(rather than four), and some weeks no groups were delivered. Furthermore, a number of 
staff who attended relevant psychological training (i.e. CBT and MBT staff training, see 
intervention section for more detail) left the ward and were replaced by staff who had not 
attended psychological training. The absence of ward staff involvement in group delivery, 
along with few psychologically trained staff suggested culture change had not taken place 
yet and it was likely that a psychological milieu had not yet been adopted. This had clear 
implications for the clinical outcomes collected in the present study. For example, under 
the assumption that ward culture and environment had not changed (i.e. become more 
therapeutic) it is unlikely that inpatients who did not attend psychological groups or 
individual sessions would have benefited from the intervention. Thus, although 
pragmatic, an intention to treat analysis is likely to underestimate treatment effects (Dunn, 
2013). For this reason, it was decided that the descriptive analysis in which all participants 
who formally entered the study are included, should be supplemented by a descriptive 
analysis in which participants in the intervention group who did not engage with the 
intervention are excluded (see ‘Analysis plan’ section for details, page 100).  
 
Other post-registration amendments include: 
1. Withdrawal of secondary outcome measures, including locus of control (LCB) 
and mindfulness (FFMQ) questionnaires, to reduce patient burden and increase 
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recruitment. This amendment was put in place before recruitment after 
discussions with charge nurses on the ward, who advised that less questionnaires 
were likely to be more manageable for patients, therefore improving recruitment. 
2. 6-month follow-up instead of 12-month follow-up assessment was carried out due 
to time limitations. This decision was driven by slow recruitment. Recruitment 
time was extended in order to increase sample size.  
3. Although aiming to keep the study as pragmatic as possible, additional 
inclusion/exclusion criteria were added after recruitment began. First, in order to 
maintain safety in the conduct of the study, patients were not deemed eligible for 
participation if presenting unsafe behaviour, i.e. severe hostility/aggression or 
sexually uninhibited behaviour towards staff. Second, participants were excluded 
from study if discharged or moved wards (to either the other participating ward 
or a non-participating ward) within 2 days of giving consent and completing 
baseline questionnaires in order to reduce the effect of participants not receiving 
the intended intervention.  This will be considered in the design of a larger 
definitive trial to avoid exclusions after randomisation. 
4. Only three groups (‘Anxiety and Stress Management’, ‘Living Well with 
Emotions’ and ‘Being Friends with Yourself’), rather than four groups, were run 
when possible due to limited resource for group delivery (see discussion above).  
5. In order to account for limitations associated with number of readmissions 
between groups as an outcome (see ‘Clinical outcomes’ section for more detail), 
additional planned data collection to estimate the number of readmission days 
(median number of days with IQR) between groups were also added as outcomes 
related to readmission, after registration of the trial. 
6. In accordance with the change in study aims (described above) the sample size 
required for the current study was recalculated after the study began. The target 
sample size changed from 160 to 150 participants. 
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5 Feasibility study findings 
The aim of this chapter is to present data from the feasibility study and to highlight the 
extent to which key methodological issues, defined by Shanyinde, Pickering and 
Weatherall (2011), were addressed by this study. The results are reported in accordance 
with such methodological issues and are summarised in Table 24 (page 139). 
 
5.1 Sample 
Sample size of current study 
The CONSORT diagram (Figure , page 116) presents the flow of participants through the 
study and the intervention received. The target sample size for this feasibility study was 
150. Due to the time restrictions of this PhD and a lower than anticipated consent rate, 
only 96 participants were able to be recruited.  
 
Sample size calculation of a future definitive trial 
The intracluster correlation coefficient (ICC) was calculated using ICCs previously 
calculated for a number of relevant outcomes and settings. The median ICC for secondary 
care settings (e.g. acute psychiatric services) has previously been calculated as 0.061, for 
clinical or participant related outcomes as 0.030, for binary outcomes with a prevalence 
of 29-63.4% as 0.089, for a sub-unit in a hospital (e.g. one ward in a hospital service) as 
0.080 and for objectively measured outcomes (such as readmissions) is 0.053 (Campbell 
et al., 2005). The average ICC for a cluster RCT with these characteristics and with a 
binary primary outcome (i.e. proportion of readmissions) was therefore calculated as 
0.063.  
 
The Scottish Government identified a meaningful reduction in readmissions as 10% in 
one year (Scottish Government, 2010). Based on this target, an individually randomised 
definitive trial would require recruitment of 808 participants (404 in each group, 80% 
power, 5% significance level, two-tailed) to detect a 10% change in the primary outcome 
measure (proportion of readmissions). The design effect was calculated as 4.528, based 
on an intra-class correlation coefficient of 0.063 (see ICC section) and an average cluster 
size of 56.5 (i.e. 57) (based on the average number of participants recruited to each cluster 
in this trial (allowing 12 months for recruitment)). The total sample size calculated was 
1829, with an average of 32 clusters. To account for 10% attrition in the primary outcome, 
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observed in this feasibility study (see attrition section later in this chapter), 2012 
participants should be recruited between 36 clusters within 12 months. In any future 
definitive trial, the services of a registered Clinical Trials Unit would be engaged and a 
dedicated statistician would check and advise further. 
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Figure 8 CONSORT flowchart through feasibility study 
Assessed for eligibility (n=364)
Approached (n=248)
Consented and completed 
baseline measures (n=116)
Officially entered trial (n=96)
Violated inclusion/exclusion criteria 
prior to being approached (n=116)
Declined participation n=132)
Excluded after giving consent for 
violating inclusion/exclusion criteria: 
discharged or moved ward within 2 
days of giving consent and completing 
baseline measures (n=6)
Excluded after giving consent for 
violating inclusion/exclusion criteria: 
discharged or moved ward within 2 days 
of giving consent and completing baseline 
measures (n=14)
Intervention ward (n=63) Control ward (n=33)
-Received intervention (n=31; 49%)
-Did not receive intervention (n=32; 61%)
-Completed post-intervention assessment (n=57; 
90%)
-Loss to post-intervention assessment (n=6; 
10%)
-Completed follow-up assessment (n=33; 52%)
-Loss to follow-up (n=30; 48%)
-Analysed for primary outcome (n=63; 100%)
-Analysed for secondary outcome (n=63; 100%)
-Received TAU (n=33; 100%)
-Did not receive TAU (n=0; 0%)
-Completed post-intervention assessment (n=32; 
97%)
-Loss to post-intervention assessment (n=1; 3%)
-Completed follow-up assessment (n=18; 55%)
-Loss to follow-up (n=15; 45%)
-Analysed for primary outcome (n=33; 100%)
-Analysed for secondary outcome (n=33; 100%)
ENROLMENT
ALLOCATION
POST-INTERVENTION
FOLLOW-UP
ANALYSIS
- eceived intervention (n=32; 51%) 
- id not receive intervention (n=31; 49%) 
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5.2 Eligibility 
Participants 
Between October 2015 and October 2016 364 people were screened for eligibility and 
248 initially met eligibility criteria. The initial eligibility rate was 68%. As seen in Figure 
8, a further 20 people were excluded after consenting to participate and completing 
baseline measures, therefore the overall eligibility rate was 63%. Reasons for ineligibility 
are presented in Table 9 (below). 27% of participants were excluded because staff 
anticipated their admission to the study ward would be less than three days. However, 
when staff misjudged admission length or where anticipated length of stay changed due 
to unforeseen circumstances, some initially eligible patients were excluded. The 
proportion of participants wrongly excluded was not directly measured. Participants were 
also excluded after consenting to participate and completing baseline measures (15%) if 
they moved wards or were discharged within two days of doing so.  
 
Table 9 
Reasons for ineligibility (as judged by ward staff) 
 
Criteria for exclusion 
n 
% 
Not classed as ‘stabilised’ by ward staff (i.e. too distressed/unwell or likely to 
find questionnaires too distressing) 
27 
(20%) 
Not able to complete questionnaires (e.g. due to impaired attention/distracted) 12 
(9%) 
Unlikely to be admitted for more than 3 days (discharged or moving 
wards)/discharged before able to meet for baseline assessment 
36 
(27%) 
Diagnosis of moderate to severe learning disability, dementia or organic mental 
disorder 
6 
(4%) 
Presented unsafe behaviour (violent or sexually inappropriate) 12 
(9%) 
Did not speak English 3 
(2%) 
Not available to meet on ward (i.e. in medical hospital/on pass/sleeping and asked 
not to be disturbed, with visitors, with medical team, with occupational therapist) 
 
18 
(13%) 
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Delayed discharge1 2 
(1%) 
Excluded after consenting to participate and completing baseline measures due 
to being discharge or moving wards within 2 days of doing so 
20 
(15%) 
Total  136 
(100%) 
1. Delayed discharge refers to patients who are admitted but are considered well, e.g. 
waiting for appropriate accommodation on discharge, or waiting for available bed 
in another service.  
 
Clusters 
As the main aim of this study was to pilot and test the feasibility of implementing and 
evaluating the intervention, few clusters (i.e. acute psychiatric inpatient wards) were 
considered for inclusion (k=3). Initially, two clusters were considered and asked to 
participate, both of which agreed. However, one was then excluded due to other 
therapeutic input. A third cluster was invited and agreed to participate. Cluster 
inclusion/exclusion criteria remained broad, which resulted in clinical context differences 
between included wards. For example, patient care pathways differed between wards in 
that psychiatrists in the control ward worked consistently with patients, whether treated 
in hospital or in the community, while psychiatrists in the intervention ward were resident 
psychiatrists, therefore patients in the intervention group received input from different 
psychiatrists, depending on whether they were admitted or not. 
 
5.3 Recruitment 
A reasonable number of participants were recruited for the trial, but recruitment was 
labour intensive and slower than anticipated. Six months were initially allocated to 
recruitment, however due to slow recruitment this period was extended to 12 months to 
increase the sample recruited for this study. Participants were recruited between October 
2015 to October 2016 from the control ward and between October 2015 and October 2016 
from the intervention ward. All participants were recruited by one full time researcher. 
Of the 116 participants who consented and completed baseline measures, 96 officially 
entered the study (83%): 63 were recruited from the intervention group and 33 from the 
control group. The other 17% did not officially enter the trial because they violated post 
hoc inclusion/exclusion criteria after consenting and completing baseline measures (see 
eligibility section and Figure 8). It should be noted that the difference in sample size 
between groups reflects the time spent recruiting each group rather than more 
acceptability in either group. The average number of participants recruited from one ward 
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per month was four. No participants responded to the poster advertisement. All 
participants were recruited in person.  
 
5.4 Consent 
Participants 
A proportion of 47% of patients deemed eligible to participate consented to participate in 
the study. No participants withdrew consent after this point. Reasons for not consenting 
were recorded where possible, however this trial did not have ethical approval to formally 
ask patients for reasons. Although not formally measured, anecdotal evidence regarding 
refusal to participate was recorded where possible. One patient felt that participating in 
the study would be ‘too much’, one patient refused participation because they felt 
‘uncomfortable being part of a study’, two patients had concerns that if they completed 
questionnaires medical staff may think they were ill, one patient told the researcher that 
their concentration was too poor to complete questionnaires, one participant reported they 
were ‘not the right person’, one patient refused because their experience was too personal 
to share, one patient refused because they were ‘not just an experiment’ and one patient 
felt that ‘ticking boxes doesn’t explain how I feel’. 
 
Clusters 
All ward charge nurses (i.e. of each cluster) asked to take part in this trial gave consent.  
 
5.5 Randomisation procedures 
Neither participants nor clusters were randomised. 
 
5.6 Blinding procedures 
Participant and personnel blinding was not possible in this study due to the nature of the 
intervention. Assessors were also not blind to trial arm due to limited resource of the 
study, namely there were no funds available to employ an independent outcome assessor.  
 
5.7 Implementation of and engagement with the intervention 
5.7.1 Implementation 
Some components of the intervention were well implemented, while others were not. 
Over the study period a total of 133 therapy sessions (group and individual) were 
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delivered to 32 participants. Participants received a median of 3 sessions in total (IQR=4). 
Individual sessions were implemented well in this trial. A total of 105 individual sessions 
(‘Emotion focused formulation’) were delivered to 16 participants. Participants received 
a median of 3.5 sessions (IQR=4). Of the 16 participants who received individual 
sessions, 5 (31%) self-referred and 11 (69%) were referred by ward staff.  
 
Group components were poorly implemented in this study. According to the intervention, 
four different group therapies should be delivered to patients each week. If implemented 
as planned, approximately 208 group sessions should have been delivered during the 
study period (12 months). In practice, only three of the four group sessions were 
implemented, and a total of 28 group sessions were delivered overall. 20 participants 
received a median of 2 group sessions (IQR=2). 15 emotion regulation groups (‘Living 
well with emotions’), 4 anxiety management groups (‘anxiety and stress management’) 
and 9 compassionate mind groups (‘Making friends with yourself’) were delivered. The 
hearing voices group was not implemented during the study period due to limited resource 
for delivery. Resource from the clinical psychologist and advanced nurse practitioner was 
primarily used for individual sessions, and nursing staff reported having little time for 
group delivery after completing usual ward tasks.  
 
5.7.2 Engagement with the intervention 
Patient engagement 
Patient adherence to the intervention and treatment attrition was challenging to measure 
due to the flexible nature of the intervention (i.e. patients could attend as many or as few 
sessions as they wish). Instead, participant engagement was recorded and defined as 
attending at least one group or individual session. Of the 63 participants in the 
intervention group, only 32 (51%) engaged with the psychological intervention. Reasons 
for not engaging in the intervention were not directly and systematically recorded, 
however reasons were recorded where possible and are reported in Table 10 (below). Ten 
(16%) participants in the intervention group expressed interest but were unable to engage 
in the intervention due to limited resource or unexpected discharge. Comparison of 
engaging and non-engaging participant characteristics is reported in the ‘Baseline 
symptom severity and sample characteristics’ section. 
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Table 10 
Number of participants not engaged in the intervention with reasons where possible 
Reason for not engaging in psychological therapy N (%) 
Did not provide a reason  20 (31%) 
Made appointment but did not attend  1 (1%) 
Did not think it would help  1 (1%) 
Expressed interest but did not attend Discharged while on 
waiting list for individual 
session 
5 (8%) 
 Discharged before next 
scheduled group session 
5 (8%) 
Total number of participants not engaging in the intervention 31 (49%) 
 
Staff engagement 
Staff engagement was not directly investigated in this study. However, poor group 
implementation suggests poor staff engagement. According to the intervention, once 
appropriately trained, staff should facilitate group components. Although not directly 
measured, few staff did so. Reasons for not engaging were not formally recorded, 
however it was observed that staff lacked confidence and time during shifts to deliver 
groups. Furthermore, many staff who had received the relevant psychological training left 
the ward during the study period, resulting in fewer staff who were able to facilitate 
groups. Lack of adequately trained staff was a barrier to consistent group implementation 
in combination with staff sickness and inflexible rotating staff rotas (i.e. shift patterns 
tended to be a block of day shifts followed by a block of night shifts). Future steps to 
address staff adherence in a future trial are considered in Chapter 6.  
 
5.8 Acceptability of intervention 
Acceptability of the intervention was not formally measured in this study. However, 16% 
of participants in the intervention group expressed an interest in receiving it, but did were 
unable to due to being discharged while on a waiting list. This data suggests that there is 
some demand for the intervention. Further investigation of intervention acceptability is 
considered in Chapter six. 
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Table 11 
Completion rate of each outcome measure at each time point (n (%)) 
 Pre-intervention Post-intervention 6-month follow-up  
Readmissions 
(dichotomous 
and continuous)  
 
CTQ-
SF Group CORE-
10 
BSI-18 MHCS CORE-
10 
BSI-18 MHCS CORE-
10 
BSI-18 MHCS 
Intervention 
(n=63) 
63  
(100%) 
62 
(98%) 
63 
(100%) 
57  
(90%) 
56 
(89%) 
57 
(90%) 
33 
(52%) 
32 
(51%) 
33 
(52%) 
58 
(92%) 
38 
 (60%) 
Control (n=33) 33  
(100%) 
33  
(100%) 
33  
(100%) 
32  
(97%) 
32 
(97%) 
32 
(97%) 
18 
(55%) 
18 
(55%) 
18 
(55%) 
30 
(91%) 
23 
(70%) 
Total (n=96) 96  
(100%) 
95  
(99%) 
96  
(100%) 
89 
(93%) 
88 
(92%) 
89 
(93%) 
51 
(53%) 
50 
(52%) 
51 
(53%) 
88 
(92%) 
61 
(64%) 
Brief Symptom Inventory Scale (BSI); Clinical Outcomes Routine Evaluation (CORE); Mental Health Confidence Scale (MHCS); Modified intention to treat (mITT); 
Per treatment protocol (PtP); Standard deviation (SD). 
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5.9 Cost of intervention 
No economic evaluation was carried out with this study.  
 
5.10 Completion of outcome measures 
Outcomes measured in this study included questionnaires, regarding patient 
psychological distress and mental health related self-efficacy, and electronic medical data 
regarding acute inpatient readmissions. Completion rates and associated missing data 
mechanisms of all outcomes are as follows.  
 
Completion rates of pre- and post-intervention were very good (92-100%). Overall, seven 
participants (7%) provided no questionnaires at post-intervention. Four of the participants 
(4%) were discharged quickly and were unable to be met before, or contacted after, and 
were lost to follow-up. This represents the unpredictable nature of an acute inpatient ward 
and the related challenges of data collection within this environment. Such missing data 
was assumed to be MCAR. Three participants (3%) declined assessment without giving 
a reason. There was no reason to think this was due to the intervention, as the intervention 
was well received, therefore such data was assumed to be MAR. One participant in the 
intervention group also chose not to complete the BSI-18 due to its similarities to the 
CORE-10 and was assumed to be MAR. While patterns of missing values in 
questionnaires were investigated, no patterns of missingness emerged in pre- or post-
intervention questionnaire data. One notable pattern, however, was identified in follow-
up questionnaire data: a large proportion of participants failed to complete all 
questionnaires at follow-up (51-55%, depending on the questionnaire and group) (see 
Table 11, above). Missingness was of even proportions across groups and questionnaires, 
therefore supporting the assumption that data were MAR. Reasons for missing 
questionnaires at follow-up and assumed missing data mechanisms are reported in Table 
12 (below).  
 
Readmission data were available for 92% of participants (n=88). Reasons for missing 
readmission data and related missing data assumptions are presented in Table 13 (page 
125). 
 
Completion rate of the predictor outcome (CTQ-SF) was calculated overall and for each 
group at 6-month follow-up. A proportion of 64% of participants completed the CTQ-SF. 
Reasons for non-completion were not recorded.  
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While the chosen outcomes are relevant to the aims of the intervention, other relevant 
outcomes were not measured in the current study, but could be considered in a future 
definitive trial. For example, the intervention also aims to improve outcomes for staff, 
e.g. staff burnout and staff understanding of patient problems, and it aims to improve the 
milieu. Appropriate tools could be used to measure such outcomes in future. 
 
Table 12 
Number and proportion of participants missing all follow-up questionnaires per group (n 
(%)) with reasons  
 
Reason 
Group  Assumed 
missing data 
mechanism 
Intervention 
(n=63) 
Control 
(n=33) 
Total 
(n=96) 
No contact number 
recorded/no CPN 
 
5 (8%) 1 (3%) 6 (6%) MAR 
Number available 
but could not 
contact1 
 
8 (13%) 5 (15%) 16 (17%) MAR 
Successfully 
contacted but unable 
to contact again2 
 
4 (6%) 1 (3%) 5 (5%) MAR 
Declined 10 (16%)3 
 
5 (15%)4 15 (16%) MAR 
Moved out of 
country/area 
 
4 (6%) 1 (3%) 5 (5%) MCAR 
Died 0 (0%) 
 
2 (6%) 2 (2%) MCAR/MAR 
Total 31 (49%) 15 (45%) 46 (48%) MCAR/MAR 
Community psychiatric nurse (CPN); Missing at random (MAR); Missing completely at 
random (MCAR).  
1. Unable to contact via recorded contact number, via contact number given by 
participant or via CPN or other healthcare professional.  
2. Successfully contacted and organised meeting for follow-up assessment (in person or 
via telephone) however participant was unable to be contacted again, e.g. at time of 
arranged telephone meeting or otherwise. 
3. Reasons given for decline in intervention group: did not want to be reminded of 
admission (n=2), CPN said no on participants’ behalf (n=2), too busy (n=1), no 
reason given (n=2), not feeling well (n=1), family member said no on participants’ 
behalf (n=1), too physically unwell (n=1). 
4. Reasons given for decline in control group: did not want to be reminded of admission 
(n=1), too busy (n=1), no reason given (n=2), too unwell (n=1). 
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Table 13 
Number of participants missing readmission data per group (n (%)) with reasons  
 
Reason 
Group  
Assumed missing 
data mechanism 
Intervention 
N=63 
Control 
N=33 
Total 
N=96 
Moved to an area or country 
linked to a different health 
board 
 
4 (6%) 1 (3%) 5 (5%) MCAR 
Died Relating to mental 
health 
0 (0%) 1 (3%) 1 (1%) MAR 
Not relating to 
mental health 
 
0 (0%) 1 (3%) 1 (1%) MCAR 
Not discharged from index 
admission 
 
1 (2%) 0 (0%) 1 (1%) MAR 
Total 5 (8%) 3 (9%) 8 (8%) MCAR/MAR 
Missing at random (MAR); Missing completely at random (MCAR).  
 
5.11 Outcome assessments (clinical outcome results) 
In this section, baseline symptom severity and sample characteristics are presented (Table 
14 and Table 15, page 126 and 127). Descriptive statistics are reported for all between 
group outcomes such as mean change (SD) and frequencies (%). Hedge’s g and absolute 
risk difference with 95% confidence intervals were calculated for between group 
differences. All data were analysed in SPSS (version 23). The main analysis of between 
group differences was done under modified intention to treat (mITT) principles. A per 
treatment protocol (PtP) analysis is also reported to supplement the main analysis (see 
Chapter 4 for further detail). As data MCAR can be treated as MAR (Dziura et al., 2013) 
all data were analysed under the assumption that data are MAR. However, a large 
percentage of questionnaire data was missing at follow-up (see section 5.10). Sensitivity 
analysis was conducted to assess the robustness of missing data assumptions. All 
outcomes including follow-up questionnaires were reanalysed under the assumption that 
data is MCAR, therefore missing data was ignored (i.e. a complete case analysis). 
Sensitivity analysis was not conducted on outcomes not including follow-up 
questionnaire data because missingness was minimal (see section 5.10).  
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Table 14 
Summary of sample characteristics 
Characteristic 
Intervention 
(mITT) (n=63) Control1 (n=33) 
Total 
(n=96) 
Intervention (PtP) 
(n=32)2 
Intervention non-
engagers (n=31)2 
Gender (n (%)) Male 35 (56%) 
 
12 (36%) 47 (49%) 17 (53%) 18 (58%) 
Female 28 (44%) 
 
21 (64%) 49 (51%) 15 (47%) 13 (42%) 
Total 63 (100%) 
 
33 (100%) 96 (100%) 32 (100%) 31 (100%) 
Diagnosis (n (%)) Bipolar (manic) 13 (21%) 
 
10 (30%) 23 (24%) 6 (19%) 7 (23%) 
Bipolar (depression) 4 (6%) 
 
2 (6%) 6 (6%) 2 (6%) 2 (6%) 
Personality disorder 6 (10%) 
 
5 (15%) 11 (12%) 2 (6%) 4 (13%) 
Depression 11 (18%) 
 
8 (24%) 19 (20%) 6 (19%) 5 (16%) 
Schizophrenia and 
psychosis 
29 (46%) 8 (24%) 37 (39%) 16 (50%) 13 (42%) 
Total 63 100% 33 (100%) 96 (100%) 32 (100%) 31 (100%) 
Age (M, SD) 43.03 (12.34) 44.03 (9.59) 43.38 (11.43) 40.75 (13.17) 45.38 (11.15) 
Previous admission (n, %) 37 (59%) 20 (61%) 57 (59%) 17 (53%) 20 (65%) 
LOS (median, IQR) 34.50 (48.75) 24.00 (29.50) 28.00 (44.00) 35.00 (63.00) 33.00 (38.00) 
Modified intention to treat (mITT); Per treatment protocol (PtP); Standard deviation (SD). 
1. As all participants in the control group received treatment, the control group includes the same participants whether mITT ot PtP. For ease, this group will 
only be referred to as control group. 
2. As a subgroup of intervention (mITT). 
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Table 15 
Summary of baseline symptom severity 
Outcome measure 
Intervention (mITT) 
(n=63) Control1 (n=33) 
Total 
(n=96) 
Intervention (PtP) 
(n=32)2 
Intervention non-
engagers (n=31)2 
Baseline CORE-10  
(M, SD) 
Total score 21.63 (10.44) 22.27 (10.56) 21.85 (10.43) 22.72 (9.65) 20.52 (11.25) 
Problems 14.40 (6.95) 15.12 (7.25) 14.65 (7.02) 15.09 (6.58) 13.68 (7.34) 
Functions 5.70 (3.31) 5.45 (3.04) 5.6 (3.21) 6.16 (3.04) 5.23 (3.56) 
Baseline BSI  
(M, SD)  
Total 34.56 (20.69)3 37.88 (19.76) 35.37 (20.30)4 37.06 (20.39)5 32.06 (21.01) 
Somatization 8.76 (6.94) 3 9.33 (6.70) 8.96 (6.83) 4 10.03 (7.45) 5 7.48 (6.24) 
Depression 12.61(8.17) 3 13.94 (8.48) 13.07 (8.26) 4 13.29 (8.06) 5 11.94 (8.35) 
Anxiety 13.21 (8.28) 3 13.88 (6.97) 13.44 (7.82) 4 13.84 (7.83) 5 12.58 (8.80) 
MHCS6 
(M, SD) 
Total  54.63 (23.60) 58.94 (24.82) 56.11 (23.98) 52.84 (22.06) 56.48 (25.32) 
Optimism 21.41 (9.23) 23.06 (9.63) 21.98 (9.35) 21.78 (8.35) 21.03 (10.18) 
Coping 22.16 (10.94) 22.15 (11.69) 22.16 (11.14) 22.09 (10.46) 22.23 (11.59) 
Advocacy 12.14 (4.83) 13.09 (4.72) 12.47 (4.79) 11.16 (4.68) 13.16 (4.85) 
Brief Symptom Inventory Scale (BSI); Clinical Outcomes Routine Evaluation (CORE); Mental Health Confidence Scale (MHCS); Modified intention to treat 
(mITT); Per treatment protocol (PtP); Standard deviation (SD). 
1. As all participants in the control group received treatment, the control group includes the same participants whether mITT ot PtP. For ease, this group will 
only be referred to as control group. 
2. As subgroup of intervention (mITT). 
3. N=62 (one participant chose not to complete the BSI-18 due to similarities with the CORE-10). 
4. N=95 (see 3). 
5. N=31 (see 3). 
6. Lower score indicates higher severity.  
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5.11.1 Baseline symptom severity and sample characteristics  
Table 14 and Table 15 (page 126 and 127) present baseline symptom severity and sample 
characteristics for the intervention group, the control group and the total sample. As seen 
in table 14, psychosis and schizophrenia was slightly more prevalent in the intervention 
group, however why this way the case is unknown. Symptom severity appears to be 
slightly worse in the intervention group (PtP) compared to the intervention non-engagers 
group (see table 15). This may be due to a small bias towards more severely ill patients 
to receive treatment, however, the difference is small. There were little group differences 
on other measures of baselines symptom severity and sample characteristics. 
 
5.11.2 Outcomes 
5.11.2.1 Readmissions  
Within the modified intention to treat analysis, readmissions were slightly lower in the 
intervention group (18/63 (29%)) compared to the control group (11/33 (33%)). This 
corresponds with an absolute risk difference of -5% (95% CI: -24%, 14%), indicative of 
a direction of effect (if weak) necessary to take forward feasibility work to a future trial. 
However, a smaller, and more precise, difference is observed between the intervention 
group and the control group when data is analysed under per treatment protocol principles 
(10/32 (31%), 11/33 (33%), respectively), relating to an absolute risk difference of -2% 
(95% CI: -24%, 0%).   
 
When analysed as modified intention to treat, the mean days spent readmitted was similar 
in the intervention group (m=11.34, SD=14.55) and the control group (m=11.46, 
SD=15.02). This similarity corresponds with no treatment effect (Hedge’s g=-0.01, 95% 
CI -0.43, 0.41). Within the per treatment protocol analysis the intervention group 
(m=13.57, SD=18.59) spent marginally more days readmitted than the control (m=11.46, 
SD=15.02), corresponding to a negligible estimated treatment effect (Hedge’s g = 0.12, 
95% CI -0.36, 0.61).  
 
5.11.2.2 Psychological distress and mental health related self-efficacy 
Means and standard deviations are presented in Table 16 (page 131) by time point and 
group (i.e. intervention group (mITT), control group and the intervention group as per 
treatment protocol principles). Mean change and effect sizes are also presented for pre-to 
post-intervention change (Table 17, page 132) and pre-intervention to follow-up change 
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(Table 18, page 133). All SMDs were interpreted using Cohen's (1988) guidelines: 0.2 
signifies a small effect, 0.5 a medium effect and 0.8 a large effect. 
  
Change at post-intervention 
As seen in Table 17 (page 132), when analysed as modified intention to treat, group 
differences in change at post-intervention all favoured the intervention, however with 
varying degrees, depending on the outcome. Many of these were either trivial or small to 
moderate. Treatment effects were smaller on outcomes of psychological distress, while 
the largest effect was on the MHCS advocacy subscale (SMD=0.37; CI -0.05, 0.79).  
 
All group differences also favoured the intervention when analysed as per treatment 
protocol. Most group differences increased when analysed as per treatment protocol, with 
the exception of coping in relation to mental health (MHCS coping) and overall mental 
health related self-efficacy. The largest group differences were mainly observed on 
outcomes of psychological distress, specifically, overall psychological distress (BSI-18 
total score, SMD=-0.48, CI -0.97, 0.06; and CORE-10 total score, SMD=-0.48, CI -0.97, 
0.01) and somatization (BSI-18 somatization subscale, SMD=-0.47, CI -0.97, 0.02) and 
were all of medium magnitudes. Mental health related advocacy also produced a medium 
effect (MHCS advocacy, SMD=0.48, CI -0.02, 0.97 (positive effect favours 
intervention)). These results suggest that measures of psychological distress are most 
sensitive at post-intervention and could be used in a main trial.  
 
Change at follow-up 
As seen in Table 18 (page 133), when analysed as modified intention to treat, group 
differences in change at follow-up favoured the intervention on most outcomes, with the 
exception of CORE-10 problems subscale (SMD=-0.01, CI -0.43, 0.41) and the BSI-18 
total score (SMD=0.02, CI -0.40, 0.44), which had no effect, and the BSI-18 somatization 
subscale (SMD=0.04, CI -0.38, 0.47) and the BSI-18 depression subscale (SMD=0.11, -
0.31, 0.54) which favoured control but to a marginal degree.  
 
When analysed as per treatment protocol, group differences favoured the intervention on 
all outcomes but depression (BSI-18 depression subscale). Again, the magnitude of 
effects was larger on most outcomes of mental health related self-efficacy, however the 
largest effect was observed on the CORE-10 functioning subscale, (SMD=-0.60, CI-1.10, 
-0.10) which includes questions of general and social functioning. These results suggest 
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that measures of self-efficacy and functioning are most sensitive at follow-up and could 
be used in a main trial. 
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Table 16 
Descriptive summary of questionnaire data by group and assessment point 
 mITT intervention group (n=63) Control group(n=33) PtP intervention group (n=32) 
Outcome 
Baseline  
(mean  
SD) 
Post-
intervention 
(mean  
SD) 
Follow-up 
(mean  
SD) 
Baseline  
(mean  
SD) 
Post-
intervention 
(mean  
SD) 
Follow-up 
(mean  
SD) 
Baseline  
(mean  
SD) 
Post-
intervention 
(mean  
SD) 
Follow-up 
(mean  
SD) 
CORE-10 Total 22.08 
11.51 
14.78 
9.45 
15.70 
7.38 
22.33 
10.51 
16.56 
9.31 
17.59 
8.56 
23.59 
11.65 
13.44 
7.41 
15.44 
7.47 
CORE-10 Problems 14.67 
7.38 
9.44 
6.35 
10.30 
5.24 
15.12 
7.24 
10.67 
7.30 
10.82 
5.34 
15.63 
7.47 
8.59 
5.15 
10.52 
5.32 
CORE-10 Functioning 5.98 
3.97 
4.70 
3.10 
4.78 
3.02 
5.52 
3.04 
4.77 
2.76 
5.81 
2.93 
6.59 
4.36 
4.26 
2.43 
4.33 
2.83 
BSI-18 Total 34.58 
20.40 
21.78 
16.11 
24.05 
12.06 
37.33 
19.82 
27.06 
18.84 
26.30 
14.02 
37.26 
19.97 
19.03 
12.28 
24.59 
12.95 
BSI-18 Somatization 8.68 
6.91 
4.96 
4.76 
4.88 
3.89 
9.42 
6.72 
6.56 
6.09 
5.30 
4.02 
9.84 
7.35 
4.04 
3.79 
4.96 
4.19 
BSI-18 Depression 12.78 
8.02 
8.51 
6.59 
10.14 
5.56 
14.03 
8.50 
9.85 
7.64 
10.29 
6.72 
13.60 
7.64 
7.21 
5.37 
10.20 
5.83 
BSI-18 Anxiety 13.12 
8.02 
8.31 
6.43 
9.03 
5.56 
13.88 
6.89 
10.65 
7.35 
10.71 
6.03 
13.83 
7.75 
7.78 
5.26 
9.44 
5.76 
MHCS Total 55.18 
22.62 
64.27 
18.18 
59.24 
12.62 
58.88 
24.59 
63.54 
19.53 
54.18 
15.05 
55.98 
21.10 
64.42 
13.35 
59.78 
11.82 
MHCS Optimism 21.19 
9.29 
24.48 
7.62 
22.17 
5.64 
23.06 
9.59 
25.23 
8.04 
20.17 
6.38 
21.09 
8.37 
25.07 
5.66 
22.64 
4.98 
MHCS Coping 22.29 
11.03 
26.29 
8.89 
24.30 
7.14 
22.72 
12.12 
25.00 
9.19 
22.06 
6.78 
21.95 
10.52 
26.14 
7.24 
24.56 
6.84 
MHCS Advocacy 11.70 
4.76 
13.50 
3.49 
12.77 
3.41 
13.09 
4.71 
13.31 
3.96 
11.95 
3.85 
10.94 
4.75 
13.21 
2.88 
12.59 
3.62 
Brief Symptom Inventory Scale (BSI); Clinical Outcomes Routine Evaluation (CORE); Mental Health Confidence Scale (MHCS); Modified intention to treat (mITT); Per 
treatment protocol (PtP); Standard deviation (SD). 
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Table 17 
Summary of pre- to post-intervention change scores as per mITT and PtP analyses  
 
 
Primary analysis of pre- to post-intervention mean change 
(mITT analysis) 
Supplementary analysis of pre- to post-intervention mean 
change (PtP analysis) 
 
 
Outcome Group 
 
n 
Mean  
change 
 SD 
g 
(95% CI) Summary1 
 
n 
Mean  
change SD 
g 
(95% CI) 
 
Summary1 
CORE-10 
Total 
Intervention 63 -7.30 9.52 -0.17 
-0.59, 0.26 
Favouring intervention 
Very small  
32 -10.15 9.84 -0.48 
-0.97, 0.01 
Favouring intervention 
Medium Control 33 -5.78 8.16 33 -5.78 8.16 
CORE-10 
Problems 
Intervention 63 -5.23 6.91 -0.12 
-0.54, 0.30 
Favouring intervention 
Very small 
32 -7.03 6.79 -0.40 
-0.89, 0.09 
Favouring intervention 
Small to medium Control 33 -4.45 5.97 33 -4.45 5.97 
CORE-10 
Functioning 
Intervention 63 -1.28 3.65 -0.15 
-0.57, 0.27 
Favouring intervention 
Very small 
32 -2.33 4.13 -0.43 
-0.92, 0.06 
Favouring intervention 
Small to medium Control 33 -0.75 3.10 33 -0.75 3.10 
BSI-18 Total Intervention 63 -12.80 18.81 -0.14 
-0.56, 0.28 
Favouring intervention 
Very small 
32 -18.24 18.10 -0.48 
-0.97, 0.02 
Favouring intervention 
Medium Control 33 -10.31 14.71 33 -10.31 14.71 
BSI-18 
Somatization 
Intervention 63 -3.72 7.06 -0.13 
-0.55, 0.29 
Favouring intervention 
Very small 
32 -5.80 6.84 -0.47 
-0.97, 0.02 
Favouring intervention 
Medium Control 33 -2.87 5.34 33 -2.87 5.34 
BSI-18 
Depression 
Intervention 63 -4.27 6.75 -0.01 
-0.43, 0.41 No effect 
32 -6.39 6.68 -0.34 
-0.83, 0.15 
Favouring intervention 
Small to medium Control 33 -4.18 6.03 33 -4.18 6.03 
BSI-18 
Anxiety 
Intervention 63 -4.81 7.06 -0.23 
-0.65, 0.19 
Favouring intervention 
Small 
32 -6.05 7.01 -0.42 
-0.91, 0.07 
Favouring intervention 
Small to medium Control 33 -3.22 6.32 33 -3.22 6.32 
MHCS Total Intervention 63 9.09 17.07 0.282 
-0.15, 0.70 
Favouring intervention 
Small 
32 10.44 24.49 0.292 
-0.20, 0.78 
Favouring intervention 
Small Control 33 4.66 13.44 33 4.66 13.44 
MHCS 
Optimism 
Intervention 63 3.28 7.14 0.172 
-0.25, 0.59 
Favouring intervention 
Very small 
32 3.98 7.30 0.292 
-0.20, 0.78 
Favouring intervention 
Small Control 33 2.18 4.83 33 2.18 4.83 
MHCS 
Coping 
Intervention 63 4.00 9.13 0.202 
-0.22, 0.63 
Favouring intervention 
Small 
32 4.19 16.74 0.152 
-0.34, 0.64 Very small effect Control 33 2.26 6.95 33 2.27 6.95 
MHCS 
Advocacy 
Intervention 63 1.80 4.44 0.372 
-0.05, 0.79 
Favouring intervention 
Small to medium 
32 2.27 4.70 0.482 
-0.02, 0.97 
Favouring intervention 
Medium Control 33 0.22 3.79 33 0.22 3.79 
Brief Symptom Inventory Scale (BSI); Clinical Outcomes Routine Evaluation (CORE); Mental Health Confidence Scale (MHCS); Modified intention to treat (mITT); Per 
treatment protocol (PtP); Standard deviation (SD). 
1. Summary is based on Cohen’s (1988) benchmarks.  
2. Positive effect favours intervention.  
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Table 18  
Summary of pre-intervnetion to follow-up change scores as per mITT and PtP analyses  
  
Primary analysis of pre-intervention to follow-up mean 
change (mITT analysis) 
Supplementary analysis of pre-intervention to follow-up mean 
change (PtP analysis) 
Outcome Group 
 
n 
Mean  
change 
 
SD 
g 
(95% CI) 
 
Summary1 
 
n 
Mean  
change 
 
SD 
g 
(95% CI) 
 
Summary1 
CORE-10 Total Intervention 63 -6.38 11.35 
-0.14 
-0.56, 0.28 
Favouring intervention 
Very small effect 
32 -8.15 11.37 
-0.30 
-0.79, 0.19 
Favouring intervention 
Small to medium Control 33 -4.74 11.37 33 -4.74 11.37 
CORE-10 Problems Intervention 63 -4.37 7.86 
-0.01 
-0.43, 0.41 No effect 
32 -5.11 7.64 
-0.10 
-0.59, 0.38 
Favouring intervention 
Very small Control 33 -4.30 7.87 33 -4.30 7.87 
CORE-10 
Functioning 
Intervention 63 -1.21 4.37 
-0.36 
-0.78, 0.07 
Favouring intervention 
Small to medium 
32 -2.27 4.58 
-0.60 
-1.10, -0.10 
Favouring intervention 
Medium to large Control 33 0.30 3.85 33 0.23 3.85 
BSI-18 Total Intervention 63 -10.53 21.75 0.02 
-0.40 ,0.44 No effect 
32 -12.76 22.74 
-0.07 
-0.56, 0.41 
Favouring intervention 
Very small Control 33 -11.00 20.68 33 -11.00 20.68 
BSI-18 Somatization Intervention 63 -3.84 7.62 0.04 
-0.38, 0.47 No effect 
32 -4.88 7.92 
-0.10 
-0.59, 0.39 
Favouring intervention 
Very small Control 33 -4.13 6.72 33 -4.13 6.72 
BSI-18 Depression Intervention 63 -2.65 8.97 0.11 
-0.31, 0.54 
Favouring control 
Very small 
32 -3.40 9.90 0.03 
-0.45, 0.52 No effect Control 33 -3.74 10.40 33 -3.74 10.40 
BSI-18 Anxiety Intervention 63 -4.09 8.73 
-0.11 
-0.53, 0.31 
Favouring intervention 
Very small 
32 -4.39 8.77 
-0.15 
-0.64, 0.34 
Favouring intervention 
Very small Control 33 -3.17 7.35 33 -3.17 7.35 
MHCS Total2 Intervention 63 4.05 23.34 0.35 
-0.08, 0.77 
Favouring intervention 
Small to medium 
32 5.80 24.38 0.40 
-0.09, 0.89 
Favouring intervention 
Small to medium Control 33 -4.70 27.57 33 -4.70 27.57 
MHCS Optimism2 Intervention 63 0.98 9.68 0.37 
-0.05, 0.80 
Favouring intervention 
Small to medium 
32 1.54 9.90 0.41 
-0.08, 0.90 
Favouring intervention 
Small to medium Control 33 -2.89 11.43 33 -2.89 11.43 
MHCS Coping2 Intervention 63 2.00 11.51 0.21 
-0.21, 0.64 
Favouring intervention 
Small 
32 0.65 18.27 0.20 
-0.29, 0.69 
Favouring intervention 
Small effect Control 33 -0.66 13.73 33 -0.66 13.73 
MHCS Advocacy2 Intervention 63 1.07 6.11 0.38 
-0.05, 0.80 
Favouring intervention 
Small to medium 
32 1.65 6.45 0.47 
-0.02, 0.97 
Favouring intervention 
Medium Control 33 -1.14 5.17 33 -1.14 5.17 
Brief Symptom Inventory Scale (BSI); Clinical Outcomes Routine Evaluation (CORE); Mental Health Confidence Scale (MHCS); Modified intention to treat (mITT); Per treatment protocol 
(PtP); Standard deviation (SD). 
1. Summary is based on Cohen’s (1988) benchmarks.  
2. Positive effect favours intervention.  
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Comparison of participants with completed and missing follow-up questionnaire data 
As seen in Table 19 (below), there is little difference in most baseline symptom severity 
or sample characteristics between participants who completed follow-up questionnaires 
and those that did not.  
 
Table 19 
Summary of symptom severity and sample characteristics of participants who did and did not 
provide follow-up questionnaires 
Characteristic 
Follow-up 
completers 
(n=51) 
Follow-up non-
completers 
(n=45) 
Total 
(n=96) 
Gender  
(n (%)) 
Male 24 (47%) 23 (51%) 47 (49%) 
Female 27 (53%) 22 (49%) 49 (51%) 
 Total  51 (100%) 45 (100%) 96 (100%) 
Diagnosis  
(n (%)) 
Bipolar (manic) 13 (25%) 10 (22%) 23 (24%) 
Bipolar (depression) 3 (6%) 3 (7%) 6 (6%) 
Personality disorder 6 (12%) 5 (11%) 11 (11%) 
Depressions 10 (20%) 9 (20%) 19 (20%) 
Schizophrenia and 
psychosis 19 (37%) 18 (40%) 37 (39%) 
 Total  51 (100%) 45 (100%) 96 (100%) 
Age (M (SD)) 42.60 (11.57) 44.20 (11.47) 43.38(11.43) 
Previous admission (n (%)) 29 (57%) 28 (62%) 57 (59.4%) 
LOS (median (IQR)) 27 (42.25) 33 (44.50) 28.00 (44.00) 
Baseline 
CORE-10  
M (SD) 
Total score 23.48 (10.08) 20.22 (10.71) 21.85 (10.43) 
Problems 15.48 (6.76) 13.76 (7.34) 14.65 (7.02) 
Functions 6.26 (3.19) 5.00 (3.09) 5.6 (3.21) 
Baseline BSI  
(M (SD))  
Total 38.28 (19.71) 32.13 (20.67) 35.37 (20.30) 
Somatization 9.48 (6.69) 8.38 (7.00) 8.96 (6.83) 
Depression 14.46 (8.16) 11.53 (8.17) 13.07 (8.26) 
Anxiety 14.34 (7.69) 12.44 (7.93) 13.44 (7.82) 
Baseline 
MHCS1 
(M (SD)) 
Total 53.4 (23.15) 59.02 (25.13) 56.11 (23.98) 
Optimism 21.40 (8.93) 22.60 (9.96) 21.98 (9.35) 
Coping 21.08 (10.51) 23.49 (12.20) 22.16 (11.14) 
Advocacy 12.14 (4.64) 12.84 (5.02) 12.47 (4.79) 
Brief Symptom Inventory Scale (BSI); Clinical Outcomes Routine Evaluation (CORE); Mental 
Health Confidence Scale (MHCS) 
1. Lower scores indicate greater severity.  
 
Sensitivity analysis 
As seen in Table 20 (below), only marginal differences exist between descriptive statistics 
(i.e. means and standard deviations) of follow-up questionnaires when missing data is 
  
135
ignored and imputed. As seen in Table 21 (page 136), when analysed as modified 
intention to treat, group differences in change on all outcomes at follow-up increased 
when missing data was not imputed, compared to when missing data was imputed. This 
was also the case for most outcomes when analysed as per treatment protocol, except for 
BSI-18 depression, CORE-10 problems and CORE-10 total. However more importantly, 
group differences favoured the intervention on all outcomes.  
 
Table 20 
Descriptive summary of follow-up questionnaire data by group where data is imputed and 
not imputed 
 No imputed data  Imputed  
Outcome 
mITT 
intervention 
group 
(mean  
SD) 
(n=33) 
Control 
group  
(mean  
SD) 
(n=18) 
PtP 
intervention 
group 
(mean  
SD) 
(n=19) 
mITT 
intervention 
group 
(mean  
SD) 
(n=63) 
Control 
group  
(mean  
SD) 
(n=33) 
PtP 
intervention 
group 
(mean  
SD) 
(n=32) 
CORE-10 
Total 
15.64 
7.38 
17.50 
8.56 
15.38 
7.58 
15.70 
7.38 
17.59 
8.56 
15.44 
7.47 
CORE-10 
Problems 
10.25 
5.32 
10.78 
5.40 
10.48 
5.43 
10.30 
5.24 
10.82 
5.34 
10.52 
5.32 
CORE-10 
Functioning 
4.78 
2.86 
5.74 
2.93 
4.30 
2.83 
4.78 
3.02 
5.81 
2.93 
4.33 
2.83 
BSI-18 Total 24.04 
11.99 
26.17 
14.02 
24.52 
12.84 
24.05 
12.06 
26.30 
14.02 
24.59 
12.95 
BSI-18 
Somatization 
4.86 
3.89 
5.32 
4.08 
4.92 
4.19 
4.88 
3.89 
5.30 
4.02 
4.96 
4.19 
BSI-18 
Depression 
10.19 
5.48 
10.21 
6.78 
10.28 
5.77 
10.14 
5.56 
10.29 
6.72 
10.20 
5.83 
BSI-18 
Anxiety 
9.00 
5.64 
10.64 
5.97 
9.33 
5.66 
9.03 
5.56 
10.71 
6.03 
9.44 
5.76 
MHCS Total 59.23 
12.86 
54.20 
15.22 
59.69 
11.88 
59.24 
12.62 
54.18 
15.05 
59.78 
11.82 
MHCS 
Optimism 
22.21 
5.71 
20.16 
6.55 
22.70 
5.09 
22.17 
5.64 
20.17 
6.38 
22.64 
4.98 
MHCS 
Coping 
24.35 
7.14 
22.16 
6.83 
24.49 
6.84 
24.30 
7.14 
22.06 
6.78 
24.56 
6.84 
MHCS 
Advocacy 
12.67 
3.25 
11.88 
3.91 
12.50 
3.51 
12.77 
3.41 
11.95 
3.85 
12.59 
3.62 
Brief Symptom Inventory Scale (BSI); Clinical Outcomes Routine Evaluation (CORE); Mental 
Health Confidence Scale (MHCS); Modified intention to treat (mITT); Per treatment protocol (PtP); 
Standard deviation (SD). 
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Table 21 
Summary of pre-intervention to follow-up change in questionnaire scores where no data is imputed  
   Pre to follow-up mean change (mITT analysis)  Pre to follow-up mean change (PtP completer analysis) 
Outcome Group n Mean SD g 
(95% CI) 
Summary1 n Mean SD g 
(95% CI) 
Summary1 
CORE-10 
Total 
Intervention 33 -8.25 9.32 -0.31 
(-0.89, 0.27) 
Favouring intervention 
Small to medium effect 
19 -8.89 9.92 -0.35 
(-1.00, 0.30) 
Favouring intervention 
Small to medium effect Control 18 -5.00 11.77 18 -5.00 11.77 
CORE-10 
Problems 
Intervention 33 -5.09 7.17 -0.05 
(-0.63, 0.53) No effect 
19 -4.95 6.78 -0.03 
(-0.68, 0.61) No effect Control 18 -4.72 7.78 18 -4.72 7.78 
CORE-10 
Functioning 
Intervention 33 -1.88 3.67 -0.64 
(-1.23, -0.05) 
Favouring intervention 
Medium to large effect 
19 -2.84 3.39 -0.92 
(-1.60, -0.24) 
Favouring intervention 
Large effect Control 18 0.50 3.70 18 0.50 3.70 
BSI-18 Total Intervention 33 -15.19 21.91 -0.15 
(-0.73, 0.43) 
Favouring intervention 
Very small effect 
19 -16.00 24.18 -0.18 
(-0.83, 0.47) 
Favouring intervention 
Small effect Control 13 -11.89 19.99 18 -11.89 19.99 
BSI-18 
Somatization 
Intervention 32 -5.41 7.76 -0.20 
(-0.78, 0.38) 
Favouring intervention 
Small effect 
19 -6.11 7.80 -0.31 
(-0.96, 0.34) 
Favouring intervention 
Small effect Control 18 -3.94 5.76 18 -3.94 5.76 
BSI-18 
Depression 
Intervention 33 -4.41 9.16 -0.01 
(-0.59, 0.57) No effect 
19 -5.11) 10.59 -0.07 
(-0.72, 0.56) 
Favouring intervention 
No to very small effect Control 18 -4.33 10.59 18 -4.33 10.59 
BSI-18 
Anxiety 
Intervention 33 -5.94 9.08 -0.28 
(-0.86, 0.30) 
Favouring intervention 
Small effect 
19 -5.21 8.87 -0.20 
(-0.85, 0.45) 
Favouring intervention 
Small effect Control 18 -3.56 7.04 18 -3.56 7.04 
MHCS Total2 Intervention 33 9.03 21.39 0.61  
(0.02, 1.20) 
Favouring intervention 
Medium to large effect 
19 14.16 23.45 0.75 
(0.09, 1.42) 
Favouring intervention 
Large effect Control 18 -5.83 28.43 18 -5.83 28.43 
MHCS 
Optimism2 
Intervention 33 1.84 9.10 0.54 
(-0.05, 1.12) 
Favouring intervention 
Medium effect 
19 3.11 10.55 0.59 
(-0.07, 1.25) 
Favouring intervention 
Medium effect Control 18 -3.72 11.99 18 -3.72 11.99 
MHCS 
Coping2 
Intervention 33 3.91 10.37 0.42 
(-0.16, 1.00) 
Favouring intervention 
Small to medium effect 
19 5.32 11.11 0.51 
(-0.07, 1.25) 
Favouring intervention 
Medium effect Control 18 -1.00 13.11 18 -1.00 13.11 
MHCS 
Advocacy2 
Intervention 33 1.13 6.14 0.36 
(-0.23, 0.94) 
Favouring intervention 
Small to medium effect 
19 2.16 6.59 0.57 
(-0.13, 1.17) 
Favouring intervention 
Medium effect Control 18 -1.00 5.40 18 -1.00 5.40 
Brief Symptom Inventory Scale (BSI); Clinical Outcomes Routine Evaluation (CORE); Mental Health Confidence Scale (MHCS); Modified intention to treat (mITT); Per treatment 
protocol (PtP); Standard deviation (SD). 
1. Summary is based on Cohen’s (1988) benchmarks.  
2. Positive effect favours intervention. 
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5.11.2.3 Adverse events 
When analysed as modified intention to treat or as per treatment protocol, more people 
died in the control group (n=2) compared to the intervention group (n=0). People in the 
control group also had more A&E episodes and contact with IHTT, within 6 months of 
discharge, compared with the intervention group (see Table 22 and Table 23, below). One 
person in the intervention group, in comparison to no people in the control group, had not 
been discharged at follow-up, however this difference is negligible.  
 
Table 22 
Summary of the proportion of participants who had A&E episodes during 6-month follow-up 
  Number participants who had x number of A&E episodes 
 
 
 
Group 
 
 
 
n 
Participan
ts that 
had 1 
episodes 
(n (%)) 
Participan
ts that 
had 2 
episodes 
(n (%)) 
Participan
ts that 
had 3 
episodes 
(n (%)) 
Participan
ts that 
had 4 
episodes 
(n (%)) 
Participan
ts that 
had 5 
episodes 
(n (%)) 
Participan
ts that 
had at 
least 1 
episode (n 
(%)) 
Interventi
on (mITT)  
 
6
3 
7 (11%) 3 (5%) 1 (2%) 0 0 11 (17%) 
Control 
 
3
3 
5 (15%) 2 (6%) 1 (3%) 0 1 (3%) 9 (27%) 
Interventi
on (PtP) 
3
2 
3 (9%) 1 (3%) 0 0 0 4 (13%) 
Intensive home treatment team (IHTT);Modified intention to treat (mITT); per protocol (PtP) 
1. IHTT is the home crisis resolution team in NHS Lothian. 
 
 
Table 23 
Summary of the proportion of participants who had intensive home treatment team (IHTT)1 
episodes during 6-month follow-up 
  Number of IHTT episodes 
 
 
 
 
Group 
 
 
 
 
n 
Participan
ts that 
had 1 
episode (n 
(%)) 
Participan
ts that 
had 2 
episodes 
(n (%)) 
Participan
ts that 
had 3 
episodes 
(n (%)) 
Participan
ts that 
had 4 
episodes 
(n (%)) 
Participan
ts that 
had 5 
episodes 5 
(n (%)) 
Participan
ts that had 
at least 1 
episode (n 
(%)) 
mITT 
interventi
on 
63 6 (10%) 2 (3%) 0 0 0 8 (13%) 
 
Control 33 5 (15%) 2 (6%) 1 (3%) 0 1 (3%) 9 (27%) 
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PtP 
interventi
on 
32 3 (9%) 1 (3%) 0 0 0 4 (13%) 
Intensive home treatment team (IHTT);Modified intention to treat (mITT); per protocol (PtP) 
1. IHTT is the home crisis resolution team in NHS Lothian. 
 
 
5.12 Retention (trial attrition rate) 
Treatment retention/attrition could not be recorded given the flexible nature of the 
intervention (i.e. patients were encouraged to attend as many or as few therapy sessions 
as they chose). Instead, intervention engagement was recorded and has been discussed in 
section 5.7. Trial retention/attrition was calculated as the number of participants who 
provided no questionnaires, therefore has been described in the section 5.10. 
 
5.13 Logistics of multicentre trial 
The logistics of running a multicentre trial could not be assessed in this study as multiple 
centres were not recruited. 
 
5.14 Summary of all components of the protocol working together 
As seen in Table 24 (below), while some components of the protocol worked well, data 
from this feasibility study revealed problems existing in other components. The main 
problems identified were that some eligible participants were excluded from the study 
and ineligible patients were initially recruited, some components of the intervention 
protocol were poorly implemented, questionnaires were poorly completed at follow-up 
and no staff related outcomes were included. Adaptations to both clinical context and the 
trial protocol are necessary to progress to a full definitive trial. Methodological issues not 
addressed by the current feasibility study include the logistics of running a multi-centre 
trial, the cost-effectiveness of the intervention, the acceptability of the intervention for 
patients and staff, assessor blinding and cluster randomisation.  
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Table 24 
Summary of findings against key methodological issues in feasibility research1  
Methodological Issue Findings and evidence 
1. Was target sample size 
recruited? Did the 
feasibility study allow a 
sample size calculation 
for the main trial? 
• Target sample size was not successfully 
recruited.  
o Target sample size (n=150); actual 
sample recruited (n=96). 
• Sample size for a future definitive trial has been 
calculated, although only attrition data from 
this trial was used. 
• 2012 participants should be recruited between 
36 clusters.  
2. What factors influenced 
eligibility? 
Participant  
• 63% of those 248 screened were eligible. 
• Main reasons for ineligibility were as follows: 
• Anticipation that patients would be 
discharged or moved wards within three 
days of completing baseline measures 
(27%) or participants excluded after 
completing baseline measures and 
consenting if discharged or moved 
wards within 2 days of doing so (15%). 
• Patients were considered too distressed 
or unwell by ward staff (20%). 
Cluster 
• All clusters that were approached agreed to 
participate.  
• One cluster was excluded due to external 
therapeutic input.  
3. Was recruitment 
successful? 
• Recruitment was reasonable, but slower than 
expected and labour intensive.  
• 96 participants were recruited over 12 months 
from 2 wards. Therefore, average number of 
participants recruited from one ward per month 
is 4.  
4. Did eligible participants 
consent? 
• 47% of those who were eligible consented. 
• Reasons for not consenting were not formally 
measured but some anecdotal evidence was 
recorded where possible (see consent section). 
5. Were participants 
successfully randomised 
and did randomisation 
result in equality 
between groups? 
• No randomisation procedure used.  
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Table 24 
Summary of findings against key methodological issues in feasibility research1  
Methodological Issue Findings and evidence 
6. Were blinding 
procedures adequate? 
• Neither assessors nor participants were blind to 
trial group.  
7. (i) Was the intervention 
implemented as 
planned?2 
• Some intervention components were well 
implemented (individual sessions) while others 
were not (groups). 
• Individual sessions were consistently delivered 
during the study period (k=105), while groups 
were not (k=28).  
7 (ii) Did participants and 
staff engage with the 
intervention? 
Patient engagement  
• Approximately half of the intervention group 
engaged with the intervention (51%).  
Staff engagement 
• Not directly measured but poor implementation 
of groups suggests poor staff engagement. 
• Not directly measured but observed that, 
despite encouragement, no management staff or 
psychiatrists attended psychological training, 
suggesting little commitment to implementing 
the model. 
8. Was the intervention 
acceptable to 
participants 
• This was not formally measured, however 16% 
participants in the intervention group expressed 
interest in receiving the intervention but could 
not (see section 5.7 and 5.8).  
9. Was it possible to 
calculate intervention 
costs and duration? 
• Not calculated in this study.  
10. Were outcome measures 
completed? 
• All outcomes had good completion rates at 
baseline and post-intervention, however there 
was poor completion of questionnaires at 
follow-up and of the CTQ-SF.  
Baseline completion rates: CORE-10: 100%; BSI-
18: 99%; MHCS: 100% 
Post-intervention completion rates: CORE-10: 93%; 
BSI-18: 92%; MHCS: 93% 
6-month follow-up completion rates: CORE-10: 
53%; BSI-18:52%; MHCS: 53% 
• Readmission rate at 6 months: 92% 
• CTQ-SF completion rate: 64% 
11. Were outcome measures 
those that were the most 
important? 
• Chosen outcomes assessed areas of interest (see 
outcome assessments section).  
• No staff or milieu related outcomes measured. 
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Table 24 
Summary of findings against key methodological issues in feasibility research1  
Methodological Issue Findings and evidence 
12. Was retention to the 
study good? 
Treatment retention 
• Treatment retention/attrition measured as 
patient engagement (see number 7).  
Study retention/attrition 
• No participants explicitly dropped out, 
therefore retention was based on available 
outcome data (see number 10).  
13. Were the logistics of 
running a multicentre 
trial assessed? 
• Not formally assessed. 
14. Did all components of 
the protocol work? 
Some components worked well while others did not.  
Components that did not work include: 
• Issues with eligibility criteria.  
• Poor intervention implementation.  
• Poor completion of questionnaires at 
follow-up.  
• No staff or milieu outcomes were included. 
1. Table adapted from Bugge et al. (2013) 
2. Extra methodological issue not included by Shanyinde, Pickering and 
Weatherall (2011) 
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6 Discussion 
The previous chapter presented results of the feasibility study using Shanyinde, Pickering and 
Weatherall (2011) as an analytical framework to highlight the extent to which this study 
addressed each issue, and to identify problems encountered during the study. This chapter aims 
to summarise the thesis and then discusses key findings, interpretation of the findings and 
strengths and limitations of the feasibility study.  
 
6.1 Summary of the thesis 
This thesis investigated the role of brief psychological intervention for acute mental health 
inpatients. The process was guided by the Medical Research Council (MRC) framework for 
developing and evaluating complex interventions (see Chapter 1) (Craig et al., 2008, 2013).  
 
The first aim of the thesis was to systematically-review and meta-analyse controlled trials of 
brief psychological intervention delivered in acute inpatient settings (reported in Chapter 3), 
therefore mapping onto phase one of the MRC framework (Craig et al., 2008, 2013). 
Specifically, the meta-analysis aimed to evaluate the benefit of psychological therapy in this 
context with regards to psychotic symptoms, readmissions and emotional distress. Results 
showed that in randomised and single-blind studies psychological intervention had little effect 
on psychotic symptoms, however, other outcomes showed more promising results. For 
example, although not statistically significant, there is some evidence to suggest that brief 
psychological therapy may reduce emotional distress and risk of readmission for some acute 
inpatients. 
 
The second aim of the thesis was to conduct a feasibility study to pilot and test the feasibility 
of implementing and evaluating a cross-diagnostic, psychologically informed acute mental 
health care intervention versus treatment as usual (TAU), and to collect some preliminary 
outcome data relating to any potential treatment effect and adverse events. This study maps 
onto phase two of the MRC framework.  
 
The results relating to the first aim were discussed in Chapter 3 of the thesis. The remainder of 
this chapter focuses on the findings from the feasibility study and considers how progression 
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to a full sized definitive trial of cross-diagnostic, psychologically informed model of acute 
mental health inpatient care versus TAU could be achieved.  
 
6.2 Discussion of feasibility trial 
6.2.1 Main findings 
This trial piloted and tested the feasibility of implementing and evaluating a cross-diagnostic 
psychological intervention for acute psychiatric inpatients and assessed whether the 
intervention demonstrated evidence for the desired direction of effect, in comparison to TAU. 
Overall, this trial has provided valuable insight into implementing a psychological intervention, 
and running a trial, in an acute psychiatric inpatient context. The data collected shows that 
some aspects of the trial were successful, i.e. clinical outcomes had good completion rates at 
pre- and post-intervention, some intervention components were successfully implemented (e.g. 
individual therapy) and some promising group differences were observed on some outcomes 
(e.g. overall psychological distress and somatization at post-intervention, and functioning and 
self-efficacy at follow-up). However, other aspects of the trial were problematic and need 
refinement to fully implement the intervention in real world settings and progress to a full trial. 
Key issues identified in this study include problematic eligibility criteria, poor implementation 
of some intervention components, poor engagement, poor completion of follow-up 
questionnaires, and therefore poor trial retention, and no staff or milieu related outcomes were 
included. Furthermore, the intervention was not associated with clear group differences in the 
primary outcome, namely a reduction in the proportion of those readmitted. This study did not 
address some important methodological issues, such as randomisation and blinding procedures, 
acceptability and cost effectiveness of the intervention and the logistics of running a 
multicentre trial.  
 
6.2.2 Interpretation of the findings  
6.2.2.1 Challenges of implementing the intervention  
Implementing complex interventions in any healthcare setting is well known to be challenging 
(Craig et al., 2008; Moore et al., 2015). Although the intervention piloted in this study has been 
implemented in other acute psychiatric services in the UK (Araci & Clarke, 2016; Durrant & 
Tolland, 2009), some components, i.e. groups, were poorly implemented in this feasibility trial, 
while others, i.e. individual sessions, were implemented well. Few group sessions were 
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successfully delivered during the study period, and those that were, were done so infrequently, 
inconsistently and with little notice for patients. It is possible that challenges were faced in 
implementing group sessions, and not individual sessions, because individual sessions were 
delivered by staff from the psychological team, i.e. not ward staff. Group sessions on the other 
hand, relied largely on consistent input from staff nurses. Individual sessions, therefore, ran 
independently of day to day ward activity, while group sessions required the intervention to be 
integrated into routine practice. Many barriers to routine delivery of group therapies were 
observed. Such barriers included staff shortages, staff sickness, inflexible rotas (i.e. rotational 
night shifts), many relevantly trained ward staff left during the study period and other duties 
were prioritised over therapeutic work in the presence of a busy workload. In a time of 
austerity, many of these challenges, e.g. staff shortages, are common in acute inpatient services, 
and may be a consequence of service cuts (King’s Fund, 2015). However, high stress working 
environments have also long been associated with staff burnout, high staff turnover and staff 
shortages (Cronin-Stubbs & Brophy, 1985; Price & Mueller, 1981). Further consideration of 
how to integrate group therapies into routine practice in a high stress, resource restricted service 
is necessary (discussed later in this chapter). Some staff also expressed a lack of confidence in 
their ability to facilitate groups. Given that key aims of offering therapies in a group format is 
to create a therapeutic milieu through increased awareness of CBT knowledge and skills within 
different staff groups and increased access to psychological therapy for more patients, this has 
major implications for the reach of the intervention to both service users and staff. Similar 
challenges have previously been acknowledged in establishing routine psychological group 
session in acute psychiatric inpatient services (Clarke & Wilson, 2009; Bright, 2008). One 
solution is to ensure the members of staff interested in facilitating groups works one nine-to-
five day once a week on a specific day for a fixed period of time (Hill et al., 2009). This time 
should be used to facilitate and co-facilitate groups (Hill et al., 2009). Furthermore, additional 
staff training should be offered to ensure staff feel well equipped to deliver specific group 
therapies. Together, these solutions may facilitate the integration of group sessions into routine 
practice, improve staff psychological knowledge and therefore improve the therapeutic milieu. 
 
In the current study, it was also observed that, despite invitation, managerial staff and 
psychiatrists did not attend the relevant psychological training, suggesting a lack of support for 
the intervention. This was considered another barrier to achieving full implementation because 
support from staff in such positions is likely to have a profound effect on the success or failure 
of a new intervention. It is possible that this affected the routine delivery of group therapies. 
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Recent studies have shown that nursing staff, charge nurses and psychiatrists find 
psychological therapy acceptable and beneficial in rehabilitation and acute psychiatric inpatient 
units (Berry et al., 2016; Donaghay-Spire, McGowan, Griffiths, & Barazzone, 2016). 
Therefore, perhaps low levels of attendance at training observed in the current study, was due 
to time and resource restrictions. Alternatively, it may be that the intervention was not 
promoted well enough or that it was not akin to their disciplinary model of mental illness. This 
study lacked information on staff (at all levels) perceptions of the intervention and on 
facilitators and barriers to implementation, therefore definitive reasons are unknown. However, 
as identified in previous studies and in the current trial, successful implementation and 
evaluation of new interventions rely heavily on agreement and commitment from the 
organisation and staff at all levels (Berry et al., 2016; Berry & Haddock, 2008; Ince, Haddock, 
& Tai, 2016), therefore further investigation of these issues is warranted, e.g. using qualitative 
methods.  
 
Another major problem identified in this study was that only half of the participants in the 
intervention group engaged with the intervention, i.e. attended at least one group or individual 
session. This was lower than expected and lower than that reported in other trials of acute 
inpatient psychotherapy (Bechdolf et al., 2004; Haddock et al., 1999: 97%, 95%, respectively). 
This suggests that the intervention piloted in the current study was less acceptable or that not 
everyone wanted to receive psychological intervention during an acute admission. However, 
16% of participants in the intervention group (or 32% of non-engaging participants in the 
intervention group) expressed an interest in receiving it, but were unable to due to being 
discharged while waiting for the next available individual session or the next scheduled group 
session. This suggests that while it is likely that some patients simply did not want to receive 
the intervention, others were unable to due to limited provision. It is also possible that some 
patients did not receive the intervention because they were not offered it. This may have 
implications for the results of the current study and of future trials. It is recognised that failure 
to implement an intervention properly may result in misleading conclusions regarding its 
impact (Moore et al., 2015). However, whether this was the case in the current study is 
unknown. Due to ethical restrictions and poor planning, participants were not asked why they 
did not receive psychological intervention in the current study, therefore such conclusions are 
speculative. In a future trial, it is important to record reasons for engagement and non-
engagement, as this will provide valuable insight into the interventions demand, acceptability 
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and reach, and will better inform conclusions that can be made based on the estimated treatment 
effects.  
 
Based on the clinical outcome data collected in this study, the impact of the intervention varied, 
depending on the outcome and analysis. When analysed as intention to treat (i.e. including all 
participants who officially entered the trial, despite treatment received), few group differences 
were observed on most outcomes compared to per treatment protocol analyses, with the 
exception of some outcomes of self-efficacy. In contrast, when analysed under principles of 
per treatment protocol, the intervention was favoured on a range of outcomes, specifically 
outcomes of change in psychological distress at post-intervention and change in outcomes of 
self-efficacy and functioning at follow-up. Estimated treatment effects also tended to be more 
precise under per treatment protocol principles. However, the 95% confidence interval all 
overlapped zero which, like the results in the meta-analysis (see Chapter 3), demonstrates that 
the sample was likely too small to detect significant group differences. This is to be expected 
given that this was a feasibility study. The differences in results observed between the intention 
to treat and per treatment protocol analyses reflects the large proportion of participants in the 
intervention group not engaging with the intervention. This suggests that, in terms of the 
milieu, there was no clear change as a result of the intervention.  
 
Minimal group differences were observed on the primary outcome (proportion of readmissions 
and number of days spent readmitted) whether analysed under intention to treat or per treatment 
protocol principles. It is possible that the intervention simply had little impact on readmissions, 
however it is also possible that poor implementation diluted the impact of the intervention 
(Moore et al., 2015). Another explanation for the lack of clear differences on the primary 
outcome is that the intervention group was more severely ill at baseline. Participants in the 
intervention group reported slightly worse distress and slightly worse mental health related 
self-efficacy at baseline compared to the non-engaging intervention group and the control 
group. Those who received the intervention were primarily referred by ward staff. Therefore, 
although this difference was slight, it is possible that participants perceived to be more ill were 
more readily referred to, or encouraged to attend, psychological therapy during their admission 
by ward staff. Allocation bias is a well-known risk associated with non-randomised trials 
(Sedgwick, 2013b), and may be a limitation of the current study (discussed later is in this 
chapter). 
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6.2.2.2 Challenges of conducting the trial 
Although recruiting patients with severe mental illness to trials is known to be difficult, the 
number of participants recruited to the current trial was considered reasonable, given the 
available resource and time. However, adequate time should be allocated for recruitment in a 
future trial. In contrast, the eligibility rate in this trial was considerably lower than that reported 
in other trials conducted in acute psychiatric inpatient settings: 94% (Schramm et al., 2007), 
85% (Lewis et al., 2002) and 91% (Gaudiano & Herbert, 2006). Such differences may be due 
to problems identified with the eligibility criteria in the current study. For example, some 
patients were excluded if ward staff anticipated that their admission would be three days or less 
(26%). This exclusion criterion aimed to minimise recruitment of patients who received almost 
no treatment from either the control or intervention group. However, although not formally 
recorded, it was observed that some patients who were predicted to have short admissions were 
admitted for longer than expected. Therefore, some patients who were initially deemed 
ineligible and excluded from the trial may have indeed been eligible, had the short admission 
criteria not been in place from the outset. The eligibility criteria were also problematic in this 
trial in that 15% of patients were excluded after consenting to participate and completing 
baseline measures because they moved to a different ward or were discharged within two days 
of doing so. This demonstrates the challenges of conducting research in a service which moves 
at a fast pace and has a quick turnover of patients. This criterion was added after the study 
began in order to reduce the number of participants who did not receive the allocated treatment, 
i.e. to measure the effect of treatment more directly, and it aimed to reduce contamination 
between trial arms. However, in doing so the principles of an intention to treat analysis were 
violated. Deviating from an intention to treat analysis for such reasons has been referred to as 
modified intention to treat and is common in medical literature (Abraha et al., 2015). However, 
modified intention to treat analysis is associated with inflated estimates of treatment effect 
(Abraha et al., 2015), therefore excluding participants after consenting to enter a main trial may 
raise questions about the validity of the analysis. To address this issue, amendments must be 
made to the current trial protocol to progress to a full trial (discussed later in this chapter). 
 
Completion rates for some of the clinical outcomes collected in this study also threaten the 
validity of an intention to treat analysis. While completion of questionnaires was good at pre- 
and post-intervention, 48% of participants were lost to follow-up, therefore a large proportion 
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of follow-up questionnaires were missing. This highlights the challenges of collecting data 
from a population with severe mental illness. Furthermore, in comparison to the proportion of 
drop-out or loss to follow-up in other trials of psychological intervention for acute psychiatric 
inpatients that follow-up up patients to collect outcome data, 48% is at the higher end of the 
range: 63% (Owen, Sellwood, et al., 2015); 19% (Bechdolf et al., 2004); 18% (Lewis et al., 
2002). This pattern of missing questionnaire data is to be expected as meta-analysis has shown 
that inpatient settings are associated with higher outcome completion rates, or lower drop-out, 
compared to outpatient settings (Villeneuve, Potvin, Lesage, & Nicole, 2010). Missing 
outcomes are extremely problematic for accurate parameter estimations, because it is unlikely 
that missingness is completely random (Dunn, 2013). The benefit of randomisation is therefore 
lost, thus exposing parameter estimations to a risk of bias. In order to increase confidence in 
the conclusions drawn from a main trial, further consideration of how to improve contact with 
participants as outpatients (i.e. to complete follow-up questionnaires) is needed, or more 
appropriate outcomes should be considered prior to progression.  
 
Completion of the childhood trauma questionnaire (CTQ-SF) was also low in this trial (64%). 
While this may indicate that participants found this questionnaire unacceptable, it is also likely 
that failure to contact participants for follow-up assessment is associated with poor completion 
of the CTQ-SF. Therefore, improving contact with participants at follow-up in a main trial 
should also improve completion of the CTQ-SF. 
 
6.2.3 Strengths and limitations of the trial 
Using a framework for developing and evaluating complex interventions (Craig et al., 2008, 
2013), the aim of this feasibility trial was to test the intervention of interest in a real-world 
setting. As recommended by Bugge et al. (2013), this study has also benefited from the use of 
Shanyinde, Pickering and Weatherall (2011) methodological issues as an analytical 
framework. The study provided insight into the extent to which each issue was addressed and 
highlighted problems with the trial, intervention and clinical context.  
 
Another strength of the trial is that it tested a theoretically driven intervention (Clarke, 2009), 
which has produced promising treatment outcomes for patients in initial exploratory studies 
(Araci & Clarke, 2016; Durrant, Clarke, Tolland, & Wilson, 2007; Durrant & Tolland, 2009; 
Wilson, Clarke, & Phillips, 2009). However, such studies are small and have either not 
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included a control group (Araci & Clarke, 2016; Durrant & Tolland, 2009) or have tested a 
single component of the intervention (Owen, Sellwood, et al., 2015). Therefore, the current 
trial builds on this previous work, in that it is the first study to test this intervention as a whole 
and use a control group. It is also the first study of this intervention to include service related 
outcomes (i.e. readmissions) and record adverse events. More serious adverse events were 
recorded in the control group, compared with no evidence of serious adverse effects in the 
intervention group during the follow-up period (i.e. deaths). This preliminary result may have 
important implications for the design of a future definitive trial of acute psychiatric inpatient 
services, in terms of carefully capturing adverse event information, including thoughtful 
consideration of trial stopping rules.  
 
Two major issues identified in this trial were poor implementation of some intervention 
components within the clinical context and poor staff engagement. Consequently, the 
intervention was poorly integrated into the service. It is possible that the intervention had little 
impact on the therapeutic milieu, however this trial did not directly measure change in milieu 
therefore further research investigating this is required. Staff related outcomes, of effect (e.g. 
burnout) or process (i.e. average number of relevantly trained staff, number of sessions 
facilitated by staff, etc.), were also not collected (discussed later in this chapter). However, 
given that the intervention sought to achieve change at all organisational levels, these outcomes 
are important to measure in future trials (Craig et al., 2008).  
 
Other limitations of this study are that clusters and participants were not randomised, and 
assessors were not blind to the treatment arm. Both methodological features are fundamental 
in the design of a main trial. Lack of randomisation in non-cluster trials is well known to 
increase the risk of selection bias and allocation bias, and introduce bias associated with 
unbalanced sample characteristics, such that estimated parameters may not reflect the true 
treatment effectiveness or efficacy (Eldridge & Kerry, 2012). In cluster trials, the issue of 
randomisation is more complex in that possible bias can be introduced at cluster level, e.g. 
allocation bias, and at individual participant level, e.g. selection bias, if randomisation is not 
implemented, therefore it is imperative that a future definitive trial employs both design 
features, and with sufficient randomised clusters to adequately control for bias.  
 
Contextual factors should also be recorded in a future trial. There were two notable contextual 
differences between the control and intervention ward. First is that the control and intervention 
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ward provided acute inpatient care for patients residing in rural or urban areas, respectively. 
The second difference is that patients in the intervention ward received different psychiatric 
care, depending on whether they were an outpatient or inpatient. In contrast, psychiatric care 
for patients in the control ward was consistent, despite hospitalisation. Such contextual 
differences may have implications for treatment outcomes, therefore contextual factors like 
these should be considered in a process evaluation in a main trial to increase confidence in the 
conclusions drawn from it (Moore et al., 2015). Cluster randomisation designs, such as 
stratification or minimisation, should account for such differences to ensure groups are equally 
balanced and improve the external validity of the trial (Eldridge & Kerry, 2012).  
 
A further limitation of the current feasibility study is that, due to insufficient planning (see 
‘Protocol amendments’ in Chapter 5), some feasibility outcomes were not included. For 
example, no information on the acceptability of the intervention (i.e. content, format, logistics 
of delivering it in routine practice) was formally gathered. As recommended by the MRC, 
qualitative investigation of such issues, i.e. staff and patient experience of the intervention, 
should be conducted to develop and refine the intervention further before progressing to a main 
trial (Craig et al., 2008, 2013; Lancaster et al., 2010). Quantitative methods, e.g. a 
questionnaire, would also inform the acceptability of the intervention. Reasons for non-
engagement in the intervention group were also not recorded in the current trial, due to ethical 
restrictions. However, investigating of such issues could further inform the design of the 
intervention, with the view to increase its acceptability, and should therefore be considered in 
the design of future research (discussed later in this chapter).  
 
Other limitations of this trial are that participants were followed up at six months, rather than 
the pre-specified 12 months, and the specified sample size was not recruited. This was 
unavoidable, due to the time restrictions of the PhD. However, a future trial should ensure 
adequate time is allocated for recruitment and follow-up assessment. 
 
6.2.4 Implications for future research and practice  
It is clear that conducting a full trial of the intervention would have problems without 
modifying the trial protocol, the clinical context and the intervention. Using the ADePT process 
(Bugge et al., 2013), various amendments have been identified and considered (see Appendix 
16 for all identified amendments) to address the problems discussed in the previous section. 
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Required amendments to progress to a full trial are discussed in the following sections and 
summarised in Table 24 (page 156). Key design features of a main trial are summarised in 
Table 25 (page 156).  
 
 
6.2.4.1 Changes to the trial design 
From the results of this trial, it is clear that the eligibility criteria and the process of collecting 
follow-up questionnaires need refinement. The first possible change to the eligibility criteria is 
that patients who do not want to receive the intervention could be excluded. This could reduce 
the number of non-engaging participants in the intervention group, therefore allowing for an 
intention to treat analysis which measures the effects of the intervention on patient level 
outcomes more directly (Dunn, 2013). One way to achieve this is by asking patients to rate 
their interest in receiving the intervention before entering the trial. Although increasingly 
restrictive eligibility may be a sign of a less pragmatic trial and reduce external validity 
(Loudon et al., 2015), asking participants whether they want to receive the intervention is 
common in routine clinical practice and, if the intervention were to be fully implemented, could 
improve the quality of an intention to treat analysis on patient level outcomes. Furthermore, 
such information will quantify demand for the intervention, and characteristics of those who 
do and do not want to receive psychological intervention during their acute admission could be 
identified. Second, patients should not be excluded based on anticipation of a short admission. 
Instead, different options should be considered, for example patients could continue to be 
excluded if they are discharged within two days of completing baseline measures, however to 
avoid excluding eligible patients and excluding participants after entering the trial, baseline 
measures could be collected from everyone who provides initial consent to do so, and consent 
could be sought from participants twice; once when completing baseline measures and once 
three days after doing so to enter the trial. This would avoid exclusion of patients who have 
officially entered the trial but ensure data is collected for those who stay longer than expected, 
and for those who have a very short admission (i.e. three days). This method, however, should 
be carefully considered with a dedicated clinical trials unit before progressing to a full trial. 
Another option to avoid excluding participants based on a short-term admission is to continue 
to provide therapy after discharge. This is likely to reduce the number of participants being 
excluded based on this criterion, however the logistics of offering therapy in this way would 
require consideration.  
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Various solutions should be considered to improve the completion of follow-up questionnaires 
in a main trial. One solution is to identify characteristics of patients who are unlikely to provide 
follow-up data and exclude them (Eldridge & Kerry, 2012). This is likely to reduce the risk of 
bias associated with large proportions of missing outcome data. However, in doing so, the trial 
results may not apply to a proportion of patients who have such characteristics but may benefit 
from the intervention. This has implications for the external validity of the trial and the 
generalisability of the results. Given that a future trial should remain as pragmatic as possible 
to evaluate the effectiveness of the intervention in real life (see Table 24, page 156), a 
combination of other solutions would therefore be preferred. More suitable changes include 
collecting contact details directly from patients, arranging follow-up meeting with patients at 
the point of discharge assessment, increasing contact with patients between discharge and 
follow-up (Jacobsen et al., 2016) and offering incentives for completion of follow-up 
assessments which compensate for time taken to complete measures (Brueton et al., 2014; 
Royal College of Physicians, 2007), e.g. a £10 shopping voucher. A combination of these 
modifications is likely to improve completion of follow-up questionnaires in a main trial, 
however support from a research assistant will be required. While the changes described above 
are likely to be effective, given that loss to follow-up is common in clinical trials of complex 
interventions, and that major problems are associated with missing data (Dunn, 2013), it is 
recommended that the primary outcome of a main trial is not reliant on patients completing 
questionnaires, as in the current study.  
 
Other recommended changes, or additions, to the trial design are the inclusion of outcomes 
which address staff and ward level outcomes, i.e. staff burnout and potential change in milieu: 
two key outcomes of the intervention (Clarke & Wilson, 2009). A validated measure of 
burnout, for example the Maslach Burnout Inventory (Maslach & Jackson, 1981), is 
recommended to assess intervention impact on staff outcomes. The impact of treatment on 
milieu, however, is more difficult to measure directly. Multiple factors, such as communication 
between staff and patients, decision-making procedures, organisational hierarchy and power 
structures, morale and the handling of conflict (Lewis, Beck, King, & Stephen, 1971) 
contribute to a successful therapeutic milieu. Therefore, while an outcome of general ward 
atmosphere should be included, for example the Ward Atmosphere Scale (Moos, 1974), more 
specific outcomes relating to milieu would also be informative. A specific aim of the 
intervention investigated in this study was to improve the quality of staff-patient interactions 
(i.e. facilitate more therapeutic interactions) (Clarke & Wilson, 2009). Therefore, a validated 
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measure of the quality of such interactions, for example the Working Alliance Inventory 
(Tracey & Kokotovic, 1989), could also be included in the design on a future trial, to provide 
an indication of change in milieu. Further consideration of other indicators or milieu targeted 
by this intervention should also be considered before progressing to a main trial. In addition, 
although the current study recorded some data regarding intervention implementation, a formal 
process evaluation which targets intervention fidelity should be included in future research. 
For example, thorough documentation and audio recordings of sessions will make clear the 
extent to which the intervention is delivered, and how this impacts treatment outcomes (Moore 
et al., 2015) 
 
6.2.4.2 Changes to the clinical context and intervention 
This trial highlighted that either the intervention or the clinical context, or both, need 
modifications to work in harmony. To improve implementation of the group components of 
the intervention, a protocol which focusses on fewer than four group therapy types may be 
more feasible because less staff time is required to fully implement the intervention and staff 
may feel more confident in their knowledge of the therapy. However, negotiations with 
management will still be essential to protect time for delivery and the aims of the intervention, 
and its reach, may need to be reconsidered. Another solution is to increase psychological 
resource to facilitate groups. There is evidence that consistent delivery of groups is achievable 
when delivered by a member of the psychological team and co-facilitated by member of ward 
staff (Owen, Sellwood, et al., 2015). Furthermore, increased psychological resource will 
increase time for staff training, which is recommended in psychiatric inpatient services to 
promote staff awareness of therapeutic principles because staff play a key role in encouraging 
and enabling participant attendance (Jacobsen, Morris, Johns, & Hodkinson, 2011). Therefore, 
increasing psychological resource may also have a positive effect of patient engagement. The 
recommended optimum ratio of full time clinical psychologist to inpatients is 1:20 (Sainsbury 
Centre for Mental Health, 2005). However, given that the recommended minimum is half a 
day per week (Royal College of Psychiatrists Centre for Quality Improvement, 2014), this 
seems unfeasible. Discussions at organisational level are necessary if the intervention is to be 
implemented in its current form. 
 
An alternative solution to improve group implementation is to employ a designated member of 
staff as group facilitator. However, this is not conducive to integrating the intervention into the 
whole service, which is a key aim of the intervention. Consideration of available funding is 
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also necessary for this solution. Amendments that are more akin to the aims of the intervention 
are to improve the flexibility of nursing staff rotas, to ensure nursing staff have protected time 
for group facilitation, and to increase the psychological resource to support nurse engagement. 
Identifying staff who are interested in facilitating groups and are willing to work one day a 
week, at the same time, on the same day, for a fixed period of time may also be useful. This 
time can be used to facilitate and co-facilitate groups with a psychologist (Hill et al., 2009). To 
achieve this, managerial staff must allow a degree of flexibility in rotas. Furthermore, an 
assigned project ‘champion’ who is influential (e.g. a senior staff member) and responsible for 
supporting implementation of the intervention is also likely to be beneficial (Shaw et al., 2012). 
These approaches may be effective in terms of improving implementation of group therapies, 
however this study lacks knowledge of whether managerial staff will support nursing staff to 
routinely delivery groups. Discussion with managerial and nursing staff is needed to identify 
the most feasible option before progressing to a full trial. 
 
This trial clearly shows that further work is needed to better understand and improve the 
process of service redesign, implementation and multi-level culture change in acute psychiatric 
inpatient services. The field of implementation science has recently grown and recent literature 
(e.g. Pfadenhauer et al., 2017) should be consulted to seek guidance for successful 
implementation of the intervention into routine acute psychiatric inpatient practice, if it is 
shown to be effective, safe and cost-effective. Formal process evaluation should be used to 
inform how this intervention works in this context and why. This is also important to inform 
how the intervention may need altered for implementation in different contexts (Moore et al., 
2015). 
 
6.2.4.3 Consideration of methodological issues not addressed in the current study 
Some methodological issues, which are considered important to address in pilot/feasibility 
trials (Shanyinde et al., 2011), were not tested in this study but require careful consideration 
before progressing to a main trial. Such issues include cluster randomisation and blinding 
procedures, acceptability and cost-effectiveness of the intervention and the logistics of running 
a multicentre trial.  
 
Given the nature of the intervention, cluster randomisation should be used in a main trial, and 
should ideally take place after receiving consent from clusters to minimise potential bias 
(Eldridge & Kerry, 2012). However, to ensure a future trial is successful, agreement from ward 
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managers (i.e. charge nurses) should be sought to ensure ward staff are able to attend relevant 
training and deliver group therapies, irrespective of being in the intervention or TAU arm as 
allocation to treatment should not be known until after cluster level consent is given (Eldridge 
& Kerry, 2012). Furthermore, as seen in this feasibility trial, acute psychiatric inpatient units 
can vary, for example in terms of the care pathway (i.e. continuity of inpatient and outpatient 
psychiatric care) or in size (i.e. the number of patients cared for per ward). The patients within 
each service may also differ, for example, in terms of their residential location (i.e. rural or 
urban) or diagnosis. To avoid imbalance between trial arms, methods such as stratification or 
minimisation could be employed, depending on the number of factors and clusters included 
(Eldridge & Kerry, 2012). Another possibility is to use a stepped wedge design, where by all 
clusters (wards) begin receiving TAU and then all clusters are added to the intervention arm at 
different, pre-specified time-points. Like stratification and minimisation, this approach avoids 
imbalanced influential factors between treatment arms. It is also beneficial in that 
psychological input would not be withheld from any ward, which has previously been deemed 
unethical by some clinicians (Clarke & Wilson, 2009).  
 
Due to restricted resource, the assessor in the current study was not blind to treatment 
allocation. Lack of assessor blinding, however, is known be associated with inflated estimates 
of treatment effects (Eldridge & Kerry, 2012). Indeed the results of the meta-analysis reported 
in chapter three are consistant with this. Blinding of assessors is therefore imperative to 
progress to a main trial to improve scientific rigor and increase confidence in the conclusions 
drawn from it. Eldridge & Kerry (2012) highlight the risk of bias associated with identifying 
and recruiting participants after treatment has been allocated to clusters. However, given the 
high turnover and fast pace of an acute psychiatric inpatient unit, and the time needed to 
implement the intervention, patients cannot be recruited before treatment is randomly allocated 
to clusters. To avoid potential bias, a research assistant who is blind to allocation could be used 
to recruit participants and collect data. While this would reduce the risk of bias associated with 
lack of assessor blinding (e.g. at post-intervention and follow-up), a research assistant would 
still need to consult a member of ward staff to identify appropriate patients to participate, 
therefore an unavoidable risk of bias (i.e. selection bias) will remain (Eldridge & Kerry, 2012). 
 
This study lacks information regarding the cost-effectiveness of the intervention and logistics 
of running a multi-centre trial. However, given the preparation involved in implementing the 
intervention and the cost and organisation of conducting a multisite trial, such issues should be 
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considered before progressing to a definitive trial. Furthermore, in a time of austerity, 
information regarding the expense of introducing and sustaining new interventions is extremely 
important for decision-makers. Therefore, as recommended by the MRC (Craig, 2012), a full 
economic evaluation is recommended alongside an investigation of effectiveness in order to 
determine the cost-effectiveness of the intervention, provide a more comprehensive overall 
evaluation and highlight potential savings for the NHS.  
 
Table 24  
Summary of changes and additional feasibility research required for progression to a full 
trial 
Type of 
change Change 
Changes to 
the clinical 
context 
Discussions with managerial staff in participating wards is necessary to 
ensure ward staff have adequate support and resources to facilitate groups. 
 
Designated project ‘champion’. 
Increase psychological resource to full time clinical psychologist to inpatient 
ratio of 1:20, to achieve this, discussions at an organisational level are 
necessary. 
Guidance should be sought from the implementation science literature on 
implementing complex interventions in routine practice. 
Changes to 
the 
intervention 
Consider reducing number of group therapy types offered. 
Consider offering access to group therapies after discharge. 
Changes to 
the trial 
design 
Refine eligibility criteria to exclude patients who do not want to receive the 
intervention. 
Possible introduction of two consent points. 
Increase contact between discharge assessment and follow-up assessment. 
Inclusion of staff and ward level outcomes, e.g. burnout and change in milieu. 
Additional 
feasibility 
research 
Process evaluation including qualitative investigation of staff and patient 
experience of the intervention 
Full economic evaluation 
Formal assessment of intervention fidelity 
 
 
Table 25 
Example of main trial design 
Aim: To determine the effectiveness of cross-diagnostic psychologically informed acute 
psychiatric inpatient care. 
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Clusters: 36 UK National Health Service acute psychiatric inpatient units. Matching using 
stratification of the following factors should be considered: residency (rural/urban), size 
(small/large), continuity of care (yes/no). 
 
Consent (cluster level): Verbal consent from clusters (i.e. ward managers) before allocation.  
 
Participants: 2012 acute psychiatric inpatients who express an interest in receiving 
psychological intervention. Adjust for matching if used.  
 
Recruitment: Participants are recruited after clusters are randomised and recruiters will not 
be blind to allocation due to the nature of the intervention. 
 
Consent (participant level): Initial consent and baseline measures obtained from participants 
and second consent to officially enter the trial is obtained after three days of initial consent. 
 
Intervention: CBT based intervention (Clarke & Wilson, 2009) (see Methods chapter). 
Should be fully implemented before data collection begins.  
 
Primary outcome: Readmission at 12-month follow-up (proportion of readmissions and total 
number of readmitted days during follow-up); possibly in preference, number of days to first 
readmission using a survival analysis approach (requires discussion with clinical trials unit 
statistician).  
 
Secondary outcomes (patient related): Psychological distress, self-efficacy, adverse events. 
 
Secondary outcomes (staff related): Burnout 
 
Secondary outcomes (ward related): Milieu 
 
6.3 Concluding remarks 
With guidance from the MRC framework (Craig et al., 2008, 2013), the findings of this thesis 
have contributed to the development and evaluation of cross-diagnostic psychological 
intervention for acute mental health inpatients and has provided direction for future evaluation. 
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This thesis has done so using two main studies. First, it has provided the first systematic review 
and meta-analytical synthesis of controlled trials of the effectiveness of psychological 
intervention delivered in acute psychiatric inpatient settings (Chapter 3). Second, it has carried 
out the first study which has assessed the feasibility of conducting a definitive RCT to 
investigate the impact of a cross-diagnostic psychological intervention, with a specific focus 
on readmissions (Chapter 4, 5 and 6). This thesis has therefore contributed to phase one (i.e. 
development) and phase two (i.e. feasibility/piloting) of the MRC framework (Craig et al., 
2008, 2013) (see Chapter 1). It has also made detailed consideration of progressing to phase 
three (i.e. evaluation) of the MRC framework (Craig et al., 2008, 2013).  
 
The systematic review and meta-analysis focused on the effectiveness brief inpatient 
psychological therapy in terms of reducing psychotic symptoms, emotional distress and risk of 
readmissions. The findings indicate that in randomised, single-blind trials brief inpatient 
psychological intervention is not effective in reducing psychotic symptoms. However more 
promising findings were observed on other outcomes. The results also suggest that therapy may 
reduce emotional distress and risk of readmissions for patients with a variety of diagnoses. This 
is an important finding, given that psychological therapy is not currently routinely offered in 
acute inpatient services (British Psychological Society, 2012; Joint Commissioning Panel for 
Mental Health, 2013). This study has also highlighted that many of the studies contributing to 
the current evidence base are of low quality and that minimal work has investigated the benefit 
of psychological intervention applied cross-diagnostically. Good quality studies, e.g. RCTs, 
are necessary to strengthen the evidence base, definitively determine the effectiveness of cross-
diagnostic psychological intervention for acute inpatients and make specific recommendations 
for practice. It is recommended by the MRC that large definitive trials are informed by initial 
feasibility work (Craig et al., 2008, 2013). The feasibility study in this thesis has contributed 
to the preparation required for a definitive trial of cross-diagnostic psychological care for acute 
inpatients.  
 
The feasibility study aimed to investigate the feasibility of implementing and evaluating cross-
diagnostic psychological intervention, largely based on the Woodhaven Approach (Clarke & 
Wilson, 2009). With guidance from a methodological framework (Shanyinde et al., 2011), the 
results of the feasibility study demonstrated that some trial processes were conducted 
effectively, i.e. good completion of some clinical outcomes, some components of the 
intervention were well implemented and some clinical outcomes produced effects which 
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favoured the intervention group. However, some aspects of conducting the trial and 
implementing the intervention were challenging. These included problematic eligibility 
criteria, poor completion of clinical outcomes at follow-up, poor engagement with the 
intervention and poor implementation of some intervention components. Using the ADePT 
process (Bugge et al., 2013), such problems were assessed, potential solutions were considered 
in detail and further feasibility work thought to be informative to future evaluation and 
implementation of the intervention was identified. This feasibility study has also highlighted 
methodological issues which have not yet been address, but are imperative to the design of a 
future definitive trial, e.g. randomisation and assessor blinding. Methods to implement such 
methodological features were also considered in this study.  
  
Overall, this thesis has indicated that cross-diagnostic psychological therapy may be feasible 
for delivery in acute psychiatric inpatient settings, however further work is required to refine 
the intervention and fully implement and evaluate it in routine practice.  
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Appendices 
 
Appendix 1 
Justification of outcomes, detail of data conversion and linked studies 
 
The primary outcome was post intervention means measured by Positive and Negative 
Symptom Scale (PANSS) total scores (Hall & Tarrier, 2003; Kim et al., 2010; Moritz et al., 
2011; Shelley et al., 2001). Where PANSS total scores were not reported the PANSS subscale 
scores were combined to create the total score which was calculated using Jauhur’s (Jauhar et 
al., 2014) method (Bechdolf et al., 2004; Habib et al., 2015; Hayashi et al., 2001; Kumar et al., 
2010). Where PANSS was not available the Brief Psychiatric Rating Scale (BPRS) or the 
Global Assessment of Functioning (GAF) mean scores were converted into PANSS using 
Leucht, and colleague’s (Leucht et al., 2013) and Samara and colleague’s (Samara et al., 2014) 
conversion (Bach & Hayes, 2002; Gaudiano & Herbert, 2006; Haddock et al., 1999; Schramm 
et al., 2007; Startup et al., 2004). Leucht et al.’s (Leucht et al., 2013) total score conversion 
table was used to convert BPRS standard deviations into PANSS standard deviations (10 point 
difference on BPRS converted to 19 point difference on PANSS).  
 
Other outcomes included symptoms of depressions and anxiety at post intervention. 7 studies 
measured symptoms of depression (Bowers, 1990; Gibson et al., 2014; Hall & Tarrier, 2003; 
Kim et al., 2010; Miller et al., 1989; Mortan et al., 2011; Schramm et al., 2007). Within these 
7 studies 6 measures of depression were used (BDI, DAS, HAD-D, HMRD, M-HMRD, SCL-
90-R-D). HMRD and BDI are the most commonly used measures of depression in these 
studies, therefore where a study used either of these measures and another measure of 
depression, the BDI or HMRD was chosen. In a previous meta-analysis (Belvederi Murri et 
al., 2015) the BDI was found to be used more in research in the area of depression in 
schizophrenia, therefore if both the BDI and HMRD were reported the BDI was chosen. Other 
included measures used by studies that did not use the BDI or HMRD were the HAD-D (Hall 
& Tarrier, 2003) and the SCL-90-R-D (Gibson et al., 2014). Therefore, a total of 4 measures 
of depression were included (BDI, HAD-D, HMRD, and SCL-90-R-D). Psychometric 
properties of all measures were explored and found to be sufficient (see Appendix 2). Of the 
22 identified studies 4 measured symptoms of anxiety (Gibson et al., 2014; Hall & Tarrier, 
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2003; Kim et al., 2010; Mortan et al., 2011). Within these studies 3 measures were used (HAD-
A, HAMA, SCL-90-R-A). All these measures were included in order to increase the number 
of studies included in the meta-analysis. 
 
Some studies were linked as multiple publications had been produced from the same research. 
It is vital that the studies are independent, therefore the following studies were coded once: 
Bechdolf et al., (2004); linked with (Bechdolf, Köhn, Knost, Pukrop, & Klosterkötter, 2005; 
Bechdolf et al., 2010), Startup, Jackson, & Bendix, (2004); linked with Startup, Jackson, Evans, 
& Bendix, (2005), and Veltro et al., (2006); linked with Veltro et al. (2008), Lewis et al., 
(2002)linked with Tarrier et al. (2004). Bach et al., (2013) combined readmission datasets from 
Bach & Hayes, (2002) and Gaudiano and Herbert (2006) in order to use an ITT analysis. This 
combined dataset was used for readmission outcomes only. This left 20 independent studies 
for meta-analysis. 
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Appendix 2 
Properties of depression and anxiety measures 
 
Table summarising properties of measures of depression 
Measure Reference 
Reporting 
style Items Properties of scale 
Concepts aimed 
to be measured Previously validated (psychometric properties) 
Included 
studies 
using 
measure 
Beck 
depression 
inventory 
(Beck, 
Steer, & 
Brown, 
1996) 
Patient 
reported 
outcomes 
21 -continuous. 
-each question 0-3. 
-total score 
between 0-63. 
-High score 
indicate higher 
severity. 
Aims to measures 
characteristic 
attitudes and 
symptoms of 
depression 
Internal consistency found to be high in 
psychiatric patients (.86) ( Beck, Steer, & Carbin, 
1988). 
 
Construct validity found to be high in relation to 
clinical ratings (0.72) and HMRD (0.73). 
Bowers 
Miller 
Mortan 
Schramm 
Hospital 
Anxiety 
and 
Depression 
Scale-
Depression 
 
(Zigmond 
& Snaith, 
1983) 
 
Patient 
reported 
outcomes 
7 -continuous. 
-each question 0-3. 
-total score 
between 0-21. 
-High score 
indicate higher 
severity. 
To detect states 
of depression 
In Norwegian population the depression subscale 
found to: share 30% variance with anxiety 
subscale, have to be internally consistent  
 
Internal consistency: good in mental health 
population (Cronbach’s alpha was 0.83) 
(Mykletun, Stordal, & Dahl, 2001). 
Hall 
Hamilton 
Rating 
Scale for 
Depression 
(Hamilton, 
1960) 
Observer 
rated 
21 but 
scoring 
based 
on first 
17 
-higher scores 
indicate higher 
severity. 
-8 items scored 0-
4. 
-9 items scored 0-
2. 
-total score 
between 0-50. 
Depression 
severity among 
patients 
Internal consistency: extremely varied as it ranges 
between 0.48 and 0.92 because 2 patients identical 
scores have different meanings (i.e. high rating on 
1 item can produce same score as low ratings on a 
few items) 
Validity: found to range between 0.65 and 0.90 . 
Limitations: i. excludes some symptom domains of 
MDD, ii. Some items measure different constructs 
(e.g. irritability and anxiety), iii. Symptom 
domains are weighted differently 
 (Cusin, Yang, Yeung, & Fava, 2009).  
Bowers 
Kim 
Mortan 
Schramm 
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Modified 
Hamilton 
Rating 
Scale of 
Depression 
(Miller, 
Bishop, 
Norman, 
& 
Maddever, 
1985) 
 
Observer 
rated 
25 25 item score: 
-reflects total of all 
symptoms 
assessed. Same 
properties as 
HMRD.  
 
17 item score: 
Same as HMRD 
Severity of 
depression. 
HMRD with the 
following 
modifications: i. 
items were added 
to include greater 
depressive 
symptoms, ii. 
Rating points 
were altered to 
increase 
specificity and 
linearity, iii. 
Prompt questions 
added with each 
item so 
paraprofessionals 
could administer 
also. 
Interrater reliability in paraprofessionals was high 
(Miller, Bishop, Norman, & Maddever, 1985).  
 
Relationship between clinician ratings on MHRSD 
and HRSD were high (Miller, Bishop, Norman, & 
Maddever, 1985). 
Miller 
Hamilton (HMRD) 
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Table summarising properties of measures of depression 
Measure 
Reporting 
style Items Properties of scale 
Concepts aimed to be 
measured Previously validated (psychometric properties) 
HAD-A PRO 7 -continuous. 
-each question 0-3. 
-total score between 
0-21. 
-High score indicate 
higher severity. 
To detect states of anxiety In Norwegian population the anxiety subscale found to have: 
30% variance with the depression subscale, internal 
consistency 
 
Internal consistency: good in mental health population 
(Cronbach’s alpha was 0.85) (Mykletun et al., 2001) 
HAMA 
(Hamilton, 
1960) 
Clinician 
rated 
14 -continuous. 
-each question 0-4. 
-total score 0-54. 
-higher score 
indicates higher 
severity.  
 
Measures anxiety 
symptoms (e.g. tension, 
insomnia, respiratory) 
Internal consistency: ranges from adequate to excellent (.77 
(Moras, Nardo & Barlow, 1992) to .92 (Kobak, Reynolds & 
Greist, 1993). 
SCL-90-R-A 
(Derogatis, 
1994) 
PRO 10 -continuous 
-each question 0-4 
(not at all to 
extremely).  
-total score 0-40.  
Symptoms of anxiety and 
related distress 
High internal consistency (alpha=.88) and high test-retest 
reliability (Horowitz, et al., 1988, cited in Derogatis, 1994).  
Cronbach’s alpha coefficient found to be .88 by Gibson et al. 
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-high score 
indicates higher 
severity. 
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Appendix 3 
Summary of selected study characteristics of included studies 
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Aghotor 
(Aghotor 
et al., 
2010) 
Schizophrenia 
spectrum disorder 
(ICD-10 criteria, 
diagnoses F2.x)  
UC 1.  MCT 
2. NRG 
26 MCT NRG N 1. pre 
2. post 
N/A C Y Y H 
Bach et al 
2002 
Psychotic disorder 
(DSM-IV) 
10.7 1. ACT 
2. ETAU 
40 ACT ETAU Y 1. pre 
2. FU 
4 ITT Y N L 
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Bach 
2012 
Psychotic disorder 
(DSM-IV) 
10.7 1. ACT 
2. ETAU 
120 ACT ETAU Y 1. pre 
2. post 
3. FU 
4 ITT Y N L 
Bechdolf 
et al 2004 
Schizophrenia and 
related disorders 
(ICD-10 criteria, 
diagnoses F20, F23, 
F25) 
UC 1. Brief GCBT 
2. PE 
88 GCBT PE Y 1. pre 
2. post 
3. FU 
6 ITT Y Y H 
Bowers 
1990 
DSM-III unipolar 
depression 
29.43 1. CT&M 
2. RT&M 
3. M 
30 CT&M 1. 
RT&M 
2. M 
Y 1. pre 
2. post 
N/A ITT Y Y H 
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Gaudiano 
& Herbert 
2006 
DSM-IV diagnosis of 
psychotic disorder or 
affective disorder 
10.7 1. Brief GCBT 
2. PE 
40 ACT ETAU Y 1. pre 
2. post 
3. FU 
4 ITT Y N L 
Gibson et 
al 2014 
Engaged in DSH or 
meet diagnostic 
criteria for BPD 
UC 1. LTD 
2. TAU 
103 LTD TAU N 1. pre 
2. post 
N/A ITT N N L 
Habib et 
al 2015 
DSM-IV-TR 
diagnosis of 
schizophrenia 
UC 1. CaCBTp 
2. TAU 
42 CaCBTp TAU N 1. pre 
2. post 
N/A ITT Y Y H 
Haddock 
et al 1999 
DSM-IV diagnosis of 
schizophrenia or 
schizo-affective 
disorder 
46.49 1. CBT 
2. SC+PE 
21 CBT SC Y 1. pre 
2. post 
3. F/U 
24 C Y Y H 
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Hall et al 
2003 
Diagnosis of 
psychotic disorder and 
low self esteem (as 
scored by RSCQ) 
UC 1. CBT for self 
esteem. 
2. TAU 
25 CBT for 
self 
esteem 
TAU N 1. pre 
2. post 
3. F/U 
3 C Y N L 
Hayashi et 
al 2001 
DSM-IV diagnosis of 
schizophrenia 
78.3 1. CBTa 
2. TAU 
58 CBT TAU N 1. pre 
2. post 
 
N/A C Y N L 
Kim et al 
2010 
DMS-(V axis 1 
disorders 
UC 1. EMDR 
2. PMR 
3. TAU 
45 EMDR 1. 
PMR 
2. 
TAU 
Y 1. pre 
2. post 
3. F/U 
3/ 
24 
C Y Y H 
Kumar et 
al 2010 
ICD-10 diagnosis of 
paranoid 
schizophrenia 
UC 1. MCT 
2. TAU 
 MCT TAU N 1. pre 
2. post 
 
N/A UC Y UC L 
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Lewis et 
al 2002 
1st or 2nd admission 
and meets criteria for 
DSM-IV diagnosis of 
schizophrenia, 
schizophreniform 
disorder, 
schizoaffective 
disorder or Delusional 
disorder 
UC 1. CBT for 
early acute 
schizophrenia 
2. SC 
3. TAU 
309 CBT 1. SC 
2. 
TAU 
Y 1. pre 
2. post 
3. F/U 
24 ITT Y Y H 
Miller et 
al 1989 
Diagnosis of Major 
Depressive Disorder 
25.35 1. CBT 
2. SST 
3. TAU 
45 1. CBT 
2. SST 
TAU N 1. pre 
2. post 
3. F/U 
6/12 ITT Y N L 
Moritz et 
al 2011 
Fulfilled criteria for 
schizophrenia 
diagnosis. 
UC 1. MCT 
2. CR 
48 MCT CR Y 1. pre 
2. post 
 
N/A ITT Y Y H 
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Mortan et 
al 2011 
Diagnosis of 
schizophrenia or 
schizoaffective 
disorder (DSM-IV) 
UC 1. GCBT 
2. TAU 
12 GCBT TAU N 1. pre 
2. post 
 
N/A C N UC L 
Schramm 
et al 2007 
Diagnosis of MDD 
(DSM-IV) 
UC 1. IPP 
2. TAU 
124 IPP TAU N 1. pre 
2. post 
3. F/U 
6/12 ITT/Cb Y Y H 
Shelley et 
al 2001 
Diagnosis of 
schizophrenia or 
schizo-affective 
disorder 
UC 1. CBT 
2. TAU 
48 CBT TAU N 1. pre 
2. post 
 
N/A ITT N N L 
Startup et 
al 2004 
Diagnosis of 
schizophrenia or 
schizo-affective 
disorder and 
UC 1. CBT 
2. TAU 
90 CBT TAU N 1. pre 
2. F/U 
6/12 ITT Y N L 
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Study characteristics of included studies.  
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experiencing an acute 
psychotic episode 
(DSM-IV) 
Veltro et 
al 2006 
All inpatients 12.2 1. GCBT 
2. TAU 
733 GCBT TAU N 1. F/U 48 ITT N N/A L 
BPD, Borderline Personality Disorder; CBT, CR, Cognitive Remediation; Cognitive behavioural therapy; CBTp, CBT for psychosis; C, Completer analysis; CT, 
Cognitive Therapy; CaCBTp , Culturally adapted CBT for psychosis; DSH, Deliberate self harm; EMDR, Eye Movement Desensitisation & Reprocessing; ETAU, 
Enhanced treatment as usual; F/U, Follow-up; GCBT, Group CBT; H, High quality; ICD-10, International Classification of Diseases; IPP, Interpersonal 
Psychotherapy; ITT, Intention to treat; LTD, Living through distress; L, Low quality; LOS, length of stay; MDD, Major Depressive Disorder; M, Medication; MCT, 
Metacognitive training; N/A, Not Applicable; N, No; NRG, Newspaper reading group; PE, Psychoeducation; Post, Post-intervention assessment; Pre, Pre-
intervention assessment; PMR, Progressive Muscle Relaxation; RM, Relaxation therapy; RSCQ, Robson Self Concept Questionnaire; SC, Supportive Counselling; 
UC, Unclear; Y, Yes. 
a. Intervention described as psychological approach, however considered CBT for the purpose of this meta-analysis.  
b. ITT analysis for pre-post analysis but Completer analysis for follow-up.  
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Appendix 4 
Summary of outcomes reported in included studies grouped by concept 
Outcomes in included studies grouped by concept 
 Construct Measure Studies using 
measure 
Total No. studies 
reporting measure 
0 Global 
Functioning 
GAF Schramm, Startup 2 
GAS Haas a 1 
RPTS Haas  a 1 
CGI Gaudiano 1 
SDS Bach, Gaudiano 2 
1 Psychiatric 
symptom 
severity 
PANSS (total) Aghotor, Bechdolf, 
Habib, Hall, 
Hayashi, Kim, 
Kumar, Lewis, 
Moritz, Shelley 
10 
BPRS Bach, Gaudiano, 
Haddock, Startup 
4 
PAS Drury  a 1 
PEF Haas  a 1 
PSE Drury  a 1 
SCL-90-G Miller 1 
PSYRATS Habib, Haddock, 
Lewis, Owen  a, 
Moritz 
5 
Symptom 
Checklist 
Mortan,  1 
2 Distress 
related to 
symptoms 
Distress Total: 5 
H-distress  Bach, Gaudiano 2 
Symptomology-
D 
Haas  a 1 
Problem 
Distress 
Mortan 1 
CORE-10 Owen  1 
3 Negative 
symptoms 
severity 
Negative General Total: 10 
PANSS 
(negative 
subscale 
Bechdolf, Habib, 
Hall, Hayashi, Kim, 
Kumar, Lewis , 
Shelley 
8 
SANS Mortan, Startup 2 
4 Positive 
symptoms 
severity 
Positive General Total: 12 
SAPS Mortan, Startup 2 
PANSS 
(positive 
subscale); 
Aghotor, Bechdolf, 
Habib, Hall, 
Hayashi, Kim, 
Kumar, Lewis, 
Moritz, Shelley,  
10 
Specific: 
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SCL-90-Pos Miller 1 
BCS Drury  a 1 
BABS Kumar 1 
H-frequency  Bach, Gaudiano 2 
5 Depressive 
symptoms 
severity 
Depression General Total: 7  
BDI Bowers, Miller, 
Mortan, Schramm 
4 
HRSD Bowers, Kim, 
Miller, Schramm 
4 
HAD (D-scale) Hall 1 
HDI Mortan 1 
SCL-90-R-D Gibson 1 
Specific: 
DAS Bowers 1 
ATQ Bowers 1 
HS Bowers  1 
BHS Mortan 1 
BADE (JTC) Aghotor, Moritz 2 
6 Anxiety 
Symptoms 
severity 
 
 
Anxiety Total: 4 
HAMA Kim 1 
HAI Mortan 1 
SCL-90-R-A Gibson 1 
HAD (A-scale) Hall 1 
7 Coping/self 
efficacy 
SCQ  Hall 1 
Problem Coping Mortan  1 
MHSC Owen  a 1 
8 Service use 
 
Readmission 
(%) 
Bach, Bechdolf, 
Gaudiano, Haddock, 
Kim, Lewis, 
Schramm, Veltro 
7 
Days in hospital Bach, Veltro 2 
Mean no. of total 
readmissions  
Drury  a 1 
Median time in 
acute care 
Drury  a 1 
9 Social 
functioning 
SFS Hall, Startup 2 
SAS Miller 1 
IPDC Miller 1 
10 Deliberate Self 
Harm/Suicide 
DSI Gibson 1 
MSSI Miller 1 
11 Emotion 
Regulation 
DERS, Gibson 1 
CERQ-short Gibson 1 
12 Self Esteem RSES Mortan 1 
13 Insight PANSS G12 
(judgement and 
insight subscale) 
Hayashi 1 
ABPS Hayashi 1 
H-believability  Bach 1 
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SAI Habib 1 
14 Personality MPI Hayashi  1 
15 Quality of Life MSQoL Bechdolf 1 
ABPS, Awareness of Being a Patient Scale; A-Scale, Anxiety Scale; ATQ, Automatic 
Thoughts Questionnaire; BABS, Brown Assessment of Beliefs Scale; BCS, Belief and 
Conviction Scale; BDI, Beck Depression Inventory; BHS, Becks Hopelessness Scale; 
BPRS, Brief Psychiatric Rating Scale; CERQ-Short, Cognitive Emotion Regulation 
Questionnaire- Short Form; CGI, Clinical Global Impression Scale; CORE-10, Clinical 
Outcome Routine Evaluation-10; DAS, Dysfunctional Attitudes Scale; DERS, 
Difficulties in Emotion Regulation Scale; D-Scale, Depression Subscale; DSI, 
Deliberate Self Harm Inventory; GAF, Global Assessment of Psychological 
Functioning; GAS, Global Assessment Scale; HAD, Hospital Anxiety and Depression 
Scale; HAI, Hamilton Anxiety Inventory; HAMA, Hamilton Anxiety Rating Scale; H-
believability, Hallucinations- believability; H-distress, Hallucination-distress; HDI, 
Hamilton Depression Inventory; H-frequency, Hallucinations frequency; HRSD, 
Hamilton Rating Scale of Depression; HS, Hopelessness Scale; IPDC, Interpersonal 
Dependency Scale; JTC, Jumping to Conclusions; MHCS, Mental Health Confidence 
Scale;  MPI, Maudsley Personality Inventory; MSQoL, Modular System of Quality of 
Life; MSSI, Modified Scale of Suicide Ideation; PANSS, Positive and Negative 
Symptom Scale; PANSS G12, PANSS judgement and insight subscale; PAS, 
Psychiatric Assessment Scale; PEF, Psychiatric Evaluation Form; PSE, Present State 
Examination; PSYRATS, Psychotic Symptom Rating Scale; RPTS, Role Performance 
Treatment Scale; RSES, Rosenberg Self-Esteem Scale; SAI, Schedule for Assessment 
of Insight; SANS, Scale for the Assessment of Negative Symptoms; SAPS, Scale for 
the Assessment of Positive Symptoms;  SAS, Social Adjustment Scale; SCL-90-A, 
Symptom Checklist 90 anxiety symptoms; SCL-90-D, Symptom Checklist 90 
depression symptoms; SCL-90-G, Symptom Checklist 90 General Symptom Index; 
SCL-90-P, Symptom Checklist 90 Positive Symptoms; SCQ, Stress Coping 
Questionnaire; SDS, Sheenan Disability Scale; Symptomology-D, Symptomology-
distress; SFS, Social Functioning Scale.  
 
a. Studies excluded due to outcome measures used (Drury, Birchwood, & Cochrane, 
2000; Drury, Birchwood, Cochrane, & Macmillan, 1996a, 1996b; Haas et al., 1988; 
Owen, Sellwood, et al., 2015). 
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Appendix 5 
Trim and fill results for primary outcome 
 
Funnel plot showing publication bias in primary outcome 
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Appendix 6 
List of excluded studies 
Excluded studies with rationale 
Study (first 
author and 
date) Reason for exclusion 
Reason 
Code a 
Andres (1998) Full text not in English   1 
Andres (2000) No access to required data  2 
Andres (2003) No access to required data 2 
Arnevik (2010) Therapy specialised for PD 3 
Ascher-Svanum 
(1999) 
Comparing 2 psycho-education styles.  3 
Bartak (2011a) Study is a comparison of locations of psychotherapy, 
therefore same psychotherapy in both groups. 
3 
Bartak (2011b) Study is a comparison of locations of psychotherapy, 
therefore same psychotherapy in both groups. 
3 
Bateman (1999) Service specialised for PD 3 
Bateman (2001) Service specialised for PD 3 
Bateman (2008) Service specialised for PD 3 
Beecham (2006) Service specialised for PD 3 
Bellack (2006) Treatment targets drug abuse  3 
Berglund (2003) Psycho-education  3 
Bertelsen (2008) Community treatment 3 
Bertolin-Colilla 
(2011) 
Review/meta-analysis (including mixed patient group) 3 
Bertolin-Guillen 
(2011) 
Conference paper. Emailed authors for more information 
but no response.  
4 
Bohus (2000) Treatment specialised for PD/no comparator 3 
Bohus (2004) Treatment specialised for PD/waiting list control group 
in community 
3 
Bout (2008) Centre specifically designed for couples therapy 
therefore not acute service 
3 
Brady (1984) Outdated review 4 
Candini (2013) Outpatients 3 
Carter (2010) Outpatient/treatment specialised for PD 3 
Chien (2004) Outpatient service 3 
Chien (2013) Outpatient treatment 3 
Clarke (2013) Outpatients 3 
Clarkin (1990) Does not include chosen outcomes 2 
Colom (2003) Outpatients/psychoeducation 3 
Colom (2004) Outpatients 3 
Comtois (2010) Treatment focus on reintegration 3 
Crameri (2009) Not in English 1 
Davidson (2006) Not inpatient  3 
Davidson 
(2010_ 
Not inpatient 3 
Durham (2003) Long term treatment  (9 months) 3 
Drury (1996i) Not correct outcome measures  2 
Drury (1996ii) Not correct outcome measures 2 
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Drury (2000) Not correct outcome measures 2 
Dyck (2002) Outpatients 3 
Falloon (1985) Community treatment 3 
Feldmann 
(2002) 
Outpatients 3 
Fisher (1996) Therapy tailored for substance abused/outpatients and 
inpatients included but not separated.  
3 
Fox (2015) Within subjects design 3 
Frank (1990) No control group 3 
Frank (2005) Participants recruited from inpatient and outpatient 
services. Emailed author and author responded that 
17.5% patients began as inpatients.   
3 
Gaudiano (2005) Outpatients/all participants received same treatment 3 
Giron (2010) Not inpatient; long term treatment 3 
Glick (1985) Does not include chosen outcomes 2 
Glick (1990) Does not include chosen outcomes 2 
Glick (1991) Does not include chosen outcomes 2 
Glick (1993) Does not include chosen outcomes 2 
Glynn (2010) Therapy targets substance abuse/not inpatients  3 
Gratz (2014) Community treatment 3 
Grawe (2006) Not inpatients  3 
Grawe (2013) Not inpatients  3 
Haller (2009) Article in German 1 
Haas (1988) Does not include chosen outcomes 2 
Haas (1990) Does not include chosen outcomes 2 
Healey (1998) Compliance therapy 3 
Herz (2000) Outpatients 3 
Herz (1979) Comparison of hospital length not effectiveness of 
psychotherapy/before 1980 
3 
Huang (2005) Not typical acute inpatients (all soldiers) 3 
Isasi (2010) Refractory bipolar disorder therefore not acute 3 
Jackson (2008) 57% participants were outpatients.  3 
Jacob (2010) Outpatients 3 
James (2004) Therapy aims to reduce drug use.  3 
Javadpour 
(2013) 
Outpatients  3 
Kanas (1980) US airforce teaching hospital-not typical acute inpatients  3 
Kessing (2011) Outpatient 3 
Kessing (2014) Outpatients  3 
Kim (2005) Rehabilitation service- longer term and not acute.  3 
Kleindienst 
(2011) 
Inpatient service specifically for PD 3 
Kliem (2010) Specifically for PD 3 
Kohler (2014) Not a controlled trial (within design) 3 
Kopelowicz 
(1998) 
Community re-entry  3 
Kopelowicz 
(2012) 
Treatment aimed at adherence 3 
Kopinke (2007) Within group 3 
Kroger (2006) No control group.  3 
Kuipers (1998) Community treatment 3 
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Lam (2003) Not inpatient treatment 3 
Lana (2015) Outpatients 3 
Lee (2013) Community  3 
Leerer (1997) Thesis. No access 4 
Li (1994) Long term hospitalisations 3 
Liang (2004) Published in Chinese 1 
Liberman (1981) Psychoeducation rather than psychotherapy  3 
Linehan (1991) Control= TAU in community; 1 year of treatment; 
service specifically for PD 
3 
Linehan (1993) Control in community; service for PD 3 
Linehan (2006) Outpatient and community clinic 3 
Linehan (2015) Community setting 3 
Links (2013) Within group; long treatment; treatment for PD 3 
Linszen (1996) Outpatient intervention evaluation 3 
Lipton (1988) Not acute inpatient setting 3 
Liu (1999) Not psychological therapy  3 
Lukoff (1986) Not an acute inpatient environment. Holistic programme  3 
Lykke (2010) Therapy for substance abuse 3 
Malik (2009) Community treatment 3 
Manning (1997) Not controlled trial 3 
Marois (2011) Not acute inpatients  3 
Marziali (1995) Service specific for PD 3 
McFarlane 
(1995) 
2 year treatment; outpatient treatment 3 
Miklowitz 
(2003) 
Therapy began after acute hospitalisation 3 
Millson (1993) Treatment aimed at increasing water intake 3 
Min (2001) Published in Chinese 1 
Monroe-Blum 
(1995) 
Treatment specific to BPD 3 
Mueser (2008) Community treatment; treatment specific for PTSD 3 
Naoki (2003) Community re-entry therapy 3 
Newton (2007) Cognitive remediation therapy 3 
Ng (2006) Rehabilitation ward (long term) 3 
Norman (2002) Not inpatient 3 
Norrie (2013) Treatment in community 3 
Novakovic 
(2011) 
Not controlled trial 3 
O’Donnell 
(2003) 
Compliance therapy; not psychological 3 
Ohlenschlaeger 
(2007) 
Community as comparison 3 
Ojeda (2012) Rehabilitation ward  3 
Owen (2015) Does not include chosen outcomes 2 
Pabst (2014) Therapy for PTSD 3 
Penn (2009) Community and outpatient clinical 3 
Penn (2011) Community and outpatient clinical 3 
Pereira (1994) Published in Spanish 1 
Petersen (2008) Day hospital treatment; service for PD 3 
Phillips (2007) Not relevant patient group/context 3 
Puschner (2011) Not psychological therapy 3 
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Qu (2007) Cognitive remediation 3 
Quee (2014) Outpatients  3 
Rabovsky 
(2012) 
Psychoeducation 3 
Rea (2003) Treatment began after hospitalisation 3 
Reker (1997) Work therapy 3 
Roder 
(2006/2011) 
Meta-analysis about psychiatric rehabilitation therefore 
not acute. Mixed inpatients and outpatients (not 
separated in analysis) 
3 
Roder (2006) Vocational rehabilitation is aim of therapy and in 
German 
1 
Rodriguez 
(2007) 
Case study 3 
Ruggeri (2015) Community service 3 
Salkever (2014) Community and rehabilitation treatment 3 
Schilling (2015) BDI data not presented – emailed author but no response 2 
Schmidt-
Kraeplin (2009) 
Participants recruited on discharge from hospital 3 
Scott (2001) Not inpatient 3 
Scott (2009) No psychological therapy  3 
Sellwood (2007) Not inpatient 3 
Sieftert (2012) Not controlled trial 3 
Sigrunarson 
(2013) 
Not directly accessing addition of psychological therapy 
to TAU (also included home based crisis management, 
etc).  
3 
Silverstein 
(2006) 
Long term inpatients (1-7 years) 3 
Soloman (2008) Outpatient and long term treatment 3 
Spencer (1988) Does not include chosen outcomes 2 
Srihari (2015) Community treatment 3 
Stevenson 
(1999) 
Outpatients 3 
Styla (2012) Residential ward therefore not acute setting. 66 
participants in day-treatment setting and 39 participants 
in residential ward.   
3 
Svensson (1999) Long term stay (average 230 days) 3 
Tao (2015) Cognitive rehabilitation 3 
Tarrier (1998) Outpatient treatment 3 
Tarrier (1999) Outpatient treatment 3 
Thekiso (2015) Treatment for substance abuse 3 
Thunnissen 
(2008) 
Assessing continued community treatment following 
hospitalisation 
3 
Turner (2000) Not acute inpatient (recruited from emergency room and 
treated in community) 
3 
Valencia (2010) Outpatients 3 
Valmaggia 
(2005) 
22 weeks of therapy (over 90 days).  3 
Van den Bosch 
(2014) 
Service for PD 3 
Van der Gaag 
(2011) 
Community treatment 3 
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Van Wel (2009) Published in Dutch 1 
Vancampfort 
(2011) 
Not psychotherapy (PMR) 3 
Van Meerten 
(2013) 
Therapy in community (counting how many inpatient 
admissions following this) 
3 
Vaslamatzis 
(2014) 
Comparing presence or absence of medication 
(psychological therapy in both groups) 
3 
Vauth (2005) Rehab ward (not acute) 3 
Vauth (2001) Published in German 1 
Veltro (2006) Community; not in English? 3 
Wang (2000) Published in Chinese 1 
Wang (2000) Psychoeducation; Published in Chinese  1 
Wykes (1999) Cognitive Remediation  
Wykes (2003) Cognitive Remediation  
Wykes (2007) Cognitive Remediation 3 
Xiang (2007) Community re-entry (not psychological therapy). For 
clinically stable inpatients and outpatients.  
3 
Xiong (1994) Therapy adapted specifically for complex family 
situation in China. Not relevant for typical acute setting.  
3 
Zaretsky (2008) Patients in remission. Therefore assumed not acute.  3 
Zhou (2005) Published in Chinese; long term hospitalisation  1 
Zieba (1996) All participants received psychotherapy  3 
BDI, Beck Depression Inventory; PD, Personality Disorder; PMR, Progressive Muscle 
Relaxation; PTSD, Post Traumatic Stress Disorder; TAU, Treatment as Usual.  
a. The following codes were given for exclusion reasons: 1) Not in English, 2) 
Adequate data not presented/does not present data for chosen outcomes, 3) Not acute 
inpatient setting/appropriate psychotherapy/controlled trial, and 4) Other. 
  
209
Appendix 7 
Risk of bias methods and assessment 
 
Appendix 7.1: Risk of bias methods 
Selection Bias: randomisation 
Low risk rating given if randomisation is reported (even is method not specified). Unclear risk 
rating given if randomisation is not reported. High risk rating given if non-randomisation is 
specified. 
 
Selection Bias: allocation concealment 
If unreported an unclear rating was given. If method for concealment was reported a low risk 
rating was given. If non-concealment was reported or it seemed unlikely that concealment was 
possible a high risk rating was given.  
 
Performance Bias: blinding of participants and personnel 
Blinding of participants and personnel is uncommon in trials of psychotherapy (Slade & Priebe, 
2001) and unrealistic in an acute inpatient environment, however where unreported bias was 
rated as high. 
 
Detection Bias: blinding of subjective outcomes; self and observer reported 
Where non-blinding was reported a high risk of bias rating was given. If blinding was reported 
a low risk of bias was reported. If unreported an unclear risk of bias rating was given.  
 
Detection Bias: blinding of objective outcomes (readmission) 
Where applicable, a low risk of bias rating was given if the decision of readmission was 
separate from the researchers. An unclear risk rating was given if unreported. A high risk rating 
was given is researchers were involved in the decision of readmission.  
 
Attrition Bias: incomplete outcome data 
A high risk rating was given if ≥ 25% of those who entered the trial did not complete it (Xia et 
al., 2009) or if attrition was not reported (or not clearly reported) and a completer analysis was 
carried out. If attrition was low (≥ 25%) and completer analysis was used risk of bias was rated 
as low.  
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Reporting Bias: selective outcome reporting 
If outcomes are pre-specified and reported a low risk of bias rating was given. However, if no 
protocol is reported a high risk of bias rating was given. If subgroup analysis is reported but 
not pre-specified a high risk rating was given. 
 
  
211
Appendix 7.2: Risk of bias assessment of included studies 
Study 
Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance 
Bias: blinding 
of participants 
and personnel 
Detection Bias: 
blinding of 
subjective 
outcomes: self 
and observer 
reported 
 
Detection 
Bias: blinding 
of objective 
outcomes 
(readmission) 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective 
outcome 
reporting 
Aghotor 
(Aghotor 
et al., 
2010) 
‘non-stratified 
randomisation 
method’ 
established by 
statistician. 
Randomisation 
used.  
‘Predetermined 
random plan’.  
Group 
assignment was 
previously 
planned.  
Not reported.  Observer rater 
blinding.  
N/A Attrition not 
reported clearly. 
Completer 
analysis. 
All outcomes 
pre-specified and 
reported but no 
protocol  
Low risk High risk High risk Low risk N/A High risk High risk 
Bach 
(Bach & 
Hayes, 
2002) 
States 
randomisation but 
method not 
reported 
Unreported Staff were blind 
to treatment 
allocation.  
Subjective 
measures 
presented orally. 
Assessor not blind.  
Readmission 
data taken 
from hospital 
records.  
Completer 
analysis 
No protocol. 
Scores from one 
outcome not 
reported.  
Low risk Unclear risk Low risk High risk Low risk High risk High risk 
Bach 
(Bach et 
al., 2013)a 
Randomisation 
reported 
Unreported 
(Bach) 
No concealment 
(Gaudiano). 
Staff blind to 
treatment 
allocation 
(Bach)/staff not 
blind to 
treatment 
allocation 
(Gaudiano) 
Subjective 
measures 
presented orally. 
Assessor not blind 
(Bach).  
Observer raters 
unblind to group 
allocation. Self 
report measures 
Readmission 
data taken 
from hospital 
records (Bach).  
Readmission 
determined 
independently 
of study 
(Gaudiano).  
About 6% 
missing data. 
ITT analysis. 
All pre-specified 
outcomes 
reported.  
 
No protocol 
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Appendix 7.2: Risk of bias assessment of included studies 
Study 
Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance 
Bias: blinding 
of participants 
and personnel 
Detection Bias: 
blinding of 
subjective 
outcomes: self 
and observer 
reported 
 
Detection 
Bias: blinding 
of objective 
outcomes 
(readmission) 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective 
outcome 
reporting 
also used 
(Gaudiano).  
Low risk High risk High risk High risk Low risk Low risk High risk 
Bechdolf 
(A 
Bechdolf 
et al., 
2004) 
‘Randomization 
conducted by 
computer-
generated random 
numbers’ Blocks 
of 8.  
‘results were 
placed in sealed 
envelopes’  
Not reported Psychopathology 
and compliance 
measures mostly 
done by 
independent rater. 
Secondary 
outcomes were 
self-report.  
Readmission 
decided 
independent of 
study. 
24% lost to 6-
month follow-up 
and around 50% 
lost to 24 month 
follow-up. ITT 
used.  
 
 
ITT reported. All 
pre-specified 
outcomes were 
reported. But no 
protocol. 
Low risk Low risk High risk Low risk Low Risk High risk High risk 
Bowers 
(W. A. 
Bowers, 
1990) 
‘Assignment to 
one of three 
groups was done 
on a rotating 
basis.’ 
Unreported Unreported Self-report 
measures used. 
But observer rated 
measures were 
blind.  
N/A Attrition not 
reported.  
All pre-specified 
outcomes 
reported but no 
protocol 
Low risk Unclear risk High risk Low risk N/A High risk High risk 
Gaudiano 
(Gaudiano 
& Herbert, 
2006) 
‘Simple 
randomisation 
without blocking 
or stratification 
‘…without 
concealment.’  
‘Staff were not 
blinded to 
treatment 
allocation’.  
Observer ratersnot 
blind to group 
allocation. Self-
Readmission 
determined 
independently 
of study. 
Around 24% 
missing data.  
All outcomes 
said to be 
reported were. 
But no protocol  
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Appendix 7.2: Risk of bias assessment of included studies 
Study 
Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance 
Bias: blinding 
of participants 
and personnel 
Detection Bias: 
blinding of 
subjective 
outcomes: self 
and observer 
reported 
 
Detection 
Bias: blinding 
of objective 
outcomes 
(readmission) 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective 
outcome 
reporting 
based on a 
computer 
generated list was 
used’ 
report measures 
also used. 
Completer and 
ITT data 
analysed.  
Low risk High risk High risk High risk Low Risk Low risk High risk 
Gibson 
(Gibson et 
al., 2014) 
Non-randomised. 
Assigned by 
timing of referrals.  
Not reported Not reported. Assessor blinding 
not reported.  
N/A 27% missing 
data. Completer 
analysis used 
where entire 
measures 
missing. 
No protocol. 
Although pre-
specified 
outcomes were 
reported.  
High risk Unclear risk High risk Unclear risk N/A High risk High risk 
Habib 
(Habib et 
al., 2015) 
Randomised using 
online programme 
Unreported Not reported Blind assessors N/A Percentage of 
missing data not 
reported.  
Previously 
specified 
outcomes were 
reported. Means 
and SDs not 
reported but 
available through 
contact with 
author.  
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Appendix 7.2: Risk of bias assessment of included studies 
Study 
Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance 
Bias: blinding 
of participants 
and personnel 
Detection Bias: 
blinding of 
subjective 
outcomes: self 
and observer 
reported 
 
Detection 
Bias: blinding 
of objective 
outcomes 
(readmission) 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective 
outcome 
reporting 
No protocol 
reported.  
Low risk Unclear risk High risk Low risk N/A High risk High risk 
Haddock 
(Haddock 
et al., 
1999) 
Reported 
randomisation but 
no detail. 
Not reported  Staff blind to 
treatment 
allocation. 
Blinding of 
assessors reported. 
Blind 
independent 
assessor using 
case notes.  
10% attrition. 
Analysis unclear 
(likely to be 
completer 
analysis).  
Subscales of 
measures 
reported-not 
previously 
specified.  
 
Follow-up data 
not presented due 
to missing data.  
 
No protocol 
Low risk Unclear risk Low risk Low risk Low risk Low risk High risk 
Hall (P. L. 
Hall & 
Tarrier, 
2003) 
Reported clearly. 
‘Sealed envelope 
technique’ 
‘Neither 
participants nor 
investigator 
knew which 
condition had 
been assigned 
until baseline 
Blinding not 
reported. 
Assume staff 
are not blinded 
as they were 
consulted before 
Assessor not blind. 
Inter-rater 
reliability checked 
by blind assessor.  
N/A 8% attrition at 
post-treatment. 
28% attrition at 
follow-up. 
Unclear what 
analysis was 
used.  
All data pre-
specified was 
reported with 
means and 
variance.  
 
No protocol. 
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Appendix 7.2: Risk of bias assessment of included studies 
Study 
Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance 
Bias: blinding 
of participants 
and personnel 
Detection Bias: 
blinding of 
subjective 
outcomes: self 
and observer 
reported 
 
Detection 
Bias: blinding 
of objective 
outcomes 
(readmission) 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective 
outcome 
reporting 
assessments 
were complete’.  
assessor 
approached. 
Low risk Low risk High risk High risk N/A High risk High risk 
Hayashi 
(Hayashi 
et al., 
2001) 
States 
randomisation. 
Not reported Not reported Assessors not 
blind. 
N/A Attrition not 
reported.   
Subscale 
analyses carried 
out which were 
not pre-specified.  
 
No protocol 
reported.  
 
Low risk Unclear High risk High risk N/A High risk High 
Kim (Kim 
et al., 
2010) 
Reports 
randomisation. 
Not reported Unreported  All observer rated. 
Blind assessor. 
Unreported 12% attrition at 
post-treatment. 
25% attrition at 
follow-up. 
Analysis type 
unknown.  
 
‘Study protocol 
was approved by 
the institutional 
research board of 
this institution’  
 
Low risk Unclear High risk Low risk Unclear risk Low/High risk Low risk 
‘names of patients 
were shuffled and 
Participants were 
aware of 
Participants 
were aware of 
Observer reported 
measures used. 
N/A Attrition not 
reported and 
All pre-specified 
outcomes 
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Appendix 7.2: Risk of bias assessment of included studies 
Study 
Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance 
Bias: blinding 
of participants 
and personnel 
Detection Bias: 
blinding of 
subjective 
outcomes: self 
and observer 
reported 
 
Detection 
Bias: blinding 
of objective 
outcomes 
(readmission) 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective 
outcome 
reporting 
Kumar 
(Kumar et 
al., 2010) 
given numbers 
sequentially. Once 
numbers were 
assigned, each 
even numbered 
patient was 
included in the 
experimental 
group….’ 
allocation after 
randomisation. 
allocation after 
randomisation. 
Blinding of staff 
not reported.  
Blinding 
unreported 
analysis type not 
specified.  
reported 
adequately. 
 
No protocol  
Low risk Low risk  High risk Unclear risk N/A High risk High risk 
Lewis (S. 
Lewis et 
al., 2002) 
Randomised Allocation 
concealed 
Not reported Raters were blind N/A 18% missing 
data post-
treatment.28% 
missing data at 
follow-up .ITT 
analysis.  
All outcomes 
reported, 
however 
subscales also 
reported but not 
previously 
specified. No 
prospective 
protocol 
reported.  
Low risk Low risk High risk Low risk N/A Low/high risk High risk 
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Appendix 7.2: Risk of bias assessment of included studies 
Study 
Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance 
Bias: blinding 
of participants 
and personnel 
Detection Bias: 
blinding of 
subjective 
outcomes: self 
and observer 
reported 
 
Detection 
Bias: blinding 
of objective 
outcomes 
(readmission) 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective 
outcome 
reporting 
Miller (I. 
W. Miller 
et al., 
1989) 
Reports 
randomisation. 
Not reported Not reported Assessor not blind 
but some 
interviews taped 
and check by blind 
independent raters.  
N/A ITT and 
completer data 
analysed. 33% 
dropout.  
All means and 
variance reported 
for pre-specified 
outcomes. 
 
No protocol 
Low risk Unclear risk High risk High risk N/A High risk High risk 
Moritz 
(Moritz et 
al., 2011) 
Randomization 
plan created by 
statistician. 
Patient informed 
of allocation by 
independent 
person 
Patients were 
asked not to 
reveal group 
allocation 
therefore 
unlikely staff 
would know.  
Observer reported 
measures blind to 
groups.  
N/A 8% missing data 
at post-
intervention. 
ITT used. 
All pre-specified 
outcomes 
reported.  
 
Protocol 
registered.  
Low risk. Low risk Low risk Low risk N/A Low risk Low risk 
Mortan 
(Mortan et 
al., 2011) 
Not randomised- 
based on number 
of psychotic 
patients admitted 
at one time 
Unreported  Unreported Unreported N/A 14% dropout at 
post intervention 
and 50% 
missing data at 
follow-up. Only 
completers 
analysed.  
Mean and 
variance reported 
for only 
completers.  
 
No protocol 
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Study 
Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance 
Bias: blinding 
of participants 
and personnel 
Detection Bias: 
blinding of 
subjective 
outcomes: self 
and observer 
reported 
 
Detection 
Bias: blinding 
of objective 
outcomes 
(readmission) 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective 
outcome 
reporting 
High risk Unclear risk High risk Unclear risk N/A High risk High risk 
Schramm 
(Schramm 
et al., 
2007) 
‘dynamic 
allocation using 
minimisation 
method’ 
Unreported Unreported ‘assessments were 
performed by 
blind and 
independent 
raters’.  
Unreported 
who decides 
readmission. 
15% missing 
data at post 
intervention. 
22% missing 
data at follow-
up. Only ITT for 
post analysis. 
Completer 
analysis at both 
post and follow-
up.  
All pre-specified 
outcomes 
reported.No 
protocol 
reported. 
Low risk Unclear risk High risk Low risk Unclear risk Low/high risk 
(depending on 
outcome) 
High risk 
Shelley 
(Shelley et 
al., 2001) 
 
Not randomised. 
Allocated 
depending on 
ward. 
Not reported  Unreported Rated by group 
leader. Not 
blinded 
Not reported Not reported but 
ITT used. 
No protocol 
High risk Unclear risk High risk High risk Unclear risk High risk High risk 
Coin toss Coin tossed at 
allocation 
Unreported Assessor not blind, 
however 12 blind 
N/A 45% dropout 
from 
All pre-specified 
outcomes are 
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Appendix 7.2: Risk of bias assessment of included studies 
Study 
Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance 
Bias: blinding 
of participants 
and personnel 
Detection Bias: 
blinding of 
subjective 
outcomes: self 
and observer 
reported 
 
Detection 
Bias: blinding 
of objective 
outcomes 
(readmission) 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective 
outcome 
reporting 
Startup (M 
Startup et 
al., 2004) 
re-ratings showed 
inter-rater 
reliability.  
intervention 
group during 
treatment. No 
control group 
drop out. 
Methods for 
missing data not 
reported.  
reported with 
adequate data. 
However sample 
divided by 
disorganisation 
score and 
reanalysed-not 
pre-specified.  
 
No protocol 
Low risk Low risk High risk High risk N/A High risk High risk 
Veltro 
(Veltro et 
al., 2006) 
Not randomised. 
Retrospective 
control 
No concealment 
as retrospective 
design 
Blinding to 
group allocation 
not possible due 
to retrospective 
design 
N/A Unclear who 
assessors of 
readmission 
were 
N/A  Pre-specified 
outcomes were 
reported 
adequately.  
 
No protocol 
High risk High risk High risk N/A Unclear risk N/A High risk 
N/A, Not applicable.  
a. Bach (Bach et al., 2013) carries out an intention to treat analysis using data from Bach (Bach & Hayes, 2002) and Gaudiano (Gaudiano & Herbert, 
2006), therefore data from Bach (Bach et al., 2013) was used in outcomes where Bach (Bach & Hayes, 2002) and Gaudiano (Gaudiano & Herbert, 
2006) were both included. 
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Appendix 8 
GRADE assessment methods and results 
 
Appendix 8.1 
GRADE Assessment Methods 
While observational studies increase the risk of bias included in an outcome, the current 
available literature specifically involved in evaluating psychotherapy in acute inpatient settings 
is limited and some of that literature is not randomised. Therefore, despite the known 
limitations of such inclusions, the current meta-analysis included both randomised and non-
randomised trials. However, if an outcome included less than 50% RCTs the quality rating of 
the evidence started as moderate instead of the recommended high for RCTs or low for 
observational studies.  
4=high; 3=moderate; 2=low; 1=very low 
 
Risk of bias 
If >50% of studies included 2 high risk of bias ratings, according to the Cochrane Risk of Bias 
assessment that was conducted, the quality of the outcome was downgraded (-2). If >50% of 
studies included 1 or more high risk of bias rating the quality of the outcome was downgraded 
(-1). A ‘high’ risk rating for non-randomisation or performance bias was excluded as one of 
the two ratings because non-randomisation has already been addressed (see above) and 
blinding of personnel and participants is uncommon and near impossible in psychotherapy 
trials (Slade & Priebe, 2001). If the risk of bias was not related to the outcome being assessed, 
the quality was not downgraded. For example, if the study was rated ‘high risk’ for missing 
data that did not relate to the outcome of interest it was not noted for that outcome. 
 
Inconsistency 
Quality was downgraded by 1 point if the I-squared statistic was >40% in the context of an 
unclear direction of effect or >75% in the context of a clear direction of effect. 2 points were 
deducted if the I-squared statistic was >75% in the context of an unclear direction of effect. An 
unclear direction of effect was identified by an outcome including studies which favoured both 
intervention and control.  
 
Indirectness 
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Study population, intervention and outcome measures were considered in the rating outcomes 
for indirectness.  
 
Imprecision 
Precision was downgraded by 1 if “a recommendation or clinical course of action would differ 
if the upper versus the lower boundary of the CI represented the truth”, for example if the 
confidence intervals include no effect and a large effect (Guyatt, Oxman, Kunz, Brozek, et al., 
2011). Therefore clinical, over statistical, significance was considered. In addition to or instead 
of clinical significance, precision was also downgraded if the OIS (i.e. sample size or number 
of events) was not reached. Optimum information size (OIS) was generated using G-Power to 
judge imprecision. If the OIS (i.e. sample size or number of events) was not reached the 
outcome was downgraded (-1). Guyatt’s (Guyatt, Oxman, Kunz, Brozek, et al., 2011) 
recommendations were used to calculate OIS of continuous outcomes: alpha was 0.05, beta 
was 0.20 and the effect size used was 0.2 therefore recommending OIS of 400 (n=200 in each 
arm). The OIS for readmission outcomes was calculated using 
http://www.stat.ubc.ca/~rollin/stats/ssize/ b2.html. Proportions entered into the programme 
were taken for all included studies reporting number of readmissions (intervention (p1)=0.24; 
control (p2)=0.37). The calculated OIS was n=392 (n=196 in each arm). 
 
Publication Bias  
Quality was downgraded by one level if, for outcomes including over 10 studies, funnel-plots 
showed asymmetry. Quality was not downgraded if less than 10 studies were included in the 
analysis as no evidence was available although publication bias may exist.   
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Appendix 8.2 Summary of GRADE assessment results 
Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
Is end of 
treatment 
PANSS total 
score in 
psychological 
therapy 
statistically 
superior to 
control? 
4 
 
All but 1 of 
the included 
studies were 
randomised 
-2 
 
9 of 13 
studies 
had 2 
high 
risk of 
bias 
ratings 
-1 
 
High 
heterogeneity 
(67.86%) and 
unclear effect.  
0  0 
 
0 1 Very low Aghotor (Aghotor 
et al., 2010); 
Bechdolf 
(Bechdolf et al., 
2004); Gaudiano 
(Gaudiano & 
Herbert, 2006); 
Habib (Habib et 
al., 2015); 
Haddock 
(Haddock et al., 
1999); Hall (Hall 
& Tarrier, 2003); 
Hayashi (Hayashi 
et al., 2001); Kim 
(Kim et al., 2010); 
Kumar (Kumar et 
al., 2010); Lewis 
(Lewis et al., 
2002); Moritz 
(Moritz et al., 
2011); Schramm 
(Schramm et al., 
2007); Shelley 
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Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
(Shelley et al., 
2001); Startup (M 
Startup et al., 
2004). 
Is end of 
treatment 
PANSS total 
score in 
psychological 
therapy 
statistically 
superior to 
control in 
randomised 
and single-
blind studies? 
4 
All studies 
randomised 
-1 
>50% 
studies 
had 1 or 
more 
high 
risk of 
bias 
ratings.  
-1 
>40% 
heterogeneity 
and unclear 
direction of 
effect. 
0  -1  
N exceeded 
OIS but 
wide 
confidence 
intervals (-
0.46, 0.14).  
N/A 1 Very low Aghotor (Aghotor 
et al., 2010); 
Bechdolf 
(Bechdolf et al., 
2004); Habib 
(Habib et al., 
2015); Haddock 
(Haddock et al., 
1999); Kim (Kim 
et al., 2010); 
Lewis (Lewis et 
al., 2002); Moritz 
(Moritz et al., 
2011); Schramm 
(Schramm et al., 
2007). 
Is end of 
treatment 
PANSS total 
4 -2 
>50% 
of 
0 0 -1 N/A 1 Very low Gaudiano 
(Gaudiano & 
Herbert, 2006); 
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Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
score in 
psychological 
therapy 
statistically 
superior to 
control in 
non-
randomised 
and non-
blind studies? 
All but 1 
study was 
randomised 
studies 
had 2 or 
more 
high 
risk of 
bias 
ratings 
>40% but has 
clear direction 
of effect.  
N not 
exceeded 
OIS  
Hall (Hall & 
Tarrier, 2003); 
Hayashi (Hayashi 
et al., 2001); 
Kumar (Kumar et 
al., 2010); Shelley 
(Shelley et al., 
2001); Startup 
(Startup et al., 
2004). 
Is end of 
treatment 
PANSS total 
score in CBT 
and cognitive 
therapy 
group 
statistically 
superior to 
control? 
4 
All but 1 
study was 
randomised 
-2 
>50% 
of 
studies 
had 2 or 
more 
high 
risk of 
bias 
ratings 
-2 
>75% 
heterogeneity 
and unclear 
direction of 
effect. 
0 -1 
N exceeded 
OIS but 
wide CI (-
0.82, -0.07) 
N/A -1 Very low Bechdolf 
(Bechdolf et al., 
2004); Habib 
(Habib et al., 
2015); Haddock 
(Haddock et al., 
1999); Hayashi 
(Hayashi et al., 
2001); Lewis 
(Lewis et al., 
2002); Shelley 
(Shelley et al., 
2001); Startup 
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Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
(Startup et al., 
2004). 
Is end of 
treatment 
PANSS total 
score in third 
wave therapy 
group 
statistically 
superior to 
control? 
4 
All studies 
were 
randomised 
-2 
>50% 
of 
studies 
had 2 or 
more 
high 
risk of 
bias 
ratings 
0 
0% 
heterogeneity 
and clear 
direction of 
effect 
0 -1 
N not 
exceeded 
OIS and 
wide CI (-
0.95, 0.06) 
N/A 
 
1 Very low Aghotor (Aghotor 
et al., 2010); 
Gaudiano 
(Gaudiano & 
Herbert, 2006); 
Kumar (Kumar et 
al., 2010); Moritz 
(Moritz et al., 
2011). 
Is end of 
treatment 
PANSS total 
score in other 
therapies 
group 
statistically 
superior to 
control? 
4 
All studies 
were 
randomised 
-1 
50% of 
studies 
had 1 or 
more 
high 
risk of 
bias 
rating 
0 
0% 
heterogeneity 
and clear 
direction of 
effect.  
0 -1 
N not 
exceeded 
OIS and 
very wide 
CI (-0.90, 
0.53).  
N/A 
 
2 Low Kim (Kim et al., 
2010); Schramm 
(Schramm et al., 
2007) 
 
Is end of 
treatment 
4 -1  0 0 -1 N/A 2 Low Bechdolf 
(Bechdolf et al., 
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Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
PANSS total 
score in 
psychological 
therapy 
statistically 
superior to 
control group 
that had 
increased 
contact with 
a therapist? 
All studies 
were 
randomised 
50% of 
studies 
had 1 or 
more 
high 
risk of 
bias 
ratings 
Heterogeneity 
did not exceed 
40%  
N exceeded 
-1 
OIS but 
wide CI (-
0.38, 0.13).  
2004); Gaudiano 
(Gaudiano & 
Herbert, 2006); 
Haddock 
(Haddock et al., 
1999); Kim (Kim 
et al., 2010); 
Lewis (Lewis et 
al., 2002); Moritz 
(Moritz et al., 
2011); Schramm 
(Schramm et al., 
2007) 
Is end of 
treatment 
PANSS total 
score in 
psychological 
therapy 
statistically 
superior to 
control 
groups that 
4 
All but one 
study was 
randomised 
-2 
>50% 
studies 
had 2 or 
more 
high 
risk 
ratings. 
0 
>40% 
heterogeneity 
but clear 
direction of 
effect. 
0 -1 
N not 
exceeded 
OIS 
N/A 1 Very low Aghotor (Aghotor 
et al., 2010) 
Habib (Habib et 
al., 2015) 
Hall (Hall & 
Tarrier, 2003) 
Hayashi (Hayashi 
et al., 2001) 
Kumar (Kumar et 
al., 2010) 
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Appendix 8.2 Summary of GRADE assessment results 
Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
did not have 
increased 
contact with 
a therapist? 
Shelley (Shelley et 
al., 2001) 
Startup (M Startup 
et al., 2004) 
Is follow-up 
PANSS total 
score in 
psychological 
therapy 
statistically 
superior 
compared to 
control? 
4  
All included 
studies 
randomised 
-2 
>50% 
studies 
had 2 or 
more 
high 
risk 
ratings 
-1  
>40% 
heterogeneity 
but unclear 
direction of 
effect 
0 
  
 
-1 
N exceeded 
OIS but 
wide CI (-
0.53, 0.10) 
N/A 
 
0 Very low Bechdolf 
(Bechdolf et al., 
2004) 
Hall (Hall & 
Tarrier, 2003) 
Kim (Kim et al., 
2010) 
Lewis (Lewis et 
al., 2002) 
Startup (Startup et 
al., 2004) 
 
 
Is follow-up 
PANSS total 
score in 
psychological 
therapy 
statistically 
4  
All studies 
randomised 
-2 
>50% 
have 2 
or more 
high 
risk of 
0 
No 
heterogeneity 
(I²=0.00) 
0 -1 
N exceeded 
OIS but 
wide CI (-
0.22, 0.19).  
N/A 1 Very low Bechdolf 
(Bechdolf et al., 
2004) 
Kim (Kim et al., 
2010) 
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Appendix 8.2 Summary of GRADE assessment results 
Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
superior 
compared to 
control in 
randomised 
and single-
blind studies? 
bias 
ratings. 
Lewis (Lewis et 
al., 2002) 
Schramm 
(Schramm et al., 
2007) 
 
 
Is follow-up 
PANSS total 
score in 
psychological 
therapy 
statistically 
superior 
compared to 
control in 
non-
randomised 
and non-
blind studies? 
4 
All studies 
randomised 
-2 
>50% 
have 2 
or more 
high 
risk of 
bias 
ratings.  
0 
No 
heterogeneity 
(I²=0.00) 
0 
 
-1 
N did not 
exceed OIS.  
N/A 1 Very low Hall (Hall & 
Tarrier, 2003) 
Startup (Startup et 
al., 2004) 
 
Is there a 
significant 
difference in 
4 
¾ studies 
randomised 
-2 
>50% 
have 2 
0 
Heterogeneity 
<40% 
 0 0 
 
0 2 Low Bach (Bach et al., 
2013) (including 
Bach (Bach & 
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Appendix 8.2 Summary of GRADE assessment results 
Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
number of 
readmissions 
during 
follow-up 
period 
between 
psychological 
therapy and 
control 
group? 
or more 
high 
risk of 
bias 
ratings. 
Hayes, 2002) and 
Gaudiano 
(Gaudiano & 
Herbert, 2006); 
Bechdolf 
(Bechdolf et al., 
2004); 
Kim (Kim et al., 
2010); 
Lewis (Lewis et 
al., 2002); 
Schramm 
(Schramm et al., 
2007); 
Veltro (Veltro et 
al., 2006); 
  
Is there a 
significant 
difference in 
number of 
readmissions 
during 
4  
All studies 
randomised  
-1  
> 50% 
studies 
have 1 
or more 
high 
0 
Heterogeneity 
<40% 
0 -1 
N exceeded 
OIS but 
wide CI 
(OR: 0.54, 
1.28) 
N/A 
 
2 Low Bechdolf 
(Bechdolf et al., 
2004) 
Kim (Kim et al., 
2010) 
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Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
follow-up 
period 
between 
psychological 
therapy and 
control group 
in 
randomised 
and single-
blind studies? 
risk of 
bias 
ratings.  
Lewis (Lewis et 
al., 2002) 
Schramm 
(Schramm et al., 
2007) 
 
Is there a 
significant 
difference in 
number of 
readmissions 
during 
follow-up 
period 
between 
psychological 
therapy and 
control group 
in non-
4 
All but 1 
study 
randomised  
-2 
All 
studies 
have 2 
or more 
high 
risk of 
bias 
ratings.  
0 
Heterogeneity 
<40% 
0 0 
 
N/A 
 
2 Low Bach (Bach et al., 
2013) (including 
Bach (Bach & 
Hayes, 2002) and 
Gaudiano 
(Gaudiano & 
Herbert, 2006); 
Veltro (Veltro et 
al., 2006) 
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Appendix 8.2 Summary of GRADE assessment results 
Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
randomised 
and non-
blind studies? 
Is there a 
significant 
difference in 
depression 
between 
psychological 
therapy and 
control 
group? 
4  
5/7 included 
studies are 
randomised 
-2 
All 
studies 
have 2 
or more 
high 
risk of 
bias 
ratings. 
0 
Heterogeneity 
>40% with 
clear direction 
of effect 
0 
 
-1 
N does not 
reach OIS 
0 1 Very low Bowers (Bowers, 
1990) 
Gibson (Gibson et 
al., 2014) 
Hall (Hall & 
Tarrier, 2003) 
Kim (Kim et al., 
2010) 
Miller (Miller et 
al., 1989) 
Mortan (Mortan et 
al., 2011) 
Schramm 
(Schramm et al., 
2007) 
 
Is there a 
significant 
difference in 
depression 
4 
All studies 
are 
randomised  
-1 
Over 
50% of 
studies 
0 
0% 
heterogeneity 
0  -1 
N does not 
reach OIS 
and wide CI 
N/A 2 Low Bowers (Bowers, 
1990) 
Kim (Kim et al., 
2010) 
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Appendix 8.2 Summary of GRADE assessment results 
Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
between 
psychological 
therapy and 
control group 
in 
randomised 
and single-
blind studies? 
included 
at least 
one 
high 
risk of 
bias 
rating 
(-0.84, 
0.18). 
Schramm 
(Schramm et al., 
2007) 
 
 
 
Is there a 
significant 
difference in 
depression 
between 
psychological 
therapy and 
control group 
in non-
randomised 
and non-
blind studies? 
3 
50% of 
studies were 
not 
randomised 
-2 
Over 50 
% of 
studies 
included 
as least 
2 risk of 
bias 
ratings.  
0 
>40% 
heterogeneity 
but clear 
direction of 
effect.  
  
 
0 -1 
N does not 
reach OIS 
and wide CI 
(-1.18, 
0.18). 
N/A 1 Very low Gibson (Gibson et 
al., 2014) 
Hall ( Hall & 
Tarrier, 2003) 
Miller (Miller et 
al., 1989) 
Mortan (Mortan et 
al., 2011) 
 
 
Is there a 
significant 
difference in 
4 
50% if 
included 
-2 
Over 50 
% of 
0 
heterogeneity 
>40% with 
0 -1 
N does not 
reach OIS 
N/A 1 Low Hall (Hall & 
Tarrier, 2003) 
  
234
Appendix 8.2 Summary of GRADE assessment results 
Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
depression 
between 
psychological 
therapy and 
control group 
in patients 
diagnosed 
with 
psychosis? 
studies are 
randomised 
studies 
included 
as least 
2 risk of 
bias 
ratings. 
clear direction 
of effect  
and wide CI 
(-1.18, 
0.16). 
Kim (Kim et al., 
2010) 
Mortan (Mortan et 
al., 2011) 
 
 
Is there a 
significant 
difference in 
depression 
between 
psychological 
therapy and 
control group 
in patients 
diagnosed 
with 
depression? 
4 
50% if 
included 
studies are 
randomised 
-2 
Over 50 
% of 
studies 
included 
as least 
2 risk of 
bias 
ratings.. 
0  
no 
heterogeneity.  
0 -1 
N does not 
reach OIS 
and wide CI 
(-1.03, 
0.08).  
N/A 1 Low Bowers (Bowers, 
1990) 
Miller (Miller et 
al., 1989) 
Schramm 
(Schramm et al., 
2007) 
 
 
Does 
psychological 
4 -2 0 0 -1 N/A 0 Very low Gibson (Gibson et 
al., 2014) 
  
235
Appendix 8.2 Summary of GRADE assessment results 
Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
therapy have 
a significant 
effect on 
symptoms of 
anxiety at 
post 
intervention 
compared to 
control? 
50% of 
included 
studies are 
randomised 
Over 50 
% of 
studies 
included 
as least 
2 risk of 
bias 
ratings. 
Heterogeneity 
>40% with 
clear direction 
of effect.  
N does not 
reach OIS 
and wide CI 
(-0.70, 
0.10).  
Hall (Hall & 
Tarrier, 2003) 
Kim (Kim et al., 
2010) 
Mortan (Mortan et 
al., 2011) 
  
Does 
psychological 
therapy have 
a significant 
effect on 
‘coping’ at 
post 
intervention 
compared to 
control? 
N/A N/A N/A 0 N/A N/A N/A Important 
outcome 
for patients 
however 
too few 
report this 
outcome 
(k=3) 
 
Does 
psychological 
therapy have 
a significant 
N/A N/A N/A 0 N/A N/A N/A Important 
outcome 
for patients 
however 
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Appendix 8.2 Summary of GRADE assessment results 
Outcomes 
and 
questions 
Starter 
number 
(what % of 
studies are 
randomised) 
Quality 
(risk of 
bias) Inconsistency Indirectness Imprecision 
Publication 
bias Overall Comments Included studies 
effect on 
quality of life 
at post 
intervention 
compared to 
control? 
too few 
studies 
directly 
report this 
outcome 
(k=1) 
CBT, Cognitive Behavioural Therapy; OIS, Optimal Information Size; PANSS, Positive and Negative Symptom Scale.   
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Appendix 9 
Subgroup analyses forest plots 
 
 
Appendix 9.1 Forest plot showing effect of randomisation and assessor blinding on psychotic symptoms at post-intervention
Group by
Quality
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper 
g limit limit
1=high quality Aghotor 2010 -0.224 -0.973 0.525
1=high quality Bechdolf 2004 0.289 -0.129 0.707
1=high quality Habib 2015 -1.048 -1.682 -0.413
1=high quality Haddock 0.532 -0.328 1.392
1=high quality Kim 2010 -0.105 -0.754 0.544
1=high quality Lewis 2002 -0.025 -0.348 0.297
1=high quality Moritz 2011 -0.449 -1.013 0.115
1=high quality Schramm 2007 -0.242 -0.594 0.109
1=high quality -0.160 -0.445 0.125
2=low quality Bach 2002 -0.444 -1.060 0.172
2=low quality Gaudiano 2006 -0.444 -1.060 0.172
2=low quality Hall 2003 -1.152 -2.008 -0.296
2=low quality Hayashi 2001 -0.248 -0.796 0.300
2=low quality Kumar 2010 -0.619 -1.570 0.332
2=low quality Shelley 2001 -1.540 -2.177 -0.904
2=low quality Startup 2004 -0.564 -1.051 -0.077
2=low quality -0.682 -1.015 -0.349
Overall -0.380 -0.597 -0.164
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Psychotic symptoms (effect of randomisation and blinding)
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Appendix 9.2 Forest plot for effect of study quality on symptoms at follow-up   
Group by
Study quality
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper 
g limit limit
1: High quality Bechdolf 2004 0.166 -0.250 0.583
1: High quality Kim 2010 -0.092 -0.822 0.637
1: High quality Lewis 2002 -0.109 -0.426 0.208
1: High quality Schramm 2007 0.000 -0.384 0.384
1: High quality -0.012 -0.215 0.190
2: Poor quality Hall 2003 -1.009 -1.954 -0.064
2: Poor quality Startup 2004 -0.780 -1.287 -0.273
2: Poor quality -0.831 -1.278 -0.384
Overall -0.152 -0.336 0.033
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Psychotic symptoms at follow-up (effect of randomisation and blinding)
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Appendix 9.3 Forest plot for effect of study quality on readmission
Group by
Study quality
Study name Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit
1 = good quality (randomisation and blinding) Bechdolf 2005 0.413 0.116 1.469
1 = good quality (randomisation and blinding) Kim 2010 0.357 0.058 2.217
1 = good quality (randomisation and blinding) Lewis 2002 0.999 0.602 1.659
1 = good quality (randomisation and blinding) Schramm 2007 0.764 0.192 3.039
1 = good quality (randomisation and blinding) 0.829 0.538 1.278
2 = poor quality (no randomisation and blinding) Bach 2012 0.419 0.191 0.919
2 = poor quality (no randomisation and blinding) Veltro 2006 0.545 0.373 0.796
2 = poor quality (no randomisation and blinding) 0.519 0.369 0.730
Overall 0.621 0.475 0.812
0.1 0.2 0.5 1 2 5 10
Psychotherapy Control
Readmissions (effect of randomisation and blinding)
M ta Analysis
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Appendix 9.4 Forest plot for effect of study quality on depression
Group by
Study quality
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper 
g limit limit
1 = good quality Bowers -0.436 -1.183 0.311
1 = good quality Kim -0.108 -0.757 0.541
1 = good quality Schramm -0.402 -0.755 -0.048
1 = good quality -0.324 -0.829 0.182
2 = poor quality Gibson -1.125 -1.690 -0.561
2 = poor quality Hall -1.205 -2.067 -0.343
2 = poor quality Miller -0.012 -0.604 0.580
2 = poor quality Mortan -0.148 -1.234 0.939
2 = poor quality -0.645 -1.143 -0.147
Overall -0.487 -0.842 -0.132
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Depression (effect of randomisation and blinding)
Meta Analysis
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Appendix 9.5 Forest plot for effect of ‘contact with therapist in control group’ on overall psychotic symptoms at end of treatment
Group by
Therapist Contact
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper 
g limit limit
1=probable contact Bach 2002 -0.444 -1.060 0.172
1=probable contact Bechdolf 2004 0.289 -0.129 0.707
1=probable contact Gaudiano 2006 -0.444 -1.060 0.172
1=probable contact Haddock 0.532 -0.328 1.392
1=probable contact Kim 2010 -0.105 -0.754 0.544
1=probable contact Lewis 2002 -0.025 -0.348 0.297
1=probable contact Moritz 2011 -0.449 -1.013 0.115
1=probable contact Schramm 2007 -0.242 -0.594 0.109
1=probable contact -0.121 -0.375 0.132
2=no probable contact Aghotor 2010 -0.224 -0.973 0.525
2=no probable contact Habib 2015 -1.048 -1.682 -0.413
2=no probable contact Hall 2003 -1.152 -2.008 -0.296
2=no probable contact Hayashi 2001 -0.248 -0.796 0.300
2=no probable contact Kumar 2010 -0.619 -1.570 0.332
2=no probable contact Shelley 2001 -1.540 -2.177 -0.904
2=no probable contact Startup 2004 -0.564 -1.051 -0.077
2=no probable contact -0.751 -1.064 -0.438
Overall -0.370 -0.567 -0.173
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Psychotic symptoms (effect of control)
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Appendix 9.6 Forest plot for effect of therapy type on overall psychotic symptoms at end of treatment 
Group by
Therapy type
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper 
g limit limit
1=CBT/CT Bechdolf 2004 0.289 -0.129 0.707
1=CBT/CT Habib 2015 -1.048 -1.682 -0.413
1=CBT/CT Haddock 0.532 -0.328 1.392
1=CBT/CT Hall 2003 -1.152 -2.008 -0.296
1=CBT/CT Hayashi 2001 -0.248 -0.796 0.300
1=CBT/CT Lewis 2002 -0.025 -0.348 0.297
1=CBT/CT Shelley 2001 -1.540 -2.177 -0.904
1=CBT/CT Startup 2004 -0.564 -1.051 -0.077
1=CBT/CT -0.436 -0.803 -0.069
2=Third Wave Aghotor 2010 -0.224 -0.973 0.525
2=Third Wave Bach 2002 -0.444 -1.060 0.172
2=Third Wave Gaudiano 2006 -0.444 -1.060 0.172
2=Third Wave Kumar 2010 -0.619 -1.570 0.332
2=Third Wave Moritz 2011 -0.449 -1.013 0.115
2=Third Wave -0.430 -0.922 0.062
3=Other Kim 2010 -0.105 -0.754 0.544
3=Other Schramm 2007 -0.242 -0.594 0.109
3=Other -0.184 -0.885 0.517
Overall -0.396 -0.668 -0.125
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Psychotic symptoms (effect of therapy type)
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Appendix 9.7 Forest plot for effect of diagnosis on depression 
Group by
Diagnosis (majority)
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper 
g limit limit
1=psychosis Hall -1.205 -2.067 -0.343
1=psychosis Kim -0.108 -0.757 0.541
1=psychosis Mortan -0.148 -1.234 0.939
1=psychosis -0.458 -0.991 0.076
2=depression Bowers -0.436 -1.183 0.311
2=depression Miller -0.012 -0.604 0.580
2=depression Schramm -0.402 -0.755 -0.048
2=depression -0.297 -0.685 0.092
Overall -0.352 -0.667 -0.038
-2.00 -1.00 0.00 1.00 2.00
Psychotherapy Control
Depression (effect of diagnosis)
Meta Analysis
  
244
Appendix 10 
Manual for ‘Living Well with Emotions’ 
 
 
 1 
 
 
 
Living Well with Emotions 
 
 
 
6 Session Group program 
 
Facilitators Guide  
 
 
 
 
 
 
Adapt ed f r om DBT skills t raining manual (Linehan 1993).  
Resour ces f r om The Happiness TRAP - ACT (Har r is, 2008);  
WI SE choices manual (Spect rum & Har r is 2009).   
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 3 
into our faces.  How would it be different if instead of trying to push the 
plastic ball under the water, we just let it float on the water around us?  
The plastic ball would still be the same (i.e.: the emotion would still be the 
same), but you would not be involved in such a struggle.  When we are so 
focused on pushing away the negative emotion, we might not have any 
space left to pay attention to the more positive emotions.  In this group 
the goal is not about getting rid of all emotions – it is about learning how 
to cope with the more painful emotions, so that you are not struggling and 
fighting against them all the time.    
 
                                                            
 
*Flip chart –Identifying and labelling emotions – Ask group members to 
see if they can identify and label any emotions that they have 
experienced in past 24 hours.  Provide your own responses to model for 
the group members if needed. Prompt for different names for emotions, 
and body experiences that accompany different emotions.  Prompt for 
positive emotions.   
 
 
*Discussion - It can be hard to identify or be aware of our emotions.  It 
can also be difficult because we can experience numerous emotions at the 
same time.   
 
Reflect on how it can be difficult to see the positive experiences.  It can 
be like we are wearing blinkers, which are making us focus on the painful 
experiences, and block out any of the positive experiences.    It can also 
be difficult because we can experience numerous emotions at the same 
time.   
 
*Discussion – Emotions involve body changes such as tensing or relaxing 
muscles, change in blood vessels, change in heart rate and temperature, 
changes in facial muscles. What body changes have people in the group 
noticed? 
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 4 
Mindf ulness Pr act ice–  
Find a comf or t able posit ion, sit t ing upr ight  but  not  t oo r igid.  Hands 
r est ing comf or t ably in your  lap or  on t he arm r est .  Feet  gr ounded on t he 
f loor . Gent ly br ing your  f ocus t o your  br eat h.   
 
Be awar e as you br eat he in… and be awar e as you br eat he out ……..  Not ice 
your  br eat h wit hout  t r ying t o change it .  J ust  acknowledge it  as it  is.   
 
Focusing on your  st omach as you br eat he in... and as you br eat he out …..  
Not ice if  your  mind wander s, j ust  acknowledge t his, and gent ly br ing your  
f ocus back t o your  br eat h.   
 
Not ice any physical sensat ions in your  body; not ice how your  body f eels 
against  t he chair  – your  back against  t he chair , t he air  against  your  skin, 
your  f eet  against  t he soles of  your  shoes.  Not ice any t ension or  
t ight ness in your  body – j ust  not ice wit hout  any j udgement . 
 
Now gent ly br ing your  f ocus t o your  f eelings or  emot ions. Not ice any 
sense of  emot ions, unpleasant  f eelings, pleasant  f eelings, discomf or t .  
J ust  not ice t heir  pr esence wit hout  any j udgment .  Acknowledge t heir  
pr esence.   
 
Gent ly br ing your  f ocus back t o your  br eat h.  Not icing as you br eat he in… 
and not icing as you br eat he out ….  
being awar e as you br eat he in.. and awar e as you br eat he out ….  Not icing 
how your  st omach may r ise and f all as you br eat he in… and out …..   
 
And when you ar e r eady r et ur n your  f ocus t o t he r oom, opening your  eyes 
when you f eel r eady, and st r et ching t o wake your  body up if  you need t o.   
 
 
 
*Enquiry 
What did people notice during that exercise? 
____________________ 
 
 
Homework –  
Practice mindfulness exercise – stopping and noticing feelings.   
Practice exercise of labelling different emotions that you experience.   
 
  
248
 
 
  
249
 
 
 6 
POINT - Sometimes it can be helpful to think of emotions as “waves in 
the sea”.  Some waves can be bigger than others.  But all emotions will 
pass like all waves pass.  Emotions will pass if we don’t struggle with them 
or try to get rid of them.  
 
*Point – So why we do experience emotions?  
Emotions have a purpose.  And because they have a purpose they can be 
hard to change.   
1. Emotions communicate to others.  Our facial expressions 
communicate to others how we are feeling without words.  When we 
really want someone else to know how we are feeling it can be hard 
for us to change the emotion until this happens.   Some people can 
mask their facial expressions (both consciously and subconsciously) 
– what do you think happens to the emotion in these cases? 
 
2. Emotions organise us and get us ready for action.  For example 
they motivate us.  If we feel really passionately about a certain 
charity the emotion might motivate us to get involved and do some 
volunteer work.  Emotions can be helpful in certain situations – fear 
motivates us to leave a dangerous situation without having to think 
about it.  It can be a hard wired response (leaving a building that is 
on fire).  Strong emotions can help us overcome obstacles (in our 
mind or the environment). EG: Woman lifting a heavy object that 
her pet dog was trapped under, motivated by love/fear.    
 
3.  Emotions can be self validating - Our emotional reactions to 
certain situations can be a signal about that situation (or person).  
For example –if we are feeling excited it may give us information 
that we are looking forward to the situation, if we are feeling love 
it may give us information that the person we are near is important 
to us.   But sometimes we can get this wrong. If we treat emotions 
as facts we can run into difficulty, for example “If I’m afraid I 
might automatically assume that what I’m afraid of it threatening”. 
So treating the emotion as a fact, even when this is not the case.    
 
*Group brainstorm – Can people think of an emotion that they recently 
experienced.  What do you think was purpose of that emotion? Highlight 
that sometimes it is not clear. People can have emotions related to painful 
memories – maybe the emotion is highlighting to the person that the 
painful experience from the past was difficult – self validating, signalling 
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that it was awful.  However that signal can get stuck in the “on” position, 
even though the experience was in the past.    
 
*Point - So what can we do to cope with emotions? 
The key to remember, it is not about doing “what is right” – it is about 
doing what works. There is no right way to feel, and there is no wrong way 
to feel.  In the same way, there is not right or wrong way to cope with our 
emotions.  What we need to do is figure out what is an effective way for 
us to cope with our emotions.  What do we mean by effective? (Doing 
what works, coping with the emotion without causing harm to 
ourselves/others).    
 
Group brainstorm – write suggestions on flip board (give group 
members the associated handout so they can write some of these 
coping ideas down on their own sheet).     
What effective ways to cope with emotions have people come across? So, 
ways to cope with emotions that aren’t harmful to yourself or others, and 
don’t make the painful emotion worse.   
 
E.G.: when feeling sad – notice feeling that way – be kind to myself.  Wrap 
up in a nice duvet and watch favourite comedy show. Provide other 
examples for the group if needed, going for a walk, listening to music, 
having a bath, talking to a friend.   
 
 
 
Mindfulness Exercise –  
Find a comf or t able posit ion, sit t ing upr ight  but  not  t oo r igid.  Hands 
r est ing comf or t ably in your  lap or  on t he arm r est .  Feet  gr ounded on t he 
f loor . Gent ly br ing your  f ocus t o your  br eat h.  Be awar e as you br eat he in 
and be awar e as you br eat he out .  Not ice your  br eat h wit hout  t r ying t o 
change it .  J ust  acknowledge it  as it  is.  Focusing on your  st omach as you 
br eat he in… and as you br eat he out …….  Not ice if  your  mind wander s, j ust  
acknowledge t his, and gent ly br ing your  f ocus back t o your  br eat h.   
 
Be awar e t hat  t he mind likes t o wander , t hat  is what  it  does.  I t  is 
complet ely nor mal f or  t he mind t o wander .  J ust  not ice when t his happens 
and t r y t o gent ly br ing your  f ocus back t o your  br eat h.  Being awar e as 
you ar e br eat hing in…. and awar e as you ar e br eat hing out ……….  
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 8 
Somet imes we can have dif f icult  t hought s or  memor ies in our  mind.  We 
can acknowledge t hat  t hese t hought s or  memor ies ar e t her e, but  t hen 
gent ly r et ur n our  f ocus t o our  br eat h.  Being awar e as we br eat he in……. 
and being awar e as we br eat he out …….. Not icing how your  st omach may 
r ise and f all as you br eat he in and out . Each t ime we r et ur n our  f ocus t o 
t he br eat h you can allow t he dif f icult  t hought s or  memor ies t o f all int o 
t he backgr ound, not icing t hat  t heir  volume is r educing.   
 
Each t ime it  wander s, br inging your  f ocus back t o your  br eat h.  Not icing 
as you br eat he in and not icing as you br eat he out …. being awar e as you 
br eat he in and awar e as you br eat he out .  Not icing how your  st omach may 
r ise and f all as you br eat he in and out .   
 
And when you ar e r eady r et ur n your  f ocus t o t he r oom, opening your  eye 
when you f eel r eady, and st r et ching t o wake your  body up if  you need t o.   
 
*Enquiry 
What did people notice during that exercise? 
   ____________________ 
 
Homework  
Practice the mindfulness exercise – returning focus to the breath. 
Try out a different (“effective”) way of coping with your emotions.   
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 11 
emotions which help you to communicate how you are feeling in a way that 
has not resulted in making things more difficult for you?   
 
Intro to Mindfulness exercise 
Mindfulness can help up to observe our emotions, and step back from 
them giving us some distance from them.  The distance can give us the 
chance to problem-solve things.  It can help us to experience our 
emotions, but not act on them.   
 
Mindfulness exercise –  
Find a comf or t able posit ion, sit t ing upr ight  but  not  t oo r igid.  Hands 
r est ing comf or t ably in your  lap or  on t he arm r est .  Feet  gr ounded on t he 
f loor . Gent ly br ing your  f ocus t o your  br eat h.  Be awar e as you br eat he in 
and be awar e as you br eat he out .  Not ice your  br eat h wit hout  t r ying t o 
change it .  J ust  acknowledge it  as it  is.  Focusing on any movement  in your  
st omach as you br eat he in… and as you br eat he out …….  
 
Gent ly shif t  your  at t ent ion t o any body sensat ions you ar e exper iencing.  
See if  you can not ice any physical sensat ions in your  body, any t ension or  
t ight ness in your  muscles, j ust  not ice wit hout  j udgment . Ar e t her e ot her  
physical sensat ions t hat  you ar e exper iencing in your  body, any t ingling or  
war mt h in your  body?  Do you not ice any pain or  discomf or t ? Do you 
not ice any muscles t hat  f eel mor e r elaxed?  J ust  see if  you can label what  
you not ice wit hout  any j udgment , j ust  acknowledging t hese sensat ions as 
t hey ar e.    
 
Now can you gent ly br ing your  f ocus t o any emot ions t hat  you ar e 
exper iencing?  Tr y t o j ust  obser ve any of  t hese emot ions, wit hout  any 
j udgement .  See if  you can become awar e of  t hem, as if  you ar e j ust  an 
obser ver .  Can you label t he emot ion, and give t hem a name.  J ust  
acknowledge t he emot ions, not icing t he emot ion j ust  as it  is.  Being awar e 
t hat  you can exper ience t he emot ion, wit hout  having t o act  on it .  You can 
acknowledge it s pr esence. 
 
And now gent ly r et ur n your  f ocus t o your  br eat h, being awar e as you 
br eat he in and awar e as you br eat he out .  Not icing t hat  t he emot ion can 
f all int o t he backgr ound as you r et ur n your  f ocus t o your  br eat h.  
Br inging your  at t ent ion back t o t he r ise and f all of  your  st omach as you 
br eat he in and as you br eat he out .  Not icing if  your  mind wander s, 
acknowledging what  it  has wander ed t o, and t hen gent ly br inging your  
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 12 
f ocus back t o you br eat he.  Following your  in br eat h, and f ollowing as you 
br eat he out .  Br eat hing in… and br eat hing out ………   
 
 
And when you ar e r eady r et ur n your  f ocus t o t he r oom, opening your  eye 
when you f eel r eady, and st r et ching t o wake your  body up if  you need t o.   
 
*Enquiry 
What did people notice during that exercise? 
   ____________________ 
 
 
Homework  
Practice the mindfulness exercise – labelling body sensations and 
emotions. 
Try out a different (“effective”) ways of expressing your emotions.   
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*Group Discussion – Have people had the experience of having 
painful/difficult emotions, and been able to sit back and observe the 
emotion? Or label the emotion without acting on it? 
 
*Group Brainstorm – (use flip chart to write up ideas). 
There are certain times when we are more likely to feel our emotions 
more intensely.  For example when we are very tired.  Can people think of 
other times/situations when you notice you can experience your emotions 
more intensely?  
 
*Point - There are some strategies that we can use to reduce our 
vulnerability to experiencing overwhelming emotions. A lot of these 
strategies are things that we might already know, but sometimes it can 
be hard to put these things into practice.  
 
POINT - How to reduce our vulnerability to overwhelming emotions 
 
1. Treat Physical Illness 
Being sick can make you more vulnerable to painful/difficult emotions. Do 
the group have any examples of this? 
What stops us from looking after our physical health, can we problem 
solve any of these barriers?  
 
2. Balanced eating 
When we are hungry we are more vulnerable to difficult/painful emotions.  
What foods do people notice makes them feel better (e.g. chocolate).  
Thinking about having a balanced diet, eating things in moderation.  
 
3. Avoid mood altering drugs (that are not prescribed for you) 
Alcohol and drugs can make us more vulnerable to experiencing painful 
emotions.  Discuss with group what they have noticed.  Discuss any 
difficulties with staying off/away from mood altering drugs – how to 
problem solve this.    
 
4. Balanced Sleep 
When we are not sleeping, or tired we are more vulnerable to over 
whelming emotions.  Have people experience of this?  What kinds of 
things have people noticed that have helped with their sleep? 
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5. Get Exercise 
Doing exercise that gets your heart beating faster, such as walking at a 
brisk pace or climbing a flight of stairs, can help improve mood. Discuss- 
What sort of things stop us from doing exercise? Any group members 
have suggestions on how to problem solve this?  
 
6. Doing things that give you a sense of achievement 
When we do things that make us feel good, or give us a sense of 
achievement it can have a positive impact on our mood.  Examples might 
be getting dressed that day, or registering at the GP, or playing a musical 
instrument.  These things will be different for everyone.  Does anyone 
have any examples? 
*The key is to do things that might be a bit challenging, but once you have 
done them you feel good or have a sense of achievement.   
 
 
Mindfulness exercise – Making room for emotions.  
 
Find a comf or t able posit ion, sit t ing upr ight  but  not  t oo r igid.  Hands 
r est ing comf or t ably in your  lap or  on t he arm r est .  Feet  gr ounded on t he 
f loor . Gent ly br ing your  f ocus t o your  br eat h.  Be awar e as you br eat he 
in… and be awar e as you br eat he out ……..  Not ice your  br eat h wit hout  
t r ying t o change it .  J ust  acknowledge it  as it  is.  Focusing on any 
movement  in your  st omach as you br eat he in… and as you br eat he out …….  
 
Br ing your  awar eness t o any emot ions you ar e exper iencing in your  body.  
See if  you can label t hat  emot ion, wit hout  any j udgement .  
 
Somet imes our  emot ions can have uncomf or t able physical sensat ions, such 
as t ight ness in t he chest  when we ar e anxious, or  a lump in our  t hr oat  
when we ar e f eeling sad.  Focus on t he emot ion or  t he associat ed physical 
sensat ion, and see if  you can pinpoint  exact ly wher e in t he body you ar e 
f eeling it .  What  shape does t his sensat ion have? Can you t r ace t he 
out line of  t he sensat ion in your  mind?  Ar e t he edges r ough or  smoot h? 
Does t he sensat ion have a colour ?  What  t emper at ur e is t he sensat ion? 
How would you descr ibe t he t ext ur e of  t he sensat ion, r ough, smoot h? I s 
it  close t o t he sur f ace of  your  skin or  is it  closer  t o t he cent r e of  your  
body?  
 
Now I  want  you t o use your  br eat h, and br eat he int o t he sensat ion.  
Not ice t hat  as you ar e br eat hing in, your  breat h is sur r ounded t he 
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sensat ion.  Each t ime you br eat he in your  br eat h sur r ounds t he sensat ion, 
and wit h each br eat h you ar e cr eat ing mor e r oom f or  t he sensat ion.  Each 
br eat h cr eat es mor e and mor e r oom, giving space f or  t he sensat ion t o be 
pr esent .  Each in br eat h cr eat es mor e space f or  t he sensat ion, making it  
easier  t o allow t he sensat ion t o be t her e.  Cont inue br eat hing in, not icing 
your  br eat h sur r ound t he sensat ion, cr eat ing space f or  it .   
 
And when you ar e r eady r et ur n your  f ocus t o t he r oom, opening your  eye 
when you f eel r eady, and st r et ching t o wake your  body up if  you need t o.   
 
*Enquiry 
What did people notice during that exercise? 
   ____________________ 
 
Homework  
Practice the mindfulness exercise – creating space for 
emotions/sensations. 
Think about the strategies that can reduce your vulnerability to over 
whelming emotions.  
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allow the emotion to be there and create more room for it, your life can 
change.   
 
*Group brainstorm – Use Flip chart to write up group ideas. 
It is important to try and bring in a balance of positive 
emotions/experiences into your life.   What type of pleasurable 
experiences do people have in their lives? What types of things give you 
positive emotions?  Think about the small things (e.g. seeing a rabbit 
outside).    
 
*Point - One of the ways to increase positive emotions can be through 
learning to be kind to ourselves.  Sometimes we can find that this is a 
difficult thing to do.  What stops us from looking after ourselves and 
being kind to ourselves? 
 
Point - One strategy to develop kindness to ourselves can be learning how 
to self sooth.  We can sooth each of our senses.  (Use self soothing box 
to illustrate point below).   
 
Self Soothing 
Vision: light a candle and watch the flame, visit a museum and look at the 
wonderful art, watch the stars at night.  
 
Hearing: Try listening to some music, pay attention to natural sounds 
such as the chirping of the birds, sounds of the waves.   
 
Smell: use some smelly oils or your favourite perfume, Walk in a wooded 
area and be aware of all the natural smells. 
 
Taste: Have a delicious meal, or your favourite drink. Eat your food 
mindfully, slowly and taste every bite. 
 
Touch: Take a bubble bath, put clean sheets on your bed.  Stroke your 
pet.  Hug someone.   
 
*Point – It is important to have positive experiences in our lives in order 
to feel happy.  Sometimes we need to work hard to make changes so that 
we can have positive events more frequently.  Sometimes we can find it 
difficult to focus on the positive events in our life, we might notice that 
our mind drifts to thinking about negative things, or worrying about when 
the positive event might end.  Has anyone experienced this?   
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t hese sensat ions. Can you pinpoint  wher e in your  body you ar e f eeling 
t hem? 
 
Not ice if  your  f ocus is dr if t ing away t o any wor r ies or  t hought s. J ust  
acknowledge t his has happened and gent ly br ing your  f ocus back t o your  
soot hing obj ect .  Gent ly r et ur ning your  f ocus back t o any pleasant  
sensat ions in your  body.   
 
Again not ice if  your  mind has dr if t ed away t o wor r ies about  when t he 
pleasant  exper ience will end, or  ot her  wor r ies of  t hought s you might  be 
having.  J ust  not ice if  t his has happened, acknowledge it  wit hout  any 
j udgement .  Then gent ly guide your  f ocus back t o t he soot hing obj ect , 
not icing how it  f eels t o hold. Not icing any pleasant  sensat ions t hat  you 
ar e exper iencing in your  body, not ice is t her e a sense of  r elaxat ion or  
calm? And j ust  cont inue t o guide your  f ocus back t o t hese posit ive 
exper iences. 
 
And now gent ly r et ur n your  f ocus t o your  br eat h, being awar e as you 
br eat he in and awar e as you br eat he out .  Br inging your  at t ent ion back t o 
t he r ise and f all of  your  st omach as you br eat he in and as you br eat he 
out .  Following your  in br eat h, and f ollowing as you br eat he out .  Br eat hing 
in… and br eat hing out ………   
 
And when you ar e r eady r et ur n your  f ocus t o t he r oom, opening your  eye 
when you f eel r eady, and st r et ching t o wake your  body up if  you need t o.   
 
*Enquiry 
What did people notice during that exercise? 
   ____________________ 
 
 
 
Homework  
Practice the mindfulness exercise – being mindful of positive events. 
Think about introducing some activities/events that increase positive 
emotions.   
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Point - One of the ways we can reduce our emotional suffering is learning 
to allow the painful emotion to be there, but to give ourselves some 
distance from it.  We can sometimes become fearful of our painful 
emotions, and worry about having them around. When we are fearful, we 
can try to push away our painful emotion.  In these situations we then 
have to deal with fear on top of the painful emotion.  If we can allow 
ourselves to notice the painful emotion we will probably notice that while 
the painful emotion might be the same, the fear might reduce.  This is a 
bit like the idea of “facing what we are afraid of”.  If we can face these 
painful emotions, our fear might reduce.   
 
*Discussion Point – write up on Flip chart 
Different painful emotions can create different urges.  So for example 
when we are: 
Fearful - urge is avoid or run away  - keeps the fear present 
Depressed - urge to withdraw/isolate -keeps depression around 
Anger  -urge to attack   -keeps anger around 
 
When we act on these urges, we can notice that it just keeps the emotion 
going. We can learn to change or reduce these painful emotions by acting 
opposite to the emotion urges. 
 
Acting Opposite  
Fearful – face what you are afraid of (if safe) - fear reduces 
Depressed – be active/around others   -depression reduces 
Anger – gently avoid person/situation   - anger reduces 
          - do something nice for person    - anger reduces 
 
*Group brainstorm - Do people have examples of how the could act 
opposite to anger, fear, and depression? Share on flip chart.  
 
 
Mindfulness Exercise – Mindfulness of Painful Emotions 
Find a comf or t able posit ion, sit t ing upr ight  but  not  t oo r igid.  Hands 
r est ing comf or t ably in your  lap or  on t he arm r est .  Feet  gr ounded on t he 
f loor . Gent ly br ing your  f ocus t o your  br eat h.  Be awar e as you br eat he 
in… and be awar e as you br eat he out ……..  Not ice your  br eat h wit hout  
t r ying t o change it .  J ust  acknowledge it  as it  is.  Focusing on any 
movement  in your  st omach as you br eat he in… and as you br eat he out …….  
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Br ing your  awar eness t o any emot ions you ar e exper iencing in your  body.  
Somet imes our  emot ions can have uncomf or t able physical sensat ions, such 
as t ight ness in t he chest  when we ar e anxious, or  a lump in our  t hr oat  
when we ar e f eeling sad.  Focus on t he emot ion or  t he associat ed physical 
sensat ion, and see if  you can pinpoint  exact ly wher e in t he body you ar e 
f eeling it . 
 
See if  you can label t hat  emot ion, wit hout  any j udgement .  J ust  st ep back 
f r om t he emot ion and obser ve it , as if  you ar e j ust  wat ching it . 
 
Be awar e t hat  you can exper ience t his emot ion wit hout  needing t o act  on 
it .  Not ice any ur ges t hat  you have t o act  on t he emot ion and j ust  
acknowledge t hem.  Holding t he awar eness t hat  you don’t  need t o r eact  t o 
t he emot ion.  You can let  it  be t her e wit hout  doing anyt hing.  
 
Hold in mind t he idea t hat  t his emot ion is like a wave, coming and going.  
You don’t  need t o ignor e it , you can be aware of  it  wit hout  needing t o pay 
any ext r a at t ent ion t o it .  Not ice t hat  you can exper ience it  in t he 
backgr ound. You can allow it  t o be t her e. Cont inue t o not ice t his emot ion, 
being awar e t hat  you can exper ience it  wit hout  needing t o r eact  t o it .  
Not ice t he emot ion as if  it  is a wave, coming and going.   
   
And now gent ly r et ur n your  f ocus t o your  br eat h, being awar e as you 
br eat he in and awar e as you br eat he out .  Br inging your  at t ent ion back t o 
t he r ise and f all of  your  st omach as you br eat he in and as you br eat he 
out .  Following your  in br eat h, and f ollowing as you br eat he out .  Br eat hing 
in… and br eat hing out ………   
 
And when you ar e r eady r et ur n your  f ocus t o t he r oom, opening your  eye 
when you f eel r eady, and st r et ching t o wake your  body up if  you need t o.   
 
*Enquiry 
What did people notice during that exercise? 
   ____________________ 
 
Homework  
Practice the mindfulness exercise – mindfulness of painful emotions 
Try out acting opposite.   
Below is a story which can be helpful in explaining the idea of learning to 
accept emotions (allow emotions to be present).   
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Dandelions 
 
St or y Adapt ed f r om Ant hony de Mello 
 
A man bought a new house and decided that he was going to have a very 
beautiful lawn.  He worked on it every week, doing everything the 
gardening books told him to do.  His biggest problem was that the lawn 
always seemed to have dandelions growing where he didn’t want them.  
The first time he found dandelions, he pulled them out. But they grew 
back.  He went to his local gardening shop and bought weed killer.  This 
worked for some time but after summer rain the dandelions grew back. 
He worked and pulled and killed dandelions all summer long.  The next 
summer he thought he would have no dandelions at all, since none have 
grown over winter.  But then all of a sudden he had dandelions again.  This 
time he decided the problem was with the type of grass.  So he spent a 
fortune putting down new sods of grass.  The worked for some time and 
was very happy.  Just as he had started to relax, a dandelion came up.   A 
friend told him it was due to the dandelions in the lawns of his 
neighbours.  So he went on a campaign to get all his neighbours to kill all 
their dandelions.  By the third year he was exasperated.  He still had 
dandelions.  So after consulting every local expert and garden book he 
decided to write to the department of agriculture for advice.  Surely the 
government could help him.  After waiting several months he finally got a 
letter back. He was so exciting, help at long last!  He tore open the letter 
and read the following: 
“Dear Sir: We have considered your problem and have consulted all of our 
experts.  After careful consideration, we think we can give you very good 
advice.  Sire, our advice is that you learn to love those dandelions”  
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Appendix 11 
Questionnaires used in feasibility study 
 
Appendix 11.1 Clinical outcome routine evaluation (CORE)-10 
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Appendix 11.2 Brief symptom inventory (BSI) 18 
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Appendix 11.3 Mental health confidence scale (MHCS) 
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Appendix 11.4 Childhood trauma questionnaire- short form 
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Appendix 12 
Patient information sheet and consent form for intervention group 
 
 
Psychologically Informed Acute Mental Healthcare (1/10/15 version 5) 
Participant Information Sheet and Consent Form for Intervention Group 
Psychologically Informed Acute Mental Healthcare 
 
You are being invited to take part in a research study. Before you decide whether or not to 
take part, it is important for you to understand why the research is being done and what it 
will involve. Please take time to read the following information sheet carefully. Talk to others 
about the study if you wish. Contact us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part.  
 
What is the purpose of the study? 
The purpose of the study is to investigate whether psychological input within an acute mental health 
service is beneficial when applied along side treatment as usual. Psychological input refers to 
offering inpatients individual and group therapy during hospital admission and providing 
psychologically based training for staff working in the service.  
 
Why have I been asked to take part? 
You have been asked to take part as you are currently an inpatient within an acute mental health 
service.  
 
Do I have to take part? 
No, it is up to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to take part 
you are still free to withdraw at any time and without giving a reason. Deciding not to take part or 
withdrawing from the study will not affect the healthcare that you receive, or your legal rights.  
 
What will happen if I take part? 
During your admission you will receive standard care from the acute mental health service (e.g. 
typically involving contact with ward staff and a psychiatrist). You will have a routine meeting with 
healthcare staff on admission to the ward. After you are settled in a research student will approach 
you to explain the study and answer any questions you may have. You will have up to 24 hours to 
decide if you would like to take part. The research student will approach you again after this time. If 
you choose to take part, she will ask you to read and sign a consent form. This will give the research 
student permission to look at your medical files and inform your GP of your participation. She will 
also ask you to fill out four questionnaires before attending any psychological sessions (please see 
details of questionnaires in table 1.). If you do not wish to take part in the study you will not be 
asked to fill out any questionnaires and your treatment/care will not be affected. You may be 
offered individual therapy with a Psychologist or Nurse Therapist which will involve identification 
of current problems being experienced and possible ‘exit strategies’. Ward staff, the Psychologist or 
the Nurse Therapist may recommend certain group therapies that could benefit you, however you 
will have access to all group therapies running on the ward and you are able to leave these group 
sessions at any point. Details of these group therapies are as follows: 
 
Anxiety and Stress Management 
This group includes 2 sessions (once a week), each lasting approximately 1 hour. You will learn 
how anxiety and stress can occur and effect individuals. You will also learn coping strategies to 
help recognise and handle anxiety and stress.  
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Making Friends with Yourself (MFY) 
This group includes 3 sessions (once a week). It is based on a therapy approach called 
Compassionate Mind Training (CMT). This group is designed for those with low self-esteem and 
promotes acknowledgment of negative automatic thoughts and reactions, and helps patients learn 
how to be kinder to themselves.  
 
What is real and what is not? 
This group includes 4 sessions (once a week), each lasting approximately 1 hour. It is designed for 
individuals who have encountered unusual perceptual experiences such as hearing voices or 
sensory/visual hallucinations. The aim is to help patients normalise the phenomena of these 
experiences, help gain control of these experiences and increase self-esteem.  
 
Mindfulness 
This group includes just 1 session. It is designed to teach the ability to become aware of internal and 
external experiences while maintaining an accepting and non-judgemental attitude.  
 
 
Before discharge, the research student will approach you again and ask you to fill three of the same 
questionnaires and a feedback form (see table 1 for detail). Following discharge, you will continue 
to have access to group therapies if you wish to attend. Six months and twelve months following 
discharge the research student will contact you via telephone to arrange a convenient time to meet. 
This could be at the hospital or in a private room at a local community centre. She will ask you to 
fill out the same three questionnaires.  
 
After the study has finished you will have access routine mental health care and continue to have 
access to the group therapies if you wish to attend.   
 
Table 1. Details of questionnaires 
Questionnaire  Administered (after 
admission/before 
discharge/follow-up) 
Description 
CORE-10  Admission, discharge, 
follow-up 
10 questions about feelings of distress 
Brief Symptom 
Inventory-18  
Admission, discharge, 
follow-up 
18 questions about psychological symptoms 
Mental Health 
Confidence Scale 
Admission, discharge, 
follow-up 
16 questions about your self-efficacy in relation 
to mental health 
Childhood Trauma 
Questionnaire Short 
Form 
admission 28 questions about adverse childhood 
experience 
 
 
What are the possible benefits of taking part in the study? 
The psychological intervention offered in this study may be beneficial to you, however if you 
decline participation you will still have access to this psychological intervention. The results from 
this study might also inform future healthcare of other patients.  
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What are the possible disadvantages and risks of taking part? 
It is not thought that there are many disadvantages, however one questionnaire in the first batch of 
questionnaires includes questions of a sensitive nature (e.g. adverse childhood experiences). Ward 
staff will be accessible for support if necessary.  
 
Additionally, approximately 20 minutes of your time will be required on four occasions (after 
admission, before discharge, 6 month follow-up and 12 month follow-up).  
 
What if there is a problem? 
If you have a concern about any aspect of this study please contact Charlotte Paterson 
(40188096@live.napier.ac.uk) who will do their best to answer your questions.  
 
In the unlikely event that you feel distressed due to questionnaires you will be urged to discuss this 
with ward staff, your community care team or the ward Clinical Psychologist, Dr. Sean Harper 
(0131 6932).  
 
In the unlikely event that something goes wrong and you are harmed during the research and this is 
due to someone's negligence then you may have grounds for a legal action for compensation against 
NHS Lothian but you may have to pay for legal costs. The normal National Health Service 
complaints mechanisms will still be available to you (if appropriate).  
 
What happens when the study is finished?  
At the end of the research we will securely hold the data for a maximum of three years. You will 
still have access to group therapies running on the ward following your discharge.  
 
Will my taking part in the study be kept confidential? 
All the information we collect during the course of the research will be kept confidential and there 
are strict laws which safeguard your privacy at every stage. Hard copies of your questionnaires will 
be coded in order to protect your identity. These will be kept in a locked cabinet in a locked room 
within NHS grounds. Your questionnaires will be stored electronically in NHS computers which are 
password protected. Consent forms containing personal information (e.g. name, contact detail, 
identifying code) will be locked in a separate cabinet in a locked room in NHS grounds. Your GP 
will be informed of your participation. In the event that your responses indicate risk to yourself or 
others, your GP or an appropriate member of your healthcare team will be informed. All 
information gathered during the study (questionnaires, consent forms, information from medical 
records, etc.) will be responsibly disposed of after three years.  
 
To ensure that the study is being run correctly we will ask your consent for responsible 
representatives from the Sponsor (Edinburgh Napier University) and NHS Institution to access your 
medical records and data collected during the study, where it is relevant to you taking part in this 
research. The Sponsor is responsible for overall management of the study and providing insurance 
and indemnity.  
 
Identifiers (i.e. any information that can identify you personally such as initials) will be removed 
from all data.  
 
What will happen to the results of the study? 
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The study will be written up as part of a PhD Thesis. You will not be identifiable in any published 
results.  
 
This, or a general summary of findings, will be available to you if you contact Charlotte Paterson 
(40188096@live.napier.ac.uk).  
 
Who is organising the research and why? 
This study is being sponsored and funded by Edinburgh Napier University. 
 
Who has reviewed the study? 
The study proposal has been reviewed by Edinburgh Napier University. All research in the NHS is 
looked at by an independent group of people, called a Research Ethics Committee. A favourable 
ethical opinion has been obtained from South East Scotland REC. NHS management approval has 
also been obtained.  
 
If you have any further questions about the study please email Charlotte Paterson: 
40188096@live.napier.ac.uk 
 
If you would like to discuss the study with someone independent of the study please contact 
Dr. Barabara Neades (b.neades@napier.ac.uk). 
If you wish to make a complaint about the study please contact NHS Lothian: 
NHS Lothian Complaints Team 
2nd Floor  
Waverley Gate 
2-4 Waterloo Place 
Edinburgh 
EH1 3EG 
Tel: 0131 465 5708  
craft@nhslothian.scot.nhs.uk 
 
Thank you for taking the time to read this information sheet.  
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Patient information sheet and consent form for control group 
 
Psychologically Informed Acute Mental Healthcare (1/10/15 Version 5)   
 
Participant Information Sheet and Consent Form for Control Group 
Psychologically Informed Acute Mental Healthcare 
 
You are being invited to take part in a research study. Before you decide whether or not to 
take part, it is important for you to understand why the research is being done and what it 
will involve. Please take time to read the following information sheet carefully. Talk to 
others about the study if you wish. Contact us if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take part.  
 
What is the purpose of the study? 
The purpose of the study is to investigate whether psychological input within an acute mental 
health service is beneficial when applied alongside treatment as usual.  
 
Why have I been asked to take part? 
You have been asked to take part in this study as part of the control group (i.e. you will receive 
treatment as usual which does not involve psychological input), as you are currently an inpatient 
within an acute mental health service.  
 
Do I have to take part? 
No, it is up to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to take 
part you are still free to withdraw at any time and without giving a reason. Deciding not to take 
part or withdrawing from the study will not affect the healthcare that you receive, or your legal 
rights.  
 
What will happen if I take part? 
During your admission you will receive standard care from the acute mental health service (e.g. 
typically involving contact with ward staff and a psychiatrist). Choosing not to take part in the 
study will not affect the healthcare you receive. You will have a routine meeting with healthcare 
staff following admission to the ward. After you are settled in a research student will approach 
you to explain the study and answer any questions you may have. You will have up to 24 hours to 
decide if you would like to take part. If you would like to take part in the study a research student 
will ask you to read and sign a consent form. This will give the research student permission to 
look at your medical files and inform your GP of your participation. She will also ask you to fill 
out four questionnaires (details of questionnaires are below in table 1). You will then receive 
acute mental health treatment as usual. If you so not wish to take part in the study you will not be 
asked to fill in any questionnaires. Your treatment will not be effected in any way if you do not 
wish to take part in the study.  
 
Table 1. Details of questionnaires 
Questionnaire Time of 
administration (after 
admission, before 
discharge, at follow-
up) 
Description 
CORE-10 Admission, discharge, 
follow-up 
10 questions about feelings 
of distress 
Brief Symptom Inventory-
18 
 
Admission, discharge, 
follow-up 
18 questions about 
psychological symptoms 
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Mental Health Confidence 
Scale 
 
Admission, discharge, 
follow-up 
16 questions about your 
self-efficacy in relation to 
mental health 
Childhood Trauma 
Questionnaire Short Form 
Admission 28 questions about adverse 
childhood experience 
  
 
Before discharge, the research student will approach you again and ask you to fill three of the 
same questionnaires and a feedback questionnaire. Six months and twelve months following 
discharge the research student will contact you via telephone to arrange a convenient time to 
meet. This could be arranged at the hospital or in a private room at a local community centre. She 
will ask you to fill out the same three questionnaires. 
 
What are the possible benefits of taking part in the study? 
Choosing not to take part in the study will not affect the healthcare you receive therefore there are 
no additional benefits of taking part in the study. However, the results from this study might 
inform future healthcare of other patients.  
 
What are the possible disadvantages and risks of taking part? 
It is not thought that there are many disadvantages, however one questionnaire in the first batch of 
questionnaires includes questions of a sensitive nature (e.g. adverse childhood experiences). Ward 
staff will be accessible for support if necessary. 
 
Additionally, approximately 30 minutes of your time will be required on four occasions (after 
admission, before discharge, 6 month follow-up and 12 month follow-up).  
 
What if there is a problem? 
If you have a concern about any aspect of this study please contact Charlotte Paterson 
(40188096@live.napier.ac.uk) who will do her best to answer your questions. In the unlikely 
event that you feel distressed due to questionnaires you will be urged to discuss this with ward 
staff, your community care team or the ward Clinical Psychologist, Dr. Sean Harper (0131 537 
6932). 
 
In the unlikely event that something goes wrong and you are harmed during the research and this 
is due to someone's negligence then you may have grounds for a legal action for compensation 
against NHS Lothian but you may have to pay for legal costs. The normal National Health 
Service complaints mechanisms will still be available to you (if appropriate).  
 
What happens when the study is finished?  
At the end of the research we will securely hold the data for a maximum of three years. You will 
receive routine community care appropriate to you and you will continue to have access to group 
therapies on the ward if you wish to attend.  
 
Will my taking part in the study be kept confidential? 
All the information we collect during the course of the research will be kept confidential and 
there are strict laws which safeguard your privacy at every stage. Hard copies of your 
questionnaires will be coded in order to protect your identity. These will be kept in a locked 
cabinet in a locked room within NHS grounds. Your questionnaires will be stored electronically 
in NHS computers which are password protected. Consent forms containing personal information 
(e.g. name, contact details, identifying code) will be locked in a separate cabinet in a locked room 
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in NHS grounds. Your GP will be informed of your participation. In the event that your responses 
indicate risk to yourself or others, your GP or an appropriate member of your healthcare team will 
be informed. All information gathered during the study (questionnaires, consent forms, 
information from medical records, etc.) will be responsibly disposed of after three years.  
 
To ensure that the study is being run correctly we will ask your consent for responsible 
representatives from the Sponsor (Edinburgh Napier University) and NHS Institution to access 
your medical records and data collected during the study, where it is relevant to your taking part 
in this research. The Sponsor is responsible for overall management of the study and providing 
insurance and indemnity.  
 
Identifiers (i.e. any information that can identify you personally such as initials) will be removed 
from all data.  
 
What will happen to the results of the study? 
The study will be written up as part of a PhD Thesis. You will not be identifiable in any published 
results.  
 
This, or a general summary of findings, will be available to you if you contact Charlotte Paterson 
(40188096@live.napier.ac.uk).  
 
Who is organising the research and why? 
This study is being sponsored and funded by Edinburgh Napier University. 
 
Who has reviewed the study? 
The study proposal has been reviewed by Edinburgh Napier University. All research in the NHS 
is looked at by an independent group of people, called a Research Ethics Committee. A 
favourable ethical opinion has been obtained from South East Scotland REC. NHS management 
approval has also been obtained.  
 
If you have any further questions about the study please email Charlotte Paterson: 
40188096@live.napier.ac.uk 
 
If you would like to discuss the study with someone independent of the study please contact 
Dr. Barabara Neades (b.neades@napier.ac.uk).  
If you wish to make a complaint about the study please contact NHS Lothian: 
NHS Lothian Complaints Team 
2nd Floor  
Waverley Gate 
2-4 Waterloo Place 
Edinburgh 
EH1 3EG 
Tel: 0131 465 5708  
craft@nhslothian.scot.nhs.uk 
 
Thank you for taking the time to read this information sheet.  
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CONSENT FORM 
Psychologically Informed Acute Mental Healthcare 
 
Participant ID: 
Contact Details: 
 
Please initial box 
 
1. I confirm that I have read and understood the information sheet (as specified in this 
document header) for the above study and have had the opportunity to consider the 
information and ask questions.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being affected.  
 
3. I understand that [relevant sections of my medical notes and] data collected during 
the study may be looked at by individuals from Edinburgh Napier University, from the 
NHS organisation, where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to my records.  
 
4. I agree that my GP will be informed of my participation in this study.   
5. I agree to my anonymised data being used for future ethically approved studies.   
6. I agree to take part in the above study.  
 
 
 
 
__________________________                 ________________              
______________________  
Name of Participant                                     Da te                                       S ignature 
 
 
 
 
 
__________________________                 ________________              
______________________  
Name of Person taking consent                   Da te                                       S ignature 
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Appendix 15 
Recruitment posters for feasibility study 
 
 
 
Research in Hermitage Ward 
 
Who am I?  
Hi, my name’s Charlotte Paterson and I am a research student.  
 
What am I doing? 
I’m looking at how people feel while in hospital. If you’d like to take part 
in this research I would ask you to fill out some questionnaires shortly 
after your admission and again just before or after your discharge.  
 
Who can take part? 
Anyone currently admitted to the ward.  
 
Where? 
I will come to meet you on the ward to tell you about the study, show you 
the questionnaires and see if you’d like to take part. If you decide to take 
part we can sit somewhere quiet while you complete them or I can leave 
them with you to fill out in your own time. If you’d like help with the 
questionnaires I can also help out.  
 
How long will it take? 
Approximately 15-20 minutes in total. This can also be broken down into 
smaller time frames (e.g. 10 minutes and 10 minutes).  
 
What will happen to your questionnaires? 
The answers in your questionnaires will be collected and written up in a 
study, however all data will be anonymous.  
 
Interested? 
Taking part in the research is entirely voluntary. Choosing not to take 
part will not affect your routine healthcare. If you’d like to be involved or 
would like some more information feel free to come and chat to me! You 
can also contact me on 0131 537 6916.  Thanks for your cooperation! 
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Research in Balcarres Ward 
 
Who am I?  
Hi, my name’s Charlotte Paterson and I am a research student.  
 
What am I doing? 
I’m looking at how people feel while in hospital. If you choose to take part 
in this research I would ask you to fill out some questionnaires shortly 
after your admission and again just before or after your discharge.  
 
Who can take part? 
Anyone currently admitted to the ward.  
 
Where? 
I will come to meet you on the ward to tell you about the study, show you 
the questionnaires and see if you’d like to take part. If you decide to take 
part we can sit somewhere quiet while you complete them or I can leave 
them with you to fill out in your own time. If you’d like help with the 
questionnaires I can also help out.  
 
How long will it take? 
Approximately 15-20 minutes in total. This can be broken down into 
smaller time frames (e.g. 10 minutes and 10 minutes).  
 
What will happen to your questionnaires? 
The answers from your questionnaires will be collected and written up in a 
study, however all data will be anonymous. 
 
Interested? 
Taking part in the research is entirely voluntary. Choosing not to take 
part will not affect your routine healthcare and you will still have access 
to group and individual therapy sessions. If you’d like to be involved or 
would like some more information feel free to come and chat to me while 
I’m around! You can also contact me on 0131 537 6916.  Thanks for your 
cooperation! 
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Appendix 16 
ADePT process 
ADePT Process 
Using the ADePT process (Bugge et al., 2013), solutions to address problems identified 
by this trial are assessed. In addition to changes to the intervention, trial design and the 
clinical context, a fourth option was included where additional feasibility research was 
deemed necessary or informative before progressing to a full trial. As this option includes 
solutions which inform a future trial, rather than directly influence the trial or real world, 
no assessment of solutions in this category were carried out.  
 
Problem B1 
Type B: Poor implementation of some components of the intervention (i.e. groups). 
 
Evidence 
- Few group therapies delivered overall and only 3 of 4 possible groups delivered 
during study period. 
- Due to lack of staff engagement -> no time, staff sickness, many staff with 
relevant psychological training left during study period, inflexible rotas and 
some staff did not feel confident in their ability to deliver groups.  
- May have been influenced by poor integration of the intervention into the whole 
service.  
- Influenced by above points and lack of support from managerial staff and 
psychiatrists.  
All of the above may influence a trial and the real world.  
 
Solutions 
Change aspects of: 
a) Intervention 
1. Alter intervention, i.e. focus on fewer group types. 
2. More thorough staff training. 
b) Trial design 
None 
c) Clinical context 
1. Increase psychological resource to increase psychological presence on the 
ward, psychological training and supervision for ward staff.  
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2. Flexible rotas, protected time for therapeutic work to ensure more consistent 
and frequent group interventions are delivered. 
3. Hire staff specifically for group facilitator role.  
4. Assign designated project ‘champion’ 
d) Additional feasibility research 
1. Qualitative work to investigate staff (from all levels) perception intervention 
acceptability and of barriers and facilitators to intervention implementation.  
 
Assessment of solutions 
A1: Alter intervention, i.e. focus on fewer group types. 
Could a1 be effective in trial setting? 
Yes, likely to be less burden for service to release staff and may improve quality 
of delivery as fewer therapeutic approaches for staff to learn. However, dependent 
on C1 and C2 but the aims of the intervention should be reconsidered and the 
impact of the intervention may be diluted.  
Could a1 be feasible in trial setting? 
Likely to be more feasible than current protocol. However, dependent on C1 and 
support from management. Aims of the intervention will need to be reconsidered.  
Could a1 be effective in real world? 
Likely to be less burden for staff and improve quality of delivery. However, 
dependent on C1 and C2.   
Could a1 be feasible in real world? 
Likely to be more feasible than current protocol. However, dependent on C1 and 
support from management. Aims of the intervention will need to be reconsidered. 
 
A2: More thorough staff training. 
Could a1 be effective in trial setting? 
Yes, likely to increase staff confidence in their ability to deliver groups, however 
dependent on C1.  
Could a1 be feasible in trial setting? 
Dependent on C1.   
Could a1 be effective in real world? 
Yes, likely to increase staff confidence in their ability to deliver groups, however 
dependent on C1.  
Could a1 be feasible in real world? 
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Dependent on C1.   
 
C1 Increase psychological resource to increase psychological presence on the ward, 
psychological training and supervision for ward staff.  
Could the solution be effective in trial setting? 
Yes, evidence of consistent delivery of groups when delivered by psychological 
team and co-facilitated by member of ward staff (Owen, Sellwood, et al., 2015) 
but dependent on C2. 1:20 full time clinical psychologist to inpatient ratio is 
recommended by the Sainsbury Centre for Mental Health (2005). Additional time 
to co-facilitate more complex groups with staff will improve staff members’ 
confidence in delivery.  
Could the solution be feasible in trial setting? 
Only if resource is available. Also dependent on C2.  
Could solution be effective in real world? 
Yes, evidence of consistent delivery of groups when delivered by psychological 
team and co-facilitated by member of ward staff (Owen, Sellwood, et al., 2015) 
but dependent on C2. Additional time to co-facilitate more complex groups with 
staff will improve staff members’ confidence in delivery.  
Could solution be feasible in real world? 
Yes, if cost-effective and psychological resource available. Also dependent on 
C2. 
 
C2 Flexible rotas, protected time for therapeutic work to ensure consistently 
delivered groups 
Could the solution be effective in trial setting? 
Staff interested in facilitating groups should work 9-5 one day a week, additional 
to shifts, on the same day for a fixed period. This time can be used to facilitate 
and co-facilitate groups with psychologist (Hill et al., 2009). 
Could the solution be feasible in trial setting? 
Discussions with management required to establish this. Agreement from 
managerial staff to support staff to develop skills and facilitate groups. 
Management support has been identified as a facilitator to successful 
implementation of new interventions in similar contexts (Berry et al., 2016; Berry 
& Haddock, 2008).  
Could solution be effective in real world? 
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Staff interested in facilitating groups should work 9-5 one day a week, additional 
to shifts, on the same day for a fixed period. This time can be used to facilitate 
and co-facilitate groups with psychologist (Hill et al., 2009). 
Could solution be feasible in real world? 
Yes, but dependent on organisational level factors, i.e. management and resource. 
Agreement from managerial staff to support staff to facilitate. Staff will need 
enthusiasm to agree to work an additional day.  
 
C3 Hire staff specifically for group facilitator role.  
Could the solution be effective in trial setting? 
Yes, would ensure groups are delivered but does not conduce integration of the 
intervention into the whole service, therefore aims of the intervention should be 
reconsidered.  
Could the solution be feasible in trial setting? 
Unlikely that resource is available.  
Could solution be effective in real world? 
Yes, but does not conduce whole service approach, therefore aims of the 
intervention should be reconsidered. 
Could solution be feasible in real world? 
Unlikely that resource is available.  
 
C4 Assign designated project ‘champion’ 
Could the solution be effective in trial setting? 
Yes, there is evidence that this technique is successfully used to improve 
intervention implementation (Shaw et al., 2012).  
Could the solution be feasible in trial setting? 
Dependant on the support received from staff members who are likely to be 
influential.  
Could solution be effective in real world? 
Yes, there is evidence that this technique is successfully used to improve 
intervention implementation (Shaw et al., 2012).  
Could solution be feasible in real world? 
Dependant on the support received from staff members who are likely to be 
influential. Discussions with management staff are required.  
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Assessment of options and tolerance of trade-off between explanatory and 
pragmatic trial 
To improve implementation of the group components of the intervention, it may be more 
feasible to focus on fewer than four types of therapy initially. However, negotiations with 
management will still be required to protect time for delivery of even one group and the 
aims and reach of the intervention may need reconsideration. Alternatively, a designated 
member of staff might be employed as group facilitator, however it is unlikely that 
resource would be available and this solution is not conducive to integrating the 
intervention into the whole service, therefore the aims will, again, need to be 
reconsidered. Solutions that are more akin to the aims of intervention, i.e. to improve staff 
knowledge and skills in relation to CBT and increasing the reach of psychological therapy 
within service users and staff, are to improve the flexibility of nursing staff rotas and 
ensure they have protected time for group facilitation and to increase the psychological 
resource for more thorough staff training. The former involves identifying staff who are 
interested in facilitating groups and are willing to work one nine-five day a week on the 
same day for a fixed period. This time can be used to facilitate and co-facilitate groups 
with psychologist (Hill et al., 2009). To achieve this, either staff must work this in 
addition to shifts, or managerial staff must allow a degree of flexibility in rotas. Both 
options are likely to be effective in terms of improving implementation of groups 
therapies, however knowledge of whether staff are willing to work additional hours to 
develop their skills or whether managerial staff will support routine delivery of groups 
by staff is lacking.  
 
 
----------------------------------------------------------------------------------------------------------
--------------- 
Problem B2 
Type B: Problem with patient engagement with the intervention. 
 
Evidence 
- Only half the participants engaged.  
- Only 1.7 patients per group.  
- Engagement may have been influenced by poor implementation of some 
components of the intervention (see poor implementation section). 
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- May have been influenced by poor integration of the intervention into the whole 
service.  
- Engagement may have been influenced by broad inclusion criteria, i.e. including 
patients who do not want to receive the intervention.  
All of the above may influence a trial and the real world.  
 
Solutions 
Change aspects of: 
a) Intervention 
None 
b) Trial design 
1. Alter eligibility criteria to exclude patients that do not want to receive 
psychological intervention during their admission.  
c) Clinical context 
1. Increase psychological resource to make intervention more available, 
increase psychological presence on the ward and increase psychological 
training and supervision for ward staff (see solution C1 of problem B1).  
2. Improve staff engagement with intervention (see poor implementation 
section).  
d) Additional feasibility research 
1. Qualitative work to investigate intervention acceptability and why patients 
do and do not want to receive psychological input during acute admission. 
 
Assessment of solutions 
B1 Alter eligibility criteria to exclude patients that do not want to receive 
psychological intervention during their admission. Use a rating scale in initial 
consent meeting.  
Could the solution be effective in trial setting? 
Yes. Likely to reduce number of participants included in the trial who do not want 
to receive the intervention.  
Could the solution be feasible in trial setting? 
Yes. Researcher would ask patients whether they want to receive psychological 
therapy during admission when patient is initially approached for the study.  
Could solution be effective in real world? 
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Yes, if psychological therapy was routinely offered patients would have the option 
to receive it. 
Could solution be feasible in real world? 
Yes, if psychological therapy was routinely offered patients would have the option 
to receive it. 
 
C1 Increase psychological resource to make intervention more available, increase 
psychological presence on the ward and increase psychological training and 
supervision for ward staff.  
Could the solution be effective in trial setting? 
Yes, 1:20 full time clinical psychologist to inpatient ratio recommended by 
(Sainsbury Centre for Mental Health, 2005). More time for staff training: staff 
education recommended to promote awareness of therapeutic principles as staff 
play a key role in encouraging and enabling participant attendance (Jacobsen et 
al., 2011). 
Could the solution be feasible in trial setting? 
Unlikely in a financially restricted service. Recognised by The British 
Psychological Society (2012) that 1:20 ratio is unrealistic but argue that 0.5 per 
ward (as recommended by (Royal College of Psychiatrists, 2010) is too little.  
Could solution be effective in real world? 
Staff education recommended to promote awareness of therapeutic principles as 
staff play a key role in encouraging and enabling patient attendance (Jacobsen et 
al., 2011). 
Could solution be feasible in real world? 
Unlikely in a financially restricted service. Recognised by The British 
Psychological Society (2012) that 1:20 ratio is unrealistic but argue that 0.5 per 
ward (as recommended by (Royal College of Psychiatrists, 2010) is too little.  
 
Assessment of options and tolerance of trade-off between explanatory and 
pragmatic trial 
Patients expressing an interest in the intervention when asked if they want to receive it 
should be added to eligibility criteria. This option will reduce the proportion of non-
engaging participants recruited to the trial and will mimic routine practice, if the 
intervention is implemented. Such data can also be used to identify characteristics of those 
who do and do not want to receive psychological intervention during their acute 
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admission. In addition, increasing psychological resource should be effective in 
improving patient engagement for both the trial and the real world. Increased 
psychological resource will allow increased staff training. Increased staff training is 
recommended in psychiatric inpatient services to promote awareness of therapeutic 
principles as staff play a key role in encouraging and enabling participant attendance 
(Jacobsen et al., 2011), however financial restrictions may be a barrier.  
 
----------------------------------------------------------------------------------------------------------
--------------- 
Problem A1 
Type A: Problem with excluding eligible patients and initially including non-eligible 
patients.  
 
Evidence 
- 26% excluded if ward staff anticipated admission should be short.  
- 15% patients excluded after consenting and completing baseline measures.  
The above issues may influence a trial. 
 
Solutions 
Change aspects of: 
a) Intervention 
1. Provide therapy on an outpatient basis.  
b) Trial design 
1. Introduce two consent points. 1 to obtain initial consent and complete baseline 
measures. 2 to obtain consent to officially enter the trial 2 days after initial 
consent. 
c) Clinical context 
None 
Assessment of Solutions 
A1 Provide therapy on an outpatient basis  
Could the solution be effective in trial setting? 
Yes, short admissions would be less of a concern if patients could continue 
therapy after discharge.  
Could the solution be feasible in trial setting? 
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The time of the end-point or post-intervention data collection point would need 
consideration for the control group. Logistics of doing so also needs 
consideration, e.g. whether resources are available to extend therapy to 
outpatients.  
Could solution be effective in real world? 
Yes, patients who have short admissions would still be eligible for therapy.  
Could solution be feasible in real world? 
The time of the end-point or post-intervention data collection point would need 
consideration for the control group. Logistics of doing so also needs 
consideration, e.g. whether resources are available to extend therapy to 
outpatients.  
 
B1 Introduce two consent points. 1 to obtain initial consent and complete baseline 
measures. 2 to obtain consent to officially enter the trial 2 days after initial consent. 
Could the solution be effective in trial setting? 
Yes, likely to reduce the number of eligible patients who are not recruited. Data 
obtained at first consent point and if patient is still admitted at second consent 
point and give consent they officially enter the trial. If patient is being discharged 
on the day of the second consent point then post-intervention outcomes should be 
collected. If the patient has been discharged by the second consent point they do 
not enter the trial.  
Could the solution be feasible in trial setting? 
Yes, if ethical approval obtained and trial has resource to introduce an extra 
meeting with participants. Recruitment is labour intensive.  
Could solution be effective in real world? 
N/A 
Could solution be feasible in real world? 
N/A 
 
Assessment of options and tolerance of trade-off between explanatory and 
pragmatic trial 
Introducing two consent points would be effective in reducing the number of eligible 
patients that are excluded and ineligible patients that are included. Additional consent 
will need ethical approval and will require more time from research assistants. 
Alternatively, therapy could continue to be received if patients were discharged quickly. 
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However, given the limited resource already allocated to such services, therefore whether 
resources are available to extend therapy to outpatients needs careful consideration.  
----------------------------------------------------------------------------------------------------------
--------------- 
Problem A2 
Type A: Poor completion of follow-up questionnaires.  
 
Evidence 
- 52-53% of follow-up questionnaires completed.  
- 20% of participants with missing follow-up questionnaires could not be 
contacted.   
- 64% of trauma questionnaires completed.  
The above issues may influence a trial. 
 
Solutions 
Change aspects of: 
a) Intervention 
None 
b) Trial design 
1. At point of discharge, collect all contact details, alternative contact number 
and arrange appointment with participants. 
2. Increase contact with participant between discharge and follow-up, i.e. 
reminder letter/phone call. 
3. Offer incentive.  
4. Primary outcome should not rely on contacting participants at follow-up.  
5. Create profile for individuals unlikely to complete follow-up assessments 
and develop more stringent eligibility criteria on that basis.  
c) Clinical context 
None 
 
Assessment of solutions 
B1: At point of discharge, collect all contact details and arrange appointment with 
participants. 
Could the solution be effective in trial setting? 
Yes, all current details are available to researcher therefore contacts lacking in medical 
files are no longer a problem. 
Could the solution be feasible in trial setting? 
Yes, can be stipulated in trial protocol. If patients can be met at post intervention this 
solution will be feasible. Completion of post-intervention assessments was good in this 
trial.  
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Could solution be effective in real world? 
N/A 
Could solution be feasible in real world? 
N/A 
 
B2: Increase contact with participant between discharge and follow-up, i.e. reminder 
letter/phone call. 
Could the solution be effective in trial setting? 
Technique used in other trials including acute inpatients (Jacobsen et al., 2016). Some 
evidence that increased phone calls improves completion in difficult to reach population 
(Kleschinsky, Bosworth, Nelson, Walsh, & Shaffer, 2009) 
Could the solution be feasible in trial setting? 
Will require support from a research assistant per site.  
Could solution be effective in real world? 
N/A does not affect real world. Patient will not be contacted at follow-up in real world.  
Could solution be feasible in real world? 
N/A does not affect real world. Patient will not be contacted at follow-up in real world.  
 
B3: Offer incentive.  
Could the solution be effective in trial setting? 
Some evidence to suggest monetary incentive improve completion of questionnaires 
(Brueton et al., 2014). 
Could the solution be feasible in trial setting? 
Payment offered to take part in research rather than receive clinical treatment is in line 
with guidance (Royal College of Physicians, 2007) but must have ethical approval.  
Could solution be effective in real world? 
Patient will not be contacted at follow-up in real world.  
Could solution be feasible in real world? 
Patient will not be contacted at follow-up in real world.  
 
B4: Primary outcome should not rely on contacting participants at follow-up. 
Could the solution be effective in trial setting? 
Good completion of outcomes collected via electronic database in this trial.  
Could the solution be feasible in trial setting? 
Easy and efficient method of data collection.  
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Could solution be effective in real world? 
Patient will not be contacted at follow-up in real world.  
Could solution be feasible in real world? 
Patient will not be contacted at follow-up in real world. 
 
B5: Exclude patients on basis of meeting profile of participants likely to be lost to follow-
up.  
Could the solution be effective in trial setting? 
Likely to reduce missing data at follow-up (Sandra. Eldridge & Kerry, 2012). 
Could the solution be feasible in trial setting? 
Work to be done before trial to identify characteristics of those likely to be lost to follow-
up.  
Could solution be effective in real world? 
Will compromise external validity in a main trial. No follow-up in real world, therefore 
may exclude participants that may benefit from intervention. 
Could solution be feasible in real world? 
Results may not apply to those likely to be missing follow-up data.  
 
Assessment of options and tolerance of trade-off between explanatory and 
pragmatic trial 
This is a pragmatic trial, therefore while excluding patients based on whether they are 
unlikely to provide follow-up data may reduce risk of bias associated with large 
proportions of missing data, it is not an option as trial results may not apply to a proportion 
of patients who may well benefit from the intervention (Eldridge & Kerry, 2012).  
 
Participants already met at discharge for assessment, therefore collecting additional 
information (i.e. best contact details) will fit with current protocol. Increased contact 
between discharge and follow-up will be useful and is a technique used in other trials 
including acute psychiatric inpatients (Jacobsen et al., 2016) and there is some evidence 
that increasing contact with patients improves outcome completion of difficult to reach 
participants (Kleschinsky et al., 2009). However, this solution will require research 
assistant report and may be time consuming. As incentives are commonly used and are 
effective in healthcare trials (Brueton et al., 2014; Royal College of Physicians, 2007) 
this also seems a helpful solution.  
 
